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Abstract 
New methodologies for the collection and analysis of biological samples from psychological, 
physical and emotional stress are described. Currently, there is little research relating to the 
elemental, VOC and small molecule changes in biological samples as a consequence of stress 
on the human body, with much of the current research indicating physical symptoms.  
This research sought to measure chemical changes in three different categories of stress. 
The first uses an existing PASAT intervention to induce psychological stress and a further two 
new methodologies using exercise to induce physical stress and a trapped human in a 
simulation of a collapsed building to induce emotion stress. Psychological, physical and 
emotional stress elemental profiles are compared against their respective chemical baseline 
profiles. Skin samples are collected from the foreheads of participants who endured 
emotional stress while drool saliva, urine, plasma and forehead skin samples were obtained 
from physically stressed participants. Furthermore, drool saliva is also obtained from the 
individual who experienced emotional stress. Multi elemental analysis of biological samples 
is performed using sector field inductively coupled plasma mass spectrometry (ICP-MS). 
Elemental data acquired from ICP-MS enabled the construction of individual biological data 
sets for examination by multivariate analysis to define potential biomarkers of stress. 
Three sets of saliva data obtained from the cohort of physically stressed participants are 
analysed using ICP-MS, thermal desorption gas chromatography mass spectrometry and 
ultra-performance liquid chromatography ion mobility mass spectrometry producing 
elemental, VOC and small molecule data, respectively. Stress biomarkers in saliva are 
discovered using multivariate analysis. 
A skin sampling device is designed, constructed and tested on cohorts of healthy 
participants. The analysis of skin samples using ICP-MS and electrospray ionisation mass 
spectrometry exhibits successful extraction of elements, VOCs, semi-VOCs and small 
molecules from localised regions of the human body. Sixty of ninety six candidate skin 
biomarkers are identified using nano electrospray ionisation mass spectrometry. 
  
Acknowledgements 
This research was funded by a Loughborough University Development Fund PhD 
studentship that was awarded to the Research School of Health and Life Sciences. 
I would like to acknowledge my supervisors Dr Helen Reid and Prof Paul Thomas for all 
their support and guidance. I am very grateful to have been presented this research 
opportunity and be a part of their research groups. This great research opportunity 
would not have existed had it not been for Helen securing the project.  
There were many people who collaborated on the projects presented in this thesis, but a 
special mention to Matthew Turner, Helen Martin and Aditya Malkar for their dedication 
into making us into a team who would always help each other. Acknowledgments must 
also be mentioned to Dr Corrinne Burns and Dr James Reynolds for their huge 
contributions on the skin sampling device.  To Dr Phillip Watson for blood sampling and 
Prof Ronald Maughan for allowing the team to use the facilities in the SSEHS during the 
physical stress study, Dr Stephan Bandelow and Dr Louisa Edwards for presenting the 
PASAT for the psychological stress study, to Dr Svetlana Riazanskaia for the opportunity 
to work on the skin sampling device and Peter Carroll for engineering it. To Prof Barry 
Sharp for allowing me to work in his laboratory and Prof Colin Creaser for his guidance. 
My gratitude goes out to all my colleagues working at the Centre for Analytical Sciences 
at Loughborough University’s Department of Chemistry especially to Dr David Douglas 
for his everlasting patience with my constant questioning regarding the ICP-MS. But also 
to Dr Aref Zayed, Dr Cris Guallar-Hoyes, Dr Dhinesh Asogan and Sarah Taylor. A mention 
must also go to Thermo Scientific engineer David Hinds, for his patience and advice in 
maintaining the ICP. 
The most important thank you goes to Sarah-Jane Dudney. Her love and support has 
given me the life I needed away from work. “Jane” ensured I found time to relax away 
from work and we have been on some truly great holidays that some people can only 
dream of. Moving on with the next chapter of our lives is something we’ve longed for 
and now it’s finally happening. I hope we create many more memories along the way. 
Completing this research could not have been possible without my family. My amazing 
mother, Pragna, for her unconditional love and support away from my research. My 
brother Atish always giving me that reality check, one which he always seemed to think I 
needed. It’s a shame you’re now living in Perth. Of the many good things to come out of 
the few years studying for my PhD this is one of the most important to me: I’ve grown a 
lot closer to my sister Maya-Krupa. And the rest of my family; Nayan, Peter, Mary, Rob, 
Owen, James, Helen, Amit and Sarah L.  
Hard work, determination and graft. It’s because of all the people I’ve come across in my 
life I find myself in the position I am today. My final gratitude must go to the influences 
of my close friends from my time at Sheffield University, without them there is 
absolutely no way I would be writing this thesis: Dr Andrew Morse, Dr Mark Moxey, 
Sean Staunton, Masim Sayed, Tom Nixon and Dr James Newby. 
 
 I 
Table of Contents 
List of Table ................................................................................................................................ V 
Table of Figures ....................................................................................................................... VIII 
Keywords................................................................................................................................. XIII 
Glossary of Terms ................................................................................................................... XIV 
1 Introduction: The potential to diagnose human vitality and wellbeing from biological 
fluids ........................................................................................................................................... 1 
1.1 Research Objective .................................................................................................... 1 
1.2 Stress .......................................................................................................................... 2 
1.3 Inductively Coupled Plasma-Mass Spectrometry ...................................................... 6 
1.3.1 Sample introduction .................................................................................... 9 
1.3.2 The Plasma ................................................................................................ 10 
1.3.3 The interface region .................................................................................. 11 
1.3.4 The mass analyser and detector ............................................................... 12 
1.3.5 Analysis ..................................................................................................... 14 
1.3.6 Data processing ......................................................................................... 18 
1.4 Electrospray Ionisation Mass Spectrometry ............................................................ 19 
1.4.1 Analysis ..................................................................................................... 21 
1.4.2 Data Processing......................................................................................... 23 
1.5 Nano-Electrospray Ionisation Mass Spectrometry .................................................. 26 
1.5.1 Analysis ..................................................................................................... 29 
1.6 Statistical Methods .................................................................................................. 29 
1.6.1 Multivariate Analysis ................................................................................ 29 
1.6.2 Descriptive Statistics ................................................................................. 32 
1.7 Ethics ........................................................................................................................ 33 
1.7.1 Recruitment of participants ...................................................................... 33 
1.8 Chemicals ................................................................................................................. 34 
1.9 Conclusion ................................................................................................................ 36 
2 A study into the effect of psychological stress on the elemental content of human 
forehead sweat as measured by ICP-MS ................................................................................. 37 
2.1 Experiment Outline .................................................................................................. 38 
2.1.1 Physiological Measurements .................................................................... 38 
2.1.2 Cognitive Function Test Battery ................................................................ 38 
2.1.3 Inducing Psychological Stress: The PASAT ................................................ 39 
2.1.4 Skin Patch Sampling Area ......................................................................... 42 
 II 
2.1.5 Skin patch sampling .................................................................................. 43 
2.1.6 Sample Analysis ......................................................................................... 43 
2.2 Results and Discussion ............................................................................................. 43 
2.2.1 Cardiovascular response ........................................................................... 43 
2.2.2 Galvanic Skin Response ............................................................................. 46 
2.2.3 Elemental profiling of skin by ICP-MS ....................................................... 49 
2.2.4 Multivariate Analysis ................................................................................ 53 
2.3 Conclusion ................................................................................................................ 55 
3 The effect of physical stress on elemental content in human plasma, skin and urine and 
the effect on elements, volatile organic compounds and small molecules in human saliva .. 56 
3.1 Removing elemental impurities from skin patches to be used for skin sampling 
during physical stress ........................................................................................................... 57 
3.1.1 Experimental Outline ................................................................................ 57 
3.1.2 Results and Discussion .............................................................................. 59 
3.1.3 Conclusion ................................................................................................. 61 
3.2 Analysis of biological fluids from physical stress ..................................................... 63 
3.2.1 Experimental Outline ................................................................................ 63 
3.3 Results and Discussion ............................................................................................. 71 
3.3.1 Physiological measurements ..................................................................... 71 
3.3.2 Skin Patches .............................................................................................. 74 
3.3.3 Saliva ......................................................................................................... 78 
3.3.4 Urine .......................................................................................................... 82 
3.3.5 Plasma ....................................................................................................... 84 
3.3.6 Identifying major elemental contributors from multivariate analysis using 
global elemental data from physical stress .............................................................. 87 
3.3.7 Conclusion for the elemental analysis of skin, saliva, urine and plasma 
obtained from physical stress ................................................................................... 89 
3.3.8 Identifying major biomarkers of physical stress from multivariate analysis 
using global elemental, VOCs and small molecules data .......................................... 90 
3.4 Conclusion ................................................................................................................ 93 
4 A study into the effect of emotion stress on the elemental content of saliva as 
measured by ICP-MS ................................................................................................................ 95 
4.1 Experimental Outline ............................................................................................... 95 
4.1.1 Collection Tubes Preparation .................................................................... 97 
4.1.2 Storage Tubes Preparation ....................................................................... 97 
 III 
4.1.3 Saliva Collection ........................................................................................ 97 
4.1.4 Sample Analysis ......................................................................................... 97 
4.2 Results and Discussion ............................................................................................. 98 
4.2.1 Elemental Profiles ..................................................................................... 98 
4.2.2 Descriptive Statistics ................................................................................. 98 
4.3 Conclusion .............................................................................................................. 102 
5 The Liquid Skin Pen ........................................................................................................ 103 
5.1 Design and construction of the Liquid Skin Pen .................................................... 103 
5.2 Target Sample Sites ................................................................................................ 104 
5.3 Sample Collection using the Liquid Skin Pen ......................................................... 105 
5.3.1 Vial Preparation ...................................................................................... 107 
5.3.2 LSP Pre Sample Collection Pen Cleaning ................................................. 107 
5.3.3 LSP Pen Blank Sample Collection ............................................................. 108 
5.3.4 Inter Participant Cleaning of the LSP ...................................................... 108 
5.4 An experiment to determine the efficiency of elemental extraction using the LSP 
  ............................................................................................................................... 110 
5.4.1 Experimental Outline .............................................................................. 110 
5.4.2 Results and Discussion ............................................................................ 111 
5.5 An experiment to determine the most efficient solvent for metal extraction using 
the LSP ............................................................................................................................... 114 
5.5.1 Experimental Outline .............................................................................. 115 
5.5.2 Results and Discussion ............................................................................ 116 
5.6 Non-invasive fast skin profiling for elements from the volar and plantar ............. 122 
5.6.1 Experimental Outline .............................................................................. 122 
5.6.2 Results and Discussion ............................................................................ 123 
5.7 Non-invasive fast skin profiling for elements from the axilla, dorsal, plantar and 
volar  ............................................................................................................................... 125 
5.7.1 Experiment Outline ................................................................................. 126 
5.7.2 Results and Discussion ............................................................................ 130 
5.8 Non-invasive fast profiling of the dorsal and plantar for semi-volatile organic 
compounds and non-volatile organic compounds ............................................................ 131 
5.8.1 Experiment Outline ................................................................................. 132 
5.8.2 Results and Discussion ............................................................................ 136 
5.9 Conclusion .............................................................................................................. 150 
6 Conclusions .................................................................................................................... 152 
 IV 
7 References ..................................................................................................................... 157 
8 Appendices ..................................................................................................................... 160 
Appendix I .......................................................................................................................... 160 
Appendix II ......................................................................................................................... 162 
Appendix III ........................................................................................................................ 168 
Appendix IV ........................................................................................................................ 171 
Appendix V Documentation for studies involving human volunteers ............................... 188 
Study Participant Information Sheets ..................................................................... 188 
PASAT Instruction .................................................................................................... 203 
Health Screen Questionnaire for study volunteers ................................................. 205 
Appendix VI Patent ............................................................................................................ 207 
Appendix VII Publications .................................................................................................. 209 
  
 V 
List of Table 
Table 1.1. Summary of elemental analysis techniques ...........................................................................8 
Table 1.2. Typical conditions for SF-ICP-MS ..........................................................................................13 
Table 1.3. ESI-MS experimental parameters for the profiling of the dorsal (TF) and plantar (BF) ........21 
Table 1.4. nESI-MS experimental parameters for the profiling of the dorsal (TF) and plantar (BF),  
from the study in Chapter 5 section 5.8 .......................................................................................29 
Table 1.5. Number of participants and age ranges for studies involving human volunteers ................34 
Table 2.1. Cardiovascular response scores of participants during the neutral (PSRN) and stress 
intervention (PSRS). HR
start
: Baseline heart rate recorded at start (BPM); HR
max
: maximum 
heart-rate (BPM); PS
start
: baseline systolic blood pressure recorded at start (mmHg); PS
max
: 
maximum systolic blood pressure (mmHg) and PSR: Stress response score, see Figure 2.4. ......48 
Table 2.2. Mean concentration (ng.mL
-1
) and relative change (RC(%)) between pre and post skin 
patches for the stress and neutral interventions. In brackets, relative standard deviation 
(%RSD) for each sample set (for blank n = 6, samples n = 12) ......................................................48 
Table 2.3. Two-way ANOVA (with replication) for elemental sweat samples obtained before and 
after each intervention .................................................................................................................50 
Table 3.1. Concentrations (ng.mL
-1
) of elements in patches from washes by SF-ICP-MS, instrument 
standard deviation (n=5) shown in brackets. Relative change (%) also shown ............................62 
Table 3.2. Physical stress response scores of participants during the exercise phase (SRPHY) ..............73 
Table 3.3. Concentration (ng.mL
-1
), change (%) and paired t-test (P) results of 10 detected 
elements found from participant skin patches for each phase. Bold values indicate statistical 
significance at 95% .......................................................................................................................77 
Table 3.4. Concentration (ng.mL-1), change (%) and paired t-test (P) results of 8 detected 
elements found from participant drool saliva collected from three phases. Bold values 
indicate statistical significance at 95% .........................................................................................81 
Table 3.5. Concentration (ng.mL
-1
), change (%) and paired t-test (P) results of 8 detected 
elements found from participant urine collected from three phases. Bold values indicate 
statistical significance at 95% .......................................................................................................84 
Table 3.6. Concentration (ng.mL-1), change (%) and paired t-test (P) results of 7 detected 
elements found from participant plasma collected from three phases. Bold values indicate 
statistical significance at 95% .......................................................................................................87 
Table 4.1. Average concentration (ng.mL
-1
) and relative standard deviation for the nine 
statistically significant (95%) elements including relative change, F- and T-test (probability) 
score .............................................................................................................................................98 
Table 5.1. LSP material ....................................................................................................................... 104 
Table 5.2. Sites samples and delivery solvent used with the LSP ....................................................... 104 
Table 5.3. Concentration of samples (µ), blank subtracted samples (µ (BS)), relative standard 
deviation (RSD) and recovery of Mn in samples obtained using the LSP. n = 3 ........................ 111 
Table 5.4. Calculated theoretical (CTHEORETICAL) and experimental concentrations (CEXPERIMENTAL) 
(ng.mL
-1
 Mn) and recovery (%) of Mn obtained from the three sample solutions collected 
using the LSP .............................................................................................................................. 118 
Table 5.5. Intensity (counts per second), mean (µ), standard deviation (σ) and relative standard 
deviation (%) of Mn signal from the three sample solutions collected using the LSP. 
Probability score for test of variance (F) and difference sample means of the previous 
sample collected (T) are also given where values P < 0.05 show evidence of statistically 
significant differences in the mean ........................................................................................... 119 
Table 5.6. Mean elemental concentrations (ng.mL
-1
) and (in brackets) standard deviations (n=10) 
for the elemental profiling of the volar (AE) and plantar (BF) using the LSP. Probability 
 VI 
scores of paired t-test (T (P)) to test significant differences between skin sites (n = 10) also 
shown ........................................................................................................................................ 124 
Table 5.7. Element concentrations (µg/L) and standard deviations (n = 5)  from female (F) and 
male (M) skin sites sampled using the LSP. Probability (P) of t-test testing significance 
between genders for each sample site where values of P < 0.05 shows evidence of 
significant difference (at 95%) ................................................................................................... 129 
Table 5.8. Element concentrations (µg/L) and standard deviations (n = 5)  from right (R) and left 
(L) skin sites sampled using the LSP. Probability (P) of t-test testing significance between 
sample side for each sample site where values of P < 0.05 shows evidence of significant 
difference (at 95%) .................................................................................................................... 129 
Table 5.9. Mean element concentrations (ng.mL
-1
) and (in brackets) standard deviations (n=10) 
for the elemental profiling of the axilla (AP), dorsal (TF), plantar (BF) and volar (AE) using the 
LSP ............................................................................................................................................. 130 
Table 5.10. Probability scores of paired t-test to test significant differences between skin sites (n 
= 10) sampled using the LSP ...................................................................................................... 131 
Table 5.11. Mean (µ), standard deviation (σ) and the difference for 34 ion intensities, of dorsal 
(TF) and plantar (BF) samples, obtained by ESI-MS n negative ion mode. Results of paired t-
test (Pcalc) and whether the H0 was accepted () or rejected () are shown. Participant 2 
excluded from data set. Also shown are accurate ion mass, empirical formula, relative 
double bond equivalents (RDB), and mass error (δppm) obtained by nESI-MS in negative ion 
mode from four participant samples. Ions ordered by intensity difference between plantar 
(BF) and dorsal (TF) samples ...................................................................................................... 140 
Table 5.12. Mean (µ), standard deviation (σ) and the difference for 61 ion intensities, of dorsal 
(TF) and plantar (BF) samples, obtained by ESI-MS n positive ion mode. Results of paired t-
test (Pcalc) and whether H0 was accepted () or rejected () are shown. Participant 2 
excluded from data set. Also shown are accurate ion mass, empirical formula, relative 
double bond equivalents (RDB), and mass error (δppm) obtained by nESI-MS in positive ion 
mode from four participant samples. Ions ordered by intensity difference between plantar 
(BF) and dorsal (TF) samples ...................................................................................................... 147 
Table 8.1. Calibration data for the eleven detected elements obtained from forehead skin 
patches by ICP-MS during the psychological stress study ......................................................... 160 
Table 8.2. ANOVA single factor for i) the stress session between male (MS) and female (FS) 
participants, ii) the neutral session between male (MN) and female (FN) participants and iii) 
between the stress (TS) and neutral (TN) session for all participants ....................................... 161 
Table 8.3. Sample information summary for biological samples (with their intended instrument of 
analysis) and heart rate (HR) readings collected from physical stress study ............................ 162 
Table 8.4. ANOVA (two way with replicates) for ten elemental skin patch concentrations (ng.mL
-1
) 
obtained by ICP-MS from ten participants who participated in the physical stress study ........ 163 
Table 8.5. ANOVA (two way with replicates) for eight elemental drool saliva concentrations 
(ng.mL
-1
) obtained by ICP-MS from ten participants who participated in the physical stress 
study .......................................................................................................................................... 164 
Table 8.6. ANOVA (two way with replicates) for eight elemental urine concentrations (ng.mL
-1
) 
obtained by ICP-MS from ten participants who participated in the physical stress study ........ 165 
Table 8.7. ANOVA (two way with replicates) for seven elemental plasma (venous blood) 
concentrations (ng.mL
-1
) obtained by ICP-MS from ten participants who participated in the 
physical stress study .................................................................................................................. 166 
Table 8.8. Heart rate t-test scores (P). Values in bold are those where H0 was rejected (P < 0.05) 
indicating statistically significant differences between the indicating phases .......................... 167 
Table 8.9. Calibration data for the nine statistically significant elements ......................................... 168 
 VII 
Table 8.10. Analysis of variance (ANOVA) data for pre and post intervention saliva ........................ 169 
Table 8.11. Descriptive statistics for all analysed elements showing Fcalc and Tcalc (P) scores............ 170 
Table 8.12. ANOVA: Two-factor with replication (n = 10) of the elements detected from the 
elemental profiling of the volar (AE) and plantar (BF) using the LSP......................................... 173 
Table 8.13. Single factor ANOVA between different solvent used for the comparison of solvents 
experiment using the LSP .......................................................................................................... 174 
Table 8.14. ANOVA: Two-factor with replication (n = 10) of the elements detected from the four 
skin sites sampled using the LSP ................................................................................................ 175 
Table 8.15. ANOVA (two way with replicates) results for ions obtained from ESI-MS in negative 
ion mode for the profiling of the doral and plantar (BF) ........................................................... 176 
Table 8.16. ESI-MS negative ion mode results for t test between gender plantar (BF) samples for 
the profiling of the doral and plantar (BF). M BF = male plantar, F BF = female plantar. 
Samples ordered by largest to smallest difference between genders ...................................... 178 
Table 8.17. ESI-MS negative ion mode results for t test between gender dorsal (TF) samples for 
the profiling of the doral (TF) and plantar (BF). M TF = male dorsal, F TF = female dorsal 
Samples ordered by largest to smallest difference between gender ........................................ 180 
Table 8.18. ANOVA (two way with replicates) results for ions obtained from ESI-MS in positive ion 
mode for the profiling of the doral and plantar (BF) ................................................................. 182 
Table 8.19. ESI-MS positive ion mode results for t test between gender plantar (BF) samples for 
the profiling of the doral and plantar (BF). M BF = male plantar, F BF = female plantar. 
Samples ordered by largest to smallest difference between genders ...................................... 184 
Table 8.20. ESI-MS positive ion mode results for t test between gender dorsal (TF) samples for the 
profiling of the doral and plantar (BF). M TF = male dorsal, F TF = female dorsal. Samples 
ordered by largest to smallest difference between genders .................................................... 186 
  
 VIII 
Table of Figures 
Figure 1.1. Schematic diagram of a SF-ICP-MS system in a reverse Nier-Johnson geometry .................9 
Figure 1.2. Schematic diagram of an ICP torch......................................................................................10 
Figure 1.3. Schematic diagram of the interface region .........................................................................12 
Figure 1.4. An example of saliva profiles from emotional stress, from the study in Chapter 4, 
showing intensity of elemental masses from 0-210 Da for (A) Post intervention B sample (B) 
Pre intervention B sample and (C) Blank B sample. Inserts show magnified range with 
second highest intensity as max ...................................................................................................17 
Figure 1.5. (A) An example of a calibration graph using intensity acquired (cps) against standards 
with known concentration (ng.mL
-1
). (B) An example of the average calculated 
concentration of pre and post samples, with standard error of the mean (95% confidence), 
in pre and post intervention saliva collected, from the emotional stress study in Chapter 4. 
This data refers to the element Mn. .............................................................................................18 
Figure 1.6. Formation of electric double layer in liquid produced as a result of the penetration of 
the imposed electric field into liquid
68
 .........................................................................................19 
Figure 1.7. Formation of electrospray droplets resulting from increasing electric fields
71
 ...................20 
Figure 1.8. An example of the total ion current (TIC) obtained from ESI-MS negative ion mode for 
participant UF3, from the study in Chapter 5 section 5.8, plantar (BF) sample range 0.0-2.0 
mins and range selected 0.2-1.2 mins ..........................................................................................22 
Figure 1.9. An example of a negative ion mode mass spectra, m/z 0-4000, of VOC in skin profiles 
obtained from the plantar (BF) site of participant UF3, from the study in Chapter 5 section 
5.8, using the LSP. (A) Profile (B) 100 x magnified profile, all inserts m/z 50-200 ........................23 
Figure 1.10. An example of spectra for participant UF3, from the study in Chapter 5 section 5.8, 
m/z 50-200: A = Plantar (BF), B = Plantar (BF) blank, C = Dorsal (TF), D = Dorsal (TF) blank, E = 
Blank. Intensity normalised to 1 from 25990 counts....................................................................24 
Figure 1.11. An example of mass spectra m/z 130-135 from participant UF3, from the study in 
Chapter 5 section 5.8, (A) Plantar (BF) sample offset by 400 cps (B) Dorsal (TF) sample offset 
by 200 cps (C) Blank sample .........................................................................................................25 
Figure 1.12. An example of overlaid extracted ion chromatograms showing responses for plantar 
(BF) (solid line), dorsal (TF) (dashed line) and blank (dotted line) sample sites in ESI-MS 
negative ion mode: (A) m/z 93.0346 (B) m/z 104.0354 (C) m/z 128.0354 and ESI-MS positive 
ion mode: (D) m/z 70.0783 (E) m/z 137.0760 (F) m/z 150.0297 from participant UF3 (Male), 
from the study in Chapter 5 section 5.8. The intensities displayed (I R) have been normalised 
with respect to the plantar (BF) sample site peaks ......................................................................26 
Figure 1.13. The electrostatic trap ('orbitrap') according to the description of Makarov.
74
 An outer 
electrode has the shape of a barrel cut into two parts separated by a small gap. Inside is a 
second spindle shaped electrode. Only DC voltages are applied. Ions turn around the central 
electrode while oscillating back and forth along the z axis resulting in a movement of 
intricate spirals.
69
 ..........................................................................................................................27 
Figure 1.14. A complete stack (includes atmospheric pressure source, analytical quadrupole, a 
storage linear trap and a quadrupole itself) of the orbitrap coupled to an electrospray 
source at (A) atmospheric pressure z spray (2 mbar). C: Guide ion (RF quadrupole, 10
-2
 
mbar). D: Lens. E: transport RF quadrupole (10
-5
 mbar). G and G’: segmented trapping 
quadrupole to store ions to inject (10
-5
 mbar). F and H: lenses. I: Ion beam deflection device 
prior to injection into orbitrap. J: Repeller electrode assists ions enter the trap and spiral 
down the field to orbit around the spindle shaped electrode. K: Side view cut of the orbitrap 
cut at the level of the gap between two half barrel electrodes.
69
 ...............................................27 
Figure 1.15. Schematic of Thermo Electron Corporations Orbitrap. A: Atmospheric pressure 
source. B: Heated capillary. C: Several multipole focussing devices. D: Gating lenses. E: 
 IX 
Focussing  octapole. E: Ion trap with two detectors. F: Focussing multipole. G: ‘C-trap’ 
quadrupole.
69
 ................................................................................................................................28 
Figure 1.16. Multivariate analysis matrix template. Each row represents a sample (observation) 
and each column represents the corresponding variables (e.g. Element) ...................................30 
Figure 1.17. An example of a supervised model (PLS-DA) Simca-P+ S-plot (PLS-DA) obtained from 
20 samples (observations) analysed by ESI-MS in negative ion mode, from the study in 
Chapter 5 section 5.8, R2X = 96.8%, Q2X = 89% ...........................................................................32 
Figure 2.1. Experiment outline for elemental sweat collection and analysis obtained by 
psychological stress ......................................................................................................................41 
Figure 2.2. Skin patch. A: 3M
TM
 Tegaderm
TM
 +pad film dressing with non-adherent pad. B: Skin 
samples were collected by sticking the patch to the middle of the participant’s forehead ........42 
Figure 2.3. Psychological stress sample collection timeline ..................................................................44 
Figure 2.4. Mean responses of 22 participants for systolic blood pressure (PS, top), and heart rate 
(HR, bottom) over the 70 min stress (solid line) and neutral (dashed line) sessions. The error 
bars designate the 95% confidence limit of the mean. MS = male stress, MN = male neutral, 
FS = female stress, FN = female neutral, TS = total stress, TN = total neutral ..............................47 
Figure 2.5. Galvanic skin response (GSR) of participant 12 during the stress (solid line) and neutral 
(dashed line) sessions where (A) indicated the start of the pre intervention cognitive battery 
and (B) indicates the start of the post intervention cognitive battery .........................................49 
Figure 2.6. Concentration of detected elements from sweat patches: blank (grey), pre stress 
intervention (pink), post stress intervention (red), pre neutral intervention (white) and post 
neutral intervention (green). Insert: relative change (%) in concentration between pre and 
post stress intervention (red) and pre and post neutral intervention (white) patches ...............52 
Figure 2.7. Multivariate analysis (MVA) using blank (black), pre neutral intervention (blue circles), 
post neutral session (blue dots), pre stress session (orange circles) and post stress session 
(orange dots) sweat patch samples. Unsupervised PCA of three elements (A) identified from 
the S-plot generated from the modelled covariance (P(corr)[1]) of the PLS-DA from the 
concentrations (ng.mL
-1
) of 10 skin components (variables) from 98 skin patch samples 
(observations). The three variables highlighted (red squares) were found to provide the 
highest magnitude (concentration) of the variables in the data set and greatest reliability 
(P(corr)[1] axis) of the variables in the data set (B). .....................................................................53 
Figure 3.1. Experiment outline for skin patch blanking .........................................................................60 
Figure 3.2. Concentration of the nine detected elements, by ICP-MS, in skin patches following 
each patch wash ...........................................................................................................................61 
Figure 3.3. Study outline for sample collection and analysis by ICP-MS in physical stress study .........66 
Figure 3.4. Physical stress sample collection timeline ..........................................................................67 
Figure 3.5. Mean relative change for heart rate responses (∆HR) of 10 male participants over the 
120 minute session. The error bars designate 95% confidence limit on the mean .....................72 
Figure 3.6. The correlation between physical stress response score (SRPHY) and rating of perceived 
exertion (RPE). Black dots show average of two data points. ......................................................74 
Figure 3.7. Top: PCA scatter plot of five stress sensitive skin components identified from PLS-DA s-
plot on 10 observations each from the baseline (black dots), physical stress (red dots), 
recovery phase 1 (green dots) and recovery phase 2 (blue dots) measurements from ten 
male participants. 100% sensitivity was obtained for stress phase observations and 100% 
selectivity was obtained for baseline measurements. These were calculated using the 
dotted line running through the ellipse obtained from the score plot dendrogram Bottom: S-
plot generated from the modelled covariance (P(corr)[1]) and modelled correlation (p[1]) of 
the PLS-DA from the concentration of 10 skin sensitive elements  (variables) from  40 skin 
samples (observations). The five variables highlighted (red square) were found to provide 
 X 
the highest magnitude (concentration) of variables in the data set and greatest reliability 
(P(corr)[1]axis) of the variables in the data set, indicating potential elements sensitive to 
exercise .........................................................................................................................................76 
Figure 3.8. Scatter plot showing the average concentration (n = 10) of the six elements where 
statistical significance was observed for baseline (black), physical stress (red), recovery 1 
(green) and recovery 2 (blue) participant skin patch samples .....................................................78 
Figure 3.9. Top: PCA scatter plot of five stress sensitive saliva components identified from PLS-DA 
s-plot on 7 observations each from the baseline (black dots), recovery phase 1 (green dots) 
and recovery phase 2 (blue dots) measurements from seven male participants. 71.4% 
sensitivity was obtained immediately following the stress phase and 71.4% selectivity was 
obtained for baseline measurements. Bottom: S-plot generated from the modelled 
covariance (P(corr)[1]) and modelled correlation (p[1]) of the PLS-DA from the 
concentration of 8 saliva sensitive elements  (variables) from 27 saliva samples 
(observations). The five variables highlighted (red square) were found to provide the 
highest magnitude (concentration) of variables in the data set and greatest reliability 
(P(corr)[1]axis) of the variables in the data set, indicating potential elements sensitive to 
exercise .........................................................................................................................................80 
Figure 3.10. Top: PCA scatter plot of two stress sensitive urine components identified from PLS-
DA s-plot on 10 observations each from the baseline (black dots), recovery phase 1 (green 
dots) and recovery phase 2 (blue dots) measurements from ten male participants. 80% 
sensitivity was obtained immediately following the stress phase and 60% selectivity was 
obtained for baseline measurements. Bottom: S-plot generated from the modelled 
covariance (P(corr)[1]) and modelled correlation (p[1]) of the PLS-DA from the 
concentration of 8 urine sensitive elements  (variables) from 40 saliva samples 
(observations). The two variables highlighted (red square) were found to provide the 
highest magnitude (concentration) of variables in the data set and greatest reliability 
(P(corr)[1]axis) of the variables in the data set, indicating potential elements sensitive to 
exercise .........................................................................................................................................83 
Figure 3.11. Top: PCA scatter plot of three stress sensitive plasma components identified from 
PLS-DA s-plot on 7 observations each from the baseline (black dots), recovery phase 1 
(green dots) and recovery phase 2 (blue dots) measurements from seven male participants. 
Bottom: S-plot generated from the modelled covariance (P(corr)[1]) and modelled 
correlation (p[1]) of the PLS-DA from the concentration of 7 plasma sensitive elements  
(variables) from 24 saliva samples (observations). The three variables highlighted (red 
square) were found to provide the highest magnitude (concentration) of variables in the 
data set and greatest reliability (P(corr)[1]axis) of the variables in the data set, indicating 
potential elements sensitive to exercise ......................................................................................86 
Figure 3.12. Top: PCA scatter plot of eight stress sensitive components identified from PLS-DA s-
plot on 5 observations each from baseline (black dots), recovery phase 1 (green dots) and 
recovery phase 2 (blue dots) measurements from five male participants. 100% sensitivity 
was obtained immediately following the stress phase and 100% specificity was obtained for 
baseline measurements. Bottom: S-plot generated from the modelled covariance 
(P(corr)[1]) and modelled correlation (p[1]) of the PLS-DA from the concentrations of 33 
elements and biological samples (variables) from 15 participants and phases (observations). 
Eight highlighted variables (red square) were found to provide the highest magnitude of 
variables in the data set and greatest reliability (P(corr)[1]axis) of the variables in the data 
set, indicating potential sensitivity to exercise. ...........................................................................88 
Figure 3.13. Top: PCA scatter plot of eight stress sensitive components identified from PLS-DA s-
plot on 7 observations each from baseline (black dots), recovery phase 1 (green dots) and 
 XI 
recovery phase 2 (blue dots) measurements from seven male participants. 71.4% sensitivity 
was obtained immediately following the stress phase and 100% specificity was obtained for 
baseline measurements. Bottom: S-plot generated from the modelled covariance 
(P(corr)[1]) and modelled correlation (p[1]) of the PLS-DA from 30 variables (8 elemental, 14 
VOC and 8 small molecule data) from 21 participants and phases (observations). Ten 
highlighted variables (red square) were found to provide the highest magnitude of variables 
in the data set and greatest reliability (P(corr)[1]axis) of the variables in the data set, 
indicating potential saliva sensitivity to exercise. ........................................................................91 
Figure 4.1. Experimental procedure for saliva sampling .......................................................................96 
Figure 4.2. Relative changes between the pre and post intervention samples for the nine 
statistically significant elements ...................................................................................................99 
Figure 4.3. Saliva profile showing intensity of elemental masses from 0-210 Da for Blank B sample 
(white), Pre intervention B sample (dark grey)and Post intervention B sample (light grey) ..... 100 
Figure 5.1. Mn sample dried for 30 minutes on a nitrile glove .......................................................... 105 
Figure 5.2. The four sites sampled using the LSP (A) Axilla (B) Dorsal (C) Plantar (D) Volar .............. 105 
Figure 5.3. LSP parts; A. LSP body; B. Sampling base; C. Delivery vial holder; D. Delivery vial; E. 
Delivery needle; F. Delivery tube connector; G. Collection vial holder; H. Collection vial; I. 
Collection needle; J. Collection tube connector; K. Sample transport tubes; L. Peristaltic 
pump connection; M. Top block ................................................................................................ 106 
Figure 5.4. Workflow for experiments sampling with the LSP ........................................................... 109 
Figure 5.5. Experimental procedure for LSP recovery testing ............................................................ 110 
Figure 5.6. Mean concentration ([i]aq/ng.mL
-1
) of Mn (σ = 5%) from samples collected using the 
LSP. Bars = Concentrations (ng.mL
-1
) Line = Blank subtracted concentrations (ng.mL
-1
). 
Insert: Bars = Blank subtracted concentration (ng.mL
-1
), Line = Recovery ................................ 113 
Figure 5.7. Experimental procedure for sample solution testing using the LSP for solvent 
comparison ................................................................................................................................ 115 
Figure 5.8. Mn concentration (ng.mL
-1
) for the comparison of the three different sample 
solutions; 2% HNO3 (green); EDTA (pink); and DI H2O (blue). Insert: Recovery (%) of the 
three different sample solutions. B = reference sample, B1 = wash sample 1, B2 = wash 
sample 2 and B3 = wash sample 3 ............................................................................................. 121 
Figure 5.9. Mean concentrations of 10 participants for plantar (BF) (50% grey) and volar (AE) (5% 
grey) skin sites of the eight recovered elements using the LSP. The error bars designate 
standard error of the mean (95% confidence) .......................................................................... 124 
Figure 5.10. Participant information summary for the elemental profiling of the axilla (AP), dorsal 
(TF), plantar (BF) and volar (AE)................................................................................................. 126 
Figure 5.11. (A) Mean concentrations of 10 participants for plantar (BF) (50% grey), dorsal (TF) 
(35% grey), axilla (AP) (15% grey) and volar (AE) (5% grey) skin sites of the six recovered 
elements using the LSP. The error bars designate 1 standard deviation of the mean. (B) Box-
whisker plot of female volar (FV), male volar (MV) and combined volar (TV) results for S. (C) 
Box-whisker plot for the K axilla (AP) (KA), K dorsal (TF) (KD) Mg plantar (BF) (MgP) and Mg 
volar (AE) (MgV) skin sites ......................................................................................................... 128 
Figure 5.12. Unsupervised PCA of LSP skin sensitive ions identified from PLS-DA on (A) 20 
observations and (B) 18 observations, in negative ion mode. 13 ions were used to model the 
scatter plot from 35 ions identified from PLS-DA. (C) PLS-DA S-plot obtained from 20 
observations analysed by ESI-MS in negative ion, R
2
X = 96.8%, Q
2
X = 89% (D) Unsupervised 
PCA of LSP skin sensitive ions identified from PLS-DA model on 18 observations in negative 
ion mode. 3 ions (m/z 93.0346, 104.0354 and 128.0354) were used to model the scatter 
plot from 34 ions identified from PLS-DA. 100% sensitivity was obtained for the plantar (BF) 
sample site observations and 100% specificity was obtained for the dorsal (TF) sample site 
 XII 
in negative ion mode. R
2
X = 100%, Q
2
X = 100%. Dots = dorsal (TF) observations, circles = 
plantar (BF) observation. ........................................................................................................... 138 
Figure 5.13. (A) PLS-DA S-plot obtained from 20 observations analysed by ESI-MS in positive ion, 
R
2
X = 86.3%, Q
2
X = 47.7%. Unsupervised PCA of LSP skin sensitive ions identified from PLS-
DA on (B) 20 observations and (C) 18 observations, in positive ion mode. 7 ions were used 
to model the scatter plot from 61 ions identified from PLS-DA. (D) Unsupervised PCA of LSP 
skin sensitive ions identified from PLS-DA model on 18 observations in positive ion mode. 2 
ions (m/z 114.9070 and 116.0842) were used to model the scatter plot from 34 ions 
identified from PLS-DA. 90% sensitivity was obtained for the plantar (BF) sample site 
observations and 100% specificity was obtained for the dorsal (TF) sample site in negative 
ion mode. R
2
X = 100%, Q
2
X = 100%. Dots = dorsal (TF) observations, circles = plantar (BF) 
observation. ............................................................................................................................... 143 
Figure 5.14. PCA ion contribution plot from dorsal (TF) observations from Figure 5.13 (C). Top 
bars show ion contribution for UF5 Dorsal (TF) sample whereas bottom bars show 
contribution from all other dorsal (TF) observations ................................................................ 144 
Figure 8.1. Schematic of the LSP, all dimensions in mm .................................................................... 171 
Figure 8.2. Dilution mass (g) of samples collected using the LSP with 2% HNO3 prior to ICP-MS 
anlysis. n = 3 .............................................................................................................................. 172 
Figure 8.3. Schematic of the Liquid Skin Pen ...................................................................................... 195 
Figure 8.4. PASAT answer sheet ......................................................................................................... 204 
  
 XIII 
Keywords 
Stress; Data stitching; ICP-MS; ESI-MS; Biomarkers; Multivariate analysis; The Liquid Skin 
Pen; Elemental analysis;  
  
 XIV 
Glossary of Terms 
µ  Arithmetic mean of a data set 
σ  Standard deviation of a data set 
µg.mL-1  Micrograms per litre (parts per million) 
A  Number of components 
ANOVA  Analysis of variance 
Axilla  Skin sample site at the human arm pit (AP) 
BP  Blood-pressure 
C2H4O2 (aq) Acetic acid (aqueous) 
DI H2O  Deionised water 
Dorsal  Skin sample site at the top of a human foot (TF) 
DMS  Differential mobility spectrometry  
EDC  Enhanced duty cycle 
EDC  Enhanced duty cycle 
EDTA  Ethylenediaminetetraacetic acid (disodium salt) 
ESI-MS  Electrospray ionisation mass spectrometry 
ES-  Negative ion mode 
ES+  Positive ion mode 
EtOH (aq) 50% ethanol (aqueous) 
FB  Field blank 
H0  Null hypothesis 
H2O  Water 
HDMS  High definition mass spectrometry 
HNO3  Nitric acid 
HR  Heart rate 
ICP-MS  Direct injection sector field inductively coupled plasma mass spectrometry 
L.min-1  Litre per minute   
LOD  Limit of detection 
LOQ  Limit of quantification 
LSP  Liquid skin pen 
ml.min-1 Millilitre per minute 
ml  Millilitre 
MVA  Multivariate analysis 
m/z  Mass-to-charge ratio 
N  Number of observations in the model 
 XV 
nESI-MS nano-Electrospray ionisation mass spectrometry 
ng.mL-1  nanograms per litre (parts per billion) 
NH3 (aq)  Ammonia (aqueous) 
P  Probability 
PASAT  Paced auditory serial addition task 
ParN  Pareto distribution (Normalised) 
PB  Pen Blank 
PC  Principal Component 
PCA  Principal Components Analysis 
PEEK  Polyether ether ketone 
pg.mL-1  picograms per litre (parts per trillion) 
Plantar  Skin sample site at the bottom of a human foot (BF) 
PLS-DA  Projection to Latent structures Discriminant Analysis 
Q2  Cumulative overall cross validated R2X 
R2X  Cumulative x-variation modelled after A components 
rpm   Revolutions per minute 
RSD  Relative standard deviation 
SRM  Standard reference material 
SS  Sampling solvent 
Semi-VOC Semi volatile organic compounds 
TMAH  Tetramethylammonium hydroxide 
TOF  Time of flight 
VOC  Volatile organic compounds 
Volar  Skin sample site at the human anterior elbow (AE) 
W  Watt 
W.kg-1   Watts per kilograms of total body weight
 1 
1 Introduction: The potential to diagnose human vitality and 
wellbeing from biological fluids 
1.1 Research Objective 
The first aim of this research was to find detectable differences in trace element profiles, 
from biological fluids in the human body, in individuals who possess different levels of health 
and lead different lifestyles and also differences in the same individual between different 
states e.g. stressed/unstressed physically or mentally. These profiles can be collected using 
fluids such as blood, saliva, sweat and urine (both invasive and non-invasive sampling 
techniques) and any differences in the profiles can be identified using a variety of techniques 
including inductively coupled plasma mass spectrometry (ICP-MS). 
Elemental data obtained from a variety of biological fluids could be integrated into one large 
data set and examined using multivariate analysis (MVA) by constructing statistical models. 
Furthermore, elemental and molecular data obtained using a range of mass spectrometry 
techniques to analyse the same biological fluid could also be combined and examined by 
MVA with the intention of creating a holistic picture of the effects of lifestyle and stress on 
the chemistry of the human body. 
The final aim was the design and development of a non-invasive skin sampling device 
targeting several human body sites. The long term goal of this device was to enable online 
analysis of a real time stress state of a person that can be identified in the skin from various 
sites of the human body. 
Details of the chemicals used for all the experiments and studies performed in this work can 
be found in this chapter along with the information regarding ethics and participant 
information for studies involving human subjects. Additionally, information regarding the 
mass spectrometry techniques used to analyse samples collected from this work, including 
inductively coupled plasma mass spectrometry, electrospray ionisation mass spectrometry 
and nano-electrospray ionisation mass spectrometry, are detailed in greater depth in this 
chapter. A brief overview is also provided of the statistical analysis used for all analysed data 
in this research. This includes an attempt at multivariate analysis to investigate changes in 
sample data obtained from human studies in combination with commonly used statistics to 
identify whether differences exist between two or more sample sets. 
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1.2 Stress 
The term stress was first applied by the endocrinologist Han Seyle in the 1930’s. It is a 
response to particular events in the way our body prepares itself to face a difficult situation 
with strength, focus and heightened alertness that has been defined as the failure of an 
organism to respond following physical or emotional threats.1 Stress is defined by 
psychologists as how the body reacts to a stressor (a stimulus that causes stress), real or 
imagined.2 
Seyle defined three reaction stages in which the body responds to stress, known as the 
general adaptation syndrome. The first of these stages, the alarm stage, is when the body’s 
natural response is a state of alarm when the stressor has been identified. The nervous 
system responds by releasing an excess of stress hormones, including cortisol and adrenaline 
to prepare for a fight or flight response. These hormones rouse the body for emergency 
action and if the stressor continues the next stage, resistance, is entered. Here the body 
begins to try and cope with the stress. However, the adaptation of the body to the strains of 
the environment cannot be maintained for an indefinite period and resources being used are 
gradually depleted. It is at this point the third and final stage, exhaustion, may be entered. 
The body is unable to maintain normal function due to the majority of its resources nearing 
depletion, and if exhaustion is prolonged, the danger of long term damage to the body may 
be the consequence. Should this stage persist, a number of illnesses may be observed 
including depression, trouble with the digestive system, ulcers, cardiovascular problems and 
mental illnesses.3 
It is anticipated that by observing composition changes in a number of biological fluids 
following stress, future medicines can inhibit these composition changes and thus suppress 
the onset of chronic stress. The primary function of sweat is thermoregulation4 but events 
such as stress induce spurts of sweating waves.5, 6 Emotional sweating is commonly 
measured on the glabrous surface of the palms.7–10, 6 However, it isn’t always possible to 
assess emotional stress using the palms when manual work is undertaken using both hands. 
Emotional sweat is often observed on the forehead but few studies have researched it. 
Sweat has been described as a good indicator by Shimoda et al. who measured mental strain 
by forehead sweat in students. They found that bursts of forehead sweating waves 
developed in 78% of the participants when they encountered difficult parts of the task. 
Students who failed to show any increase in sweat in their first attempt at the task did show 
sweating in their second attempt. Excretion of thermal sweating increases with ambient and 
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body temperature4 so during the experiment the ambient temperature was monitored 
between 21-24 °C in order to minimise heat exchange between the environment and the 
participants skin. By excluding the environmental factor, their findings show a correlation 
between increased forehead sweat and emotional stress experienced.11 Kamei et al. showed 
that when sweating is induced by physical or emotional stimuli, the behaviour of active 
sweat glands and sweat rate from the palm and forehead can be used to estimate the 
degree of emotional stress on humans. A periodical damped oscillation of sweating in both 
the sample sites was observed when a loud sound was produced behind the participant’s 
head.  If the participant was given a dose of caffeine the degree of sweating became 1.5-2 
times greater compared to without the dose.12 
Skin conductance shows the emotional state, as reflected in changes in the sympathetic 
nervous system. Storm measured behavioural state and skin conductance changes from the 
medial side of the right foot of premature infants and found that emotional sweating was 
observed in infants from 29 weeks gestational age and more than 10 days old.13 In some 
cases, prolonged stress can be dangerous in certain situations making it necessary to collect 
feedback to control it. 
Galvanic skin response (GSR) is a term coined after Luigi Galvani after he took an interest in 
the field of medical electricity. Measurement of GSR is effective when the sympathetic 
nervous system is active, especially when an individual is anxious, measuring a change in the 
electrical conductivity of the skin caused by an increase in sweat glands14. A GSR device 
sends a small current through the electrodes, measuring the conductance of skin, producing 
a continuous signal that varies with the emotional state of the subject. First documented in 
the early 1900’s to explore the GSR for psychiatric evaluation and therapy15, most 
applications since have focussed on utilizing the GSR to gauge emotional states such as 
anxiety and agitation.14  
Villarejo et al. built their own stress sensor based on GSR, in a study where participants 
completed different tasks requiring a certain degree of effort, such as breathing deeply or 
mathematical operations, and found they were able to detect different states of each user 
with a success rate of 76.56%.16 Nourbakhsh et al. used GSR for cognitive load measurement 
in arithmetic and reading tasks and found strong correlation between GSR and difficulty of 
the task being performed.17 The GSR is known today as a component of a polygraph and as 
with cardiovascular measurements, an increase in GSR can indicate anxiety or nervousness 
when questions are being asked. 
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Saliva is produced by three major salivary glands (parotid, submandibular and sublingual) 
and a number of minor salivary glands. Glands consist of specialised epithelial cells with 
defined functional and morphological end pieces (acini and intercalated ducts) as well as a 
system of glandular ducts. Secretion is thought to be a two stage process. Firstly an aqueous 
plasma-like fluid is secreted by the acinar cells and secondly the fluid is modified during 
transport through the water impermeable ductal cell system. The autonomous nervous 
system controls the secretion via signal transduction systems that couple receptor 
stimulation to ion transport and protein secretory mechanisms.18 
A number of pathologies of oral cavity have been related with stress including conditions 
such as ulcerations, periodontal disease, dental cavities, acute necrotizing ulcerative 
gingivitis and upper respiratory functions. Relationships have been discovered between 
these oral cavity conditions and stress based on epidemiological research, clinical 
observations and experiments with animals.19–24 Given the importance of the protective 
function of saliva it is surprising that little research has been carried out on possible links 
between oral disease and psychological function considering saliva possesses a multiplicity 
of defence systems against toxins, viruses, fungi and bacteria.25 Acute psychological stress 
influences both salivary composition and salivary function. It has been shown to significantly 
increase salivary protein concentration, amylase/protein ratio, α-amylase activity and s-IgA 
output.26 
Skin is an organ worn on the outside of the body consisting of two main layers, the 
epidermis and dermis, with the organ having a primary physiological function of a barrier 
between the body and the external environment, protecting the body against excessive 
water loss27 and pathogens.28 Other functions of the skin include heat regulation and 
insulation against the environment,29 control of evaporation, excretion,30 synthesis of 
vitamin D31 and sensations.32 The outer layer, the epidermis, contains several layers – the 
stratum corneum, granular cell layer, spinous cell layer and basal cell layer. Below the 
epidermis is the layer called the dermis, which contains a variable amount of fat, collagen 
and elastin fibres its strength and flexibility.33  
Skin sampling can be minimally invasive exposing subjects to less discomfort and reducing 
the risk of complications. A number of minimally invasive methods to sample skin already 
exist to monitor bodily functions and responses, monitor diseases and assess drug levels.  
A great deal of research time is presently being devoted to the analysis of skin-secreted 
compounds, with the ultimate objective of developing a system of odour-based diagnostics. 
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Katona et al. used desorption electrospray ionisation to rinse the skin and found signals of 
protonated urea, alkali adducts of urea and protonated creatinine in positive ion mode, and 
a variety of carboxylic acids, such as pyruvic acid, palmitic acid and stearic acid, in negative 
ion mode.34 Riazanskaia et al. collected sweat from human forearms and abdomens using a 
polydimethylsilicone membrane successfully recovering a number of fatty acids including 
isobutyric, butanoic, 3-methylbutanoic, pentenoic and heptanoic acids.35 Lidén et al. used 
cellulose wipes, containing 1% nitric acid, to sample contact allergens from the arms and 
palms on skin. Using this technique they recovered over 90% of all selected elements that 
included nickel, chromium and cobalt.36 Tape-stripping has been a popular method to 
evaluate processes of human skin. Stinchcomb et al. researched the chemical uptake into 
human stratum corneum from volatile and non-volatile solvents and found that increasing 
the duration of exposure of a modelled compound increased the kinetics of uptake using a 
volatile solvent when compared to the theoretical diffusion rate.37 
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1.3 Inductively Coupled Plasma-Mass Spectrometry 
Due to its high resolving power, excellent detection capabilities, large dynamic range and 
very high sensitivity, the double-focussing magnetic sector technology was employed 
throughout the presented work. Ions are initially produced in the plasma after which they 
are accelerated to a few kilovolts in a vacuum. They are then focussed through an entrance 
slit and enter the mass analyser, where ion separation takes place. Following separation the 
ions pass through an exit slit and strike a detector producing an electrical signal that is 
transferred to a computer. 
ICP-MS is an analytical technique capable of detecting metals and numerous non-metals at 
concentrations as low as parts per quadrillion (pg.L-1). ICP-MS offers further major benefits 
as well as high detection power such as wide linear calibration range, greater speed, 
precision, very low limits of detection for most elements and high sample throughput for 
clinical assays (Table 1.1). Previously, other atomic spectrometric techniques, such as atomic 
absorption spectrometry (AAS), had been the commonly used analytical method for 
screening studies and everyday clinical assays.38–40  
ICP-MS does have its limitations, especially with regard to biological applications. Spectral 
and non-spectral interferences are the major limitations the ICP-MS suffers and they are 
extremely serious in the analysis of biological materials.41, 42 These spectral interferences are 
a result of atomic or molecular ions having similar nominal masses as those of the analyte of 
interest. There are also interferences from plasma gases and solvent. Major components of 
biological matrices are renowned to form a variety of possible polyatomic ions that can 
overlap several isotopes.41, 42 
High levels of organic and inorganic salts in urine, blood and serum samples will often lead 
to isobaric overlap and matrix interferences as proved by Hsiung et al43, Barany et al44 and 
Nixon and Moyer45. In these studies, concentrations of elements such as As, Cd, Pb, Tl, Cu, 
Zn, Co, Ni and Se in blood and urine sample were determined using a quadrupole ICP-MS 
instrument. At the heart of the discussion for these studies, were problems caused by 
spectral interferences predominantly for those elements with an atomic mass lower than 80 
u. These spectral interferences are predominantly a result of a relatively high concentration 
of organic species in these biological applications. An example of this interference can be 
seen in the determination of Cu in urine samples using quadrupole ICP-MS, studied by 
Hsiung et al.43 With argon being used as the flow gas, 63Cu was found to suffer from major 
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spectral overlap from 40Ar23Na. As a result, 65Cu was selected due to a low possibility of 
interferences being present for this isotope. 
It is believed that matrix interferences is a result of ionisation energy, sample matrix, plasma 
operating conditions and mass of the internal standard relative to the analyte, as well as 
other factors.46 
A great deal of polyatomic interferences typically encountered in biological applications can 
be overcome by employing the ICP-MS in a high resolution setting, where the result of low 
background and high sensitivity can produce extremely low detection limits.47–52 High 
resolution inductively coupled plasma (HR ICP-MS) has been used in clinical applications to 
determine precious metals in blood,53, 54 uranium in urine,55 calcium isotope ratios in urine56 
and trace elements in serum.40, 49, 57 There are numerous ways used to correct the signal for 
non-spectral interferences which include internal standardisation, matrix-matched standards 
and standard additions techniques.41, 58, 59 As well as these, ICP-MS is susceptible to 
contaminations from reagents and glassware due to its high sensitivity. 
Bio monitoring of trace elements in body fluids is generally performed to investigate the 
concentration of essential traces or to determine toxic substances. Bio monitoring of toxic or 
carcinogenic elements is important as it can lead to evidence of exposure of hazardous 
substances from places such as industry or the environment. Toxic or carcinogenic elements, 
such as Be, Pb, Pt, Cd, U, are relevant in occupational and environmental medicine. For 
example, Be and its compounds cause a chronic disease that primarily affects the lungs60. 
High concentrations of Pb can cause high blood pressure, anaemia or kidney injury61. Also, 
Pt, Tl, Cr, Cu, Sn affect the kidneys if at higher concentrations whilst U compounds can 
damage the liver and cause internal haemorrhaging and Sn present in organic compounds 
have high toxicity.62–64  
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Table 1.1. Summary of elemental analysis techniques 
  Flame AAS GFAAS ICP-AES ICP-MS 
Detection limits Very good for some elements Excellent for some elements Very good for most elements Excellent for most elements 
Sample throughput 10-15 secs per elements 3-4 mins per element 1-60 elements/minute All elements <1 minute 
Dynamic range 103 102 106 108 
Precision                   Short term 0.1-1.0% 0.5-5% 0.1-2% 0.5-2% 
Long term 2-beam 1-2% 1-10% 1-5% 2-4% 
  1-beam < 10% (tube lifetime)     
Interferences                Spectral Very few Very few Many Few 
Chemical (matrix) Many Very many Very few Some 
Physical (matrix) Some Very few Very few Some 
Dissolved solids in solution 0.5-5% > 20% (slurries) 0-20% 0.1-0.4% 
Elements applicable to 68+ 50+ 73 82 
Sample volumes required Large Very small Medium Very small to medium 
Semi-quantitative analysis No No Yes Yes 
Isotopic analysis No No No Yes 
Ease of use Very easy Moderately easy Easy Moderately easy 
Method development Easy Difficult Moderately easy Difficult 
Unattended operation No Yes Yes Yes 
Capital costs Low Medium to high High Very high 
Running costs Low Medium High High 
Cost per elemental analysis         
High volume - few elements Low High Medium Medium 
High volume - many elements Medium High Low-Medium Low-Medium 
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Typically there are four major parts to the ICP-MS; the sample introduction system; the 
plasma; the interface region; and the mass analyser and detector (Figure 1.1). 
 
Figure 1.1. Schematic diagram of a SF-ICP-MS system in a reverse Nier-Johnson geometry 
1.3.1 Sample introduction 
Most ICP-MS applications involve the analysis of liquid although the technique has been 
adapted to handle solids. A number of ways are possible to introduce liquid into the ICP-MS 
but the aim of all is to generate a fine aerosol of sample in order for it to be efficiently 
ionised in the plasma discharge. However, only 1-2% of the sample finds its way into the 
plasma making the sample introduction the weak point in this technique. There are two 
separate stages for introducing the liquid into the analytical plasma. The first is aerosol 
generation using a nebuliser, and the second is droplet selection from the use of a spray 
chamber because the plasma discharge is inefficient at dissociating large droplets. The 
sample is pumped at a low pressure but high speed of approximately 1 ml.min-1 using a 
peristaltic pump, which ensures a constant flow of liquid regardless of viscosities between 
samples, standards and blanks. The liquid is then broken up into a fine aerosol by the 
pneumatic action of the gas flow smashing the liquid into small droplets when the sample 
enters the nebuliser. It must be noted that although this is the most common approach, 
some nebulisers (concentric design) rely on the natural Venturi effect of positive pressure of 
the nebuliser gas to suck the sample through the tubing. Concentric nebulisers have 
excellent sensitivity and stability but their small orifices can be plagued by blockage 
problems. Other nebulisers have proved useful for different applications, such as the cross 
flow nebuliser that is used for heavier matrixes and small undissolved matter or the micro 
flow nebuliser that is required for lower sample flow with high gas pressures used for limited 
samples. Whilst the primary function of the spray chamber is to only allow small droplets to 
DetectorExit Slit
ESA
Electromagnet
Focus & 
Acceleration
Optics
Plasma Torch
Entrance Slit
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enter the plasma, its secondary purpose is to smooth out pulses that occur during the 
nebulisation process. Large droplets fall out of the spray chamber under gravity whilst the 
small droplets are transported to the injector. Spray chambers are used to increase sample 
efficiency and sensitivity whilst improving detection limits and selecting uniform droplets to 
decrease relative standard deviations. Whilst a number of spray chambers are available, the 
two commonly used ones are the Scott double pass and cyclonic spray chambers. The Scott 
double pass spray chamber selects small droplets and directs them to a central tube whilst 
the larger droplets fall out by gravity via a drain tube. This is achieved as the liquid in the 
drain tube is at positive pressure forcing the small drops between the central and outer 
tubes. The cyclonic spray chamber discriminates the size of droplets using centrifugal forces 
by vortex from the aerosol and the flow gas, commonly argon. Smaller droplets remain in 
the main stream of the aerosol whereas the larger droplets moved to the outer walls of the 
chambers and are forces out via a drain tube. 
1.3.2 The Plasma 
Prior to introduction into the mass analyser, the sample aerosol is ionised in the plasma. The 
plasma is formed by the introduction of an inert gas, commonly argon, into a torch which is 
made from quartz. Argon is used as it is cheap, very abundant (40K decay) in the atmosphere 
and has a very high first ionisation potential (Ar+ + e- → Ar is more energetically favourable 
than M+ + e- → M) therefore samples remain ionised. The torch consists of three concentric 
tubes of different diameters; the inner tube which carries the sample aerosol; the middle 
tube carrying a gas flow to shape the plasma; and the outer tube which carries the gas flow 
that cools the torch (Figure 1.2). 
 
Figure 1.2. Schematic diagram of an ICP torch 
Upon plasma initiation, the argon gas tangentially flows through the torch and a high spark 
voltage is applied, stripping electrons from argon atoms. A magnetic field, where these 
elections are captured and accelerated, is produced from a radio frequency (RF) coil that 
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surrounds the torch and typically operates at RF power of 750-1500 W depending on the 
type of sample. Collisions between these electrons and argon atoms cause ionisations 
producing chain reactions that eventually form an ICP discharge. The plasma is sustained 
when the rate of release of free electrons is proportional to the recombination of Ar atoms. 
When the sample exits the injector it is moving at such a velocity that it punches a hole 
through the centre of the plasma discharge where it then undergoes a number of physical 
changes due to the varying temperatures (6000–8000 K) of the plasma. The sample goes 
through desolvation, vaporisation, atomisation and finally ionisation starting in the 
preheating zone and continuing through the initial radiation zone before arriving in the 
analytical zone. During the desolvation step, water molecules are stripped away from the 
sample which then becomes a very small solid particle. As the sample travels further into the 
plasma these solid particles change into gaseous form and then ground state atoms after 
which ionisation is achieved by collisions of energetic argon electrons with these ground 
state atoms. As the ion emerges from the plasma it is directed into the interface region. 
The movement of ions from the plasma to the mass spectrometer, via the interface region, 
is probably the most critical area of the ICP-MS. The role of the interface region is to 
transport ions efficiently, consistently and with electrical integrity from the plasma which is 
at atmospheric pressure (760 Torr), to the mass spectrometer analyser region which is at 
approximately 10-6 Torr.  
1.3.3 The interface region 
This region is maintained at a vacuum of ~3-4 Torr with a mechanical vacuum pump and is 
made up of two metallic cones with very small orifices (Figure 1.3). Ions generated from the 
plasma pass through the orifice (diameter of 0.8-1.2 mm) of the first cone (known as the 
sampler cone) after which they travel a short distance and through a second, much smaller, 
orifice (diameter of 0.4-0.8 mm) of the second cone (known as the skimmer cone). Typically 
these cones are made from nickel but can also be made from material such as platinum that 
are more resistant to corrosive liquid. Nickel cones are commonly used due to their low 
costs whereas aluminium cones are used when nickel is the element of interest. Also used 
are platinum cones, however, these are expensive so are used when oxygen is added for 
organic analysis. Due to the high temperature of the plasma this region is water cooled and 
made from material that dissipates heat easily such as aluminium or copper. The ion beam 
that emerges from the skimmer cone travels through the ion optics, where it is focussed, 
and guided into the mass separation device. 
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Figure 1.3. Schematic diagram of the interface region 
1.3.4 The mass analyser and detector 
The ion optics, mentioned above, consists of one or more electrostatically controlled lens 
components and are made up of a series of metallic plates, barrels, or cylinders that have 
high voltage on them. The role of the ion optics is to take ions from the hostile environment 
of the plasma at atmospheric pressure, via the interface cones, and direct them into the 
mass analyser, which is under high vacuum. It is essential the plasma is at zero potential 
ensuring that the magnitude and spread of ion energies are as low as possible and thus 
maintaining the composition and electrical integrity of the ion beam as it enters the ion 
optics.65 An additional function of the ion optics is to prevent photons, neutral species and 
particulates entering the mass analyser and detector, which affect performance of the 
system by causing signal instability and increase background levels. There are two methods 
to reduce undesirable species getting to the mass spectrometer; the first is to place a 
grounded metal stop (disk) behind the skimmer cone blocking the undesirable species from 
travelling downstream but allowing the ion beam to move around it; and the second is to set 
the ion lens or mass analyser slightly off axis where positively charged ions are steered into 
the mass analyser by the lens system while the undesirable species are ejected out the 
beam. Some lens systems incorporate an extractions lens. This is placed after the skimmer 
cone and electrostatically pulls the ions from the interface regions improving the 
transmission and detection limits of low mass elements.  
Various devices can be employed as the mass separation devices such as the quadrupole 
mass filter where a direct current (dc) field is placed on one pair of rods and a radio 
frequency (rf) field on the opposite pair, allowing ions of a selected mass to pass through the 
rods to the detector, while others are ejected from the quadrupole. Less frequently used 
devices, such as time of flight technology (TOF), can also be employed. Here, the kinetic 
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energy (EK) of an ion is directly proportional to its mass (m) and velocity (v). If the population 
of ions, all having different masses, are given some kinetic energy by an accelerating voltage 
(U) the velocities of the ions will be different, based on their masses. Ions are separated over 
a fixed flight path distance according to the mass to charge ratios. 
Table 1.2. Typical conditions for SF-ICP-MS 
Parameter Setting 
ICP radio frequency (RF) power 1250 W 
Cool gas flow rate 15.50 L min-1 
Auxiliary gas flow rate 0.80 L min-1 
Nebuliser gas flow rate 1.00 L min-1 
Sample cone Ni or Pt with B 
 Skimmer cone Ni or Pt ‘H’ with B 
 Detection mode Triple 
                 Resolution 
Low 
7Li, 11B, 23Na, 28Si, 31P, 32S, 35Cl, 44Ca, 51V, 52Cr, 55Mn, 56Fe, 
59Co, 60Ni, 63Cu, 66Zn, 75As, 85Rb, 88Sr, 89Y, 90Zr, 93Nb, 95Mo, 
105Pd, 107Ag, 111Cd, 115In, 118Sn, 127I, 137Ba, 182W, 202Hg, 208Pb 
Medium 
19F, 24Mg, 27Al, 28Si, 31P, 32S, 35Cl, 44Ca, 47Ti, 51V, 52Cr, 55Mn, 
56Fe, 59Co, 60Ni, 63Cu, 66Zn, 69Ga 
High 39K, 75As, 77Se, 78Se, 79Br 
The double focussing principle consists of two analysers, a traditional electromagnetic and 
an electrostatic analyser (ESA), positioned in either the forward (ESA before the 
electromagnet) or reverse (ESA after the electromagnet) Nier-Johnson geometry. Because 
the energy dispersion of the electromagnet and ESA are equal in magnitude but opposite in 
direction, they will focus both the ion angles (first focus) and ion energies (second focus). 
After ions are sampled in the plasma and accelerated in the ion optics region to a few 
kilovolts, they are focussed through an entrance slit after which they enter the mass 
analyser. For an instrument set up with a reverse Nier-Johnson geometry, ions enter a 
magnetic field which is dispersive with respect to momentum (and therefore ion mass) and 
focuses all ions with diverging angles of motions from the entrance slit. Ions exit the magnet 
and enter the ESA, which is dispersive only with respect to ion energy, after which ions are 
focussed onto an exit slit where the detector is positioned. Ions deflect off a plate into a 
conventional dynode, releasing electrons from its surface following collision. These 
secondary electrons released by the conventional dynode then collide with a secondary 
electron multiplier (SEM), composed of 19 dynodes. When electrons strike each dynode of 
the SEM, an electrical pulse is generated and counted with a digital counter, and multiple 
secondary electrons are released into the subsequent dynode until they arrive to the output 
electrode, which produces a signal that is transferred to a computer. The SEM detector can 
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operate in two modes of counting depending on detection count rate. As a result, the SEM 
can have a dynamic range of 109 allowing for quantification of both trace and major 
elements in a single analysis. For low count rates (< ~5 million cps) counting mode is used 
whereas the analogue mode can be used for higher count rates (~ 50 k - ~ 5 billion cps). A 
greater dynamic range can also be detected with use of a Faraday cup, increasing the range 
of detection to 1012. The ion beam enters the Faraday cup at the open end and signals are 
detected by a charge integration amplifier, at the closed end. The detection mode selected is 
dependent on the count rate and can switch between SEM (counting and analogue mode) 
and Faraday cup in less than 1 ms. 
1.3.5 Analysis 
Elemental detection of fifty six elements was performed using a Thermo Element 2XR sector-
field ICP-MS instrument (Thermo Scientific, Bremen, Germany). The instrument was fitted 
with either Ni sampler and skimmer cones (Spectron, Venture, CA, USA) (Chapters 2, 3 and 
4), or Pt (Chapter 5) sampler and skimmer cones (Spectron, Venture, CA, USA),  and a sample 
introduction system that consisted of cyclonic spray chamber (Glass Expansion, Victoria, 
Australia) and Conikal 1000 µl min -1 nebuliser (Glass Expansion, Victoria, Australia). The gas 
flows were tuned for maximum signal intensity with typical values for cool, auxiliary and 
nebuliser gases of 15.50, 0.80 and 1.00 L min -1 respectively.  
Typical instrument parameters can be found in Table 1.2. Instrument parameters for 
samples analysed in each study, that deviate from the typical values were:  
Chapter 2: The instrument was fitted with Ni sampler and skimmer cones and thirty eight 
elements were analysed with the ICP-MS operating in low resolution mode to monitor B, Na, 
Rb, Sr, Y, Zr, Nb, Mo, Pd, Ag, Cd, Sn, I, Ba, W, Hg and Pb, medium resolution to monitor F, 
Mg, Al, Si, P, S, Cl, Ca, Ti, V, Cr, Mn, Fe, Co, Cu, Zn and Ga and high resolution to monitor K, As, 
Se and Br. Samples were analysed with a calibration range of 0 – 1000 ng.mL-1. Samples were 
analysed in participant number order. Samples obtained from the placebo sessions were 
analysed first followed by stress session samples. 
Chapter 3: The instrument was fitted with Pt sampler and skimmer cones. 
a. Skin patch blanking: Twenty four elements were analysed with the ICP-MS operating 
in low resolution mode to monitor B, Na, Mo, In, Sn and I medium resolution to monitor Mg, 
Al, Si, P, S, Cl, Ca, V, Cr, Mn, Fe, Co, Ni, Cu and Zn high resolution to monitor 39K, 78Se and 
79Br. Samples were analysed with a calibration range of 0 – 100 ng.mL-1.  
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b. Skin patches: The nebuliser gas flow was tuned to 1.00 L.min-1 for maximum signal 
intensity. The ICP-MS was operated to detect twenty four elements, using low, medium and 
high resolution as described in a) above. Participant patch samples, blank patches and field 
blank patches were also analysed. 
c. Saliva samples: Tuned for maximum signal intensity, the nebuliser gas flow was 
0.913 L.min-1. Detecting twenty seven elements, the instrument was operated in low 
resolution to monitor Li, B, Na, As, Sr, Mo, In, Sn, I and Pb, medium resolution to monitor 
Mg, Al, Si, P, S, Cl, Ca, V, Cr, Mn, Fe, Co, Ni, Cu and Zn, and high resolution to monitor K and 
Se. A calibration range of 0 – 125 ng.mL-1 was used to analyse samples. 60 ng.mL-1 In was 
added to all samples as an internal standard and all samples were analysed three times 
(internal replicates). Also, external replicates of available samples were analysed too. 
d. Urine samples: The nebuliser gas flow was tuned to 0.832 L.min-1 for maximum 
signal intensity. The ICP-MS was operated to detect twenty seven elements; in low 
resolution to monitor Na, Mo, Ru, Cd, In, Sn, W and Hg, in medium resolution to monitor 
Mg, Al, Si, P, S, Ca, V, Cr, Mn, Fe, Co, Ni, Cu and Zn, and in high resolution to monitor K, As, 
Se, Se and Br. A calibration range of 0 - 125 ng.mL-1 was used to analyse samples. 50 ng.mL-1 
Ru was added to all samples as an internal standard and all samples were analysed three 
times (internal replicates). Also, external replicates of available samples were analysed too. 
e. Plasma samples: With the nebuliser gas flow tuned to 0.965 L.min-1 for maximum 
signal intensity, the ICP-MS was operated to detect fifty five elements. Low resolution was 
used to monitor Li, Be, B, Na, Sc, Ti, Ga, Ge, As, Rb, Sr, Y, Zr, Nb, Mo, Ru, Rh, Pd, Ag, Cd, In, 
Sn, Sb, Te, I, Cs, Ba, La, Hf, Ta, W, Re, Os, Ir, Pt, Au, Hg, Tl, Pb and Bi, medium resolution was 
used to monitor Mg, Al, Si, P, S, Cl, Ca, V, Cr, Mn, Fe, Co, Ni, Cu and Zn, and high resolution 
was used to monitor K, Se and Br. Three internal replicates were analysed as well as an 
external standard containing 5 ng.mL-1 of MES1, MES2 and MES4 (Spex Certi Prep) which 
was analysed between each sample to monitor instrument stability. 
Chapter 4: Elemental detection of twenty six elements was performed. The instrument was 
fitted with Pt sampler and skimmer cones. Nebuliser gas flows were tuned for maximum 
signal intensity at 0.686 L.min-1. The instrument was operated in low resolution mode to 
monitor Li, B, Na, As, Sr, Mo, In, Sn, I and Pb, medium resolution to monitor Mg, Al, Si, P, S, 
Ca, V, Cr, Mn, Fe, Co, Ni, Cu and Zn and high resolution to monitor K and Se. Samples were 
analysed with a calibration range of 0 – 100 ng.mL-1. For each sample three intra replicates 
were analysed to obtain greater accuracy and precision. 2% HNO3 was analysed as the 
solvent blank. An external calibration sample set, to quantify sample element concentration, 
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was analysed every three samples. This was analysed a total of three times using a 
bracketing technique: as the first and last sample and also after every three participant 
samples of each analysis sequence (e.g. standard, sample, sample, sample, standard). 
Chapter 5:  
Section 5.4 Elemental detection of Mn was performed with the ICP-MS instrument 
operating in medium resolution. The instrument was fitted with Ni sampler and skimmer 
cones. The nebuliser gas flow, tuned for maximum signal intensity, was 1.131 L.min-1. The 
instrument was operated in medium resolution to monitor Mn. A sample containing 10 
µg.mL-1 was analysed in order to conduct semi-quantitation. Three intra replicates were 
taken for each sample analysed. 
Section 5.5 Same parameters as those used in section 5.4 above except the instrument 
was fitted with Pt sampler and skimmer cones. Three intra replicates were taken for each 
sample analysed and samples were semi-quantified by taking the ratio of intensity obtained 
for the known Mn concentration of 100 µg.mL-1 to those obtained for each sample. 
Section 5.6 The instrument was fitted with Pt sampler and skimmer cones. Elemental 
detection of twenty six elements was performed. The ICP-MS was operated in low resolution 
mode to monitor Rb, Sr, Nb, Mo, Pd, Ag, Cd, Sn, Ba and Pb, medium resolution to monitor 
Mg, Al, Si, P, S, Ti, V, Cr, Mn, Fe, Co, Ni, Cu and Zn, and high resolution to monitor K and Br. 
Samples were analysed with a calibration range of 0 – 100 ng.mL-1. A 2% HNO3 solvent blank 
was analysed using a bracketing technique that enabled analysis after every two participant 
samples (e.g. blank, sample, sample, blank) to check the baseline element levels of the 
instrument. Also, all samples were analysed in triplicate (intra replicates) to estimate 
instrumental precision. 
Section 5.7 The instrument was fitted with Pt sampler and skimmer cones. The nebuliser 
gas flows were tuned for maximum signal intensity with a value 0.686 µl min-1. Twenty three 
elements were analysed. The instrument was operated in low resolution mode to monitor 
Rb, Sr, Nb, Mo, Ag, Cd, Ba and Pb, medium resolution to monitor Mg, Al, Si, P, S, Ti, V, Cr, 
Mn, Fe, Co, Ni, Cu and Zn, and high resolution to monitor K. Samples were analysed with a 
calibration range of 0 – 100 ng.mL-1. A 10 µg.ml-1 standard was analysed after every sample 
to ensure the instrument remained stable throughout the analysis sequence. Also, all 
samples were analysed in triplicate (intra replicates) in order to estimate instrumental 
precision. Field blanks, EDTA sampling solvent blank, a 2% HNO3 blank and a DI H2O blank 
were also analysed. 
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Figure 1.4. An example of saliva profiles from emotional stress, from the 
study in Chapter 4, showing intensity of elemental masses from 0-210 Da 
for (A) Post intervention B sample (B) Pre intervention B sample and (C) 
Blank B sample. Inserts show magnified range with second highest intensity 
as max 
Sample analysis order was randomised to remove systematic errors. Unless stated 
otherwise, samples analysed by ICP-MS were randomised in order to avoid bias. Sample 
identification numbers were listed in Microsoft Excel 2010 and were assigned a random 
number using the random number function in the software (=RAND()). These random 
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numbers were sorted from lowest to highest using the sort function to determine the order 
samples were to be analysed. 
Using the instrument software live data and mass abundance was viewed (Figure 1.4). The µ, 
σ and RSD of the sample intensities were recorded automatically for each of the selected 
elements onto Microsoft Excel spread sheets along with the sample ID numbers.  
1.3.6 Data processing 
Signal intensity (counts per second) was obtained as ICP-MS raw data. Internal replicate 
averages (n=3) were initially calculated. Concentrations, limits of detection and 
quantification of the sample elements were then determined using linearity curves, y = mx + 
c (where y = intensity, m = gradient, c = intercept and x = unknown), obtained from 
constructing intensity against concentration for each element present in the calibration 
standard (Figure 1.5). Sample dilutions were then factored into the final sample 
concentration. Internal standards were also used to semi-quantitate concentration by 
calculating the known amount of internal standard added and using the ratio between this 
known value and that observed. Element concentrations obtained for the blank sample were 
then subtracted from all sample element concentrations. All element concentrations in 
samples where either blank sample elemental concentrations were higher than those 
observed or the limit of quantification were higher, were assigned a concentration 0 ng.mL-1.  
 
Figure 1.5. (A) An example of a calibration graph using intensity acquired (cps) against standards with known 
concentration (ng.mL
-1
). (B) An example of the average calculated concentration of pre and post samples, with 
standard error of the mean (95% confidence), in pre and post intervention saliva collected, from the emotional 
stress study in Chapter 4. This data refers to the element Mn. 
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1.4 Electrospray Ionisation Mass Spectrometry 
Electrospray ionisation (ESI) is a widely used technique for protein analysis for samples in 
liquid form that are stable, not in an excited state, can be unlimited in mass and have a high 
ionisation efficiency. ESI emerged as a powerful method for producing intact ions in vacuo 
from large complex species in solution following an earlier approach to ionisation by Dole.66, 
67 Fenn et al. showed that multiply charged ions were obtained from proteins, allowing 
molecular weight determination with instruments with limited mass ranges to as low as 
2000 m/z. Fenn overcame previous issues with the analysis of volatile and semi volatile 
compounds e.g. small, low molecular weight compounds, that could be readily transferred 
to the gas phase without breaking. 
 
Figure 1.6. Formation of electric double layer in liquid produced as a result of the penetration of the imposed 
electric field into liquid
68
 
There are two major ionization mechanisms thought to be associated with ESI-MS, the ion 
evaporation and charged residue models. The ion evaporation model implies that ions are 
expelled due to Coulombic forces. As the droplet decreases and reaches a certain radius the 
field strength at the surface of the droplet becomes large enough to assist the field in 
desorption of solvated ions. The charge residue model suggests that as the droplets shrink 
the field strength at the location with the highest curvature forms a Taylor cone. 
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Consequently, highly charge smaller droplets are emitted from the Taylor cone. This is 
repeated until only one analyte molecule is present in droplets. 
A strong electric field, under atmospheric pressure, is applied to a liquid passing through a 
capillary tube with a weak flow (1-10 µl min-1). The electric field is obtained by the 
application of a potential difference of 3-6 kV between the capillary and a counter electrode 
(0.3-2 cm apart) resulting in electric fields of the order 106 V m-1 (Figure 1.6). As a result of 
the field, a charge is accumulated at the liquid surface located at the end of the capillary, 
forming a Taylor cone which eventually breaks to form highly charged droplets (Figure 1.7). 
A volatile charge modifier is added to the sample solution producing ionised analyte species. 
Common modifiers used are ammonium for negative ions or formic acid for positive ions. A 
coaxial gas is injected at a low flow rate allowing the dispersion of the spray to be limited in 
space. The droplets then pass through a heated capillary or a gas curtain, usually N2, to 
remove remaining solvent molecules.69 
The ‘Rayleigh limit’ is when an equilibrium is formed between surface tension forces and the 
ion repulsion within the droplet i.e. as the solvent evaporates, the drop shrinks and becomes 
unstable. Gomez and Tang concluded the breakdown of droplets can occur before Rayleigh 
limit is reached because the droplets are mechanically deformed. Consequently there is a 
reduction in the repulsion necessary to break down the droplets.70 
 
Figure 1.7. Formation of electrospray droplets resulting from increasing electric fields
71
 
Although ESI allows for the analysis of non-volatile species and small molecules, a 
disadvantage is the result of ion suppression as a result of competition for charge. However, 
pre-fractionation using sample purifying techniques, such as high performance liquid 
chromatography (HPLC), can be used.72 
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1.4.1 Analysis 
Samples in Chapter 5 sections 5.8 were analysed by direct injection electrospray mass 
spectrometry (ESI-MS) on a Waters Synapt G1 HDMS Time of Flight (TOF) mass spectrometer 
in firstly negative and then positive ion modes. Samples were analysed for two minutes over 
a scan range of 50 m/z to 4000 m/z for negative mode and 40 m/z to 4000 m/z in positive 
ion mode. The resolution of the instrument in V mode is between 8,000 and 10,000. Other 
important parameters can be observed in Table 1.3. 
All samples were analysed with the enhanced duty cycle (EDC) on. The EDC sets the 
instrument quadrupole over a specified region and thus enhances detection over a small 
window, of about m/z 70. Before a collected sample from the study was analysed, the lines 
were cleaned using the same solvent of EtOH that was used for skin sample collection. This 
was accomplished by drawing 1 ml of the solvent into a syringe that was then placed on a 
pump. Prior to placing the syringe onto the pump, approximately 0.01 ml of solvent was 
manually pushed through the sampling capillary to remove memory effects from previous 
samples. As a result, a low background could be maintained.  
Table 1.3. ESI-MS experimental parameters for the profiling of the 
dorsal (TF) and plantar (BF) 
Parameter Level Units 
Polarity ES- ES+ 
 Analyser V mode V mode 
 Capillary 3.0 3.0 kV 
Sampling cone 40.0 30.0 V 
Extraction cone 4.0 2.5 V 
Source temperature 120 120 °C 
Desolvation temperature 300 300 °C 
Cone gas flow 0.0 0.0 L.hr-1 
Desolvation gas flow 600 500 L.hr-1 
Sample flow 5.0 5.0 µl.min-1 
Start mass 50 40 Da 
End mass 4000 4000 Da 
Once the capillaries had been purged with EtOH the syringe was purged with the next 
sample to be analysed. This was achieved by drawing up the sample and injecting it to waste 
three times. The sample was then loaded into the syringe and placed onto the pump as 
previously carried out. When a stable signal was observed in the instrument software, data 
collection commenced and at least 60 scans (Figure 1.8) were collected over a two minute 
analysis time.  
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As well as analysing EtOH solvent (sample blank) in between each sample analysis, a pre-
made calibration solvent of 0.5M sodium formate was analysed every ten samples ensuring 
that drift of the observed m/z of ions was kept to a minimum, obtaining accurate data as a 
result. 
 
Figure 1.8. An example of the total ion current (TIC) obtained from ESI-MS negative ion mode for participant 
UF3, from the study in Chapter 5 section 5.8, plantar (BF) sample range 0.0-2.0 mins and range selected 0.2-1.2 
mins 
A randomised order to analyse the samples was determined in order to avoid bias, using the 
procedure described in section 1.3.5. 
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1.4.2 Data Processing 
Sample data was initially prepared using Waters MassLynx V4.1 (Waters). Opening the raw 
data file in the software produced a chromatogram. A stable range of one minute was 
averaged from the chromatogram (Figure 1.8) producing a spectrum showing the peak 
intensity (area) against the observed m/z. From this spectrum, a lock mass correction with 
mass m/z 112.9851 and settable parameters of Np 0.700 and resolution 8000 were selected. 
Consequently, a second spectrum was produced showing the intensity (centroid height) 
against the observed m/z (Figure 1.9).  
 
Figure 1.9. An example of a negative ion mode mass spectra, m/z 0-4000, of VOC in skin 
profiles obtained from the plantar (BF) site of participant UF3, from the study in Chapter 
5 section 5.8, using the LSP. (A) Profile (B) 100 x magnified profile, all inserts m/z 50-200 
 
(B)
(A)
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Figure 1.10. An example of spectra for participant UF3, from the study in Chapter 5 
section 5.8, m/z 50-200: A = Plantar (BF), B = Plantar (BF) blank, C = Dorsal (TF), D = 
Dorsal (TF) blank, E = Blank. Intensity normalised to 1 from 25990 counts 
Using the example the study in Chapter 5 section 5.8, five spectra for each sample obtained 
from one participant were observed together (Figure 1.10) and were then overlaid (Figure 
1.11) to gain a visual representation of the differences. This was performed for samples from 
each participant.  
(A)
(B)
(C)
(D)
(E)
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Figure 1.11. An example of mass spectra m/z 130-135 from participant UF3, from the study in Chapter 5 section 
5.8, (A) Plantar (BF) sample offset by 400 cps (B) Dorsal (TF) sample offset by 200 cps (C) Blank sample 
Ion intensities obtained from the solvent sample (EtOH) were then subtracted from all fifty 
sample values and any negative values observed were substituted by “<LOD”. Following this, 
the LSP blank sample intensities were then subtracted from their associated participant 
samples and all negative values were substituted by “<LOD”. Using participant 1 as an 
example, the intensities obtained for the dorsal LSP blank (UF1 TF PB) were subtracted from 
the intensities obtained for the dorsal (UF1 TF) sample and the intensities obtained for the 
plantar (BF) LSP blank (UF1 BF PB) were subtracted from the intensities obtained for the 
plantar (BF) (UF1 BF) sample for each observed ion. This was performed for each set of data 
obtained from each participant. Finally, intensities obtained for the field blank (FB) were 
subtracted from their associated sample set and all negative values were substituted by 
“<LOD”. Again using participant 1 as an example, the intensities for the field blank (UF1 FB) 
were subtracted from all other samples obtained for participant 1 (UF1 TF PB, UF1 TF, UF1 
BF PB and UF1 BF). 
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Figure 1.12. An example of overlaid extracted ion chromatograms showing responses for plantar (BF) (solid 
line), dorsal (TF) (dashed line) and blank (dotted line) sample sites in ESI-MS negative ion mode: (A) m/z 
93.0346 (B) m/z 104.0354 (C) m/z 128.0354 and ESI-MS positive ion mode: (D) m/z 70.0783 (E) m/z 137.0760 
(F) m/z 150.0297 from participant UF3 (Male), from the study in Chapter 5 section 5.8. The intensities 
displayed (I R) have been normalised with respect to the plantar (BF) sample site peaks 
1.5 Nano-Electrospray Ionisation Mass Spectrometry 
Mass spectra is obtained from this electrostatic ion trap using Fourier Transform (FT) based 
on a new concept by Marakov.73–75 The trap consists of an external barrel shaped electrode 
that is cut into two equal parts with a small interval and a spindle shaped central electrode 
(Figure 1.13). The maximum diameters of the outer and inner electrodes are 20 mm and 8 
mm, respectively. Ions are injected tangentially, with some kiloelectronvolts through the 
interstice between the two parts of the external electrode which is at ground potential. 
Several kilovolts (electrostatic voltage) are applied to the central electrode, negative for 
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positive ions. Following injection, ions start to oscillate in intricate spirals around the central 
electrode along the z axis under the influence of an electrostatic field. 
 
Figure 1.13. The electrostatic trap ('orbitrap') according to the description 
of Makarov.
74
 An outer electrode has the shape of a barrel cut into two 
parts separated by a small gap. Inside is a second spindle shaped electrode. 
Only DC voltages are applied. Ions turn around the central electrode while 
oscillating back and forth along the z axis resulting in a movement of 
intricate spirals.
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The frequency of this oscillation is directly linked to the mass to charge ratio and is 
independent of the kinetic energy of the injected ions. The broadband current of these 
oscillating ions is then measured and converted to FT to individual frequencies and 
intensities, generating a mass spectrum. 
 
Figure 1.14. A complete stack (includes atmospheric pressure source, analytical quadrupole, a storage linear 
trap and a quadrupole itself) of the orbitrap coupled to an electrospray source at (A) atmospheric pressure z 
spray (2 mbar). C: Guide ion (RF quadrupole, 10
-2
 mbar). D: Lens. E: transport RF quadrupole (10
-5
 mbar). G and 
G’: segmented trapping quadrupole to store ions to inject (10
-5
 mbar). F and H: lenses. I: Ion beam deflection 
device prior to injection into orbitrap. J: Repeller electrode assists ions enter the trap and spiral down the field 
to orbit around the spindle shaped electrode. K: Side view cut of the orbitrap cut at the level of the gap 
between two half barrel electrodes.
69
  
Ions are produced and focussed from A to F by classical atmospheric pressure source 
coupling (Figure 1.14). Ions are allowed to accumulate close to the exit of the orbitrap in the 
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ion trap by adjusting the potentials on the F electrode and on the last segment G’ of the 
trap; allowing rapid injection. From H to J, ions fly freely except for a beam deflection, to 
avoid helium injection, from the linear trap in the orbitrap. This field free region has a focus 
plane twice the length of the acceleration region, where ions of the same mass are focussed 
successively. Distance H to J is adjusted to correspond this distance allowing the injection of 
ions of one m/z at a time, focussed in a short period of time of nano seconds resulting in a 
total injection time of about 1 µs for successively higher m/z ions. Consequently, ions of the 
same mass group efficiently while dispersing ions of different masses to reduce space charge 
effects, resulting in improved detection. Due to the injection time of the ions with the same 
m/z being shorter than the time of one oscillation along z, movement of ions are very 
coherent resulting in very sensitive detection. This coherence is not observed around the 
central electrode therefore a reduced background is obtained. The good coherence also 
improves mass resolution and accuracy. 
 
Figure 1.15. Schematic of Thermo Electron Corporations Orbitrap. A: Atmospheric pressure source. B: 
Heated capillary. C: Several multipole focussing devices. D: Gating lenses. E: Focussing  octapole. E: Ion trap 
with two detectors. F: Focussing multipole. G: ‘C-trap’ quadrupole.
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Commercially available orbitrap instruments, by Thermo Electron Corporation (June 2005), 
uses a linear ion trap (LIT) that is used for ion storage and injection to the orbitrap by axial 
ejection, independently used as a linear trap by radial ejection (Figure 1.15). It is possible to 
inject all the ions from a LIT, or selective ones. A normal acquisition cycle time in the 
orbitrap is 1 second. Other operations can be performed in the orbitrap during this cycle 
time, after ejection to the orbitrap. For instance obtaining low resolution spectra from the 
LIT while acquiring a high resolution spectrum from the orbitrap. The gating lens before the 
LIT allows regulation of the number of ions injected and this allows optimal ions injected in 
the orbitrap resulting in optimised performance and also avoiding space charge effects. 
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1.5.1 Analysis 
From Chapter 5 section 5.8, accurate mass determination of four plantar (BF) samples from 
randomly selected participants (UF1, UF4, UF5 and UF8) were analysed in an attempt to 
determine the mass accuracy, as well as the identity, of ions by direct injection nano-
electrospray mass spectrometry (nESI-MS) using a LTQ orbitrap mass spectrometer (Thermo 
Fisher Scientific, UK) in both negative mode and positive ion modes with the resolution of 
the instrument between 50,000 to 100,000 (Table 1.4). 
Table 1.4. nESI-MS experimental parameters for the 
profiling of the dorsal (TF) and plantar (BF), from the study 
in Chapter 5 section 5.8 
Parameter Level Units 
Polarity ES- ES+ 
 Scan Low Mass 50 50 Da 
Scan High Mass 1000 300 Da 
Analyser Temperature 28.64 26.7 °C 
Capillary Voltage 92.5 -77.5 V 
Spray Voltage 1487.8 1465 V 
Spray Current 0 0 µA 
Capillary Temperature 190.1 190.0 °C 
Sweep gas flow rate 0.07 0.13   
Data obtained from nESI-MS was evaluated in the instrument software allowing the 
discovery of possible formulae, magnitude of error as well as the accurate mass for the ions 
of interest.  
1.6 Statistical Methods 
Data obtained from sample analysis by the mass spectrometry techniques, described in this 
research, was collected, organised, analysed, interpreted and modelled using statistical 
packages such as Umetrics Simca-P+ 12.0.1., Microsoft Excel 2010 or instrument software. 
These packages provided the tools to examine all data samples in a population that assisted 
in describing the nature of the data analysed, explored the relation of the data to the 
underlying population, created models to present how the data related to the underlying 
presentation, proved (or disproved) the validity of the data and predicted analytics to 
anticipate future predictions. 
1.6.1 Multivariate Analysis 
The principle of multivariate analysis (MVA) is the simultaneous, statistical study of a 
number of variables with the aim to extract information out of existing multivariate data. 
MVA essentially models reality where each situation involves more than a single variable. 
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Today’s information age has resulted in masses of data in every field that are multivariate 
due to the availability of instrumentation and complexity of systems and processes. 
Continuing the old fashioned approach of uni- and bivariate analysis is often misleading and 
inefficient. For example, it is difficult to describe the whole picture of the process when only 
performing one function on the data as a lot of potentially significant results can be 
overlooked and also performing functions on many variables is often impractical i.e. 
performing t-tests on 300 variables. When there are only two variables (univariate analysis) 
to measure this, information can be represented graphically where coordinates of a given 
point give the values taken from two variables i.e. assumes X independent variables makes 
regression of Y observations.76 However, graphical representations for three variables is 
more difficult and not possible for four or more, and it is here where computer analysis is 
useful in finding relationships between variables. MVA extracts information from data with 
multiple variables by using all the variables simultaneously. By observing all the data 
collectively, MVA generates models that can predict fundamental trends to identify latent 
variables without the loss of information. 
Each sample is known as an observation whereas each analyte is called a variable. In mass 
spectrometry a number of variables can be produced when analysing biological samples 
such as skin, urine, plasma and saliva. 
 
Figure 1.16. Multivariate analysis matrix template. Each row represents a sample (observation) and each 
column represents the corresponding variables (e.g. Element) 
The major benefit of employing MVA is its ability to reduce the dimensionality of large data 
sets. In principal components analysis (PCA) linear independent combinations of the original 
variables (X1, X2, X3,….Xn) are reformed into a new set of variables called principal 
components (PC1, PC2, PC3,….PCn), maintaining vital information from the original data set. 
For example, PC1 = a11X1 + a12X2 +……. + a1nXn. Newly created vector coefficients (amn) 
interpret maximum variability in the data and are independent principal components 
therefore are not correlated to one another. The first principal component interprets the 
maximum variance of the data, the second principal component interprets the subsequent 
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variance, the third principal components interprets the next variance, and this continues 
until no significant variance can be found. 
Partial least-squares discriminant analysis (PLS-DA) uses a training set of data to assign a 
group of unknowns so that it fits the data. In order to maximise separation approximately 
70% of a known variable, enabling the highest separation, is chosen following initial 
interpretation of known classes within the information. A model is then built and the 
process is iterated until cross validation is successful. Linear combinations of the original 
variables, X1, X2, X3,….,Xn, are used to find the linear discriminant function, Y, by selecting 
coefficients a1, a2,a3,….an, producing the maximum difference between groups of 
observations. In other words, observations in the same group will have similar Y values 
whereas those in different groups will have a different value for Y.77, 78 
The supervised model, PLS-DA, and unsupervised model, PCA, are commonly employed for 
MVA. Use of the supervised model, where the model is created using information already 
known about groups that need to be discriminated, is often criticised. PLS-DA is generally 
utilised when no conclusion can be obtained from the initial use of PCA. 
Multivariate analysis and descriptive statistics were conducted on large sets of data 
obtained from human samples (Chapter 2, Chapter 3 and Chapter 5 sections, 5.6, 5.7 and 
5.8). The data processing procedures are outlined below using data from samples obtained 
from the study in section 5.8. Depending on the study and type of data, collected ions can be 
interchanged for elements whereas sample type (dorsal (TF) or plantar (BF)) can be 
interchanged with other sample types or genders.  
In Chapter 5 section 5.8, MVA was performed using Simca-P+12.0.1 (Umetrics), on the blank 
subtracted data set to identify ions that could possibly show differences between the 
plantar (BF) and dorsal (TF) sample sites. All values of “<LOD” were replaced with the value 1 
as the software was unable to accurately process data sets that contained empty cells or the 
value zero. This was due to the inability of the software’s algorithm to process no value cells 
leading to errors. The value 1 was chosen as this low number would not prove to be 
significant when creating data models. 
Initially, data was transformed (LOG10), to normalised data, in the software and then 
grouped into two discriminant classes (PLS-DA), class 1 for dorsal (TF) samples and class 2 for 
plantar (BF) samples, with Pareto scaling (ParN) used. This type of scaling is generally used 
when only medium or small features in the data are important. Due to the small changes in 
large data sets, this method was employed. The number of significant components (A) was 
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calculated for the model and the resulting S-plot was used to determine the ions that would 
later be further inspected. 
 
Figure 1.17. An example of a supervised model (PLS-DA) Simca-P+ S-plot (PLS-DA) obtained from 20 samples 
(observations) analysed by ESI-MS in negative ion mode, from the study in Chapter 5 section 5.8, R2X = 96.8%, 
Q2X = 89% 
All ions chosen from the S-plot (Figure 1.17) were included to create a new, unsupervised 
model (PCA). The software calculated the number of significant components for the PCA 
data set and score scatter and score loading plots were constructed. From the score loading 
plot, the contribution of each ion towards the model can be viewed. The heavier the weight 
of these ions (away from the centre 0) the more likelihood distinction of observations in 
later modelled scatter plots using these ions. Initially, the heaviest weighted ions were 
chosen, as shown by the dotted ellipse in Figure 1.17, to produce further models in order to 
discover important less weighted variables. Using the score loading plot, the biggest 
weighted contributors would be removed to examine if the lower weighted ion contributors 
could produce clusters between groups of observations on the score loading plot. This 
process was iterated until no separation was observed between the two sample groups. 
Those ions that produced these clusters were chosen as the vital biomarkers. 
1.6.2 Descriptive Statistics 
Analytical methods should be free from systematic error meaning the value given for the 
amount of analyte should be the true value. However, even if no systematic errors are 
present, random errors make it unlikely that the achieved value would exactly equal to a 
reference amount (a standard or experimental value). In order to determine whether these 
differences can be attributed to random variations, significance tests can be employed. 
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Significance tests are testing the truth of a hypothesis which is known as the null hypothesis 
(H0). The term null implied there is no difference between the observed and known (or 
second experimental) values other than that which can be attributed to random variation. 
Assuming H0 is true, statistical theory can be utilized to calculate the probability that the 
differences between the observed and known values are due to random errors. The lower 
the probability that the differences occur by chance the less likely H0 is true. 
Tests for comparison of experimental means (t-tests), comparison of standard deviation (F-
test) and analysis of variance (ANOVA) are described in the supplementary information 
(Chapter 1 Statistical Analysis). 
1.7 Ethics 
Studies were conducted in accordance with the ethical principles of good clinical practice 
and the Declaration of Helsinki. The research followed the protocols that were reviewed and 
granted favourable opinion by the local ethics advisory committee, Loughborough 
University; G7-P19 Chapter 2, R10-P126 Chapter 3, R11-P107 Chapter 4 and R11-P33 
Chapter 5. All participants taking part in each study gave written informed consent. 
Prior to sampling, all participants were provided with an information sheet outlining reasons 
for the study and the procedures involved and were asked to complete a health screen 
questionnaire upon arrival on the morning of sample collection. Participants were informed 
both verbally and in writing of their right to withdraw at any time during the process. Health 
screen questionnaires were anonymised by allocation to each participant of a Participant 
Number, which was used on the questionnaire sheets instead of participant’s name. Any 
health issues were checked before proceeding with sampling. The final document presented 
to the participants before sample collection could proceed was the consent form. 
Participants filled out the important information, such as contact number in the event the 
participant needed to be contacted again and also the participants’ signature to verify they 
understood the purpose of the study and agreed to participate.  
At the end of the study all health screen questionnaires and consent forms were grouped 
and placed in a sealed envelope. Envelopes were locked in a filing cabinet and participants 
were told their personal information would remain confidential. 
1.7.1 Recruitment of participants 
For all studies participants were recruited from social networks in addition to Loughborough 
University staff and students. Participants sampled in Chapter 5.7 were recruited by internal 
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advertising within Unilever PLC, Bebington. For studies in Chapters 2, 4, 5.6, 5.7 and 5.8 all 
participant samples were taken in a small internal room at the Centre for Analytical Science 
within the Department of Chemistry at Loughborough University. For Chapter 3 all 
participant samples were taken at 25°C in the climate chamber in the School of Sport, 
Exercise and Health Sciences building at Loughborough University. A chaperone, of the same 
gender as the participant, was offered during sample collection and access to the trial zone 
was restricted to only those researchers and participants involved in the sampling process. 
Table 1.5. Number of participants and age ranges for studies involving 
human volunteers 
Study Number of participants Age (years) 
Chapter 2 24 (12 males & 12 females) 19-26 
Chapter 3 10 (all males) 18-32 
Chapter 4 1 50 
Chapter 5.6 10 (5 males & 5 females) 18-35 
Chapter 5.7 10 (5 males & 5 females) 18-59 
Chapter 5.8 10 (5 males & 5 females) 18-35 
Conditions imposed on the human participants in the various studies are detailed in the 
relevant chapter describing that study. 
1.8 Chemicals 
18.2 MΩ-cm deionised water (DI H2O; Merck Millipore Elix and Element A10, Massachusetts, 
USA) was used to dilute all samples unless stated. 10 µg.mL-1 multi-element solutions 1 (MES 
1; Ce, Dy, Er, Eu, Gd, Ho, La, Lu, Nd, Pr, Sc, Sm, Tb, Tm, Tu, Y, Yb), 2 (MES 2; Ag, Al, As, Ba, Be, 
Bi, Ca, Cd, Co, Cr, Cs, Cu, Fe, Ga, In, K, Li, Mg, Mn, Na, No, Ni, Pb, Rb, Se, Sr, Ti, V, Zn), 3 (MES 
3; Au, Hf, Ir, Pd, Pt, Rh, Ru, Sb, Sn, Te) and 4 (MES 4: B, Ge, Mo, Nb, P, Re, S, Si, Ta, T, W, Zr), 
4 (MES 4; B, Ge, Mo, Nb, P, Re, S, Si, Ta, T, W, Zr) and Hg, obtained from Spex Certi Prep 
(Middlesex, UK), were used as calibration standards of varying concentrations for all studies 
where ICP-MS was employed.  
70% ultra-pure nitric acid (Romil, Cambridge, UK) was diluted to 2% nitric acid (HNO3). This 
2% HNO3 solution was used to dilute all samples prior to ICP-MS introduction, and for 
leaching elements from skin patches in Chapter 2 and 3.  
For all studies, accurate weighing of chemicals was performed on a five figure balance (AND, 
San Jose, CA, USA) and a vortex mixer (Labnet Intl. Inc., Edison, NJ, USA) was used to ensure 
sample homogeneity. 15 and 50 ml polypropylene centrifuge tubes (Elkay Science, 
Basingstoke, UK) were used for sample collection, storage and ICP-MS analysis tubes unless 
stated otherwise. 
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For the work described in Chapter 3, 15% HNO3 was used and ethylenediaminetetraacetic 
acid disodium salt dehydrate (AnalaR, Leighton Buzzard, UK) (EDTA) was diluted with DI H2O 
to make up a concentration of 0.1M EDTA. Diluted 1000 µg.mL-1 indium (Ultra Scientific, 
North Kingstown, USA) (In) was used as an internal standard to aid element quantification 
and also to confirm instrument stability. For the removal of impurities from skin patches, 
25% tetramethylammonium hydroxide (SigmaAldrich, Gillingham, UK) was diluted to 10% 
tetramethylammonium hydroxide (TMAH). Also, aqua regia was produced by mixing 3:1 
hydrochloric acid (Romil, Cambridge, UK) with 70% ultra-pure nitric acid (Romil, 
Cambridge,UK).  
For the Liquid Skin Pen (LSP) work described in Chapter 5, 0.1M EDTA was used as the 
sampling solvent for samples that were analysed for elemental content using ICP-MS. 10,000 
µg.mL-1 manganese (Ultra Scientific, N.Kingstown, RI) was diluted to concentrations of 10 
µg.mL-1 and 100 µg.mL-1 manganese (Mn) and these samples were used in Chapter 5 
sections 5.4 and 5.5, respectively. 96% Ethanol (VWR, Leighton Buzzard, UK) was diluted 
with CHROMASOLV® Plus water (Sigma-Aldrich Company Ltd, Dorset, UK) (H2O) to produce 
50% v/v ethanol (EtOH(aq)) used as the sampling solvent for samples that were analysed for 
VOCs, semi VOCs and non-volatile organic compounds by ESI-MS. 35% ammonia (Fisher 
Scientific, Loughborough, UK) and 99% acetic acid (Sigma-Aldrich Company Ltd, Dorset, UK) 
were diluted producing 0.5% v/v ammonia (NH3(aq)) and 0.5 v/v acetic acid (CH3COOH (aq)). 
50% v/v EtOH (aq), 5% v/v NH3(aq) and CH3COOH(aq) were used as LSP cleaning solvents.  
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1.9 Conclusion 
The work presented in the subsequent chapters outlines existing and new methodologies to 
analyse elemental profiles obtained from biological samples of saliva, skin, plasma and urine 
using ICP-MS, of which is detailed in this chapter. Samples were acquired from participants 
who experienced psychological, physical and emotional stress after which multivariate 
analysis in conjunction with descriptive statistics was performed on chemical data to recover 
potential biomarkers of stress. 
ICP-MS and ESI-MS was used to analyse skin samples acquired using the engineered skin 
sampling device for elements, VOCs, semi VOCs and small molecules. Multivariate analysis 
and descriptive statistics were also employed to identify biomarkers in specific body sites of 
the human body. Subsequently, nESI-MS was utilised in order to identify the discovered 
biomarkers. 
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2 A study into the effect of psychological stress on the 
elemental content of human forehead sweat as measured by 
ICP-MS 
Psychological stress is not a condition that can be measured despite the observation of 
various symptoms of stress such as those mentioned summarised in Chapter 1 section 1.2. 
Therefore, the study presented in this chapter attempted to identify differences in 
elemental profiles obtained from human forehead sweat before and after a psychological 
intervention, a paced auditory serial addition task (PASAT), designed to induce stress. H0: 
There was no detectable differences in element concentrations of patches obtained from 
human forehead sweat from participants that had been subjected to psychological stress i.e. 
H0: E.PSPRE = E.S.POST.  
Twenty-four male and/or female volunteers aged between 19 and 26 years participated in 
the study and 22 complete sets of sweat samples were obtained. Participants attended two 
sampling sessions each involving an intervention, a neutral and stress session. During the 
neutral session intervention, participants were asked to sit comfortably and listen to eleven 
minutes of classical music. In contrast, during the stress session intervention, participants 
were asked to undertake a mental arithmetic test (PASAT), chosen to provoke stress. 
Interventions, eleven minutes long, were sandwiched in between cognitive function 
assessments that did not induce stress, and were conducted as part of another study into 
the effect of stress on cognitive function. Sampling sessions ran in the morning before which 
the participants had fasted for a minimum of nine hours. During this time, participants were 
able to drink only water and refrained from washing or using oral hygiene products on the 
morning of their visit. In each session, two 30 minutes sweat samples were collected (one 
each for elemental analysis and VOC analysis) from the participant’s forehead. The first 
sweat sample was collected before the experimental intervention (neutral/PASAT) and the 
second following the completion of the intervention. 
The data presented in this chapter is part of a wider study, devised by Matthew Turner 
(personal communication) in collaboration with the author and Helen Martin (personal 
communication), referred to in Appendix VII Publications reference 2. The PASAT was 
introduced to the experiment by Dr Stephan Bandelow (personal communication) and Dr 
Louisa Edwards (personal communication). The author, Helen Martin and Matthew Turner 
collected all VOC and elemental skin samples as well as VOC breath samples and 
cardiovascular readings. Assistance in sample collection was also given by Aditya Malkar, 
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Toni McKay and Elliot Poole. All elemental skin patch analysis and subsequent data analysis 
of the results was carried out by the author. 
2.1 Experiment Outline 
Figure 2.1 shows the experiment outline described here. 
2.1.1 Physiological Measurements 
Throughout the experiment, cardiovascular responses, including sixteen heart rate (HR), 
systolic and diastolic blood pressure (BP), were monitored and recorded from each 
participant on each visit using a Datex-Ohmeda S/5TM monitor (Instrumentarium Corp, 
Finland). Four initial measurements were taken to provide a baseline and twelve other 
measurements were taken at key pre-defined times during each session (Figure 2.3). Also 
taken were continuous galvanic skin response (GSR) measurements using a SensewearTM 
WMS (APC Cardiocascular Ltd, UK) armband. The adjustable armband was placed around the 
right bicep of the participant. The device contained two electrodes that made contact with 
the skin allowing the measurement of electrical resistance across the sampling area. This 
related to moisture levels at the skin surface and the data collected was recorded on the 
device after which the results were downloaded to a computer following the completion of 
the sampling stage of the study. The device contained a button for time stamps, which was 
pressed at key stages during the experiment (Figure 2.3). 
2.1.2 Cognitive Function Test Battery 
Subjects completed four computer based cognitive function tests prior to and following the 
intervention designed to measure reaction time and concentration levels. Shown below are 
the tests in the order they were taken as well as a brief description about each of them. 
1. Stroop test                 Duration: Approximately 3.5 minutes 
A psychological test measuring the mental vitality and flexibility of a subject. Humans have 
an ability to read words more quickly and automatically than they can name colours. This 
direct attention task involved the subject having to manage their attention, inhibit or stop 
one response in order to say or do something else. This is performed by words typed in 
different colours to what they are on a computer. For example; the word “blue” is written in 
green ink: “blue”. 
2. Flanker test               Duration: Approximately 3.45 minutes 
A test of attention in the presence of distracting information. Subjects were asked to always 
respond as quickly as possible, whilst avoiding errors, in this reaction time task. An example 
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of the Flanker test is an array of five symbols where the central symbol is always an arrow, 
which points either horizontally left or right. If the central arrows points to the left, the 
subject would press the left arrow key, if it points to the right, the subject should press the 
right arrow key. The four symbols on either side of the central arrow are called flankers. 
These can be arrows, sometimes pointing in the same direction as the middle arrow. 
Sometimes the flankers point in the opposite direction to the target. For example: if the 
arrow set visible is →→←→→, the participant should press the left arrow key (←) as quickly 
as possible. 
3. Sternberg test                 Duration: Approximately 3.5 minutes 
A test of memory storage capacity. Subjects were instructed to focus on a point on a 
computer screen where lists of words appear. In this task each word appears on the screen, 
one after another, erasing out before being replaced by the next word. For successive trials, 
the list is variable in length and a new target (the word) appears. It is important to note that 
this target may or may not have been present in previous lists. When a word appears the 
subject must press one button and a different button when the new word appears in the list. 
Feedback is given on the correctness of the decision when the button is pressed, and then 
the next list is presented. The general idea is that the longer the word list, the longer it takes 
the subject to recall whether the target word has appeared previously. 
4. Rapid Visual Information processing test (RVP)  Duration: Approximately 6.5 minutes 
A test of sustained attention requiring working memory for its successful execution. Single 
digits are presented in quick succession on the screen, and when a target sequence is 
identified a button must be pressed. A random series of numbers is presented in single 
digits, each digit disappearing before the next. A target sequence, such as 3 followed by 5 
then 7, must be identified within the random sequence. For example, on the screen the 
following numbers appear one at a time 1, 3, 5, 8, 5, 7, 6, 4, 3, 5, 7, 2, 3, 4, 5, 7, 3, 5, 7. The 
subject should identify that the target sequence appeared twice within the random numbers 
sequence by tapping the spacebar on the computer keyboard following correct recognition 
of the target sequence. 
2.1.3 Inducing Psychological Stress: The PASAT 
The paced auditory serial addition test (PASAT) was first developed to assess the effects of 
traumatic brain injury on cognitive functioning by Gronwall and Sampson in 1974 by 
measuring the speed of information.79 However, the PASAT is now known as a measure of 
multiple functional domains, requiring successful completion of a variety of cognitive 
functions, principally related to attention. The PASAT creates an excessive amount of anxiety 
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and frustration in participants which affects their performance on this test and has 
frequently been used as a psychological stressor in several recent studies80–82. 
A series of digits are presented at two second intervals via an audio feed. The test requires 
subjects to verbally respond the arithmetic sum of a new digit with a number immediately 
preceding it. For example, the participant would verbally answer the following answers (in 
brackets) if the audio feed supplied the list of numbers 2, 7 (9), 4 (11), 6 (10) etc. In this 
study, the PASAT was used to induce psychological stress. Incorrect answers, or at pre-
defined places during the PASAT, were emphasized with the use of a loud horn to confuse 
and further apply stress to the participant. The use of the horn was designed to frustrate and 
disorientate the participant as it often overlapped with the next number causing the errors 
in the following answer. Detailed instructions of the PASAT can be found in Appendix V as 
well as the PASAT answer sheet (Figure 8.4). 
Although the PASAT has demonstrated good psychometric properties such as test-retest 
reliability and internal consistency, there are issues that should be considered when 
administering and interpreting this test. The test is susceptible to practise effects and is 
negatively affected by low math ability, low IQ and increasing age. Those with speech or 
language impairments, as well as those who naturally speak slow for cultural and 
geographical reasons, are at a distinct disadvantage due to the demands for rapid 
responding placed on the subject. 
In addition to the stress condition, participants were asked to attend the lab for a placebo 
condition on a separate visit on a different day. The placebo condition involved the subject 
listening to classical music for eleven minutes in a quiet room, where their blood pressure 
and heart rate was again monitored. 
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Figure 2.1. Experiment outline for elemental sweat collection and analysis obtained by psychological stress
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2.1.4 Skin Patch Sampling Area 
Sweat glands create a minute cooling effect on the skin, an effect that increases along with 
the perspiration rate.  The forehead is one of the most visible anatomical areas of the body 
that features the highest concentration of sweat glands.83 
 
Figure 2.2. Skin patch. A: 3M
TM
 Tegaderm
TM
 +pad film dressing with non-adherent pad. B: Skin samples were 
collected by sticking the patch to the middle of the participant’s forehead 
Salvesen investigated the amount of sweating in the lateral (lateral angle of the eye) and 
medial sites (root of the nose) in the forehead after body heating, and, at another occasion, 
after intracutaneous injection of a drug (inducing emotional stress). Salvesen found there 
was an increase in the level of sweating in the lateral site compared to the medial site during 
body heating but nearly all symmetrical sweating responses were observed after the 
injection.84 
Although several studies have indicated the axillae and palms as locations for monitoring 
emotional sweating as a consequence of mental strain, due to accessibility issues as a result 
of other sampling constraints, in this study the forehead chosen as the sampling area. 
Previous literature, outlined in Chapter 1 section 1.2, exhibited a correlation between 
increased forehead sweat and emotional stress response allowing an estimation of the 
degree of emotional stress on humans.11, 12 
For each session skin elemental samples were collected using two 3MTM TegadermTM +Pad 
film dressing with non-adherent pad (3MTM, UK). The pad (size 38mm x 25mm) was bonded 
to a larger film backing (size 70mm x 50mm) with a non-latex, hypoallergenic adhesive. 
These patches are typically used as film dressings with a non-adherent pad that is 
waterproof, bacterial and viral barrier. As well as being relatively cheap, the cotton pads 
have been chemically proven to be super absorbent and remain intact without leakage, 
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unlike frequently used patches containing cotton gauzes.  Patches remained sealed in the 
sterile packaging until the moment prior to placing on participant forehead. 
2.1.5 Skin patch sampling 
A total of four samples were collected from each participant (two samples from two visits). 
Samples were obtained from the centre of the forehead with a sample collection time of 30 
minutes (Figure 2.2). The first sample, (“Pre”) was obtained prior to the intervention and the 
second (“Post”) was obtained immediately following the intervention. Upon removal from 
the forehead each patch was placed into a 50 ml polypropylene vial with a screw top and 
stored at 4°C until analysis. 
2.1.6 Sample Analysis 
On the day of analysis, the cotton pad of the 3MTM TegadermTM +Pad was then extracted off 
the adhesive with plastic tweezers and placed into 25ml of 2% HNO3. This tube was left on a 
shaker (ELMI Skyline Shaker, Riga, Latvia) for the duration of 60 minutes at a tilt of 5°. The 
pad was removed from the 2% HNO3 using plastic tweezers and disposed of appropriately. 
The remaining solution in the tube, containing leached elements from the pad, was then 
sealed ready for analysis. Ninety two participant skin samples were analysed using ICP-MS 
(Chapter 1 section 1.3.5) in ascending participant ID order (Supplementary information Table 
SI.2.2). Pre and post intervention sample data was grouped in to perform MVA followed by 
the conductance of significance testing to discover whether any elemental differences 
between samples existed.  
2.2 Results and Discussion 
Elemental analysis was performed on a total of ninety eight patches. These included ninety 
two sampled skin patches and six blank patches. Of the ninety two patches, eighty eight 
formed twenty two completed sample sets obtained from ten male and twelve female 
participants. Psychological stress scores were also determined, using a newly designed 
formula, using cardiovascular responses that were collected from each of the sessions 
participants attended. 
2.2.1 Cardiovascular response 
Cardiovascular reactivity is defined as the change in BP, HR and other haemodynamic 
parameters in response to physical or mental stimuli.85, 86 The aim of these efforts was to 
measure HR and BP changes under psychological stress conditions, and compare them to 
baseline values. 
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Figure 2.3. Psychological stress sample collection timeline 
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From each participant, HR, systolic BP (PS) and diastolic BP (PD) were collated and the 
average observations show the cardiovascular responses to the PASAT and neutral 
interventions. Figure 2.4 compares the differences in the observed cardiovascular response 
during the stress (PASAT) and neutral (placebo) sessions. 
The psychological stress score (PSR) equation was devised by Matthew Turner (personal 
communication). Individual cardiovascular responses to the PASAT and neutral interventions 
were scored on the basis of observed changes in their systolic BP and HR. An average of the 
first three baseline observations were used to give BP and HR start values (  
     and 
        . The maximum observed values of the four readings taken during the intervention 
period were assigned points of maximum ‘stress’. Equation 2.1 defines a psychological 
response score for both the PASAT (PSRS) and neutral interventions (PSRN): 
     
   
  
        
   
       
         
where        
       
      (Equation 2.1) 
 
and                      
The PSR was formulated to highlight relative change between the cardiovascular 
measurements taken by assessing i) the relative change in systolic BP (   ) compared to 
baseline observations (  
     ) and ii) the relative change in HR (   ) compared to baseline 
observations (       ). The scores were framed to give a higher score to participants who 
presented a larger cardiovascular response during the interventions. Scores are summarized 
in Table 2.1 and Figure 2.4 shows the differences in response between males and female 
participants.  
ANOVA was performed in an attempt to observe whether any statistically significant 
differences were present between the stress and neutral responses (Appendix Table 8.2). 
The results show that significant differences (95%) were observed between the two sessions 
for all participants due to a higher calculated F value (22.825) compared to the theoretical 
critical F value (4.073). All participants, except one, produced a higher stress response during 
the stress intervention compared to the neutral intervention. Participant 4 produced a stress 
response of 0.9 and 5.3 for the stress and neutral sessions, respectively, suggesting the 
participant was not affected by the PASAT intervention. The average response of the other 
21 participants was 64.7 ± 20.9 for the stress session and 4.4 ± 1.8 for the neutral session. 
There was no statistically significant evidence of a difference between male and female 
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stress scores as a calculated F value of 1.435 was attained, which was smaller than the 
critical F value of 4.351. However, female participants produced a larger range of responses 
for the stress session (PSR = 12.9 to 233.9) compared to male participants (PSR = 11.1 to 
149.9). Furthermore, for the neutral session, female participant stress responses (PSR = 0.8 
to 7.7) exhibited less variability than male stress responses (PSR = 0.1 to 18.6). 
The data indicates that although male and female participants have similar baseline stress 
scores, following the intervention, female participant stress increased larger than male 
stress scores proposing the presence of gender differences in stress. 
2.2.2 Galvanic Skin Response 
Galvanic skin response (GSR) is a change in the electrical resistance of the skin caused by 
emotional stress. GSR is the phenomenon that the skin momentarily becomes a better 
conductor of electricity when either external or internal stimuli occur that are physiologically 
arousing. However, it must be mentioned that arousal refers to the activation and is 
considered to be a dimension of emotional response but arousal is therefore not the same 
as measuring emotion, but is an important component of it. 
Electrical resistance, associated with skin moisture levels, was collected from participant 12 
for both the stress and neutral sessions (Figure 2.5). An initial spike can be observed in both 
sessions. The response may be recognised for a nervous participant whilst being briefed on 
the sampling procedures and tasks during the visit. 
Alternatively, it may be the device equilibrating once it switches itself on. On both visits, this 
response decreased from an initially high reading following the start of the first cognitive 
battery as the device stabilised. During the intervention the GSR for the stress session 
increases just after the start of the PASAT proposing the participant to be under pressure 
from the test whilst the GSR remains stable at the baseline during the placebo intervention. 
During the PASAT the GSR then begins to drop back towards the baseline prior to the 
intervention although it stabilises above the pre intervention baseline. This stabilised post 
intervention GSR level, at a higher level than prior to the PASAT intervention, is a sign that 
the body has been through stress. During the placebo intervention, no change is observed in 
the galvanic skin response. 
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Figure 2.4. Mean responses of 22 participants for systolic blood pressure (PS, top), and heart rate (HR, bottom) over the 70 min stress (solid line) and neutral (dashed line) sessions. The 
error bars designate the 95% confidence limit of the mean. MS = male stress, MN = male neutral, FS = female stress, FN = female neutral, TS = total stress, TN = total neutral 
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Table 2.1. Cardiovascular response scores of participants during the neutral (PSRN) and stress intervention (PSRS). HR
start
: Baseline heart rate recorded at start (BPM); HR
max
: maximum 
heart-rate (BPM); PS
start
: baseline systolic blood pressure recorded at start (mmHg); PS
max
: maximum systolic blood pressure (mmHg) and PSR: Stress response score, see Figure 2.4. 
Ref. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 
M/F M F M M M F F M F M M F F F M M F F F F F M 
  PASAT intervention                                       
HR
max
 90 119 70 92 80 77 105 91 90 90 96 100 82 134 95 84 146 66 97 95 105 85 
HR
start
 78 94 54 90 69 68 81 76 66 73 59 66 72 84 75 76 88 42 82 61 65 54 
PS
start
 141 121 112 136 121 113 105 120 129 141 113 119 102 117 107 138 112 112 116 126 110 144 
PS
max
 152 148 122 142 144 124 125 136 155 168 129 138 117 146 121 153 152 120 133 154 132 162 
PSRS 11.6 60.6 27.5 0.9 30.3 12.9 56.7 26.1 74.2 44.8 87.6 84.5 19.7 149 34 11.1 233 40.8 27.5 125 125 72.6 
  Neutral intervention                                       
HR
max
 81 102 65 72 74 83 98 85 69 101 71 89 101 73 82 95 113 54 79 94 71 70 
HR
start
 75 90 58 65 68 79 85 82 61 81 60 72 84 56 73 78 81 49 60 79 68 56 
PS
start
 126 120 125 118 120 107 102 125 120 135 113 113 111 116 107 133 118 108 120 119 103 147 
PS
max
 127 121 125 124 122 122 101 118 123 138 122 111 109 123 114 131 117 107 122 116 105 148 
PSRN 1.0 0.8 0.1 5.3 1.6 7.4 1.9 2.0 3.2 4.7 15.5 5.0 4.2 18.6 7.7 3.9 2.7 1.2 4.5 4.5 1.0 1.4 
Table 2.2. Mean concentration (ng.mL
-1
) and relative change (RC(%)) between pre and post skin patches for the stress and neutral interventions. In brackets, relative standard deviation 
(%RSD) for each sample set (for blank n = 6, samples n = 12) 
Sample Na Zn S Sn Ca K Ba Mg Ti Cu 
 
µ 
         Blank 7100 (7.25) 248 (3.3) 216 (2.28) 168 (7.53) 65 (91) 29 (87) 26 (4.32) 2.7 (87) 1.7 (2.13) 0.0 (0.0) 
Pre Stress 2198 (127) 178 (67.1) 139 (74.4) 49 (143) 220 (122) 80 (159) 6.9 (132) 8.3 (158) 2.0 (241) 1.5 (259) 
Post Stress 1906 (116) 160 (53.2) 135 (70.0) 37 (146) 133 (135) 29 (104) 5.9 (120) 5.3 (195) 1.0 (51) 1.5 (305) 
Pre Placebo 2385 (120) 167 (58.5) 154 (84.5) 44 (137) 126 (114) 92 (282) 7.2 (132) 5.6 (129) 1.0 (53) 1.4 (326) 
Post Placebo 1505 (162) 180 (59.5) 154 (83.7) 29 (203) 184 (146) 32 (130) 4.9 (163) 5.4 (141) 1.1 (57) 1.5 (313) 
 
RC (%) 
         Stress -13.3 -10.2 -2.59 -23.9 -39.7 -64.1 -13.5 -35.8 -52.3 -2.36 
Placebo -36.9 7.36 -0.36 -34.5 46.6 -65.5 -31.9 -3.70 4.96 3.89 
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Figure 2.5. Galvanic skin response (GSR) of participant 12 during the stress (solid line) and neutral (dashed line) 
sessions where (A) indicated the start of the pre intervention cognitive battery and (B) indicates the start of 
the post intervention cognitive battery 
The cardiovascular and GSR measurements recorded during this study prove the PASAT to 
cause change in autonomic nervous system response compared to the neutral session 
demonstrating that the PASAT was an effective stressor. The GSR produced a response at 
the skin surface during the stress intervention, proposing that the elemental profile of skin 
may also change during this time. 
2.2.3 Elemental profiling of skin by ICP-MS 
A total of ninety eight patch samples were analysed including six blank patch samples. 
Ninety two of these patch samples were skin samples from twenty four participants. From 
these twenty four participants, twenty two provided complete sample sets (two skin patch 
samples each for both the stress and placebo sessions). Forty four skin patch samples were 
collected from the placebo sessions and forty eight skin patch samples were collected from 
the stress sessions as participants 9 (labelled E11) and 23 (labelled 25) were unable to attend 
a second session which in this case was the placebo sessions. Consequently, data presented 
in this chapter excludes results attained from the non-complete participants. 
Each sample was analysed once. An external calibration sample set, to semi quantify 
element concentration, was analysed at the start of each analysis sequence. From the forty 
elements that were analysed, ten were detected in blank and participant skin patch samples 
A
A
B
B
INTERVENTION
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(Table 2.2). Very large elemental concentrations in the skin patches were detected for Na 
with approximately 2000 ng.mL-1. Over ten times smaller than Na concentrations were 
discovered for Zn, Ca and S, which were found to have average concentrations of 
approximately 170, 165 and 145 ng.mL-1, respectively. Traces of Ba, Mg, Cu and Ti were also 
detected. Relative changes (RC (%)) were also calculated for each of the detected elements 
(Table 2.2). All elements obtained from the stress intervention decreased in concentration 
from the pre to the post intervention patches. For the neutral intervention only six of the 
ten elements decreased in concentration from the pre to the post patches whereas four 
elements increased in concentration (Figure 2.6). Large relative concentration changes 
between pre to post intervention patches, in both the stress and neutral interventions, were 
observed for K. In both sessions K concentrations decreased by approximately 65%. In the 
stress session a large decrease of approximately 52% was also observed for Ti whereas in the 
neutral session Ti concentration increased by nearly 5%. Large decreases in elemental 
concentrations were also detected for Ca, Mg and Sn whilst decreases were also identified 
for Ba, Na, Zn, Cu and S in the stress session. In the neutral session, large decreases were 
observed for Na, Sn and Ba whilst smaller decreases were detected for Mg and S. However, 
in this neutral session, the elemental concentration of Ca increased between the pre and 
post intervention by almost 50% and small increases were detected for Zn, Ti and Cu. 
Table 2.3. Two-way ANOVA (with replication) for elemental sweat samples obtained before and after each 
intervention 
Source of Variation SS df MS F P-value F crit 
Between pre and post stress samples 
Sample 219922 1 219922 0.379 0.538 3.862 
Columns 160918023 10 16091802 27.765 1.55E-41 1.851 
Interaction 836238 10 83624 0.144 0.999 1.851 
Within 267762402 462 579572 
   
       Total 429736585 483 
    Between pre and post neutral samples 
Sample 788079 1 788079 1.202 0.274 3.862 
Columns 144334339 10 14433434 22.012 1.134E-33 1.851 
Interaction 7816626 10 781663 1.192 0.294 1.851 
Within 302936926 462 655708 
   
       Total 455875970 483     
Table 2.2 also shows the large relative standard deviations obtained for elemental 
concentrations observed in sampled forehead patches. This was initially due to variable 
elemental concentrations in the patches themselves prior to forehead sampling and then 
different elemental profiles from participant foreheads themselves. 
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ANOVA was conducted for skin patch samples obtained between both stress and neutral 
sessions (Table 2.3). Between pre and post PASAT intervention samples the observed the 
calculated F value (Fcalc) value of 0.144 (interaction) was smaller than the critical (Fcrit) value 
of 1.902. Between pre and post neutral intervention samples the Fcalc value of 0.294 
(interaction) was smaller than the Fcrit value of 1.902. Due to Fcalc < Fcrit it can be deemed that 
there is no evidence of statistically significant differences (95%) between pre and post 
samples for both interventions and any differences can be attributed to random errors. 
Intriguingly, when grouping pre intervention samples and comparing them with post 
intervention samples from both interventions, ANOVA showed evidence of significant 
differences (95%) resulting in Fcalc (22.825) > Fcrit (4.073) (Table 8.2). However, it must be 
noted that participants conducted these interventions on different day with different 
conditions (e.g. different room temperature). In order to explain why differences may have 
been seen by grouping all pre and post samples, elemental breakdown of patches must first 
be scrutinised.  
Figure 2.6 explains why elemental differences were not detected between the pre and post 
intervention skin patch samples for both the stress and neutral sessions. For five of the ten 
elements detected, concentrations observed in blank patches were much higher than skin 
patches obtained from participant foreheads. Table 2.2 shows that Na concentration in 
blank patches were found to be over 4.5 µg.mL-1 higher than the mean concentration 
obtained between the pre and post participant sample patches, for both the stress and 
neutral interventions. Sn, Zn and S concentrations in the blank patches are also high 
compared to those obtained from the participant skin samples, with an average 
concentration of 119, 68 and 62 ng.mL-1, respectively. There are only small differences for 
Ba, Ti, Cu and Mg between the blank patches and those obtained from the skin whereas the 
concentrations obtained for K and Ca in the participant skin patches are higher than those in 
the blank patches, with concentrations of approximately 60 and 150 ng.mL-1, respectively. 
Pre and post intervention Ca and K changes are significant, as, unlike the other elements, 
these are not drowned by the high elemental concentrations found in the blank patches. 
The elements that decrease in concentration, from the blank patches, when placed onto the 
skin may indicate that they are being absorbed into the skin from the patches. Na decreases 
in concentration so drastically that it is either transferred onto or into the skin upon contact 
with the patches.   
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Figure 2.6. Concentration of detected elements from sweat patches: blank (grey), pre stress intervention (pink), post stress intervention (red), pre 
neutral intervention (white) and post neutral intervention (green). Insert: relative change (%) in concentration between pre and post stress 
intervention (red) and pre and post neutral intervention (white) patches 
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2.2.4 Multivariate Analysis 
Due to high elemental concentrations in the blank patches, MVA was carried out as a 
training exercise rather than a tool to identify potential biomarkers of psychological stress.  
The skin data set consisted of concentrations (ng.mL-1) of the 10 element skin components 
(variables) against the participants (observations).  
 
Figure 2.7. Multivariate analysis (MVA) using blank (black), pre neutral intervention (blue circles), post neutral 
session (blue dots), pre stress session (orange circles) and post stress session (orange dots) sweat patch 
samples. Unsupervised PCA of three elements (A) identified from the S-plot generated from the modelled 
covariance (P(corr)[1]) of the PLS-DA from the concentrations (ng.mL
-1
) of 10 skin components (variables) from 
98 skin patch samples (observations). The three variables highlighted (red squares) were found to provide the 
highest magnitude (concentration) of the variables in the data set and greatest reliability (P(corr)[1] axis) of 
the variables in the data set (B). 
From the ten elements detected by ICP-MS, three elements were selected from the s-plot 
(Figure 2.7 B) created from the PLS-DA model. Using these three variables, PCA was 
performed (Figure 2.7 A). However, PCA did not appear to enable elemental separation 
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between pre and post forehead sweat sample following either intervention. The lack of 
separation was due to the high elemental concentrations observed in the blank patches. 
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2.3 Conclusion 
Ten elements were detected from forehead sweat using the 3MTM TegadermTM +Pads. 
However, analysis of the blank patches revealed high concentrations of those elements 
detected. Although it may be interesting that K concentrations decreased following both 
interventions, comparing the elemental concentrations in the blank patches to those 
obtained from participant forehead patches revealed that concentrations of elements 
decreased in at least eight of those elements. These large concentration decreases could be 
due to absorption of elements from the patches onto the forehead sampling area, through 
forehead pores and into the body. Alternatively, the elemental variability may be due to the 
unknown element amount in the patches themselves. In the blank patches, large 
concentrations of K, Zn, S and Sn were found, whilst there were also relatively large 
concentrations of Ca, K and Ba in comparison to the small amount of Mg, Ti and Cu. 
Consequently, the results presented in this chapter cannot be used to justify elemental 
markers of psychological stress. Also, Ni could not be accurately analysed due to the 
instrument analysis cones used which contained Ni material. In future studies, Pt cones 
should be used if Ni was to be analysed. However, during the analysis of this experiment no 
Pt cones were available.  
Although the elemental concentrations are observed at varied levels in the blank patches 
and the participant patch samples, further washes should be conducted to remove traces of 
impurities off the patches. In order to accurately quantify the concentration changes 
between the interventions, the blank patch elemental concentrations should ideally be as 
little as possible. The patches could be subjected to a series of washes to reduce the level of 
any acidic, basic and ionic components. Alternatively, different patches could be sought. 
Heart rate, blood pressure, galvanic skin response and breath measurements did prove that 
the PASAT intervention used in this study induced psychological stress.87 
Despite this study proving unsuccessful in determining the elemental markers of 
psychological stress, future experiments should incorporate similar patches that have been 
elementally purified in order for any changes in elemental concentrations to prove 
statistically valid. Further to the use of elementally purified patches, in order to repeat this 
study again in the future, that is to study the effect of psychological stress on the elemental 
content of human forehead sweat, participants who have not performed the PASAT will be 
required. This is due to removing any possible memory effects of the intervention which may 
provide a bias for participants.  
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3 The effect of physical stress on elemental content in human 
plasma, skin and urine and the effect on elements, volatile 
organic compounds and small molecules in human saliva  
There are numerous types of stress which are believed to exist yet there is little evidence to 
chemically measure stress in the public domain. As stated in Chapter 1 section 1.2 there are 
a number of physical symptoms associated with the condition but few can be measured. A 
form of stress thought to produce the strongest symptoms is known as physical stress where 
the body reacts to physical exertion.  
The experiment in this chapter sought to identify differences in elemental profiles from a 
variety of biological human samples following an intervention designed to induce physical 
stress. Elemental profiles were obtained by ICP-MS analysis from a number of samples, 
including skin, saliva, urine and plasma. H0: there was no detectable difference in biological 
state following induced physical stress in human participants i.e. H0: PSREST = PSSTRESS. These 
biological samples were identified for the research presented in this chapter as they covered 
the major aspects of human biological pathways, which may chemically change when 
undergoing stress. 
Further to this, data collected from samples analysed by the same method were to be 
stitched together to produce one data set that would enable successful MVA to be 
performed and to identify any major elemental contributors from modelling of this super set 
of data. Finally, data from saliva samples, obtained from participants and analysed by three 
different techniques, was to be combined using a similar method in order to identify major 
biomarkers of stress. 
The experiment in this chapter was devised and carried out by the author (primary 
investigator) in collaboration with Matthew Turner (personal communication), Helen Martin 
(personal communication) and Aditya Malkar (personal communication). Experiments were 
conducted in Prof Ronald Maughan’s laboratory in the School of Sports Exercise and Health 
Sciences (SSEHS) under the supervision of Dr Philip Watson (personal communication), who 
also collected blood from participants. The author was the primary investigator responsible 
for the participant’s welfare and collected all physical measurements, skin samples from the 
participant’s forehead, skin conductivity measurements, saliva samples, rate of perceived 
exertion data and supervised the stress intervention. Matthew Turner collected all breath 
and BioVoc samples whilst Helen Martin prepared skin patch samples prior to sample 
collection, collected cardiovascular data and assisted the author with the stress intervention. 
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Urine was provided by the participant with no aid and blood samples were collected by Dr 
Philip Watson. All samples were separated and prepared for storage by Aditya Malkar. 
Plasma, saliva, skin and urine samples analysed by ICP-MS was performed by the author 
whilst saliva samples for VOC and small molecules were analysed, in addition to processing 
the subsequent data, by Helen Martin and Aditya Malkar, respectively. All elemental data 
analysis and all data harvesting were done by the author.  
3.1 Removing elemental impurities from skin patches to be used for 
skin sampling during physical stress 
Due to high elemental concentrations observed in unconditioned patches in Chapter 2, this 
experiment sort to remove as many of these impurities as possible using a new chemical 
cleaning technique. 3MTM TegadermTM +Pad film dressing with non-adherent pads were the 
chosen patches used for sweat collection. These non-adherent pads are generally used as 
wound dressings due to a number of properties including a sterile dressing with a 
waterproof bacterial barrier consisting of non-adherent absorbent pad bonded to a larger 
thin film dressing. 
The objective of this experiment was to reduce elemental impurities in the patches to be 
used to collect sample sweat. Additionally, once cleaned, patches should be safe to be 
placed on human skin and not be too dry as to break up upon application onto the skin. H0: 
there was no detectable difference in element content of patches following elemental 
purification by solvent washing i.e. H0: PatchBlank = PatchWashed.   
3.1.1 Experimental Outline 
8 skin patches were used in this experiment. 7 of these patches were subjected to a series of 
washes in an attempt to reduce elemental impurities in the patches. Following each wash, 1 
patch was removed and stored until all seven washes had been carried out. Once the wash 
cycle had been completed, elements were leached from the patches in 2% HNO3 followed by 
ICP-MS analysis. Elemental concentrations in all patches were calculated and the amount of 
element reduction was calculated. 
3.1.1.1 Wash tray preparation 
Two plastic trays (750mm (l) x 600mm (w) x 750mm (h)) were cleaned with several washes 
of DI H2O, followed by a wash of aqua regia and a final wash of the proceeding wash solvent. 
The trays were dried under an infra-red heat bulb (Infrasatin, 240-250 V) overnight. 
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3.1.1.2 Patch preparation 
8 patches were removed from their sterile packets and covers on the back were removed to 
expose the adhesive backings of the patches. The cotton pads were extracted from the 
adhesive backings using tweezers. 
3.1.1.3 Blank Patch 
One of the 8 patches was placed into a 15 ml centrifuge tube. This patch was labelled Patch 
0 and not subjected to any washes. Elemental concentrations from this patch were used as a 
reference to calculate the reduction of elemental impurities following each wash. 
3.1.1.4 Patch washes 
7 patches were placed in a plastic tray containing 250 ml of 15% HNO3 for 6 hours to remove 
impurities with basic properties, such as alkali’s that react with water forming X-OH e.g. 
LiOH, NaOH, KOH), that may have been present in the patches. The wash solvent was 
appropriately disposed of and patches were dried in the tray under IR overnight. One patch 
(Patch 1) was removed and placed into a fresh 15 ml centrifuge tube. The remaining 6 
patches were placed in a plastic tray containing 250 ml DI H2O for 6 hours. The DI H2O was 
disposed and patches were dried in the tray under IR overnight after which one patch (Patch 
2) was removed and placed in a 15 ml centrifuge tube. This exact procedure was repeated 
using different washes (in order): 10% TMAH (Patch 3) to remove any acid-soluble impurities 
i.e. oxides formed with elements with low electron affinity e.g. SiO2, SO2, SO3 etc.; DI H2O 
(Patch 4); 0.1M EDTA (Patch 5) to remove any metal impurities by the chelating effect, 
where an octahedral geometry is formed with the EDTA forming six bonds to the metal; DI 
H2O (Patch 6); DI H2O (Patch 7). DI H2O was used to neutralised the patches so there would 
not pose any risk to participant skin. Following each wash, one patch was removed and 
placed in different 15 ml centrifuge tubes (Figure 3.1). This wash order was chosen in order 
to remove impurities from the left to the right of the periodic table in which the direction of 
basicity decreases for elements (lower electron affinity). 
During the time in which one tray was being used to wash the patches, the other tray was 
cleaned with several washes of DI H2O followed by a final wash of aqua regia. The tray was 
dried under IR overnight and the next wash solvent to be used was prepared and inserted 
into the tray.  
3.1.1.5 Sample Analysis 
Following the removal of each patch from the wash cycle, 14 ml of 2% HNO3 was added to 
the centrifuge tubes containing the samples patches (supplementary information Table 
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SI.3.3), in order to leach elemental impurities from the patches into the acid solution. The 
tubes containing the patches were subjected to 60 minutes of mixing on a roller shaker 
(ELMI Ltd, Rigia, Latvia) at 35 rpm. Patches were immediately removed from the centrifuge 
tubes using pre-cleaned (in 2% HNO3) plastic tweezers to ensure minimum contamination. 
The remaining solution in the tubes were then analysed by ICP-MS. 
Elemental detection of twenty four elements was performed using ICP-MS instrument. 
Instrument conditions can be found in (Chapter 1 section 1.3.5). 
3.1.2 Results and Discussion 
A total of eight patch samples were analysed by ICP-MS. From the twenty four elements 
analysed, ten element impurities could be detected in the untreated blank patch (patch 0). 
However, only nine of these ten could be quantified (Figure 3.2). Fe could not be quantified 
but could be detected in only the blank patch (Patch 0). Fe could not be detected in 
subsequent patches following this first wash with 15% HNO3. A very high concentration of 
Na was found in patch 0 at approximately 9000 ng.mL-1, just over twenty five times larger 
than the next largest impurity found, I, which was found at about 350 ng.mL-1. High 
impurities of S and Zn were also observed at approximately 220 and 170 ng.mL-1, 
respectively. Other element impurities observed included Si, Al, K, Ca and P at approximate 
concentrations of 90, 65, 60, 20 and 10 ng.mL-1, respectively (Table 3.1). 
All impurities that could be quantified in patch 0 displayed a general decrease in 
concentration following each successive wash (Figure 3.2). However, following the first wash 
in 15% HNO3 the concentrations of I and Si in the patch doubled whereas all other elemental 
impurities decreased, especially Na. Increasing I and Si concentrations in the patches may be 
due to the impurities present in the 15% HNO3 wash solution. Subsequent to this wash the 
concentration of Na decreased by just over 70%. As a result of this 15% HNO3 wash, any 
contamination of P could not be detected and concentration of K and Zn could be detected 
but not quantified. Concentrations of Al and S also significantly decreased following this 
wash, by approximately 75 and 80%, respectively. Only the concentration of Ca remained 
unchanged after this first wash. 
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Figure 3.1. Experiment outline for skin patch blanking
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Following the second wash in DI H2O, concentrations of Al, S, Ca and I could no longer be 
detected. K was still detected but the concentrations were so low that they could not be 
quantified. Na was still observed at a concentration of 142 ng.mL-1 as well as 44 ng.mL-1 for 
S. After the third wash in 10% TMAH only Na and K concentrations could detected. However, 
only Na could be quantified at 72 ng.mL-1. The concentration of Na decreased in the patches 
subsequent to each wash, until the final wash, in DI H2O, where a concentration of  
17 ng.mL-1 was observed. 
 
Figure 3.2. Concentration of the nine detected elements, by ICP-MS, in skin patches following each patch wash 
3.1.3 Conclusion 
H0 of the experiment was rejected and the alternative hypothesis, there was a detectable 
difference in element content of patches following blanking by solvent washing, was 
accepted, i.e. H0: PatchBlank ≠ PatchWashed. 
All detected elemental impurities in the blank patch were removed from the patches after 
the first three washes, except Na, where concentration levels in the patches was reduced to 
an acceptable level of approximately 20 ng.mL-1 following wash 5 (Patch 5). After a complete 
wash cycle the amount of Na in the patches had been reduced by almost 100% when 
compared to Patch 0. 
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Table 3.1. Concentrations (ng.mL
-1
) of elements in patches from washes by SF-ICP-MS, instrument standard deviation (n=5) shown in brackets. Relative change (%) also shown 
Patch 
Na Al Si P S K Ca Zn I 
[i] RC (%) [i] RC (%) [i] RC (%) [i] RC (%) [i] RC (%) [i] RC (%) [i] RC (%) [i] RC (%) [i] RC (%) 
0 8916 (62)   65 (0)   88 (0)   8 (0)   222 (0)   63 (0)   23 (0)   173 (0)   349 (0)   
1 2440 (63) -72.6 16 (15) -75.1 165 (79) 88.7 < LOD -100.0 46 (37) -79.4 < LOQ -100.0 25 (23) 8.9 < LOQ -100.0 719 (0) 106.2 
2 142 (3.8) -94.2 < LOD -100.0 44 (4.6) -73.1 < LOD   < LOD -100.0 < LOQ   < LOD -100.0 < LOD   < LOD -100.0 
3 72 (0) -49.6 < LOD   < LOD -100.0 < LOD   < LOD   < LOQ   < LOD   < LOD   < LOD   
4 61 (0) -15.0 < LOD   < LOD   < LOD   < LOD   < LOD   < LOD   < LOD   < LOD   
5 19 (0) -69.0 < LOD   < LOD   < LOD   < LOD   < LOD   < LOD   < LOD   < LOD   
6 18 (0) -4.9 < LOD   < LOD   < LOD   < LOD   < LOD   < LOD   < LOD   < LOD   
7 17 (0) -3.6 < LOD   < LOD   < LOD   < LOD   < LOD   < LOD   < LOD   < LOD   
Change, P0 to 
P7 (%) 
99.8 100 100 100 100 100 100 100 100 
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3.2 Analysis of biological fluids from physical stress 
Ten male volunteers aged between 18 and 32 years participated in this study. Participants 
refrained from using soap, shampoo, deodorant and fragrances the night before and the 
morning prior to the start of sample collection. Participants were also asked to record their 
dietary intake two days prior to sample collection and were asked not to go swimming nor 
consume any alcohol during this period. Samples were collected over five consecutive days 
with participants required for one visit. Two participants were sampled on each day with the 
first participant arriving at 0745 hrs. and the second at 1015 hrs. Sample collection typically 
lasted two hours fifteen minutes. The exclusion criteria for this study included participants 
with any pre-existing conditions, such as asthma, any smokers, participants with any 
communicable diseases such as a cold or flu, females, participants outside the age range of 
18 – 35 years old or carrying any injuries that could be aggravated by cycling on a bike for 
thirty minutes. The age restrictions for this experiment were put in place in order to attempt 
to normalise the health of the participant. The male human body within the given age range 
was likely to be in its optimum condition. 
3.2.1 Experimental Outline 
Participants were invited to participate in a single three hour session in which samples of 
breath, blood (plasma), saliva, sweat (skin) and urine were obtained throughout the study as 
well as the participant’s heart rate.  
Once changed into shorts, height and weight of participants were measured outside the 
chamber. A bicycle ergometer (Lode, Groningen, Netherlands) resistance was set at 2 W.Kg-1 
of total participant body weight. In phase A of the experiment approximately 100 ml of 
water (in a plastic cup) was consumed before producing a urine sample in order to normalise 
fluid intake for participants. Two skin patches (one for elemental and the other for VOC 
analysis) were then attached to the participant’s forehead for thirty minutes. A heart rate 
monitor (Polar CS100, Warwick, UK) was attached around the chest and readings were taken 
at pre-determined intervals throughout the experiment. A SensewearTM WMS armband was 
strapped around the right bicep to gauge the galvanic skin response, measuring the 
electrical resistance of the skin which is related to moisture levels at the surface. Drool 
saliva, breath (VOC) and blood samples (right volar) were collected before the skin patches 
were removed from the forehead. 
Phase B (exercise) consisted of the participant cycling at the pre-determined resistance on 
the bicycle ergometer for thirty minutes. Prior to commencing exercise, a second set of skin 
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patches were placed on the participant’s forehead. During exercise, breath samples 
(BioVOC) were also collected for differential mobility spectrometry (DMS) analysis. As soon 
as thirty minutes elapsed, the skin samples were removed and placed into pre-cleaned 
vessels. 
At the end of phase B the participant was escorted back to the sampling area where the 
third set of skin patches was placed onto the forehead to begin phase C. Saliva, breath and 
blood samples were collected. 100 ml of water was given to the participant to swallow 
before producing a urine sample. Patches were removed from the forehead after thirty 
minutes. Phase D was an exact repeat of phase C. At the end of phase D all attached devices 
were removed (Figure 3.3). 
3.2.1.1 Vials preparation 
Blood (plasma): For each participant, sixty 15 ml tubes coated in lithium heparin were 
obtained from the School of Sport, Exercise and Health Sciences (SSEHS), two every time 
blood samples were taken. Five 2 ml LoBind cryogenic tubes (Eppendorf, Stevenage, UK) 
were labelled for each plasma sample resulting in the preparation of 150 cryogenic vials to 
aliquot plasma. Also, ten 2 ml vials were needed for field blanks (one per participant) and 
ten for diluting solvent blanks resulting in a total of 170 cryogenic vials prepared for plasma 
storage.  
Saliva: Ten 30 ml glass vials (Chromacol Ltd, Herts, UK) were prepared for saliva collection. 
Three 2 ml LoBind cryogenic tubes (Eppendorf, Stevenage, UK) were labelled for each saliva 
sample leading to the preparation of 30 cryogenic vials to aliquot saliva. A further twenty 2 
ml vials were prepared for collecting field blanks during sample collection for each 
participant and also vial blanks. As a result, 50 cryogenic aliquot vials were prepared for 
saliva storage. 
Skin: Sixty patches were prepared using the exact method outlined in section 3.1. For each 
subject five patches were used, four for sweat collection from the forehead and one for 
blank patch analysis. The other ten patches were used to collect field blanks, one per 
participant. Once solvent washed, individual patches were placed in 50 ml screw capped 
polypropylene tubes. Prior to patch insertion these tubes were pre cleaned, with 2% HNO3, 
and air dried.  
Urine: A total of thirty 500 ml polyethylene terephthalate (PET) urine containers were 
labelled, one for each urine sample collected. One hundred and fifty 2 ml LoBind cryogenic 
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tubes (Eppendorf, Stevenage, UK) were labelled for storage of aliquots following urine 
collection.  
The order in which sample were collected can be observed in Figure 3.4. Physical, 
physiological, psychological and biological measurements were collected. 
3.2.1.2 Physical Stress 
Physical stress was induced using a Corival electro-magnetically braked bicycle ergometer. 
Participants exercised continuously for 30 minutes, during the stress phase (Phase B) at a 
workload of 2 W/Kg of their body weight. Electro-magnetic braking ensured participants 
always kept working their feet on the pedals. Participants found it more difficult with a low 
rpm as the electro-magnetic braking would have higher resistance. Consequently, 
participants tried to keep a consistent rpm where a rhythm was found.  
3.2.1.3 Weight & Height 
Body assessment was carried out prior to sample collection. Before entering the 
environment chamber, and whilst wearing only shorts and trainers, participants’ weight and 
height were measured to determine the resistance of the bicycle ergometer and also BMI. 
3.2.1.4 Physiological Measurements 
A polar heart rate belt was fitted around the participant’s chest upon arrival. This remained 
in place for the duration of the experiment, when it was removed. Heart rate readings were 
visualised using a watch that was paired to the monitor on the strap. Phase A readings, 
known as the baseline readings, were logged every ten minutes and included the start 
reading. Physical stress readings were recorded every five minutes during phase B. Phase B 
commenced when the participant started exercising and finished when thirty minutes of 
exercise had elapsed. These two readings were also noted. Measurements were taken every 
ten minutes during the two recovery phases 1 (phase C) and 2 (phase D). Also of note was 
the heart rate reading at the end of experiment, at the end of recovery phase 2. All phases 
were intended to last thirty minutes resulting in two hours of sample and measurement 
collection.  
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Figure 3.3. Study outline for sample collection and analysis by ICP-MS in physical stress study 
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Figure 3.4. Physical stress sample collection timeline
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GSR measurements were also recorded for each participant, using the same device 
described in Chapter 2 section 2.1.1. The SensewearTM WMS armband. Continuous GSR 
measurements were obtained from when the armband was placed on the left bicep of 
participants, activating the device, to when the armband was removed at the end of the 
experiment, deactivating the device. Four notable time stamps were taken for each 
participant, the automatic time stamps when activating and deactivating the device, at the 
start and end of the experiment, and also two manual time stamps (by pressing the Time 
Stamp button on the device) at the end of Phase A, when skin patches were removed, and at 
the beginning of Phase B, when cycling started. 
3.2.1.5 Psychological Measurements 
Rating of Perceived Exertion (RPE) was used to determine exercise intensity levels. Perceived 
exertion is how hard the participant felt their body was working based on physical 
sensations experienced during physical activity, including increased heart rate, increased 
sweating, increased respiration or breathing rate, and muscle fatigue. Although a subjective 
measure, the RPE rating may provide a good estimate of actual heart rate during physical 
exercise. Borg found a high correlation between a person’s RPE and their actual heart rate 
during physical activity.88 The rating scale ranges from 6 to 20, where 6 proposes “no 
exertion at all” and 20 suggest “maximal exertion.” Generally, practitioners agree that an 
RPE rating between 12 and 14 on the Borg Scale suggests physical activity is being 
performed at a moderate level of intensity. THE RPE scale was used ten times during the 30 
minute physical stress phase (Phase B) as participants were asked to rate the RPE every 3 
minutes. 
3.2.1.6 Biological Sample Collection 
Urine, skin patch samples, saliva and blood were collected from each participant at pre-
determined stage throughout the study (Figure 3.4). 
Urine: Participants provided a total of three urine samples in the experiment during the 
baseline and recovery phases. During phase A, urine was collected immediately after the 
height and weight measurements were taken and before the Phase A skin patches were 
applied to the participant forehead. During phases C and D urine was collected following the 
collection of all other samples. During these two recovery phases, urine was collected into a 
500 ml polyethylene terephthalate (PET) container while skin patches were in place on the 
participant forehead. The container was then screw capped and handed back to the sample 
handler who would aliquot 1 ml of urine into labelled 2 ml vials. Aliquots were immediately 
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placed onto dry ice at -20°C. Prior to collecting each urine sample, participants were asked 
to consume 100 ml in order to regulate fluid intake and normalise creatinine clearance.  
Skin Patches: Four forehead skin patch samples were collected from each participant for 
thirty minutes for the duration of each phase. Prior to sampling the phase A patch, the 
participant forehead was wiped with DI H2O using a pre-cleaned cotton pad, ensuring any 
possible environmental impurities on the forehead were removed. Cleaned patches were 
removed from 50 ml centrifuge tubes using polypropylene tweezers and applied to the 
forehead. The patches were held using pre cleaned cotton pads attached with surgical tape 
to the forehead. Once thirty minutes had elapsed, the tape and cotton pads were carefully 
removed and the sample patch was extracted from the forehead using tweezers and placed 
directly into the 50 ml storage centrifuge tube. Field blanks were also collected for each 
participant. Upon participant arrival, the tube containing the field blank patch was 
unscrewed and left in the environmental chambers, until collection of samples was complete 
and participant left the chamber. At this point the top of the tube was screwed back on. One 
un-sampled, pre-blanked, patch blank was also collected for each participant. 
Following the end of sample collection for each day, all patch tubes were transported back 
to the Department of Chemistry where 15 ml of 2% HNO3 was added to each tube containing 
the sampled skin patch to leach elements from patches. These were left on a roller mixer at 
a tilt of 5° for 60 minutes. Patches were removed using pre-cleaned tweezers and disposed 
of appropriately. The tubes containing the sampled solutions were then stored at room 
temperature until the day of analysis. 
Saliva: Three drool saliva samples were collected following the application of forehead skin 
patches. These samples were collected in 30 ml glass vials during the baseline and recovery 
phases (A, C and D). Participants were asked to rinse their mouth out, 10 minutes prior to 
sample collection, to clean the mouth and to stimulate saliva production. Five minutes of 
time was allocated for each sample of saliva in which participants were asked to place the 
head forward (looking at the floor), allowing saliva to pool at the front of their mouth and 
when ready to drool (not to force) saliva into the provided sample tube. The 20 ml collection 
tube was then screw capped and handed to the sample handler who would aliquot 500 µl of 
saliva into labelled 2 ml vials. Aliquots were immediately placed onto dry ice at -20°C. 
Blood (plasma): At three pre-determined sample points a total of six whole blood samples 
were taken from the left volar (AE) of each participant. The left arm was used to collect 
blood due to the collection of GSR measurements from the upper right arm. Blood was 
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collected, following saliva collection and prior to removal of the skin patch samples in the 
baseline and recovery phases (A, C and D), using a butterfly cannula and 15 ml collection 
tubes coated in lithium heparin. For each sample point the cannula was inserted into the 
volar (AE) and two tubes of 10 ml blood were collected (20 ml in total for each sample 
point). Collected whole blood was handed to the sample handler who spun the blood down 
to approximately 50%, using a refrigerated centrifuge for 15 minutes at 2,000 x g, in order to 
extract the plasma. With the vial placed in ice between 2-8°C, the top layer, containing only 
the blood plasma, was then extracted using a pipette and separated into aliquots of 500 µl 
into labelled 2 ml tubes. Aliquots were immediately placed onto dry ice at -20°C. 
3.2.1.7 Sample Storage 
Following collection and aliquot separation, urine, saliva and plasma were initially stored on 
dry ice at -20°C. Concluding sample collection for each participant, samples were stored in 
purpose constructed polystyrene storage containers and placed in -80°C freezers. 
3.2.1.8 Sample Preparation 
Saliva, urine and plasma samples were stored at -80°C until the day of analysis. Samples 
were allowed to thaw at room temperature for 1 hour after which all samples were 
homogenised using a vortex mixer. Skin patches were prepared for analysis on day of sample 
collection. 
Skin patches: Pre analysis preparations for skin patches are outlined in section 3.2.1.6. Prior 
to elemental analysis, 50 ng.mL-1 In was added to all samples as an internal standard 
(supplementary information Table SI.3.3).  
Saliva: Samples were stored between 144 and 164 days. Following homogenisation, all 
samples were diluted in 2% HNO3 and 60 ng.mL
-1 In was added as an internal standard to 
give a dilution factor of approximately 1:20 (saliva to total volume), in 15 ml polypropylene 
centrifuge tubes (supplementary information Table SI.3.5). 
Urine: Urine samples were stored between 229 and 274 days before analysis. Once thawed 
and homogenised on day of analysis, samples were diluted fivefold with 2% HNO3 and 50 
ng.mL-1 Ru was added as an internal standard in 15 ml polypropylene centrifuge tubes 
(supplementary information Table SI.3.7). 
Plasma: Storage of plasma samples lasted between 525 and 529 days. Once homogenised on 
the day of analysis, plasma samples were diluted fifty fold using 2% HNO3 in 15 ml 
polypropylene centrifuge tubes (supplementary information Table SI.3.9). An external 
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standard, to monitor the stability of the instrument, containing 5 ng.mL-1 MES1, MES2 and 
MES4 (Spex Certi Prep) was prepared and analysed between each sample during an analysis 
sequence on the ICP-MS. 
3.2.1.9 ICP-MS Analysis 
Elemental analysis of the four biological samples above was performed using ICP-MS. 
Instrument conditions can be found in Chapter 1 section 1.3.5. 
3.3 Results and Discussion 
In addition to the physiological measurements, data acquired from biological sample 
measurements are also presented in this section. Using the heart rate data, which was 
obtained throughout the experimental phases for all participants, alongside body mass index 
and rate of perceived exertion data, a newly formulated equation was constructed to 
measure participant physical stress scores. MVA and descriptive statistics was performed 
using the data obtained from ICP-MS data that included the analysis of twenty four elements 
in sixty skin patch samples, twenty seven elements in twenty seven saliva samples, twenty 
seven elements in thirty urine samples and thirty five elements in twenty four plasma 
samples. Using common observations and variables between the elements and participants 
from the four biological sample types, the exploration of patterns in data was analysed using 
MVA. Further to this, common observations and variables in elemental (ICP-MS), VOC (TD-
GC-MS) and small molecules (UPLC-IM-MS) data were also analysed using five participants. 
3.3.1 Physiological measurements 
Individual heart rate was collected throughout the experimental period and the average 
observations show the relative change in cardiovascular responses during the stress phase. 
Participant heart rates remained stable for the initial thirty minutes of the study, while 
baseline measurements were obtained. During the stress phase (phase B) participant heart 
rate significantly increased. Initially, this considerable increase was the consequence to 
urgently distribute oxygen around the body following the work required for exercise. 
Towards the end of phase B the heart rate only increased gradually as the work forced on 
the heart reached its maximum. 
Paired t-tests were carried out to find if any significant difference in heart rate between the 
four phases existed. H0: There was no difference in heart rate between the non-exercise and 
exercise phases (Appendix Table 8.8). Evidence of significant differences (H0 rejected) in 
participant heart rates were present for all ten participants between phases A and B, nine 
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participants between phases B and C and only three participants between phases C and D. 
This statistical evidence along with the heart readings confirms that participant heart rate 
did increase between rest and exercise, during phases A and B, respectively. Recovery then 
began in the following phase (phase C) for all participants except participant CZ9 whose 
heart rate was still very high and thus recovery was slower. Between phases C and D only 
participants CZ3, CZ8 and CZ9 had heart rate readings that had not stabilised whilst all other 
participant heart rates had stabilised. Interestingly, nine out of ten participant heart rates 
were found to be significantly different between phases A and D. Observing the heart rate 
data shows that whilst heart rates for the majority of participants had stabilised, the 
readings were higher following stress compared to prior to the intervention during phase B. 
 
Figure 3.5. Mean relative change for heart rate responses (∆HR) of 10 male participants over the 120 minute 
session. The error bars designate 95% confidence limit on the mean 
3.3.1.1 Physical Stress Response Scores 
Participants’ individual cardiovascular response to the stress intervention was scored on the 
basis of observed changes in their heart rate and BMI. The equation was adapted from the 
physical stress response score (Equation 2.1) created by Matthew Turner.87 The relative 
change (∆HR (%)) of the individual’s heart rate was calculated by first subtracting the 
maximum heart observed during phase B (HRMAX) from the baseline heart rate (HR0), which 
was calculated by averaging readings taken during phase A, and then dividing the resulting 
value by HRMAX. This number was multiplied by 100. ∆HR (%) was then multiplied by ∆HR. 
The final operation was multiplying this overall answer by the BMI, which was calculated by 
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dividing the individual’s weight (W), in kilograms, by the height2 (H2), in meters2. Equation 
3.1 defines the Physical stress response score (SRPHY). 
 
           (     
   
     
      
  
where 
    (   
(           
   
       
(Equation 3.1) 
and 
    
(           
     
 
and 
    
 
  
 
 
The SRPHY was devised to emphasize the individuals showing largest cardiovascular response 
during phase B. The SRPHY scores for the participants are summarised in Table 3.2. The SRPHY 
score where individuals with a lower score were said to not be stressed was calculated as 
SRPHY = 1099. This was calculated by using Equation 3.1 and removing the phase B and first 
two phase C heart rate readings from the individual with the highest SRPHY which was 
participant CZ9. Therefore participant CZ6 (SRPHY = 917) was not under physical stress during 
his trial whereas all the other nine participants were said to be under physical stress. It was 
later discovered that CZ6 was an athlete who trained at least days a week and therefore less 
susceptible to stress given the workload. The average response for the nine participants was 
a SRPHY of 2497 ± 1107. 
 Table 3.2. Physical stress response scores of participants during the exercise phase (SRPHY) 
Ref. 1 2 3 4 5 6 7 8 9 10 
BMI 22.3 24.4 23.1 21.7 23.8 22.4 25.1 27.8 32.1 31.4 
RPEMAX 11 18 15 14 15 11 18 19 20 19 
HR0 58 64 75 63 70 61 75 69 82 58 
HRMAX 152 173 159 169 188 114 182 176 218 154 
∆HR (%) 164 172 113 169 168 88 142 156 166 167 
∆HR/HRMAX 0.62 0.63 0.53 0.63 0.63 0.47 0.59 0.61 0.62 0.63 
SRPHY 2274 2664 1390 2310 2498 917 2089 2654 3323 3272 
SRPHY
N* 0.68 0.80 0.42 0.70 0.75 0.28 0.63 0.80 1.00 0.98 
*SRPHY normalised to highest SRPHY obtained from all participants in the study 
Despite a constant workload throughout phase B, participants felt they were working harder 
as the 30 minutes elapsed and this was reflected in the RPE scores. The average RPE 
response for all participants was 13.7 ± 6.7. However, for the scores between 0-15 minutes 
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was 12.6 ± 5.6 whilst those observed between 16-30 minutes were higher with an average 
RPE score of 14.7 ± 4.7. This data suggests that the participants felt that more physical stress 
was exerted in the second part of the intervention when compared to the first part. Also, 
less variability was observed in the second part of the intervention where participants felt a 
varying degree of stress in the first part. 
 
Figure 3.6. The correlation between physical stress response score (SRPHY) and rating of perceived exertion 
(RPE). Black dots show average of two data points. 
Interestingly, when this psychological RPE score is compared against the SRPHY score, a weak 
positive correlation is identified (Figure 3.6). Generally, participants who gave a higher RPE 
score were found to have a high SRPHY score indicating they were able to assess their physical 
state well.  
3.3.2 Skin Patches 
60 participant skin patches were stored between 73 and 86 days and were analysed over a 
13 day period by ICP-MS. 6 analytical sequences were conducted over 3 days 
(supplementary information Table SI.3.3). For each sample patch, element concentrations 
obtained from corresponding blank and field blank patches were subtracted. 10 elements 
were detected in participant skin patches from the 24 elements that were analysed. 
It is a possibility that elemental markers discovered from forehead skin may possibly show 
the effect of physical stress occurring at a different site in the body. For example, it is known 
that one of the biological pathways for forehead sweat glands is the digestive system 
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(stomach). Consequently, elemental changes in forehead skin, such as those observed for 
the elements K, S, Ca, Mg and Na, may in fact point to the differences in elemental 
concentrations released via the stomach following physical stress. 
3.3.2.1 Multivariate Analysis 
The skin data set used for MVA consisted of the 10 detected element concentrations 
(variables) against the participants’ skin patches (observations). PLS-DA was initially 
performed on skin patches obtained from all four phases of the study. The S-plot generated 
from this statistical model (Figure 3.7) indicated five potential elements from forehead skin 
that changed in response to induced physical stress experienced by the participants; Na, Mg, 
S, K and Ca. PCA of these five elements enabled separation between the baseline (phase A) 
and the physical stress (phase B) observations. This score plot, in addition to the recovery 
observations, is given in Figure 3.7. 
In Figure 3.7 responses from phases A and B appear separated. Phase A observations are 
clustered relatively close to each other, in two groups, whilst phase B observations can be 
observed in two clusters, away from phase A observations. Although a distinction can be 
made for between baseline and stress measurements, the two phase A clusters could 
indicate two groups of elemental biomarkers between the stress observations themselves. 
Observations CZ8 and CZ2 are almost adjacent to the two clusters where the stress 
observations are located suggesting that participant 2 and 8 have an initial slow stress 
recovery. However, both participant observations for the final recovery phase appear to be 
clustered with all other final recovery observations indicating that between thirty minutes 
and sixty minutes following stress their elemental levels found in skin are closer to those 
observed during phase A (baseline values) and thus all participants have recovered by then. 
Interestingly, participant 9 shows the slowest recovery and is not fully recovered to baseline 
levels by the time the experiment is completed. The final recovery observation, CZ9 D in 
Figure 3.7, shows that the blue observation is grouped within the first recovery 
observations, which have yet to fully recover following the physical stress. Participants 1, 6 
and 10, are the quickest to recover following physical stress due to the grouping of the 
observations CZ1 C, CZ6 C and CZ10 D, respectively, within the final recovery (phase D) 
observations.  The principal components identified exhibit 86.3% [PC1] and 12.5% [PC2] of 
the total explained variance of the data set for physical stress yielding a 100% sensitivity (% 
of correctly assigned true positive observations) for the physical stress observations and 
100% selectivity (% of correctly assigned true negative observations) for the baseline 
measurements. 
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Figure 3.7. Top: PCA scatter plot of five stress sensitive skin components identified from PLS-DA s-plot on 10 
observations each from the baseline (black dots), physical stress (red dots), recovery phase 1 (green dots) and 
recovery phase 2 (blue dots) measurements from ten male participants. 100% sensitivity was obtained for 
stress phase observations and 100% selectivity was obtained for baseline measurements. These were 
calculated using the dotted line running through the ellipse obtained from the score plot dendrogram Bottom: 
S-plot generated from the modelled covariance (P(corr)[1]) and modelled correlation (p[1]) of the PLS-DA from 
the concentration of 10 skin sensitive elements  (variables) from  40 skin samples (observations). The five 
variables highlighted (red square) were found to provide the highest magnitude (concentration) of variables in 
the data set and greatest reliability (P(corr)[1]axis) of the variables in the data set, indicating potential 
elements sensitive to exercise 
3.3.2.2 Descriptive statistics 
For the detected elemental concentrations, ANOVA (two-factor) was performed for skin 
patch samples which were grouped into the four phases. A significant difference was 
observed (95%) between the sample groups with a calculated F value of 14.60 which was 
much higher than the critical F value of 2.63 (Appendix Table 8.4). Subsequently, a paired t-
Two clusters  
during phase BCZ8 & CZ2 still 
stressed in phase C
Recovering 
from stress
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test was carried out on normalised data (log10) to determine if skin patch concentrations 
were statistically different between different phases (Table 3.3). For this test, H0 implied that 
no differences in element concentrations in participant skin patches were present between 
the four phases. From the ten elements detected, H0 was rejected between phases A 
(baseline) and B (stress) for the six elements Mg, Al, P, S, K and Ca. The largest relative 
increase from these six was observed for K (13500%) followed by Mg (5550%) and S 
(2900%). P increased by 1200% whilst Al and Ca also increased by 400% and 300% 
respectively. This increase suggests that these elements have been secreted through the 
pores on the forehead and absorbed into the skin patch. 
Table 3.3. Concentration (ng.mL
-1
), change (%) and paired t-test (P) results of 10 detected elements found from 
participant skin patches for each phase. Bold values indicate statistical significance at 95% 
Phase Na Mg Al Si P S K Ca Cu Zn 
A 
μ 45 1 1 7 2 10 84 70 2 101 
σ 61 4 5 12 6 17 123 175 4 273 
B 
μ 7617 70 8 6 27 303 11479 275 4 37 
σ 13095 28 11 9 21 136 6347 96 2 94 
C 
μ 3371 7 2 8 6 108 1112 101 1 6 
σ 4365 18 6 13 16 281 1577 223 2 11 
D 
μ 236 0 3 9 0 7 95 25 0 6 
σ 497 0 6 20 0 11 157 41 0 11 
Between phases 
          
∆
(%
) 
A & B 16968  5550  431  -13  1252  2937  13606  294  118  -63  
B & C -56  -90  -77  25  -76  -64  -90  -63  -76  -83  
C & D -93  -100  67  14  -100  -93  -91  -75  -100  -8  
A & D 428  -100  101  24  -100  -29  14  -64  -100  -94  
t 
te
st
 (
P
) 
A & B 0.101 0.000 0.005 0.812 0.004 0.000 0.000 0.006 0.255 0.514 
B & C 0.393 0.001 0.011 0.717 0.036 0.033 0.001 0.068 0.018 0.323 
B & D 0.112 0.000 0.023 0.719 0.002 0.000 0.000 0.000 0.000 0.334 
C & D 0.042 0.199 0.377 0.914 0.187 0.280 0.071 0.323 0.134 0.895 
A & D 0.246 0.584 0.113 0.841 0.344 0.743 0.787 0.465 0.272 0.301 
No statistically significant decreases in elemental concentrations were observed between 
the phase A and B. H0 was also rejected between phases B (stress) and C (recovery phase 1) 
for six elements Mg, Al, P, S, K and Cu. Intriguingly, all six element concentrations 
immediately decrease following the stress phase. Between the end of phase B and the first 
recovery phase element concentrations changed for Mg, Al, P, S, K and Cu by -90, -77, -76, -
64, -90 and -76 %, respectively, suggesting that recovery was underway immediately 
following the stress phase. H0 was accepted for all elements between the two recovery 
phases (B and C) except for Na, where there was evidence of significant difference. 
However, between phases A (baseline) and D (recovery phase 2) H0 was accepted for all 
elements using this statistical test and therefore there was no statistically significant 
evidence of a difference. This could also suggest that elemental concentrations in participant 
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forehead skin patches have returned to baseline levels observed prior to the physical stress 
intervention. 
This is confirmed in Table 3.3 as all detected elemental concentrations between phases A 
and D are similar when compared to the stress phase, B, where elemental concentrations for 
the six elements previously mentioned increased.  
 
Figure 3.8. Scatter plot showing the average concentration (n = 10) of the six elements where statistical 
significance was observed for baseline (black), physical stress (red), recovery 1 (green) and recovery 2 (blue) 
participant skin patch samples 
This trend is reiterated in Figure 3.8, which displays the concentrations of the six detected 
elements. Elemental skin patch concentrations increase to their highest concentration 
during the stress phase before reducing to somewhere between the concentrations found 
for the phase A and B, for the first recovery phase, before returning close to the phase A 
concentrations during the second recovery phase. 
3.3.3 Saliva 
27 participant drool saliva samples were collected. However, only 7 complete sets of 
samples were collected. For participants CZ3, CZ7 and CZ10 saliva from only two out of the 
three sample points were collected due to lack of saliva production as a consequence of 
dehydration. Consequently, the data for these participants have been excluded from the 
following statistics. Samples were stored between 144 and 164 days and were analysed over 
a 20 day period by ICP-MS. 7 analytical sequences were conducted over 16 days 
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(supplementary information Table SI.3.5). Calibration standards were used to calculate 
elemental concentrations and corrected using an In internal standard. Element 
concentrations obtained from the dilution matrix (2% HNO3) and collection tube blanks were 
then removed from each participant sample. 8 elements were detected in participant drool 
saliva from the 27 elements that were analysed (supplementary information Table SI.3.6). 
3.3.3.1 Multivariate Analysis 
The saliva data set consisted of the concentrations of 8 detected elements (variables) 
against the participants’ drool saliva samples (observations). PLS-DA was initially performed 
on the saliva data set collected from the three phases of the study. The S-plot generated 
from this statistical model (Figure 3.9) indicated five potential elements from drool saliva 
changed in response to physical stress experience by the participants; Na, P, S, K and I. PCA 
of these five elements provided some separation between baseline (phase A) and recovery 2 
(phase D) observations (Figure 3.9). The principal components identified exhibit 99.3% [PC1] 
and 0.6% [PC2] of the total explained variance of the data set for physical stress yielding a 
71.4% sensitive for recovery 1 observations and 71.4% selectivity for the baseline 
measurements. 
Although some separation is observed there are no clear patterns in the data from MVA. 
However, examining the individual observations for each participant showed varying 
elemental changes in saliva resulting from physical stress for each participant. Observations 
A and C for participants 2 and 4 are close together whereas there is a definite change when 
compared to the corresponding phase D observations. For participants 1 and 5, phase A 
observations appear to be different to the corresponding phases C and D observations, 
which are similar. The phase C observation differs from phases A and D observations for 
participant 6, which could possibly suggest good recovery, whereas there is only a negligible 
change in phases A, C and D for participants 8 and 9. Possibly, this could suggest that 
participant 6’ elemental saliva composition changes quickly and followed by the quickest 
recovery whereas the elemental change in saliva for participants 8 and 9 either does not 
change at all or the change was too slow to observe over the given time period. Somewhere 
in between these two extremes are participants 1 and 5 whose elemental saliva composition 
appears to change reasonably quickly but the recovery is slow whereas participants 2 and 4 
appear to have a delayed change in elemental saliva composition and an even slower 
recovery.  
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Figure 3.9. Top: PCA scatter plot of five stress sensitive saliva components identified from PLS-DA s-plot on 7 
observations each from the baseline (black dots), recovery phase 1 (green dots) and recovery phase 2 (blue 
dots) measurements from seven male participants. 71.4% sensitivity was obtained immediately following the 
stress phase and 71.4% selectivity was obtained for baseline measurements. Bottom: S-plot generated from 
the modelled covariance (P(corr)[1]) and modelled correlation (p[1]) of the PLS-DA from the concentration of 8 
saliva sensitive elements  (variables) from 27 saliva samples (observations). The five variables highlighted (red 
square) were found to provide the highest magnitude (concentration) of variables in the data set and greatest 
reliability (P(corr)[1]axis) of the variables in the data set, indicating potential elements sensitive to exercise 
3.3.3.2 Descriptive Statistics 
The major elemental contributions in the composition of human saliva are from the 
presence of K, P and Na (Table 3.4). ANOVA (two-factor) was performed using the elemental 
concentrations of the saliva collected from three phases. The calculated F value (1.49) was 
lower than the critical F value (3.06) therefore no statistically significant evidence was 
observed to suggest the presence of a significant difference (95%) between the groups 
(Appendix Table 8.5). 
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Table 3.4. Concentration (ng.mL-1), change (%) and paired t-test (P) results of 8 detected elements found 
from participant drool saliva collected from three phases. Bold values indicate statistical significance at 95% 
Phase Na Mg Si P S K Zn I 
A 
µ 21635 763 92 25917 6883 63621 25 7216 
σ 13828 622 67 11307 4123 58870 28 9434 
C 
µ 21945 689 72 22189 5684 42507 19 3628 
σ 11265 298 18 6627 2280 31810 12 3656 
D 
µ 22024 610 68 20441 4723 31577 21 2678 
σ 7315 235 39 4210 1504 43072 13 2033 
Between phases 
        
∆
 (
%
) A to C 1  -10  -21  -14  -17  -33  -24  -50  
C to D 0  -12  -6  -8  -17  -26  12  -26  
A to D 2  -20  -26  -21  -31  -50  -15  -63  
t 
te
st
 (
P
) A to C 0.886 0.834 0.903 0.124 0.177 0.865 0.429 0.006 
C to D 0.507 0.251 0.267 0.565 0.079 0.372 0.295 0.066 
A to D 0.461 0.598 0.252 0.128 0.029 0.367 0.492 0.012 
A paired t-test was carried out on normalised saliva data (log10) to find significant evidence 
of differences in elemental saliva between the phases in which the samples were collected 
(Table 3.4). H0: no differences in elements from participant saliva were present between the 
phases where the samples were collected. H0 was rejected between phases A and D for S 
(50% decrease) and between the phases A to C (50% decrease) and A to D (63% decrease) 
for I. All elements in participant saliva samples decreased in concentration following each 
phase of the study except for Na, which remained constant, and Zn between phases C and D, 
which increased between these phases after initially dropping in concentration between 
phases A and C.  
Interestingly, a high but unexpected level of I is observed. It is known that salivary glands 
secrete iodide in the saliva at a concentration higher than in the plasma. In the majority of 
the population iodine is introduced into the body via dietary intake. Furthermore, Iodine has 
an important role to play in oral mucosa and in salivary glands physiology. Salivary glands 
derived from primitive I-concentrating oral cells, migrate and specialise in secretion of saliva 
and iodine. Gastro salivary clearance and secretions of iodides are a considerable part of 
gastro-intestinal cycle of iodides, which constitutes to about 23% of iodides pool in the 
human body.89 An unexpected Si concentration is also recorded in the saliva data. It is 
believed that the presence of Si in the elemental saliva samples is due to the collection 
method of VOC saliva, which used a polydimethylsiloxane (PDMS) rod, as this rod was 
inserted into the mouth prior to elemental saliva sample collection. 
Elemental changes found in saliva may be an indication of stress affects from around the 
body as many of the major biological pathways are connected to the salivary glands in the 
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mouth. However, the data presents that changes in elemental concentrations in salvia, as a 
result of physical stress, are slower than the timeframe of the experimental time used in this 
study. 
3.3.4 Urine 
30 participant urine samples were split into 3 replicates and stored between 229 and 274 
days. 91 urine samples were analysed over a 45 day period by ICP-MS. 10 analytical 
sequences were conducted over 8 days (supplementary information Table 4.7). For each 
sample, concentrations were determined using calibration curves and a Ru internal 
standard. Blank elemental concentrations were subtracted from those obtained from the 
two urine collection pots analysed. 8 elements were detected from the 27 elements 
analysed (supplementary information Table SI.3.8). 
3.3.4.1 Multivariate Analysis 
Eight detected element concentrations (variables) against participants’ urine samples 
(observations) were used to construct the urine data set. PLS-DA was originally performed 
using the concentrations obtained from the three phases of the study after which an s-plot 
was modelled using this supervised model (Figure 3.10). From the s-plot two potential 
elemental biomarkers in urine as a result of stress were identified; S and K. PCA of these two 
elements displayed a separation between the baseline (phase A) and recovery 1 (phase C) 
observation with two principal components displaying 93.5% [PC1] and 4.44% [PC2] of the 
total explained variance of the data set for physical stress yielding 80% sensitivity for the 
recovery 1 measurements and 60% selectivity for the baseline measurements. Figure 3.10 
clearly shows a cluster of observations for recovery 2, whilst the baseline observations are 
scattered and the recovery 1 observations are clustered together. This could suggest that 
following stress there are different changes in elemental concentrations for urine showing 
elemental stress markers whilst recovery 2 concentrations all change towards the 
observations for the initial baseline concentrations. A few recovery 2 observations, back on 
the same side as the baseline observation are also similarly scattered to show the recovery 
in the participants’ kidneys following physical stress. However, a number of recovery 2 
observations are within or close to the recovery 1 cluster suggested that stress recovery in 
these participants are slow where participants have not fully recovered even one hour after 
the thirty minute intervention. 
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Figure 3.10. Top: PCA scatter plot of two stress sensitive urine components identified from PLS-DA s-plot on 10 
observations each from the baseline (black dots), recovery phase 1 (green dots) and recovery phase 2 (blue 
dots) measurements from ten male participants. 80% sensitivity was obtained immediately following the 
stress phase and 60% selectivity was obtained for baseline measurements. Bottom: S-plot generated from the 
modelled covariance (P(corr)[1]) and modelled correlation (p[1]) of the PLS-DA from the concentration of 8 
urine sensitive elements  (variables) from 40 saliva samples (observations). The two variables highlighted (red 
square) were found to provide the highest magnitude (concentration) of variables in the data set and greatest 
reliability (P(corr)[1]axis) of the variables in the data set, indicating potential elements sensitive to exercise 
3.3.4.2 Descriptive Statistics 
Eight elements were detected in participant urine samples mainly comprising of K, P and S. 
Other notable contributors included Mg, Ca and Si whilst small amounts of Zn and Mo were 
also detected. Large changes were observed for all elements detected between all phases 
with notable changes between phases A and C for P (-72%), Mg (-51%) and Zn (-51%), 
between phases C and D for Mg (269%), Zn (241%), Si (163%), P (162%) and S (162%), and 
between phases A and D for Si (97%) and Mg (82%). ANOVA (two-factor) indicated a 
significant difference (95%) was present between the baseline and recovery measurements 
Immediately 
following 
stress
Baseline 
observations
Slow 
recovery
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with a calculated F value (6.00) higher than the critical F value (3.04) proving statistically 
significant differences (Appendix Table 8.6). A paired t-test on normalised data (log10), to 
find any statistically significant evidence of differences, was carried out where H0 indicated 
no elemental differences were present in urine between the three phases (Table 3.5). 
H0 was rejected for seven elements in thirteen of the twenty six tests conducted. Significant 
differences were present between phases A and C for Mg, P, S, and Ca, between phases C 
and D for Mg, Si, P, S, K, Ca and Zn, and between phases A and D for Si and Zn. Interestingly, 
all the element concentrations in urine decrease, from those observed for the baseline 
readings, following physical stress. This effect is more than likely due to initial dehydration 
as the participants worked their bodies producing sweat and thus reducing the need to 
excrete excess water. All elemental concentrations then increase during the recovery phase 
back to or above the baseline concentrations. 
Table 3.5. Concentration (ng.mL
-1
), change (%) and paired t-test (P) results of 8 detected elements found 
from participant urine collected from three phases. Bold values indicate statistical significance at 95% 
Phase Mg Si P S K Ca Zn Mo 
A 
µ 185237 8709 1443731 1346512 3973237 52886 370 65 
σ  194955 7898 1469400 954312 2350893 45259 348 83 
C 
µ 91227 6523 399375 824114 2996548 32373 183 40 
σ  89387 7061 484237 533712 1830530 27423 218 69 
D 
µ 336434 17145 1045054 2157910 5526014 59413 622 38 
σ  307050 12934 779039 1331612 2612786 41284 347 38 
Between phases 
         
∆
 (
%
) A to C -51  -25  -72  -39  -25  -39  -51  -38  
C to D 269  163  162  162  84  84  241  -6  
A to D 82  97  -28  60  39  12  68  -42  
t 
te
st
 (
P
) A to C 0.015  0.113  0.005  0.018  0.188  0.038  0.343  0.150  
C to D 0.000 0.000 0.006 0.001 0.002 0.003 0.007 0.799 
A to D 0.069  0.004  0.953  0.085  0.167  0.362  0.048  0.440  
Urine is secreted in the kidneys, which extract soluble waste by cleaning the bloodstream as 
well as waters, sugars and other compounds including poisons. Elemental changes 
discovered from urine following physical stress may indicate build of possible toxic 
compounds within the body. The elements detected are those that have been excreted via 
the urine suggesting any increase in elemental concentration following physical stress 
required any build-up of excess waters, sugars or toxins to be excreted in order to protect 
the body. 
3.3.5 Plasma 
Oxygenated blood travels around the body from the left side of the heart to the tissues and 
then back to the right side of the heart and therefore collected blood had been circulated 
around the body which may show effects of physical stress. 
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Plasma was analysed instead of whole blood because it is free of minerals, proteins and 
nutrients. Plasma is left behind when blood is rid of red cells leaving a yellow colour and its 
components are majority water and blood. 24 participant plasma samples were stored 
between 525 and 529 days and were analysed by ICP-MS over a 2 day period with 1 
analytical sequence performed on each day (supplementary information Table SI.3.9). 
Elemental concentrations were calculated using calibration curves and corrected by a 5 
ng.mL-1 multi-element external standard. 7 elements were detected from the 55 elements 
analysed (supplementary information Table SI.3.10). Participants CZ8, CZ9 and CZ10 samples 
have not been included due to incomplete sample sets as they were unable to provide a full 
set of samples as a consequence of not be able to extract blood from the collection site. 
3.3.5.1 Multivariate Analysis 
The 7 detected elements (variables) against participant plasma samples (observations) made 
up the plasma data set. The s-plot generated following PLS-DA indicated that three elements 
could be potential elemental biomarkers of stress, out of the seven elements that were 
detected (Figure 3.11). PCA of the three elements, Mg, P and K, did not produce a distinct 
separation between the three observation groups. However, it may be argued that the 
baseline observations have a higher PC[2] value than the recovery 1 observations which in 
turn have a higher PC[2] value than the recovery 2 observations (Figure 3.11). This model 
produced two significant principal components exhibiting 99.1% [PC1] and 0.70% [PC2] of 
total explained variance of the data set for physical stress. 
Although there is no evidence of clear separation in human plasma obtained from the seven 
participants following physical stress, there is an indication of a slight trend when examining 
the baseline, recovery 1 and recovery 2 observations. The majority of baseline observations 
appear at a high PC[2] value and this value tends to decrease in observation following the 
stress intervention. This suggests a change in the elemental content of human plasma 
obtained following physical stress, although it is very slow. Observations from recovery 2 are 
in a separate band with the lowest PC[2] values. When viewing the baseline and recovery 2 
values in isolation, it is clear there are two definite bands suggesting changes in elemental 
concentrations following physical stress. However, due to the slow response to the 
intervention participant elemental concentrations did not recover to baseline levels as a 
consequence of limited experiment time.  
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Figure 3.11. Top: PCA scatter plot of three stress sensitive plasma components identified from PLS-DA s-plot on 
7 observations each from the baseline (black dots), recovery phase 1 (green dots) and recovery phase 2 (blue 
dots) measurements from seven male participants. Bottom: S-plot generated from the modelled covariance 
(P(corr)[1]) and modelled correlation (p[1]) of the PLS-DA from the concentration of 7 plasma sensitive 
elements  (variables) from 24 saliva samples (observations). The three variables highlighted (red square) were 
found to provide the highest magnitude (concentration) of variables in the data set and greatest reliability 
(P(corr)[1]axis) of the variables in the data set, indicating potential elements sensitive to exercise 
3.3.5.2 Descriptive Statistics 
From the 7 detected elements in participant plasma, large concentrations of Mg, P and K 
were observed whilst relatively high concentrations of Li were present. Lower 
concentrations, but still relatively high, of Fe, Zn and Cu were also detected. The largest 
changes occurred for K, Cu and Zn. Between phases A and C changes of -11, -10 and -11% 
were calculated for K, Cu and Zn, respectively. Between the two recovery phases C and D, K 
increased by 20% whilst the second biggest change between these two phases was for Cu 
with an increase of 6%. For all elements, overall change between phase A and D was less 
than 10%. Due to little change between these three phases, it may be that elemental 
Slow 
stress 
response
 87 
concentrations in plasma both change and recover so quickly that it cannot be detected 
within the time frame set for collecting samples. Alternatively, changes in elemental 
concentrations are so slow that more time may have been needed between sample 
collections.  
Table 3.6. Concentration (ng.mL-1), change (%) and paired t-test (P) results of 7 detected elements found from 
participant plasma collected from three phases. Bold values indicate statistical significance at 95% 
Phase Li Mg P K Fe Cu Zn 
A 
µ 4004 12910 94917 134503 793 683 891 
σ  1364 1377 15719 27714 284 146 275 
C 
µ 3711 12506 86462 119445 805 614 793 
σ  1551 1398 17675 33797 115 150 266 
D 
µ 3725 12327 86358 143169 835 649 814 
σ  1728 1216 18218 26162 262 144 237 
Between phases 
        
∆
 (
%
) A to C -7  -3  -9  -11  1  -10  -11  
C to D 0  -1  -0  20  4  6  3  
A to D -7  -5  -9  6  5  -5  -9  
t 
te
st
 (
P
) A to C 0.696 0.663 0.433 0.478 0.686 0.470 0.462 
C to D 0.938  0.858  0.983  0.295 0.990  0.747  0.817  
A to D 0.672 0.213 0.155 0.471 0.559 0.581 0.488 
The results of ANOVA suggested no statistical evidence of significant differences at 95% as 
the calculated F value (1.15) was lower than the critical value of F (3.07) for all elements and 
phases (Appendix Table 8.7). The paired t-test data, using normalised data (log10), confirmed 
that no differences in elemental concentrations were observed at 95% (Table 3.6). H0 for this 
test was that no difference in elemental concentrations observed prior to and following 
physical stress, was accepted for all tests conducted. Hence there was no statistically 
significant evidence of differences in elemental concentrations between phases from human 
plasma. 
3.3.6 Identifying major elemental contributors from multivariate analysis using 
global elemental data from physical stress  
A data set with values collected from skin, saliva, urine and plasma samples, all analysed by 
ICP-MS, was constructed. This data set was used to construct MVA models in order to 
observe the major elemental and matrix contributors in physical stress. Prior to modelling all 
data sets were prepared to exclude all incomplete datasets.  
Thirty three variables, from the four analysed biological samples, against fifteen 
observations were used to construct the element data set with a total of fourteen elements 
used. PLS-DA modelling was initially performed using normalised elemental concentrations 
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(variables) from phases A, C and D of the study after which an S-plot was constructed (Figure 
3.12). 
 
Figure 3.12. Top: PCA scatter plot of eight stress sensitive components identified from PLS-DA s-plot on 5 
observations each from baseline (black dots), recovery phase 1 (green dots) and recovery phase 2 (blue dots) 
measurements from five male participants. 100% sensitivity was obtained immediately following the stress 
phase and 100% specificity was obtained for baseline measurements. Bottom: S-plot generated from the 
modelled covariance (P(corr)[1]) and modelled correlation (p[1]) of the PLS-DA from the concentrations of 33 
elements and biological samples (variables) from 15 participants and phases (observations). Eight highlighted 
variables (red square) were found to provide the highest magnitude of variables in the data set and greatest 
reliability (P(corr)[1]axis) of the variables in the data set, indicating potential sensitivity to exercise.  
Eight variables, chosen from the PLS-DA s-plot, were used to create an unsupervised model. 
The eight variables were 22.9892.Sk, 30.9732.P, 30.9732.U, 31.9715.U, 38.9632.P, 
38.9632.Sa, 38.9632.Sk and 38.9632.U. PCA of these eight elements displayed a separation 
between baseline (phase A) and recovery 1 (phase C) observations with two principal 
components displaying 59.5% [PC1] and 22.1% [PC2] of the total explained variance of the 
data set for physical stress yielding 100% sensitivity for recovery 1 measurements and 100% 
Stress response
Recovery
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specificity for the baseline measurements. Interestingly, phase D measurements (blue dots) 
are clustered near the baseline measurements, indicating that for these chosen variables the 
participants have recovered by the time the study is completed. The major elements chosen, 
from the supervised model, in this model were from the elements P (30.9732) and K 
(38.9632) indicating these may be major elements in predicting physical stress. 
3.3.7 Conclusion for the elemental analysis of skin, saliva, urine and plasma 
obtained from physical stress 
A total of 14 elements were detected from skin, saliva, urine and plasma as a result of 
physical stress. 4 of these detected elements (Mg, P, K and Zn) were detected in all four 
biological samples while 3 elements (Na, Si and S) were found in three of the biological 
samples (skin, saliva and urine). Additionally, Ca was detected in skin and urine while Cu was 
found in skin and plasma. Al was only observed in skin, I in saliva, Mo in urine while Li and Fe 
were detected in plasma. Whilst independent findings of elements are observed the fact 
that many of these elements are found in multiple biological samples indicates that 
biological pathways, between the examined samples, are connected. Zn is known for its 
healing properties in the immune system therefore it is no surprised to see this element 
present in all four biological samples following physical stress requiring the need for 
immediate repair in the body. K is essential in the body for electrolyte balance, blood 
pressure and heart function, assists the nervous system, releases energy from protein and 
helps delivery oxygen to the brain promoting efficient cognitive function. Mg is known to 
maintain normal nerves and muscle function, supports the immune system, keep the heart 
beat steady, assist in maintaining strong bones, regulates blood glucose and aids the 
production of energy and protein. P, located in the bones and teeth, is essential for the 
growth and repair of body cells and tissues. It is found in the body as phosphate (important 
for ATP – energy), DNA and helps maintain the pH of the blood. Na, found in three of the 
biological samples, controls blood pressure and regulates the function of muscles and nerves 
while Fe, found in plasma only, distributes oxygen around the body via cells. Due to the 
connection of biological pathways in the body it is clear why these elements are recovered in 
most if not all four of the biological samples studied for this experiment. Therefore, physical 
stress changes in elements found in one of the biological samples at a specified location in 
the body can also be an indication of the changes occurring in a different part of the body. 
Although clear separation is achieved using MVA, it is difficult to identify the actual 
compounds of which these elements are being produced as the data, obtained from all 
biological samples analysed in this chapter by ICP-MS, only details elemental concentrations. 
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To gain a better understanding of what compounds these elements may be derived from, 
samples should be analysed using other mass spectrometry techniques which provide 
greater information on larger molecules, e.g. using TD-GC-MS to investigate VOCs or UPLC-
IM-MS to examine small molecules, respectively. 
3.3.8 Identifying major biomarkers of physical stress from multivariate analysis 
using global elemental, VOCs and small molecules data 
The chemical changes in human saliva, as a result of physical stress, can exhibit a number of 
things as both the mouth and the body are integral to each other. Signals of diseases such as 
mouth lesions (HIV), ulcers (Crohn’s disease), pale/bleeding gums (blood disorder), changes 
in the tooth (anorexia/bulimia) and presence of compounds (drugs detected in saliva) are 
observed within the mouth. Furthermore, oral system conditions can be an effect of the 
immune system. Biological interactions between oral conditions and medical conditions are 
not fully understood. However, research indicates it is certainly linked. 
Saliva was collected from three of the experimental phases and analysed by ICP-MS 
(elements), TD-GC-MS (VOCs) and UPLC-IM-MS (small molecules). VOC analysis and data 
processing was carried out by Helen Martin (personal communication) and small molecule 
analysis and data processing was carried out by Aditya Malkar (personal communication) (as 
referred to in Appendix VII Publications). The data set was constructed using data obtained 
using these techniques provided by the aforementioned people. This data set was used to 
create MVA models which in turn were used to observe major contributors for physical 
stress.  
The saliva data set were generated to include only common features from all three 
techniques used to analyse the matrix. Saliva was only collected from three phases; 
therefore no phase B samples were included. Samples from participants CZ3 (absent for 
element and VOC), CZ7 (absent from element) and CZ10 (absent from element) were also 
excluded. Data for participants CZ1, CZ2, CZ4, CZ5, CZ6, CZ8 and CZ9 were included. Each 
sample matrix for each participant was normalised to 1 using the exact method of 
normalisation used previously. Variables were renamed to enable easy identification of 
element, VOC or small molecule, and then sorted in order of name. 
Thirty variables; eight from elements; fourteen from VOCs; and eight from small molecules, 
against twenty one observations were used to construct the saliva data set. PLS-DA 
modelling was initially performed on the normalised data set of variables from the three 
selected phases of the study resulting in an S-plot modelled from PLS-DA (Figure 3.13). Ten 
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variables, chosen from the PLS-DA s-plot, were used to produce an unsupervised model 
exhibiting separation between baseline (phase A) and recovery 1 (phase C) observations 
with two principal components displaying 53.8% [PC1] and 13.2% [PC2] of the total 
explained variance of the data set for physical stress.  
 
Figure 3.13. Top: PCA scatter plot of eight stress sensitive components identified from PLS-DA s-plot on 7 
observations each from baseline (black dots), recovery phase 1 (green dots) and recovery phase 2 (blue dots) 
measurements from seven male participants. 71.4% sensitivity was obtained immediately following the stress 
phase and 100% specificity was obtained for baseline measurements. Bottom: S-plot generated from the 
modelled covariance (P(corr)[1]) and modelled correlation (p[1]) of the PLS-DA from 30 variables (8 elemental, 
14 VOC and 8 small molecule data) from 21 participants and phases (observations). Ten highlighted variables 
(red square) were found to provide the highest magnitude of variables in the data set and greatest reliability 
(P(corr)[1]axis) of the variables in the data set, indicating potential saliva sensitivity to exercise. 
The ten variables chosen were: 5 up regulated from s-plot Sal_1464_94_107_121_135, 
0.71_303.1447, 0.82_418.7209, 1.00_244.1285 and 1.31_100.0750, and 5 down regulated 
Sal_836_72_57_43, Sal_1346_57_82_55_67, Sal_1550_57_82_55_67, 1.13_93.0689 and 
1.15_210.0502. 71.4% sensitivity was observed for recovery 1 measurements and 100% 
Stress response, 
no recovery
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specificity was observed for baseline measurements. Intriguingly, phase C observations in 
Figure 3.13 move further away from phase A observations and in turn, phase D observations 
move further from phase C observations indicating that the recovery from physical stress in 
element, VOC and small molecules found in saliva, is very slow. 
Identification of these potential biomarkers proved difficult due lack of financial resource 
and time. Although accurate mass has been obtained the instrument libraries contained a 
number of possible structures for each marker. Purchasing every standard suggested and 
testing the eluted peak of the standard against the observed peaks did not prove very 
practicable considering the limited instrument time. Also, this method of validation could 
see well over one hundred standards purchased for very little initial promise.  Ideally, this 
study would be repeated with at least forty more participants with the results obtained 
compared against those observed from this study. In the event where the same masses of 
stress markers were discovered, standards should be purchased and the mass identified to 
give a known compound. However, if the libraries were unable to determine possibilities for 
these markers, it may be entirely possible that a new chemical compound of stress was 
discovered.  
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3.4 Conclusion 
This experiment studying the chemical effects of physical stress exhibits that the method to 
detect biomarkers of stress can be successful. Samples from human skin, saliva, urine and 
plasma samples were obtained prior to and following physical stress. 10 elements (Na, Mg, 
Al, Si, P, S, K, Ca, Cu, Zn) were detected in human skin. The highest concentrations were 
found for Na (7.5 µg.mL-1) and K (11.5 µg.mL-1) following physical stress with significant 
changes in elemental concentrations observed for eight of these elements (not observed for 
Si and Zn). For skin samples obtained during the final recovery phase (over 30 minutes after 
the end of the physical stress exercise) element concentrations were found to recover back 
to baseline levels observed in the pre-intervention samples. The high element 
concentrations immediately following the stress intervention was expected due to higher 
sweat levels observed during the stress period. 8 elements (Na, Mg, Si, P, S, K, Zn, I) were 
detected in human drool saliva. Highest concentrations of elements were observed in pre 
stress saliva for Na (21.6 µg.mL-1), P (26 µg.mL-1) and K (63.5 µg.mL-1) with significant 
changes presented for S and I. Evidence of a slow decrease in element concentrations in 
saliva was found following physical stress. Only I concentration decreased immediately 
following stress. S and I concentrations were found to decrease in the second recovery 
phase sample when compared to the pre stress samples. No statistically significant 
differences were observed for any element between the two recovery phases. 8 elements 
were also detected in human urine (Na, Mg, Si, P, S, K, Ca, Zn, Mo). The highest 
concentrations were found in the second recovery phase samples for the elements P (1050 
µg.mL-1), S (2150 µg.mL1) and K (5500 µg.mL-1). A general decrease in all elemental 
concentration, except Si and Zn, was found following stress after which concentrations 
returned to the levels observed prior to physical stress. Significant differences were 
exhibited for all elements except Mo. 7 elements were detected in human plasma (Li, Mg, P, 
K, Fe, Cu, Zn) with the highest concentrations found in samples collected prior to the 
physical stress exercise for Mg (13 µg.mL-1), P (90 µg.mL-1) and K (130 µg.mL-1). However, no 
statistically significant differences were found between any of the three phases for which 
the samples were collected. Consequently, future experiment should investigate elemental 
changes in whole blood following the physical stress intervention rather than examining 
blood plasma. There is a possibility more information will be available in whole blood 
compared to plasma due to the removal of many components of whole blood to yield 
plasma. 
 94 
Many elements were detected due to their important functions within the body with 
significant differences in concentrations observed following the stress intervention. For 
example, K has a role to assist the nervous system hence following physical stress the 
elements were observed in all four biological samples investigated. Similarly, Zn plays a role 
maintaining a healthy immune system as does Mg. P is found in bones and teeth yet it is 
essential for growth and repair of body cells and tissues which are affected following 
physical stress while Na regulates the functions of muscles and nerves. This evidence 
strengthens claims that biological pathways as in fact linked and where one pathway 
affected by physical stress can also cause others to be influenced too. 
Data from 8 elements, 14 VOCs and 8 small molecules were also used to create a saliva data 
set to enable identification of possible biomarkers of physical stress. MVA of the saliva data 
set showed that a wealth of information can be derived from analysing simultaneously 
collected saliva, from participants following physical stress, using three difference 
techniques. Although the definite identification of these biomarkers was not achieved due to 
financial cost and time restraints, it is possible to purchase and analyse standards to confirm 
possible formula’s identified from instrument libraries. 
Future studies could use a similar method to collect and analyse samples using at least a 
further forty participants, with the modifications of a longer experiment time in order to 
allow participant stress levels return to those observed at baseline levels as well as collecting 
and analysing whole blood instead of plasma for elemental changes. In the event similar 
biomarkers are recovered using all three techniques, known standards should be purchased 
and analysed for identification of the biomarkers of stress. These could then be used to 
produce drugs that counter act these biomarkers and seek to investigate clinical trials on 
humans who are thought to be stressed.  
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4 A study into the effect of emotion stress on the elemental 
content of saliva as measured by ICP-MS 
Emotional stress is another form of stress with little to no physical measure, as per the 
studies in the previous chapters. The objective of this study was to identify elemental 
biomarkers from elemental profiles obtained by ICP-MS in human saliva, following 
emotional stress and is part of a wider study by Ran et al. (Appendix VII, Reference 3). Saliva 
samples were collected prior to and following an intervention designed to replicate a 
trapped human in a building for twenty four hours causing emotional stress. H0: There was 
no difference in the elemental composition of human saliva obtained prior to and following 
stress i.e. H0: ESRPRE = ESPPOST.  
This study was devised by Ran Huo in collaboration with Paul Thomas. All elemental saliva 
samples were collected and analysed by the author at the Centre of Analytical Sciences at 
Loughborough University. The motive to collect samples from this study was to identify 
elemental changes in human saliva collected from an emotional stress intervention and 
compare any differences in the elemental changes in saliva collected from previous studies, 
namely from physical stress. 
4.1 Experimental Outline 
One volunteer aged 50 years old participated in this study. On the morning of sample 
collection the participant was asked not to wash with any fragranced soap. Saliva sample 
collection lasted a maximum of 10 minutes before and after the 24 hour intervention. A safe 
and reproducible simulator of a person trapped inside a collapsed building was designed, 
built and tested by members of this research group. A range of environmental conditions to 
simulate collapses in different climates could be generated. Three sub-systems were also 
used; i) an environmental chamber, providing a buffer reservoir of purified air at a specified 
humidity to the void chamber, ii) a void simulator, for a large participant (120 kg and 2m) to 
lie in, iii) a collapsed building simulator, air passed through here from the void chamber. The 
collapsed building simulator presented generic elements of a collapsed building including 
reinforced concrete and glass. Whole saliva was collection before and after one participant 
was trapped in a simulated building collapse for 24 hours. Elemental analysis of the saliva 
was performed by ICP-MS. 
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Figure 4.1. Experimental procedure for saliva sampling
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4.1.1 Collection Tubes Preparation 
Two 30 ml glass tubes (Fisher Scientific, Loughborough, UK) were pre cleaned by rinsing with 
DI H2O followed by a 5 minute soak with 5 ml of 2% HNO3. These were placed on a shaker 
(ELMI Skyline shaker, Riga, Latvia) for 5 minute at a tilt of 5°. The HNO3 was appropriately 
disposed and 5 ml of DI H2O was added. The vials were left for 5 minutes on a shaker at a tilt 
of 5° after which the DI H2O was disposed and the tubes were left to air dry for 2 hours. One 
tube was labelled ‘Pre’ and the other ‘Post’. 
4.1.2 Storage Tubes Preparation 
Six 2ml cryotube vials (VWR International Ltd, Leighton Buzzard, UK) were also labelled. 
Three were to be used to aliquot the saliva samples provided prior to the participant 
entering the chamber and three to be used once 24 hours had elapsed and the participant 
came out of the chamber. 
4.1.3 Saliva Collection 
Prior to entering the void chamber the participant was asked to provide 5 ml of mouth drool 
(saliva) into the ‘Pre’ labelled tube by tilting their head forward and letting saliva pool at the 
front of their mouth and then drooling this into the 20 ml tube. Three 1 ml aliquots of the 
drool were then placed into pre cleaned 2 ml cryotubes. These replicates were labelled ‘Pre 
A’, ‘Pre B’ and ‘Pre C’ and stored in a 4°C fridge. 
After 24 hours had elapsed, the subject was assisted out of the void chamber and was asked 
to provide 5 ml of mouth drool (saliva) in the ‘Post’ labelled tube. As with the pre saliva 
samples, three 1 ml aliquots of drool was then placed into the pre cleaned 2 ml cryotube 
vials labelled ‘Post A’, ‘Post B’ and ‘Post C’. 
4.1.4 Sample Analysis 
Samples were stored at -80°C until the day of analysis, for a maximum of 28 days. Samples 
were left to thaw out at room temperature for a minimum of 60 minutes. The six aliquots 
were then thoroughly mixed, for homogeneity, with the aid of a vortex mixer. For each 
sample, 1 ml of saliva was mixed with 4 ml 2% HNO3 in a 15 ml polypropylene centrifuge 
tube (Elkay, Hampshire, UK) (Figure 4.1). Twenty six elements were analysed using ICP-MS 
(described in Chapter 1 section 1.3.5) with a randomised analysis order for all samples 
(Figure 4.1). Three internal replicates were analysed for all samples (six saliva samples plus a 
solvent blank). Significance testing was performed to discover whether any statistical 
evidence of elemental differences between samples existed. 
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4.2 Results and Discussion 
Elemental analysis of six saliva samples (three pre intervention replicates and three post 
intervention replicates) and a solvent blank was performed by ICP-MS. No MVA was 
performed on the data set in this chapter as all samples were provided by one individual. 
4.2.1 Elemental Profiles 
The elemental profile (Figure 4.3) shows that the majority of elements with the highest 
saliva concentration can be found with elements lower in mass than 50 Daltons. Although Sn 
(117.9011 Da) and I (126.9039 Da) do show high concentrations in saliva, the blank samples 
also exhibit the highest concentrations for these samples. 
Table 4.1. Average concentration (ng.mL
-1
) and relative standard deviation for the nine 
statistically significant (95%) elements including relative change, F- and T-test 
(probability) score 
Element Pre Post Change (%) Fcalc Tcalc (P) 
Na 120276 (26.4) 52 (27.6) -99.96 0.000 0.003 
I 107567 (23.3) 10363 (5.40) -90.37 0.001 0.003 
Mn 44 (36.6) 12 (14.6) -72.40 0.024 0.027 
Fe 105 (34.2) 37 (14.1) -64.54 0.042 0.032 
P 214235 (14.0) 151849 (10.9) -29.12 0.467 0.034 
Si 340 (9.40) 541 (13.0) 37.24 0.346 0.011 
Mg 3807 (20.3) 7318 (12.2) 47.98 0.853 0.007 
As 2.7 (50.0) 7 (18.5) 63.19 0.995 0.014 
Sr 10 (27.6) 46 (10.4) 77.52 0.527 0.000 
4.2.2 Descriptive Statistics 
ANOVA was performed to determine if any significant differences (95%) were present 
between i) three replicate pre intervention samples ii) three replicate post intervention 
samples and iii) the pre and post intervention groups. The results for these tests can be 
observed in the appendix Table 8.10. Two-factor without replication ANOVA was performed 
on the pre and post intervention replicate samples. Replicate pre and post intervention 
samples showed no evidence of significant difference with calculated F values of 1.624 and 
1.340, respectively. This was lower than the critical F value of 3.183 suggesting no evidence 
of significant differences (95%) between the replicate samples. 
ANOVA (two factor with replication) was performed to find if there was any statistical 
evidence of significant difference in elemental concentration between the two groups. The 
calculated F value of 2.328 obtained was bigger than the F critical value (degrees of freedom 
25) of 1.612 therefore evidence was present to suggest that the elemental concentrations 
between the pre and post intervention groups were statistically significant. 
 99 
It was not clear from the data which of these elements were statistically significant from just 
the ANOVA testing. As a result, t-tests were carried out to determine whether element 
concentrations between the pre and post intervention groups were statistically significant 
(95%). Nine elements showed statistical significance between the pre and post samples from 
the twenty six elements that were analysed. These were Na, I, Mn, Fe, P, Si, Mg, As and Sr. 
The calculated probability of the t-test (2 tailed, equal variances) can be found in Table 4.1. 
for these nine elements. Statistical information for all 26 elements can be found in the 
Appendix Table 8.11. Tcalc (P) of less than 0.05 shows evidence of statistical significance 
between the pre and post intervention samples. 
 
Figure 4.2. Relative changes between the pre and post intervention samples for the nine statistically significant 
elements 
The element concentrations (ng.mL-1) for pre and post intervention samples for these nine 
elements can be found in (Table 4.1). The highest elemental concentrations in saliva, from 
the nine elements where statistical significance was evident, were P, Na and I. In the pre-
intervention samples the highest elemental concentration is found for P, approximately 210 
µg.mL-1, which almost doubles that of the next highest concentration which is Na, 
approximately 120 µg.mL-1. A high concentration of I is also present in the pre-intervention 
sample with a concentration approximately 100 µg.mL-1. Also in this sample, low 
concentrations were found for As, Sr, Mn, Fe and Si, at 2.7, 10, 44, 105 and 340 ng.mL-1, 
respectively. Mg was also present at a concentration of nearly 4000 ng.mL-1(Figure 4.2).  
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Figure 4.3. Saliva profile showing intensity of elemental masses from 0-210 Da for Blank B sample (white), Pre intervention B sample (dark grey)and Post 
intervention B sample (light grey) 
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Five elements decreased in concentration, whilst four elements increased in concentration, 
between the pre and post intervention samples (Figure 4.2). Na, I and Mn displayed the 
largest decreases with a relative change of 99.9, 90.4 and 72.4 %, respectively. The relative 
decrease for Fe was 64.5% whilst that for P was 29.1%. The largest relative increases were 
observed for Sr (77.5%) and As (63.2%) whilst Mg (47.98%) and Si (37.2%) also displayed a 
relative increase between the pre and post intervention samples. 
The increase in concentration of Sr is an interesting and unexpected one. However, previous 
studies into the effect of toothpaste show that Sr is used in toothpaste for very practical 
reasons. Surdacka et al. studied the effect of Sr toothpaste on artificially decalcified human 
enamel and found that regular tooth brushing with Sr supplemented toothpaste increased 
the Sr content in exposed enamel, after three months compared to the levels observed at 
the baseline, which can be advantageous in the prevention of cariogenesis.90 West et al. 
studied pain reduction in a variety of toothpastes and found that Sr based toothpastes 
resulted in the reduction of pain in the short term.91  
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4.3 Conclusion 
Whole saliva was collected from 1 human participant trapped in a replication of a building 
collapse for 24 hours in order to investigate the effects of emotional stress. Saliva was 
collected using a drool method immediately before and after the participant entered the 
void chamber for 24 hours, during which the participant did not eat and experienced sleep 
deprivation. Two saliva samples were collected and elemental analysis was performed by 
ICP-MS.  
Sixteen elements were detected in both sets of samples. Statistically significant changes 
(95%) were observed for nine elements in whole saliva for twenty-four hours of a human in 
an entrapped space with no food or water due to emotional stress and sleep deprivation. H0 
was rejected (i.e. H0: ESRPRE ≠ ESPPOST) as elemental concentrations in saliva obtained from a 
human participant who had been trapped in a chamber for twenty four hours with no food 
or drink, were affected. 
The largest changes were found for Na (-99.9%) and I (-90.4%) which both decreased by over 
90% baseline concentration. Concentration decreases were also found for Mn (-77.4%), Fe 
(64.5%) and P (-29.1%) while Sr (77.5%), As (63.2%), Mg (48.0%) and Si (37.2%) increased in 
concentration. However, it is unclear whether these changes are due to emotional stress or 
deprivation of sleep and food due to the saliva obtained from only one participant. It is 
known that there is a concentration change in teeth Sr to prevent certain diseases and these 
contributed to the concentration change in Sr in saliva due to leeching of Sr from the teeth 
to saliva. Further experiments with more participants should be conducted before any 
comparisons between emotional stress and physical stress can be achieved. 
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5 The Liquid Skin Pen 
The aim of this work was to design and engineer a non-invasive skin sampling device in 
collaboration with Unilever Plc. The long term goal was to discover biomarkers of stress 
from human skin using the device. The skin sampling device was produced to target the 
sampling of several skin sites of the human body in order to better understand the chemistry 
of these sites. Samples obtained were analysed by ICP-MS, ESI-MS or nESI-MS to deduce 
elemental and small molecule content. Results obtained from the device could be used to 
create or improve existing skin products produced by Unilever Plc.  
At the time of writing no procedures exist for the real-time, site-specific sampling and 
analysis of small molecule and elements from human skin. The Liquid Skin Pen (LSP) provides 
the first step for a device that can be developed to collect site specific real time samples 
from the skin. This would be advantageous compared to current methods such as the use of 
adhesive pads, which require precious time between sample collection and data evaluation; 
because online analysis of samples would ensure that skin conditions (such as dermatitis) 
may be diagnosed instantly. 
The experiments in sections 5.4 and 5.5 were devised and carried out by the author. Section 
5.6 outlines an experiment that was devised and carried by the author and Dr Corrinne 
Burns. The experiment stated in section 5.7 was devised by Svetlana Riazanskaia and carried 
out in collaboration with the author and Dr Corrinne Burns. The final experiment in section 
5.8 was devised by the author and carried out with the assistance of Dr James Reynolds. 
Sample analysis was performed by the author with assistance from Dr Corrinne Burns and Dr 
James Reynolds. 
5.1 Design and construction of the Liquid Skin Pen 
The LSP was engineered by Peter Carroll at (Unilever PLC, Bebington), in consultation of the 
design by the author, Dr. Corrinne Burns (Loughborough University), Prof. C.L.Paul Thomas 
(Loughborough University) and Svetlana Riazanskaia (Unilever PLC, Bebington). The outer 
casing of the device is constructed of white acetal, the inner tubing is made from PEEK 
(grade GF 30, ID = 0.254 mm OD = 1.5875 mm) and the liquid inlet sterile hypodermic 
needles (Becton, Dickinson, Plymouth, UK) are constructed of stainless steel. Material used 
to construct the device can be found in Table 5.1 and a schematic diagram of the LSP design 
can be seen in Figure 8.1.  
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Table 5.1. LSP material 
Part Material 
LSP body Acrylic 
Sampling base PEEK GF30 
Sample delivery holder Acetal 
Sample delivery vial Clear glass, silanized 
Sample delivery needle Hypodermic 
Sample delivery tube holder PEEK GF30 
Sample collection holder Acetal 
Sample collection vial Clear glass, silanized 
Sample collection needle Stainless steel 
Sample collection tube holder PEEK GF30 
Transport tubes PEEK GF30 
Top block White acetal 
Peristaltic pump outlet PEEK GF30 
5.2 Target Sample Sites 
Whilst the primary focus on the early stage of development for the LSP was use on the 
human skin, initial studies (sections 5.4 and 5.5) were performed on a non-biological surface 
using manganese (Mn). Mn was used as this was available in the laboratory as well as only 
Mn having a single isotope (55Mn). It must be worth noting that 55Mn is not an ideal element 
to experiment with due to possible polyatomic interferences of KO, NaS, ArN, ClO, ArOH, 
ArN and ArO. Therefore data analysis had to be conducted thoroughly ensuring these 
interferences did not affect the amount of Mn observed in the results. 
Table 5.2. Sites samples and delivery solvent used with the LSP 
Section Sample Type Sample Site Sampling solvent 
5.4 Mn sample Surface of nitrile glove 0.1M EDTA 
5.5 Mn sample Surface of nitrile glove 0.1M EDTA, 2% HNO3 DI H20 
5.6 Human Skin Volar & plantar 0.1M EDTA 
5.7 Human Skin Axilla, dorsal, plantar & volar 0.1M EDTA 
5.8 Human Skin Dorsal & Plantar 0.1M EDTA 
The surface of a power free nitrile glove (Barber Health Care Limited, Leyburn, UK) was 
chosen in order to replicate human skin prior to sampling on human volunteers. During 
these initial tests (sections 5.4 and 5.5), any issues that arose with sampling using the LSP 
could be resolved in order to improve the efficiency of sampling when later using human 
volunteers.  
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Figure 5.1. Mn sample dried for 30 minutes on a nitrile glove 
Four skin sites were targeted and sampled using the LSP when using human volunteers. 
Sample sites included the axilla (AP), dorsal (TF), plantar (BF) and volar (AE) (Figure 5.2). 
These sites were targeted as the device was initially used for diagnostic purposes with the 
hope that it could eventually be developed to finding stress biomarkers of human skin 
leading to the production of new skin products, for Unilever Plc., helping to aid other 
diseases such as dermatitis.  
 
Figure 5.2. The four sites sampled using the LSP (A) Axilla (B) Dorsal (C) Plantar (D) Volar 
5.3 Sample Collection using the Liquid Skin Pen 
Samples were collected from a target area using negative pressure which was achieved by 
means of a peristaltic pump. For the experiments in sections 5.4, 5.5 and 5.6, the peristaltic 
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pump (Cole Parmers’ Masterflex C/L) was set at 200 rpm. For the sections 5.7 and 5.7.2 the 
peristaltic pump (Watson-Marlow 120U with Bioprene tubing of 1.6 mm wall, 1.6 mm bore) 
was set at 32 rpm. 
A screw capped delivery vial (National Scientific, Loughborough, UK), containing 
approximately 1.5 ml of sampling solvent, was placed in the green LSP delivery vial holder 
and an empty screw capped collection vial (National Scientific, Loughborough, UK) in the red 
LSP collection vial holder (Figure 5.3). The peristaltic pump was switched on and the pump 
tubing was connected to the LSP peristaltic pump outlet. The base of the LSP was then 
gently applied to the surface of the sampling area forming a closed system in order for 
sampling to begin via negative pressure.  
Immediately after each site was sampled the vial of the collected sample was recapped with 
a new, clean screw cap with an un-pierced rubber septum in order to avoid air 
contamination.
 
Figure 5.3. LSP parts; A. LSP body; B. Sampling base; C. Delivery vial holder; D. Delivery vial; E. Delivery needle; 
F. Delivery tube connector; G. Collection vial holder; H. Collection vial; I. Collection needle; J. Collection tube 
connector; K. Sample transport tubes; L. Peristaltic pump connection; M. Top block 
SKIN
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Samples were obtained in less than 60 seconds once the face of the sampling base covered 
the target sampling area. Sampling solvent would flow from the delivery vial through the 
body of the LSP via the PEEK tubing to the target area, where sampling of the surface area 
took place, after which the sample solution was transported through the second PEEK tube 
and would drop out into the collection vial. Once the transfer of the sample solution had 
come to an end, the peristaltic pump was switched off and the collection vial was removed 
from the LSP vial holder. The screw caps (containing two pierced holes through the septum 
from the hypodermic needles) of the sampled delivery and collection vials were then 
replaced with new screw caps (VWR, Leighton Buzzard, UK) without any pierced septa. This 
was carried out in order to protect the sample from any potential impurities in the air during 
storage. Furthermore, both the delivery and collection vials (clear silanized glass I-DTM, 
National Scientific) were weighed without caps prior to and following sample collection to 
obtained the transfer efficiency of the sampling solvent.  
During sample collection, the LSP would work best when the target sample surface was as 
flat as possible and facing away from the floor with the LSP in an upright position with the 
sampling base facing (parallel) the floor. 
5.3.1 Vial Preparation 
Pre sample collection vial measurements 
Vials were prepared on the morning of sample collection. 1.5 ml sampling solvent was added 
to the delivery vials, weighed* and then capped. The remaining empty vials (collection vials) 
were also weighed* and then capped. 
*Vials were always weighed without caps 
Post sample collection vial measurements 
Delivery and collection vials were weighed and masses recorded immediately after sample 
collection. Vial caps were removed during weighing and new, clean caps were screwed onto 
the vials. 
5.3.2 LSP Pre Sample Collection Pen Cleaning 
For sections 5.4, 5.5 and 5.6 approximately 4ml of sampling solvent was flushed through the 
LSP using a hypodermic needle and syringe via the sample holes located at the base of the 
LSP (Figure 5.3 part B). 2 ml was pushed through each of the sample holes and the sampling 
solvent travelled through the PEEK sample transfer tubes exiting through needles located at 
either the sample delivery or collection side of the LSP. Following the sampling solvent flush, 
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further LSP flushes, using new syringes and needles, were performed using 4 ml of DI H2O 
and finally the sampling solvent again. 
For sections 5.7 and 5.8 all LSP’s were cleaned together using the sample method above. 
However, the solvents used to clean the LSP’s were (in order) 4 ml 0.5% v/v NH3(aq), 4 ml DI 
H2O, 4 ml 0.5% v/v CH3COOH(aq), 4 ml DI H2O and 4 ml 50% v/v EtOH(aq). Once all the LSP’s 
had been cleaned, they were placed in a clean foil tray and were dried in a vacuum oven 
(Binder, Tuttingen, Germany) at 40°C overnight. Once drying was completed, capped vials 
were placed in both the delivery and collection vial holders to protect the sampling needles 
from air contamination. 
The final solvent used to clean the LSP was EDTA, prior to collecting the LSP pen blank for 
the next sample site.  
5.3.3 LSP Pen Blank Sample Collection 
LSP Pen blanks were collected for each study for each of the LSP’s used, prior to sample 
collection. For studies where only one LSP was available, pen blanks were collected prior to 
sample collection from each participant. 
Capped sample vials were placed in both the delivery vial holder and the collection vial 
holder of the LSP. Approximately 1 ml of sampling solvent was flushed through each hole in 
the sampling base of the LSP using sterile syringes (Becton Dickinson, Plymouth, UK) and 
sterile hypodermic needles (Becton Dickinson, Plymouth, UK). Sampling solvent which had 
passed through the LSP and was present in both the delivery and collection vials were then 
mixed together, using a syringe, into the pre weighed vial. 
5.3.4 Inter Participant Cleaning of the LSP 
For studies involving human volunteers, the LSP was cleaned before and after collecting 
samples from each participant. To ensure that all the sampling solvent had been removed 
from the LSP, several injections of DI H2O were forced through the LSP from the base of the 
device using a the procedure outlined for LSP pen cleaning in section 5.3.2. The LSP was then 
dried overnight in a vacuum oven (Binder) at 40°C, for 5 hours. Once the LSP was cleaned, 
pre-cleaned empty vials with screw caps were placed in the delivery and collection holders 
of the LSP. The sampling and delivery needles of the LSP at both ends would pierce through 
the rubber septum of the vial caps ensuring they would not be exposed to the outside air for 
a significant period of time. 
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Figure 5.4. Workflow for experiments sampling with the LSP 
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5.4 An experiment to determine the efficiency of elemental 
extraction using the LSP 
As detailed in Chapter 1, there is little information regarding the elemental content of 
human skin as a result of different types of stress placed on the body. The objective of this 
experiment was to investigate if the LSP was able to extract one drop of 10 µg.ml-1 Mn from 
a nitrile surface using a sample solution of 0.1M EDTA. Furthermore, should extraction of Mn 
be successful what amount of recovery could be achieved in the primary sample and 
subsequent wash samples. H0: there was no difference in the amount of Mn recovered from 
a nitrile glove using the LSP, between surfaces that has been spiked with Mn (Sample ID: B) 
compared to one that has not (Sample ID: A). i.e. H0: [A] = [B].  
5.4.1 Experimental Outline 
One drop of 10 µg.mL-1 Mn was weighed and added onto the surface of a fresh (out of the 
box), unused nitrile glove (Barber Health Care Limited, Leyburn, UK) using a 20 µg pipette 
(Gilson Inc., Middleton, USA). The drop was allowed to sit on the surface and dry for 30 
minutes prior to sample collection. The first sample (sample B) was collected from the target 
area followed by three subsequent wash samples (B1, B2 and B3). All samples were 
collected from the exact same spiked target area of the glove. Samples were stored in a 20°C 
freezer immediately following collection. 
 
Figure 5.5. Experimental procedure for LSP recovery testing 
5.4.1.1 Sample Analysis 
All samples were analysed on the subsequent day of collection and were allowed to thaw at 
room temperature for 30 minutes after which they were homogenised using a vortex mixer 
(Scientific Industries Inc., NY, USA). For all samples, 1 ml of collected sample was diluted 
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with 10 ml 2% HNO3 in 15 ml fresh, unused, polypropylene centrifuge tubes (Elkay Ltd, 
Basingstoke, UK). 
Elemental detection of Mn was performed using an ICP-MS (as described in Chapter 1 
section 1.3.5). A 10 µg.mL-1 Mn sample was also analysed in order to semi-quantify sample 
concentrations. Three replicates were taken for each sample analysed. Elemental 
concentrations in the sample were semi quantified by using the ratio of the intensity 
obtained for the known Mn concentration against intensity obtained for all samples. 
Additionally, relative Mn recovery was determined from each of the collected samples. 
5.4.2 Results and Discussion 
A total of 8 samples were successfully analysed on the same day. Samples obtained from the 
LSP included a LSP solvent blank, one Mn sample and three Mn wash samples. Also analysed 
were two solvent blanks, which consisted of DI H2O and 2% HNO3, and a 10 µg.mL
-1 Mn 
sample. 
Table 5.3. Concentration of samples (µ), blank subtracted 
samples (µ (BS)), relative standard deviation (RSD) and recovery 
of Mn in samples obtained using the LSP. n = 3 
Sample 
Concentration ( ng.mL-1) % 
µ µ (BS) RSD Recovery 
A 2.71 
 
9.4 
 B 7.24 4.53 6.1 41.8 
B1 4.18 1.47 4.3 13.5 
B2 3.44 0.73 5.6 6.7 
B3 3.06 0.35 6.2 3.2 
C 0.34 
 
9.4 
 D 0.32 
 
10.3 
 
The LSP successfully extracted the Mn sample from the target surface (Table 5.3). 2.71 
ng.mL-1 of Mn was extracted using the LSP from the unspiked target surface and used as the 
baseline value. However, once a drop of the Mn sample was spiked on the target surface a 
concentration of 7.24 ng.mL-1 Mn was obtained. Subsequent washes exhibited a decrease in 
the amount of Mn extracted from the surface with 4.18, 3.44 and 3.06 ng.mL-1 found in 
washes 1, 2 and 3, respectively. The amount of Mn attained in the solvent blanks was less 
than the amount obtained from the blank. Figure 5.6 illustrates the reduction in the 
concentration of Mn following each wash. In the first sample, following the surface spike 
with the Mn (B), the highest concentration of Mn is acquired when compared to subsequent 
samples where the Mn concentration gradually decreases from wash 1 (B1) to wash 2 (B2) 
and finally wash 3 (B3). This data suggests that although the LSP is able to extract a 
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significant amount of Mn in the first sample on the target surface, it does not achieve 100% 
recovery, as proven by the Mn concentrations found in the wash solutions. By removing the 
amount of Mn found in the blank sample from the spiked sample as well as subsequent 
wash samples, the Mn concentration achieved are 4.53, 1.47, 0.73 and 0.35 ng.mL-1 for the 
initial spiked sample, wash sample 1, 2 and 3, respectively. 
5.4.2.1 Recovery of Mn using the LSP 
The theoretical concentration of Mn expected in the final sample analysed by ICP-MS can be 
calculated using a predicted 100% recovery. There were three transfer phases for Mn, each 
step diluting the sample analyte more than the previous phase. The three phases are; step 1, 
where a known amount of Mn sample was added to the target surface; step 2, a known 
amount of sampling solvent was used to sample the target surface; and step 3, dilution of 
the collected LSP sample with a matrix suitable for ICP-MS analysis. 
Theoretical Concentration 
Step 1 
An average mass of one drop of Mn used was 0.0179 g (σ = 0.0001, n = 3) with a measured 
concentration 10.0087 µg.mL-1. Therefore, an estimated 17.9 mg Mn was added onto the 
target surface of an unused, fresh latex glove. 
Step 2 
Using the LSP, 1.5 ml EDTA was sampled and collected over the target area containing Mn 
resulting in the first dilution.  
                (Equation 5.1) 
Where  C1 = Initial concentration 
 V1 = Initial volume 
 C2 = Final concentration 
 V2 = Final volume 
Using equation 5.1, if C1 = 10.0087 µg.mL
-1, V1 = 0.0179 and V2 = 1.5 then C2 = 119.2 µg. L
-1. 
Step 3 
1 ml of sample collected was diluted with 10 ml 2% HNO3, in a 15 ml polypropylene tube, 
prior to ICP-MS introduction. Re-arranging equation 5.1, the theoretical 100% recovery 
concentration (C2) can be calculated. C2 = 0.01083 µg.mL
-1, when C1 = 0.1192 µg.mL
-1, V1 = 
1ml and V2 = 11 ml. 
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       (Equation 5.2) 
Therefore, the theoretical concentration of 100% recovery would be 10.83 µg.mL-1. Table 5.3 
shows the calculated relative recovery of Mn for each sample, obtained using Equation 5.2. 
The initial sample contained 41.8% (4.53 ng.mL-1) of the original Mn sample whereas 
recoveries of 13.5 (1.47 ng.mL-1), 6.7 (0.73 ng.mL-1) and 3.2% (0.35 ng.mL-1) were obtained 
for the subsequent washes, 1, 2 and 3, respectively. This is illustrated in Figure 5.6. 
H0 was rejected as a difference in the amount of Mn recovered from a nitrile glove, using the 
LSP, between a spiked surface and blank surface (H0: B ≠ Blank) was discovered. Although it 
was proved that the LSP can be used to detect a sample of Mn on the surface of a nitrile 
glove, multiple washes are needed to extract as much Mn as possible. However, it is worth 
noting that the first sample taken with the LSP did achieve the highest recovery. 
Issues encountered included sample uptake stalling from the delivery vial. This was solved 
by replacing the cap and septum on both the delivery vials and re-placing them into the vial 
holders. It was important to ensure that vials were inserted into the vial holders vertically in 
order to avoid bending the hypodermic needles at both the delivery and collection vial sites 
of the LSP. 
5.5 An experiment to determine the most efficient solvent for metal 
extraction using the LSP 
EDTA has extensive medical, industrial, agricultural and engineering applications and is a 
widely used chemical compound found in cosmetic preparations and cleaning, processed 
foods, skin care and personal care products. High purity nitric acid is commonly used for 
metal analysis in mass spectrometry whereas water is used as part of everyday life. Due to 
its function as a hexadentate ligand and chelating agent, EDTA has the ability to capture 
metal ions such as Fe3+ and Ca2+. After being bound to EDTA, metal ions remain in solution 
but exhibit reduced reactivity. At a very low pH (very acidic conditions), the fully protonated 
H2EDTA
2+ form is prevalent whereas at very high pH (very basic conditions) the fully 
deprotonated form EDTA4- is predominant. EDTA4- usually binds to metal cations through its 
four carboxylates and two amines with the resulting coordination adopting an octahedral 
geometry. Metals are extensively enveloped by EDTA resulting in the suppression of their 
catalytic properties. Since complexes of EDTA4- are anionic they are likely to be highly soluble 
in water. 
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The aim of this experiment was to identify which of three readily available solvents were 
best suited as the LSP sampling solvent (SS) in order to recover a known concentration of Mn 
from a target surface. In addition, a further objective was to investigate the efficiency of the 
LSP. The three solvents investigated were 0.1M EDTA, 2% HNO3 and DI H2O. H0: there was no 
difference in the amount of Mn recovered from a nitrile glove, using the LSP, using the three 
sampling solvents. i.e. H0: SS (x) = SS (y) = Ss (z). 
5.5.1 Experimental Outline 
1 LSP was used to collect a total of 15 samples. This included 4 samples (1 sample from the 
spiked area of Mn and the 3 subsequent wash samples from the exact location) and 1 LSP 
pen blank for each of the 3 sampling solvents used. One drop of 100 µg.mL-1 Mn was initially 
weighed after which it was added onto the surface of a fresh (out of the box), unused nitrile 
glove using a 20 µL pipette. The drop was allowed to sit on the surface and dry for 30 
minutes.  
 
Figure 5.7. Experimental procedure for sample solution testing using the LSP for solvent comparison 
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A clean, fresh out of the box nitrile glove was used for each solvent sample test (3 nitrile 
gloves used in total). EDTA samples were collected first, followed by 2% HNO3 samples and 
finally DI H2O samples. Each sample was collected within 60 seconds once the face of the 
sampling base covered the target sample area. All samples were collected on the same day 
and stored at -20°C until the day analysis. 
5.5.1.1 Sample Analysis 
Samples were removed from storage after 2 days, allowed to thaw at room temperature for 
30 minutes and then homogenised using a vortex mixer. For all 15 samples, 1 ml of collected 
sample was diluted with 4 ml 2% HNO3 (1:5 dilution) in 15 ml fresh, unused, polypropylene 
centrifuge tubes (Table 5.3). 
All samples were analysed on the same day they were removed from storage. Elemental 
detection of Mn was performed using ICP-MS (Chapter 1 section 1.3.5). Each sample was 
analysed in triplicate and sample concentrations were semi quantified by taking the ratio of 
intensity obtained for the known Mn concentration of 100 µg.mL-1 against those obtained 
for samples. Comparing the concentrations of samples with the known concentration of the 
drop enabled the recovery to be calculated as well as the sampling efficiency of the LSP 
(sampling solvent transfer from the delivery to collection vial) (supplementary information 
Table SI.5.2). 
5.5.2 Results and Discussion 
A total of 15 samples obtained using the LSP, plus a sample containing 100 µg.mL-1 Mn which 
was analysed for semi quantitation purposes, were successfully analysed on the same day. 
Mn was successfully extracted from the target surface using all three delivery solvents of 
interest.  
5.5.2.1 Recovery of Mn using the LSP 
Theoretical 100% recoveries for each sample were calculated using the same procedure as 
that used in section 5.4.2.1. Once again, three phases were conducted. Step 1, where a 
known amount of a Mn sample was added to the target surface. Step 2, a known amount of 
sampling solvent was used to sample the surface using the LSP. Finally step 3, in order for 
the sample to be analysed using ICP-MS analysis, the collected sample was diluted with a 
suitable matrix.  
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Theoretical Concentration 
STEP 1 
The average mass of one drop of Mn used was 0.010 g (σ = 0.0001, n = 5) with a calculated 
concentration of 90.7877 µg.mL-1. Therefore, an estimate of 0.010 g of Mn was added onto 
the target surface of an unused, fresh latex glove. 
STEP 2 
Approximately 1.5m l of sampling solvent was delivered and collected over the target area, 
where the drop of Mn had been placed, using the LSP. Using Equation 5.1, the concentration 
of this dilution was calculated for each sample (Table 5.4). C1 = 90.7877, V1 = 0.010, V2 = 1.5, 
and C2 = unknown. For most samples this concentration was approximately 60 ng.mL
-1. 
STEP 3 
Finally, 1 ml of sample collected was diluted with 4 ml 2% HNO3, in a 15 ml polypropylene 
tube, enabling ICP-MS introduction. In this step, C1 = 60 ng.mL
-1, V1 = 1  ml, V2 = 4 ml and C2 
was the unknown concentration for a 100% theoretical recovery. These calculated values 
can be viewed in the step 2 column of Table 5.4. For most samples, 100% recovery would 
yield a concentration of approximately 11 ng.mL-1 Mn. 
The experimental concentrations for each of the samples are also shown in Table 5.4. For 
the first sample using the LSP for each sampling solvent, Mn concentrations of 6.5, 4.6 and  
2.9 ng.mL-1 were observed for the 2% HNO3, EDTA and DI H2O, respectively. Subsequent 
samples using the LSP, for each sampling solvent, showed a decrease in concentration 
obtained showing that the first sample obtained extracts the largest amount of Mn. For the 
first sample, the highest concentration achieved was with the LSP using 2% HNO3 as the 
sampling solvent, followed by EDTA and finally DI H2O. This can be seen in Figure 5.8 along 
with the decreasing trend in concentration for subsequent samples using each of the three 
sampling solvents. Very little of the Mn sample was extracted from the target surface 
following the first two samples using the LSP. 
5.5.2.2 Recovery 
Using Equation 5.2 and both the theoretical and experiment concentrations calculated 
previously, the relative recovery for each sample was calculated (Table 5.4). For the primary 
sample, the highest recovery of Mn was observed when using the sampling solvent 2% HNO3 
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with a recovery of 55.7%. The next highest achieved was when using EDTA as the sampling 
solvent and then DI H2O with relative recoveries of 39.9% and 18.6%, respectively. For the 
first wash sample, the highest recovery was attained when using 2% HNO3 (32.6%) as the 
sampling solvent followed by EDTA (19.7%) and finally DI H2O (12.0%). The LSP pen blank 
recovery when using 2% HNO3 as the sampling solvent was 12.4%, for EDTA was 4.3% and DI 
H2O was 1.2%. The last two wash samples using the LSP were lower in recovery compared to 
each of the blanks for the relevant sampling solvents and this trend is shown in the insert in 
Figure 5.8. 
Table 5.4. Calculated theoretical (CTHEORETICAL) and experimental concentrations 
(CEXPERIMENTAL) (ng.mL
-1
 Mn) and recovery (%) of Mn obtained from the three sample 
solutions collected using the LSP 
Sample CTHEORETICAL CEXPERIMENTAL Recovery (%) 
Step 1 Step 2 (final) µ (n=3) RSD (%) 
EDTA 
  
   
Blank 57.36 11.86 0.514 4.75 4.3 
Sample (B) 56.31 11.46 4.573 3.28 39.9 
Sample wash 1 (B1) 58.48 11.81 2.328 4.41 19.7 
Sample wash 2 (B2) 57.84 11.88 0.516 1.13 4.3 
Sample wash 3 (B3) 55.27 11.26 0.482 3.25 4.3 
   
Total (B to B3) 68.2 
2% HNO3 
     Blank 60.18 12.02 1.486 4.45 12.4 
Sample (B) 58.49 11.60 6.465 3.40 55.7 
Sample wash 1 (B1) 60.69 12.43 4.057 3.00 32.6 
Sample wash 2 (B2) 61.21 12.52 1.480 3.90 11.8 
Sample wash 3 (B3) 58.95 12.18 1.474 4.02 12.1 
   
Total (B to B3) 112.3 
DI H2O 
     Blank 57.29 11.55 0.144 3.33 1.2 
Sample (B) 77.71 15.48 2.871 3.98 18.6 
Sample wash 1 (B1) 60.63 12.25 1.473 5.72 12.0 
Sample wash 2 (B2) 51.81 10.49 0.100 3.67 1.0 
Sample wash 3 (B3) 59.44 11.97 0.088 3.10 0.7 
      Total (B to B3) 32.3 
Intriguingly, the total Mn recovery from the samples and washes yielded 112.3% when using 
2% HNO3 as the sampling solvent whereas total recovery when using the sampling solvents 
EDTA and DI H2O were calculated to be 68.2 and 32.3%, respectively. If it is considered that 
only a maximum of 100% should be theoretically recovered, there is an extra 12.3% recovery 
of Mn using 2% HNO3 as the sampling solvent. A number of factors should be considered to 
explain this extra recovery. The 2% HNO3 samples were the second batch of samples 
collected, using the same LSP, following sample collection using EDTA as the sampling 
solvent. It may have been possible that the LSP may not have been thoroughly cleaned and 
there were contaminants of the Mn from the previously collected batch resulting in memory 
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effects of Mn. The high blank sample recovery could point to this. Another factor could be 
extraction of traces of indigenous Mn from the nitrile glove itself. 
5.5.2.3 Significance Testing 
ANOVA was performed to investigate significant differences between the first samples 
obtained from the LSP of each of the three solvent samples used (Appendix Table 8.13). The 
calculated probability of F (346.02) was much larger than the critical value of F (5.14), 
suggesting evidence of significant differences between the first sample collected using each 
sampling solvent.  
Table 5.5. Intensity (counts per second), mean (µ), standard deviation (σ) and relative standard 
deviation (%) of Mn signal from the three sample solutions collected using the LSP. Probability score for 
test of variance (F) and difference sample means of the previous sample collected (T) are also given 
where values P < 0.05 show evidence of statistically significant differences in the mean 
Sample Intensity (cps) RSD (%) F (P) T (P) 
1 2 3 µ σ (n = 3) 
EDTA                 
Blank 51959 54551 57144 54551 2593 4.75   
Sample (B) 500856 469013 484935 484935 15921 3.28 0.05 3.35E-04 
Sample wash 1 (B1) 257746 246854 235963 246854 10891 4.41 0.64 7.24E-05 
Sample wash 2 (B2) 54716 55332 54100 54716 616 1.13 0.01 6.88E-06 
Sample wash 3 (B3) 52739 49421 51080 51080 1659 3.25 0.24 4.92E-02 
2% HNO3 
        Blank 164553 150520 157537 157537 7017 4.45   
Sample (B) 708881 685541 662201 685541 23340 3.40 0.17 2.49E-04 
Sample wash 1 (B1) 443086 430187 417287 430187 12900 3.00 0.47 3.82E-04 
Sample wash 2 (B2) 150832 163078 156955 156955 6123 3.90 0.37 8.75E-05 
Sample wash 3 (B3) 150060 162615 156337 156337 6278 4.02 0.98 9.09E-01 
DI H2O 
        Blank 14732 15748 15240 15240 508 3.33   
Sample (B) 292296 316554 304425 304425 12129 3.98 0.00 2.06E-06 
Sample wash 1 (B1) 147289 156225 165162 156225 8936 5.72 0.70 1.24E-04 
Sample wash 2 (B2) 10567 10179 10955 10567 388 3.67 0.00 9.40E-06 
Sample wash 3 (B3) 9322 9033 9611 9322 289 3.10 0.71 1.33E-02 
   
Between sample 1 of delivery matrix 
  
   
EDTA & 2% HNO3 0.64 2.51E-04 
   
EDTA & DI H2O 0.73 9.81E-05 
      2% HNO3 DI H2O 0.43 1.50E-05 
A t-test to compare the two experimental means was conducted to investigate whether 
these differences occur between the first samples obtained from each of the sampling 
solvent. Table 5.5 shows the probability of the t-test and implies there is evidence of 
significant differences between the first samples obtained using the LSP for all three 
sampling solvents. The probability obtained between the first sample when using the solvent 
samples EDTA and 2% HNO3 was 0.000251, much less than the 0.05 threshold, and thus 
there is evidence present of statistically significant differences. Evidence of statistically 
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significant differences (95%) were also present between sampling solvents EDTA and DI H2O 
(T = 0.0000981) and 2% HNO3 and DI H2O (T = 0.000015). As shown in Table 5.5, t-tests 
between results from consecutive samples showed statistically significant differences in all 
cases except between the final 2 washes of the samples using 2% HNO3. 
5.5.2.4 Efficiency 
Using the data collected for these samples, the relative efficiency of the LSP was determined 
by taking the amount of solvent sampled over the target surface (solvent collected) and 
subtracting from this the initial amount of solvent delivered (delivery solvent), from the 
delivery vial, over the target sample area. Multiplying this by 100 produces the relative 
efficiency (equation 6.3).  The relative efficiency for all samples obtained can be found in 
supplementary Table SI.5.2. 
  (                  Equation 5.3 
where E = efficiency 
 SCOL  = solvent collected 
 SDEL  = solvent delivered 
 
On average, the efficiency for samples that had been collected using EDTA was 99.9%, using 
2% HNO3 was 100.3% and DI H2O achieved 95.9% efficiency. The 100.3% average using a 
delivery solvent of 2% HNO3 suggests that extra solvent has been picked up from previous 
samples. A closer look at the breakdown shows that the blank efficiency was 102.3%. This 
may be due to traces of the sampling solvent from previous testing, in possibly the tubes of 
the LSP, following cleaning of the device prior to collecting the blank sample. Also, the first 
sample (B) collected using the sampling solvent of DI H2O showed an efficiency of 78.2%, 
very low in comparison to all other recoveries. For this to occur, some of the solvent 
delivered would not have been transferred to the collection vial via the target sampling site. 
It may have been possible that some of the sampling solvent could have been left in the 
transfer tubes or if a seal had not been retained at the sampling base of the LSP, the sample 
could have leaked out around the target surface and lost. Previously, some solvent had been 
observed to go into the collection vial via one needle but would form a drop at the end of 
the needle, a drop big enough to then touch the needle that led to the peristaltic pump 
outlet. This would then suck up the drop over this needle and the collected sample would go 
through the peristaltic pump tubing to waste. 
The observed differences in collection efficiency were not due to different uptake from the 
delivery vial. 
  
1
2
1
 
 
Figure 5.8. Mn concentration (ng.mL
-1
) for the comparison of the three different sample solutions; 2% HNO3 (green); EDTA (pink); and DI H2O (blue). 
Insert: Recovery (%) of the three different sample solutions. B = reference sample, B1 = wash sample 1, B2 = wash sample 2 and B3 = wash sample 3 
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H0 was rejected, as a statistically significant difference was found in the recovery of a Mn 
sample from a nitrile glove using the LSP, between sampling solvents (H0: SS (x) ≠ SS (y)). A 
pre-selected sample was extracted using three sampling solvents with highest first 
recoveries observed for 2% HNO3 (55.7%) followed by EDTA (39.9%) and finally DI H2O 
(18.6% recovery). Although samples collected using the sampling solvent 2% HNO3 produced 
the best recoveries, this solvent is not suitable for use on human skin. However, using EDTA 
as the sampling solvent produced acceptable recoveries and is better suited to collecting 
samples from the surface of human skin. EDTA is a good chelating agent that can extract 
metals from the skin surface better than DI H2O and is less hazardous than 2% HNO3. 
5.6 Non-invasive fast skin profiling for elements from the volar and 
plantar 
The aim of this study was to investigate the differences in elemental profiles between the 
skin volar (AE) and skin plantar (BF), using the LSP. Samples were collected from pre-
determined sites from two sampling areas of human skin, using EDTA as the LSP sampling 
solvent. All samples were collected and analysed by the author and Dr Corrinne Burns 
(personal communication). H0 of the experiment was there was no differences in the 
elemental profiles between human volar (AE) and plantar (BF) skin sites i.e. H0: volar (AE)E = 
plantar (BF)E.  
This experiment follows a similar workflow as that outlined in Figure 5.4. One LSP was used 
to collect three samples, using EDTA as the sampling solvent, per participant; (in order) 1 x 
LSP pen blank, 1 x volar (AE) site and 1 x plantar (BF) site. A total of 60 vials and 120 vial caps 
were used for this study. Ten male and/or female volunteers aged between 18 and 35 years 
participated in the study.  Participants were asked not to shower or use any deodorants or 
products on their skin or hair for fifteen hours prior to skin sampling. Only one participant 
was sampled at any one time and each participant was required for sampling for only one 
day. For each participant 6 vials and 12 vial caps were used, 2 vials and 4 caps each for 
collecting the LSP pen blank and sampling both the volar (AE) and dorsal (TF) skin sites. 10 
complete sets of sampled skin were obtained and analysed over 3 days by ICP-MS. 
5.6.1 Experimental Outline 
1 LSP was used to collect a total of 30 samples, 3 from each participant. The skin sampling 
areas of the volar (AE) and plantar (BF) can be observed in Figure 5.2. 
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5.6.1.1 Sampling the volar 
The volar (AE) sample site was cleaned with DI H2O using a clean pad of cotton, prior to 
sample initiation. The volar (AE) was sampled first, with 1.5 ml EDTA, using the LSP.  
5.6.1.2 Sampling the plantar 
Following this, the LSP was cleaned and a further LSP pen blank sample was collected. 
Participants were then asked to remove the sock from their right foot and place their dorsal 
(TF) of the bare foot flat on a chair. The plantar (BF) sample site was cleaned with DI H2O 
using a new cotton pad prior to collecting the plantar (BF) site sample.  
Following post collection weighing of the sample vials, all samples were stored in a freezer at 
-80°C until the morning of analysis. 
5.6.1.3 Sample Analysis 
Samples were allowed to thaw at room temperature for 1 hour after which they were 
homogenised using a vortex mixer. For each sample 1 ml of the sampled solvent was diluted 
with 4 ml 2% HNO3 in a pre-cleaned (with 2% HNO3) polypropylene tube and labelled ready 
for analysis. 
Elemental detection of twenty six elements was performed using ICP-MS (Chapter 1 section 
1.3.5). A 2% HNO3 solvent blank was bracketed in the analysis sequence every two samples 
to assess the baseline elemental levels of the instrument. Also, all samples were analysed in 
triplicate to obtain more reliable results. During data analysis the dilution factor for all 
samples was taken into account after which LSP pen blanks were subtracted from the 
relevant samples. Volar (AE) and plantar (BF) samples were grouped in order to perform 
ANOVA and then a paired t-test. 
5.6.2 Results and Discussion 
A total of 32 samples were analysed that included 10 samples from the plantar (BF), 10 
samples from the volar (AE), 10 LSP pen blank samples, 1 EDTA solvent sample and 1 EDTA 
vial blank sample. From the 26 elements that were determined, 8 were detected in the two 
sample sites (Table 5.6). 
As shown in Table 5.6 elemental concentrations from the volar (AE) followed the order 
(highest first) Si > S > K > Al > Fe > P > Zn > Ni, and a similar trend was seen for the plantar 
(BF) except that the order of S and K was reversed. In both cases, concentrations ranged 
from about 2000 µg.mL-1 for Si to about 7 µg.mL-1 for Ni, individual variations being indicated 
by the standard deviations. The data is plotted in Figure 5.9. 
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Table 5.6. Mean elemental concentrations (ng.mL
-1
) and (in brackets) standard deviations (n=10) for the 
elemental profiling of the volar (AE) and plantar (BF) using the LSP. Probability scores of paired t-test (T (P)) to 
test significant differences between skin sites (n = 10) also shown 
Element Volar Plantar (BF) T (P) 
Si 1701 (42.5) 2161 (54.0) 0.12 
S 626 (15.7)  358 (8.95) 0.22 
K 279 (6.98) 736 (18.4) 0.14 
Al 94 (2.35) 103 (2.58) 0.60 
Fe 74 (1.85) 41 (1.03) 0.08 
P 24 (0.60) 22 (0.55) 0.82 
Zn 21 (0.53) 15 (0.38) 0.31 
Ni 6.2 (0.16) 7.5 (0.19) 0.47 
ANOVA was carried out on the data set to determine whether there was any difference in 
variance between the two skin sample sites (Appendix Table 8.12). There was no statistical 
evidence of significant difference in the variation between the two skin sample sites as the 
calculated F value, 1.11, was much lower than the critical F value, 3.91. This is confirmed by 
the results of a paired t test that was performed to identify significant differences in 
elemental recoveries from the two skin sample sites. All T (P) values are above 0.05 
indicating there is no statistically significant evidence of differences in elemental recoveries 
between the two skin sample sites (Table 5.6). As expected, there are differences observed 
in variation between the amounts of different elements recovered from the sample sites as 
the calculated F value (40.11) is much bigger than the critical F value (2.07). 
 
Figure 5.9. Mean concentrations of 10 participants for plantar (BF) (50% grey) and volar (AE) (5% 
grey) skin sites of the eight recovered elements using the LSP. The error bars designate standard 
error of the mean (95% confidence) 
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H0 was accepted as no difference in elemental profiles between human volar (AE) and 
plantar (BF) skin sites (H0: volar (AE)E = plantar (BF)E) was discovered. Although 8 elements 
were extracted from the two sample sites, there was no statistically significant evidence of 
differences in the elemental content between the two sample sites. 
High Si levels were found in both the volar (AE) and plantar (BF) skin sample sites. There is a 
possibility that this was the result of Si leaching from the LSP vials and transport tubing. As a 
result, an updated LSP cleaning method should be implemented removing any impurities 
from future samples. The LSP should be pre cleaned and dried in a vacuum oven prior to 
collecting samples to reduce any elemental carry over from previous samples. Further to 
this, a new peristaltic pump should be used in order to prevent sample loss via the peristaltic 
pump tubing, something that was observed during sample collection. 
The skin sample sites should not be treated with deionised water prior to sample collection 
as this procedure may remove any elemental traces that may be of interest. Instead samples 
should be collected from skin sample sites without any pre-treatment. 
5.7 Non-invasive fast skin profiling for elements from the axilla, 
dorsal, plantar and volar 
The aim of this study was to investigate the differences in elemental profiles obtained 
between the four skin sites on the human body using the LSP. Samples were collected from 
the axilla (AP), dorsal (TF), plantar (BF) and volar (AE) using an EDTA sampling solvent. The 
experiment was conducted by Dr Svetlana Riazanskaia (personal communication) and all 
samples were collected and analysed by the author and Dr Corrinne Burns (personal 
communication). H0: there was no difference in elemental profiles, obtained using the LSP, 
between human skin axilla (AP), dorsal (TF), plantar (BF) and volar (AE) sites i.e. H0: axilla 
(AP)E = dorsal (TF)E = plantar (BF)E = volar (AE)E.  
This experiment follows a similar workflow as that outlined in Figure 5.4. A total of 10 LSPs 
were used with each LSP collecting 8 samples, using EDTA as the sampling solvent, per 
participant; (in order) 1 x LSP pen blank axilla (AP) site, 1 x axilla (AP) site, 1 x LSP pen blank 
dorsal (TF) site, 1 x dorsal (TF) site, 1 x LSP pen blank plantar (BF) site, 1 x plantar (BF) site, 1 
x LSP pen blank volar (AE) site, 1 x volar (AE) site. A total of 160 vials and 320 vial caps were 
used for this study. For each participant 16 vials and 32 vial caps were used, 8 vials and 16 
caps each for collecting the LSP pen blank and sampling all four sample skin sites. 10 
complete sets of sampled skin were obtained over 2 days. Sample analysis commenced 5 
days after collection by ICP-MS over a 27 day period.  
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5.7.1 Experiment Outline 
Ten (5 male and 5 female) volunteers aged between 18 and 59 years participated in the 
study.  Participants were recruited by internal advertising within Unilever PLC, Bebington. 
Participants refrained from using perfumed soap, shampoo and deodorant for three weeks 
prior to the start of skin sampling. Participants were provided with unperfumed cosmetics 
and were allowed to use these as frequently as necessary. Participants were provided with 
Simple unfragranced soap to use for showering for a week prior to sample collection and 
were asked not to wash in the twenty-four hours preceding skin sampling. They were also 
provided with pre-cleaned cotton T-shirts and socks, by Unilever Plc, to wear during this 
time. Participants were required for only one visit. All female participants were sampled on 
the first day and all male participants were sampled on the following day. 
Assistance for pre-sample preparation and sample collection was given by Dr. Corrinne 
Burns. 
Figure 5.10. Participant information summary for the elemental profiling of the axilla (AP), dorsal (TF), plantar 
(BF) and volar (AE) 
Sample 
Date 
Sample 
Day 
Participant 
ID 
Gender 
Sample site No. of 
samples 
Sample 
storage Axilla Dorsal Plantar  Volar 
29/09/2011 1 UP1 Female Right Left Left Left 8  -80°C 
29/09/2011 1 UP2 Female Left Right Right Right 8  -80°C 
29/09/2011 1 UP3 Female Right Left Left Left 8  -80°C 
29/09/2011 1 UP4 Female Left Right Right Right 8  -80°C 
29/09/2011 1 UP5 Female Right Left Left Left 8  -80°C 
30/09/2011 2 UP6 Male Right Left Left Left 8  -80°C 
30/09/2011 2 UP7 Male Left Right Right Right 8  -80°C 
30/09/2011 2 UP8 Male Left Right Right Right 8  -80°C 
30/09/2011 2 UP9 Male Right Left Left Left 8  -80°C 
30/09/2011 2 UP10 Male Left Right Right Right 8  -80°C 
18 LSP’s were used to collect a total of 80 elemental samples, 8 from each participant. 
Participants were asked to lie on their back, on a portable masseuse table, during sample 
collection. Samples were collected in the following order; axilla (AP), dorsal (TF), plantar (BF) 
and volar (AE). Participants were asked to remove socks on the selected foot for sampling 
prior to collecting the dorsal (TF) and plantar (BF) site samples.  
Throughout the study, alternate sides of the body were sampled between participants to 
randomise sample sites and thus avoid bias. For example, if the right axilla (AP) was sampled 
for the first participant, then the left axilla (AP) would be sampled for the second participant. 
The skin sampling areas of the axilla (AP), dorsal (TF), plantar (BF) and volar (AE) can be 
observed in Figure 5.2. 
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5.7.1.1 Sampling the axilla 
A LSP pen blank was initially collected prior to collecting the first sample on the axilla (AP) 
site (labelled AP Blank). The t-shirt sleeve was lifted to the shoulder of the participant on the 
selected axilla (AP) sample side. Participants lay back on the masseuse table with the 
selected arm raised by their ear so the axilla (AP) sampling site was exposed and parallel to 
the ceiling. One sample was collected from the axilla (AP) site using the LSP with EDTA as the 
sampling solvent. 
5.7.1.2 Sampling the dorsal 
Following sample collection from the axilla (AP) site, the LSP was then cleaned. The second 
LSP pen blank was collected (labelled TF pen blank). Participants then sat up at the end of 
the masseuse table and removed the sock on the foot selected for sampling, ensuring the 
foot remained suspended and did not come into contact with the table or floor. With the 
dorsal (TF) parallel to the ceiling, one sample was collected from the dorsal (TF) using the 
LSP with EDTA as the sampling solvent. 
5.7.1.3 Sampling the plantar 
Next, the LSP was then cleaned again. The third LSP pen blank was collected (labelled BF pen 
blank). Participants were asked to then lie on their stomach ensuring the foot remained 
suspended and did not come into contact with the table or floor. With the plantar (BF) 
parallel to the ceiling, one sample was collected from the plantar (BF) using the LSP with 
EDTA as the sampling solvent. 
5.7.1.4 Sampling the volar 
Finally, the LSP was then cleaned. The fourth and final LSP pen blank was collected (labelled 
AE pen blank). Participants were asked to sit on the edge of the masseuse table with the 
selected sampling arm outstretched so that the volar (AE) sampling site was parallel to the 
ceiling. One sample was collected form the volar (AE) using the LSP with EDTA as the 
sampling solvent. 
5.7.1.5 Field Blank Collection 
One field blank was collected on each of the two days during participant sampling. When the 
first participant arrived, the cap of one vial containing 1.5 ml EDTA (sampling solvent) was 
unscrewed and removed from the top of the vial. This was then exposed to the environment 
of the sampling room until the last sample was collected from the final participant on that 
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given day. The cap was then replaced and the vial was placed in storage, with all other vials, 
after which samples were stored in a freezer at -80°C until the morning of analysis. 
5.7.1.6 Sample Analysis 
Samples were prepared for analysis as detailed in section 5.6.1.3. Elemental detection of 
twenty three elements was performed using ICP-MS (Chapter 1 section 1.3.5).  
 
Figure 5.11. (A) Mean concentrations of 10 participants for plantar (BF) (50% grey), dorsal (TF) (35% grey), 
axilla (AP) (15% grey) and volar (AE) (5% grey) skin sites of the six recovered elements using the LSP. The error 
bars designate 1 standard deviation of the mean. (B) Box-whisker plot of female volar (FV), male volar (MV) 
and combined volar (TV) results for S. (C) Box-whisker plot for the K axilla (AP) (KA), K dorsal (TF) (KD) Mg 
plantar (BF) (MgP) and Mg volar (AE) (MgV) skin sites 
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Table 5.7. Element concentrations (µg/L) and standard deviations (n = 5)  from female (F) and male (M) skin sites sampled using the LSP. Probability (P) of t-test testing 
significance between genders for each sample site where values of P < 0.05 shows evidence of significant difference (at 95%) 
Element 
Axilla Dorsal Plantar Volar 
F M P F M P F M P F M P 
K 600 (560.0) 335 (129.6) 0.68 2768 (3966.4) 1614 (1537.4) 0.87 1178 (745.8) 3096 (4214.0) 0.29 495 (403.0) 1221 (1119.3) 0.37 
S 55 (75.5) 61 (36.0) 0.35 37 (36.3) 93 (42.4) 0.13 1237 (2675.8) 133 (84.0) 0.78 4 (5.2) 107 (73.1) 0.03 
Mg 18 (36.5) 5 (6.0) 0.92 23 (17.3) 11 (9.3) 0.46 24 (18.1) 61 (40.4) 0.50 8 (17.2) 10 (23.4) 0.88 
Fe 9 (12.7) 27 (38.3) 0.33 14 (15.3) 15 (10.3) 0.66 23 (10.7) 12 (11.0) 0.11 18 (38.1) 14 (8.1) 0.29 
Al 0 (0) 34 (76.5) 0.35 3 (7.6) 24 (24.3) 0.07 0 (0.0) 21 (30.5) 0.06 10 (22.8) 48 (33.7) 0.07 
Cu 2 (3.2) 10 (14.5) 0.33 1 (2.2) 2 (2.7) 0.57 2 (3.3) 2 (2.3) 0.87 3 (5.7) 2 (2.4) 0.97 
 
Table 5.8. Element concentrations (µg/L) and standard deviations (n = 5)  from right (R) and left (L) skin sites sampled using the LSP. Probability (P) of t-test testing 
significance between sample side for each sample site where values of P < 0.05 shows evidence of significant difference (at 95%) 
Element 
Axilla Dorsal Plantar Volar 
R L P R L P R L P R L P 
K 392 (278) 543 (532) 0.43 3371 (3814) 1011 (951) 0.32 1279 (559) 2995 (4296) 0.94 806 (781) 910 (1062) 0.97 
S 41 (63) 75 (49) 0.25 82 (31) 48 (59) 0.16 106 (71) 1264 (2662) 0.93 42 (61) 69 (88) 0.50 
Mg 0 (0) 24 (34) 0.00 14 (9) 20 (20) 1.00 48 (30) 37 (43) 0.71 0 (0) 19 (25) 0.08 
Fe 7 (11) 29 (38) 0.23 8 (11) 21 (10) 0.07 18 (7) 16 (16) 0.38 8 (10) 24 (35) 0.35 
Al 0 (0) 34 (76) 0.35 12 (14) 16 (27) 0.80 21 (30) 0 (0) 0.06 20 (32) 38 (36) 0.50 
Cu 3 (5) 9 (15) 0.50 2 (2) 1 (3) 0.63 1 (2) 3 (3) 0.18 1 (1) 4 (6) 0.29 
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5.7.2 Results and Discussion 
A total of 84 samples were analysed which included 10 samples each from the axilla (AP), 
dorsal (TF), plantar (BF) and volar (AE), 40 LSP blank samples and 4 solvent blank samples. 
From the 23 elements that were measured, 6 were detected in all four sample sites. While 
all elements detected were observed in each sample site, the highest concentrations were 
observed in the plantar (BF) sample site followed by the dorsal (TF), axilla (AP) then volar 
(AE). K, S, Mg and Fe were discovered in large quantities in the plantar (BF) sample site with 
concentrations of 2137, 685, 43 and 17 ng.mL-1, respectively. Smaller amount of Al and Cu 
were also found in all sample sites where the largest concentration of Al found in the volar 
(AE) and the largest concentration of Cu found in the axilla (AP), were concentrations at 29 
and 6 ng.mL-1, respectively (Table 5.9). 
Table 5.9. Mean element concentrations (ng.mL
-1
) and (in brackets) standard 
deviations (n=10) for the elemental profiling of the axilla (AP), dorsal (TF), 
plantar (BF) and volar (AE) using the LSP 
Element Plantar Dorsal Axilla Volar 
K 2137 (53.4) 2191 (54.8) 468 (11.7) 858 (21.5) 
S 685 (17.1) 65 (1.63) 58 (1.45) 55 (1.38) 
Mg 43 (1.08) 17 (0.43) 12 (0.30) 9 (0.23) 
Fe 17 (0.43) 15 (0.38) 18 (0.45) 16 (0.40) 
Al 11 (0.28) 14 (0.35) 17 (0.43) 29 (0.73) 
Cu 2 (0.05) 1 (0.15) 6 (0.15) 2 (0.05) 
Initially, ANOVA (two-factor with replication, n = 10, P = 0.05) was conducted (Appendix 
Table 8.14) to observe if any differences between the four sample sites was present. The F 
value (3.75) obtained was larger than the critical F value (2.65) between sample sites, 
suggesting there is evidence of differences in the elemental concentrations present. Also, a 
calculated F value of 62.19 was obtained, much bigger than the critical F value of 2.26.  
Table 5.10 shows the probability values (P) of a paired t-test between the four skin sites. 
Evidence of significant difference (95%) in elemental concentration was present for K 
between the axilla (AP) and dorsal (TF) sample sites and also a difference in Mg between the 
plantar (BF) and volar (AE) sample sites. Mg plantar (BF) concentrations averaged 43 µg.mL-1 
whereas those found in the volar (AE) averaged only 9 µg.mL-1. K axilla (AP) concentrations 
averaged 468 µg/ml. In contrast, the dorsal (TF) site K concentration averaged 2191 µg.mL-1.  
Evidence of gender differences for S in the volar (AE) were observed using a t-test (95%) 
(Figure 5.11 (B)). The concentration in males was found to be significantly higher than in 
females with an average S concentration of 107 µg.ml-1 observed in male volar (AE) whereas 
only 4 µg.ml-1 was observed in female volar (AE). Statistically significant differences were 
 131 
also found for Mg between the axilla (AP) sides. An average of 24 µg.ml-1 was determined in 
the left axilla (AP) of participants whereas the amount of Mg in the right side was below the 
limit of detection. 
Table 5.10. Probability scores of paired t-test to test significant differences between skin sites (n = 10) sampled 
using the LSP 
Element 
Axilla & 
Dorsal 
Axilla & 
Plantar 
Axilla & 
Volar 
Dorsal & 
Plantar 
Dorsal & 
Volar 
Plantar & 
Volar 
K 0.03 0.06 0.35 0.93 0.16 0.10 
S 0.29 0.44 0.73 0.74 0.22 0.19 
Mg 0.14 0.05 0.66 0.27 0.07 0.04 
Fe 0.74 0.20 0.85 0.52 0.51 0.23 
Al 0.13 0.50 0.05 0.33 0.53 0.25 
Cu 0.29 0.35 0.16 0.70 0.91 0.84 
H0 was rejected as differences in elemental profiles between human skin axilla (AP), dorsal 
(TF), plantar (BF) and volar (AE) sites were found (H0: axilla (AP)E ≠ dorsal (TF)E ≠ plantar (BF)E 
≠ volar (AE)E.). Across the four sampling sites, 6 elements were detected where K was found 
to be the highest in each of the four sample sites, especially in the axilla (AP) and volar (AE) 
sites, when compared to the other elements. Other elements detected included S, Mg, Fe, Al 
and a trace amount of Cu. Statistically significant differences were demonstrated for K 
between axilla (AP) and dorsal (TF) sampling sites, Mg between plantar (BF) and volar (AE) 
sites, S from the volar (AE) sample site between male and females, and Mg in the axilla (AP) 
between the right and left sample site. 
5.8 Non-invasive fast profiling of the dorsal and plantar for semi-
volatile organic compounds and non-volatile organic 
compounds 
The objective of this study was to identify and investigate the differences in semi-volatile 
organic compounds (semi-VOCs), volatile organic compounds (VOC) and small molecule 
profiles obtained between the dorsal (TF) and plantar (BF) skin sites on the human body 
using the LSP. Samples were collected from the dorsal (TF) and plantar (BF) using 50% v/v 
EtOH(aq) sampling solvent. All samples were collected by the author and analysed by the 
author with assistance from Dr. James Reynolds (personal communication). All data was 
processed by the author. H0: there was no difference in profiles, obtained using the LSP, 
between human skin dorsal (TF) and plantar (BF) sites i.e. H0: dorsal (TF)V = plantar (BF)V. 
The LSP was evaluated as a non-invasive method to obtain small molecules in human skin. 
Extracted small molecules were collected from the dorsal (TF) and plantar (BF) from a 
sample solution containing 1ml EtOH (aq) using the LSP.  
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This experiment follows a similar workflow as that outlined in Figure 5.4. In the pre-sampling 
phase of the study, all eighteen LSP’s were cleaned with selected solvents and samples were 
obtained using 50% v/v EtOH as the sampling solvent and analysed by ESI-MS. Acceptable 
(low) baseline levels were observed for all LSP’s. All LSP’s were re-cleaned ready for sample 
collection from participant skin. Socks, pre-cleaned in non-fragranced washing powder, and 
a non-fragranced body soap bar (Simple) were given to the participants prior to the morning 
of sampling. Collection and delivery vials were weighed before and after sample collection. 
50% v/v EtOH was used as the sampling solvent and 1.5 ml was added to delivery vials and 
attached to the LSP’s ready for sample collection. Pre weighed and clean collection vials 
were also attached to the LSP.  
Ten (5 male and 5 female) volunteers aged between 18 and 35 years participated in the 
study. Participants were provided with Simple non fragranced soap to shower with the night 
prior to sample collection and were asked not to wash the morning of sampling. Participants 
were also provided with pre-cleaned cotton socks to wear during this time and were asked 
to refrain from using deodorants or products for the skin or hair and not consume any food 
or drink (other than unflavoured water) on the morning of sampling. Nine complete sets of 
sampled skin were obtained over a period of thirteen days with participants required for one 
visit. Males and females were alternatively sampled. 
In the sample collection phase of the study, two LSP’s were used to collect skin samples from 
each participant, one LSP to collect from the dorsal (TF) and one from the plantar (BF). LSP 
pen blanks were collected from each LSP before the participant arrived. Samples were 
collected using 50% v/v EtOH. A total of eighteen LSP’s were used with each LSP collecting 
one sample, using EtOH as the sampling solvent, per participants; (in order) 1 x LSP pen 
blank dorsal (TF) site (LSP pen 1), 1 x LSP pen blank plantar (BF) site (LSP pen 2), 1 x LSP 
dorsal (TF) site (LSP pen 1), 1 x plantar (BF) site (LSP pen 2). A total of 92 vials and 130 vial 
caps were used for this study. For each participant, 9 vials and 13 vial caps were used, 8 vials 
and 12 caps each for collecting the LSP pen blanks and 1 vial and 1 cap to collect a field blank 
during sample collection. Samples were stored at -80°C until day of analysis. 
5.8.1 Experiment Outline 
18 LSP’s were used to collect a total of 40 samples, 4 from each participant. Also collected 
from each participant was a field blank sample. Participants were asked to sit on a chair 
during sample collection of the dorsal (TF) and place their knee on a chair for the collection 
of the plantar (BF) sample. LSP pen blank samples were collected from each LSP prior to 
participant arrival. One field blank sample was collected while participant was in the 
 133 
sampling room. Dorsal (TF) samples were always collected first followed by the plantar (BF) 
samples. Samples were collected, using the method outlined in Chapter 5 section 5.3. 
Participants were asked to remove socks on the selected foot for sampling prior to collecting 
samples. Immediately after each site was sampled, the vial of the collected sample was 
recapped with a new, clean screw cap with an un-pierced rubber septum. Once all samples 
were collected for each participant, the samples were refrigerated at -80°C until analysis.  
Each participant was required for a single 30 minute session in order to fill out the relevant 
documentation as well as complete the sample collection process. Once samples were 
collected, the socks that the participants had been wearing were wrapped in foil and placed 
in a sealed secondary container. Participants were asked to bring a spare pair of socks with 
them to wear following the sample collection session. Once samples were collected, the 
participant was free to leave. 
In the sample analysis stage of the experiment, sample were allowed to thaw at room 
temperature on the morning of analysis and then analysed by ESI-MS in firstly negative and 
then positive ion mode. Raw data was obtained by peak profiling after which MVA was 
conducted and then descriptive statistics was performed. Accurate mass determination and 
possible ion identity was conducted nESI-MS.  
Assistance for sample collection and ESI-MS and nESI-MS analysis was given by Dr. James 
Reynolds. ESI-MS and nESI-MS conditions can be found in Chapter 1 sections 1.4 and 1.5, 
respectively. 
The skin sampling areas of the dorsal (TF) and plantar (BF) can be observed in Figure 5.2 (B) 
& (C). 
5.8.1.1 Protection of dorsal and plantar sample sites 
The purpose of protecting the sample site was to avoid any contamination of the feet. 20 
white cotton socks (10 with a grey marking to be used for male participants and 10 with a 
pink marking to be used for female participants) were washed in a washing machine (Bosch 
Exxcel 1400 Express) at 30°C for 62 minutes with non-fragranced washing powder (Persil). 
Following the completion of the wash cycle all socks were then placed into a tumble dryer 
(Zanussi Electrolux Condenser Dryer, TCE 776 W) for 75 minutes. Once the cycle was 
completed, the socks were paired, wrapped in foil (shiny side outwards for males and dull 
side outwards for females) and placed into a sealed secondary container. 
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Two days prior to the sample collection date, participants were provided with a participant 
information sheet, clean socks and non-fragrance bar of SIMPLE soap. The night before 
sample collection participants washed both of their feet using the provided soap and did not 
use any other skincare products until sample collection. Feet were covered immediately 
after being washed with the provided sock and these were not removed until the feet were 
sampled the following morning. While the socks were on the feet, participants were told not 
to consume any food or drink (except water). 
5.8.1.2 LSP pre sample cleaning 
All LSP’s were cleaned and dried using the sample procedure outlined in Chapter 1 section 
5.3.2. Following this first clean, LSP pen blanks were collected using the sampling solvent 
EtOH. 18 samples were analysed by ESI-MS in negative ion mode and blank levels were 
viewed in MassLynx and deemed low enough to be acceptable. 
All eighteen* LSP’s were cleaned and dried again, using the outlined method, ready for 
sample collection. 
*An extra cycle of cleaning and drying was carried out for two LSP’s once participant samples 
had been collected using them due to the need to have twenty clean LSP’s. 
5.8.1.3 Foot Selection 
Within each gender, an alternative foot was selected to be sampled. For example, the first 
male participant was chosen to have the left foot sampled thus the second and third male 
participants would have the right and left foot sampled, respectively. The same selection 
process was applied to the female participants where the first female participant’s right foot 
was sampled first. This resulted in 3 right foot samples and 2 left foot samples selected for 
male participants and 3 left foot samples and 2 right foot samples being selected for female 
participants. Consequently, 5 right foot samples and 5 left foot samples were taken in total 
(supplementary information Table SI.5.3). 
5.8.1.4 Sampling the dorsal 
The participant was asked to sit on a chair and remove their shoes and socks (socks were 
immediately wrapped in foil and placed in a sealed container) on the selected foot, resting 
the heel of the foot on a piece of paper towel on the floor ensuring that the plantar (BF) of 
the foot did not come into contact with the floor and the dorsal (TF) was parallel to the 
ceiling (or as close to parallel as possible without the dorsal (TF) of the foot touching the 
floor). One sample was collected from the dorsal (TF) site using LSP 1 with EtOH as the 
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sampling solvent. The collection vial cap was then replaced with a new screw cap with no 
piercings from the LSP sample needles. LSP 1 was then re-racked. 
5.8.1.5 Sampling the plantar 
Following sample collection from the dorsal (TF) site, the participant carefully turned around 
and placed their knee on the chair, holding on to the back of the chair to balance, ensuring 
the plantar (BF) of the sampling foot did not come in contact with the floor. The foot was 
raised so the plantar (BF) site was now parallel to the ceiling. One sample was collected from 
the plantar (BF) site using LSP 2 with EtOH as the sampling solvent. The collection vial cap 
was then replaced with a new screw cap with no piercings from the LSP sample needles. LSP 
2 was then re-racked. 
5.8.1.6 Field Blank Collection 
One field blank was collected for each participant. When the first participant arrived, the cap 
of one vial containing 2 ml EtOH (same as the sampling solvent) was unscrewed and 
removed from the top of the vial. This was then exposed to the environment of the sampling 
room until the participant left the sample room. The cap was then replaced and the vial was 
placed in storage with all other vials. 
Samples were stored in a freezer at -80°C until the morning of analysis. 
5.8.1.7 Sample Analysis 
All 51 (5 per participant and 1 EtOH sampling solvent blank) samples were analysed on the 
same day. The storage duration of the sample vials was between 22-35 days for ESI-MS 
negative mode analysis, and between 138-151 days for ESI-MS positive mode analysis. On 
the day of analysis samples were allowed to thaw at room temperature for 1 hour prior to 
commencing sample analysis. All samples were analysed by ESI-MS (Chapter 1 section 1.4). 
Four plantar (BF) samples from randomly selected participants (UF1, UF4, UF5 and UF8) 
were analysed by nESI-MS in an attempt to determine the mass accuracy, as well as the 
identity, of ions (Chapter 1.5). 
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5.8.2 Results and Discussion 
A total of 51 samples were analysed that included 10 dorsal (TF) samples, 10 plantar (BF) 
samples, 10 field blank samples, 20 LSP blank samples and 1 solvent sample by ESI-MS. 
H0 was rejected as there were differences in profiles between human dorsal (TF) and plantar 
(BF) sample sites analysed by ESI-MS (H0: dorsal (TF)Y ≠ plantar (BF)Y). A total of 96 ions were 
detected in samples analysed by ESI-MS in positive or negative ion mode (data processing 
procedures for these samples are outlined in Chapter 1 section 1.6) and 60 ions showed 
significant differences (95%) between the two skin sample sites. A PCA model based on the 
ions significant to each sample site, obtained by supervised modelling, predicted dorsal (TF) 
versus skin sites with 100% sensitivity and selectivity using negative ion mode sample data 
and 90% sensitivity and 100% selectivity using positive ion mode sample data. 
5.8.2.1 ESI-MS Negative ion mode 
Over 54400 features were identified between m/z 50-4000 and over 20100 between m/z 50-
200 in negative ion mode (Figure 1.9). Many were exogenous background contaminants. 
Multivariate Analysis 
34 ions were discovered from profiling data using MassLynx. From the initial 34 ions (Table 
5.11), 13 ions were selected from the S-plot (Figure 5.12 (C)) created from the PLS-DA 
model. These 13 ions were furthest from the centre of the S-plot suggesting possible 
difference between the dorsal (TF) and the plantar (BF) sample regions. The ions selected 
were found to have observed m/z of 74.0248, 89.0245, 90.0278, 92.9281, 93.0346, 
104.0354, 115.0185, 116.0506, 118.0511, 128.0354, 129.0389, 130.0875 and 137.0358. 
Using these thirteen variables, PCA was performed using all twenty observations producing a 
model with two significant components with a cumulative variation (R2X) of 98.7% of which 
97.5% could be cross validated (Q2X). Two clusters can be observed in the score scatter plot 
(Figure 5.12 (A)). Plantar (BF) samples appear to be tightly clustered whereas the dorsal (TF) 
samples are slightly more spread out. However, one observation, UF2 TF, is positioned closer 
to the plantar (BF) cluster than any other dorsal (TF) observation. 
Data obtained from participant 2 was excluded from the data analysis due to the participant 
not conforming to the pre-study guidelines outlined in the participant information sheet. 
During the morning of sampling, prior to sample collection, participant 2 ate breakfast 
consisting of toast, vegetable salad (carrots, peas, cauliflower) and pork with a glass of 
orange juice. As a result, data for participant 2 was not used.  
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Using the thirteen variables and only eighteen observations (participant 2 dorsal (TF) and 
plantar (BF) data excluded), a model was produced consisting of four significant components 
with a cumulative variation (R2X) of 99.9% of which 99.1% could be cross validated (Q2X). 
Two clusters can be observed in the score scatter plot (Figure 5.12 (B)). Plantar (BF) samples 
appear to be tightly clustered whereas the dorsal (TF) samples are slightly more spread out. 
The sensitivity of the data producing this model was 100% as all 9 plantar (BF) observations 
(true positives) were grouped together with no dorsal (TF) observations (false positives) 
within the group. Also, the specificity was 100% as all nine dorsal (TF) observations (true 
negatives) were grouped together with no plantar (BF) observations (false negatives) within 
the group.  
The weight contributions of the selected 13 ions from the s-plot where then examined and 
the biggest ion contributors were removed to highlight the importance of the smaller ions 
contributors. Removing one ion at a time, a model showing the separation between the 
dorsal (TF) and plantar (BF) sample site groups was observed with only three ions used in the 
data set. Ions (variables) with m/z 128.0354, 104.0354 and 93.0346 produced a model with 
two significant components with eighteen observations with a cumulative variation (R2X) of 
100% of which could be cross validated (Q2X) and 100% sensitivity and specificity (Figure 
5.12 (D)). 
Descriptive Statistics 
Using the intensity obtained for each ion the differences between the dorsal (TF) and plantar 
(BF) samples were calculated for all thirty one observed ions from the averages obtained 
from nine participants (excluding participant 2). ANOVA was performed on the data set to 
discover whether any differences in variance could be found. At 95%, ANOVA provided a 
calculated F value of 5.96 between the sample sites (Appendix Table 8.15). This value was 
much larger than the critical F value of 1.45 thus evidence of significant difference between 
the sample sites was present. Following this a paired t-test was carried out, on normalised 
data (log10 of original value) due to the data set not being from a normal distribution, to 
determine whether the two sample sites were significantly different (Table 5.11). H0: no 
difference in intensity obtained from dorsal (TF) and plantar (BF) samples. 
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Figure 5.12. Unsupervised PCA of LSP skin sensitive ions identified from PLS-DA on (A) 20 observations and (B) 18 observations, in negative ion mode. 13 ions were used to 
model the scatter plot from 35 ions identified from PLS-DA. (C) PLS-DA S-plot obtained from 20 observations analysed by ESI-MS in negative ion, R
2
X = 96.8%, Q
2
X = 89% (D) 
Unsupervised PCA of LSP skin sensitive ions identified from PLS-DA model on 18 observations in negative ion mode. 3 ions (m/z 93.0346, 104.0354 and 128.0354) were used 
to model the scatter plot from 34 ions identified from PLS-DA. 100% sensitivity was obtained for the plantar (BF) sample site observations and 100% specificity was obtained 
for the dorsal (TF) sample site in negative ion mode. R
2
X = 100%, Q
2
X = 100%. Dots = dorsal (TF) observations, circles = plantar (BF) observation. 
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The largest difference between the dorsal (TF) and plantar (BF) sample sites was found for 
the ion m/z 128.0354 with a difference of 51426 counts. Statistically significant evidence of 
differences between the two sample sites for the ion m/z 128.0354 was discovered at 99.9% 
using the paired t-test. Other large differences were found from ions with m/z 89, 93, 104 
and 137 with intensities obtained of 29209, 27005, 26991 and 10976, respectively. However, 
it is worth noting that for the ion m/z 89.0245 there was no statistically significant evidence 
of differences between the two sample sites at 95% whereas for the other four stated ions 
significant differences were found at 99.9% using a paired t-test. This is attributed to high 
intensities obtained for this ion from both the dorsal (TF) and plantar (BF) sample sites with 
the difference found to be smaller than both the plantar (BF) and dorsal (TF) average 
intensity values. 
The ion m/z 89.0245 was present in the air duster (Maplin, Loughborough) used to remove 
blockages in the sample transfer tubes of the LSP. The smallest difference of intensity 
between the plantar (BF) and dorsal (TF) sample sites was found for ion m/z 61.9884. For 
this ion, no statistically significant evidence of differences between the two sample sites was 
found. Interestingly, for all thirty four ions the intensities obtained for the plantar (BF) was 
higher than those obtained for the dorsal (TF). From the thirty four ions, using a paired t-
test, significant differences were found between the plantar (BF) and dorsal (TF) sample sites 
for twenty one ions at 95%, eighteen ions at 99% and thirteen ions at 99.9% (Table 5.11).  
An F-test followed by a T-test was also carried out in order to investigate whether gender 
differences existed (5 males, 4 females). Statistical evidence of a significant difference 
between male and female plantar (BF) samples at 95% was found for only one ion, m/z 
129.0389 (Appendix Table 8.16). For this ion, the average intensity obtained for male plantar 
(BF) samples was 5686, a value higher than that obtained for female plantar (BF) samples of 
3564. There was no statistical evidence of significant differences between male and female 
dorsal (TF) samples (Appendix Table 8.17). 
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Table 5.11. Mean (µ), standard deviation (σ) and the difference for 34 ion intensities, of dorsal (TF) and plantar (BF) samples, obtained by ESI-MS n negative ion mode. Results of paired t-
test (Pcalc) and whether the H0 was accepted () or rejected () are shown. Participant 2 excluded from data set. Also shown are accurate ion mass, empirical formula, relative double 
bond equivalents (RDB), and mass error (δppm) obtained by nESI-MS in negative ion mode from four participant samples. Ions ordered by intensity difference between plantar (BF) and 
dorsal (TF) samples 
Ion (m/z) 
TF (Total) BF (total) 
µ (BF) - µ (TF) Pcalc 
H0 accepted (Pcalc>Pcrit) Ion (m/z) 
Empirical formula RDB δppm 
µ σ (n = 9) µ σ (n = 9) Pcrit  (0.05) Pcrit (0.01) Pcrit (0.001) Accurate Mass 
128.0354 13792 7186 65218 28492 51426 0.000    128.0354 C5 H6 O3 N 3.5 0.887 
89.0245 49582 39468 78791 30771 29209 0.201    89.0245 C3 H5 O3 1.5 0.591 
93.0346 10462 4138 37467 23309 27005 0.000    93.0346 C6 H5 O 4.5 0.557 
104.0354 6923 4440 33914 14697 26991 0.000    104.0354 C3 H6 O3 N 1.5 0.996 
137.0358 4901 2128 15878 11849 10976 0.000    137.0358 C6 H5 O2 N2 5.5 1.162 
130.0875 1611 908 11402 4887 9791 0.000    130.0875 C6 H12 O2 N 1.5 1.215 
118.0511 1256 793 7060 3334 5803 0.000    118.0511 C4 H8 O3 N 1.5 1.216 
132.0304 208 243 5651 2224 5443 0.001    132.0304 C4 H6 O4 N 2.5 1.356 
116.0506 827 718 5504 2729 4677 0.000    116.0718 C5 H10 O2 N 1.5 1.104 
74.0248 1143 1179 5632 2833 4489 0.001    74.0248 C2 H4 O2 N 1.5 0.787 
92.9281 1608 1537 5789 4796 4181 0.054    92.9281 
 
  
115.0185 3124 3341 7303 2189 4179 0.057    115.0185 
 
  
72.0091 351 633 4055 2725 3704 0.001    72.0092 C2 H2 O2 N 2.5 1.366 
129.0389 1337 1368 4743 1780 3406 0.028    129.0389 C6 H9 O S 2.5 7.215 
94.0492 405 221 2310 1940 1905 0.000    94.0493 
 
  
82.0299 143 186 1871 1180 1729 0.001    82.0299 C4 H4 O N 3.5 1.01 
87.0088 1795 3082 3243 4347 1448 0.237    87.0088 C3 H3 O3 2.5 0.606 
131.0828 812 1384 2246 2402 1435 0.056    131.0828 C5 H11 O2 N2 1.5 1.442 
90.0278 2254 2261 3668 1937 1413 0.150    90.0278 
   114.0215 512 745 1471 503 959 0.014    114.0198 C4 H4 O3 N 3.5 0.822 
154.0625 109 99 1053 829 944 0.002    154.0625 C6 H8 O2 N3 4.5 1.948 
146.9833 956 889 1805 1091 849 0.119    147.0454 C9 H7 O2 6.5 1.817 
  
1
4
1
 
138.0392 271 193 1050 935 779 0.000    138.0392 C7 H8 N S 4.5 6.641 
114.0561 247 411 972 1048 726 0.268    114.0562 C5 H8 O2 N 2.5 0.861 
133.0316 354 612 924 841 570 0.208    133.0316 C5 H9 O2 S 1.5 -9.874 
116.0278 17 52 525 556 507 0.002    116.0507 C8 H6 N 6.5 0.926 
146.0461 35 61 513 354 477 0.000    146.0461 C5 H8 O4 N 2.5 1.636 
151.0403 0 0 471 221 471 0.178    151.0403 C8 H7 O3 5.5 1.606 
84.0456 3 9 425 541 422 0.000    84.0456 C4 H6 O N 2.5 0.747 
91.0221 443 376 786 292 343 0.093    91.0221 C3 H7 O S 0.5 -1.416 
124.0075 18 53 296 609 279 0.049    124.0074 C2 H6 O3 N S 0.5 1.153 
150.0175 34 49 278 157 245 0.002    150.174 C3 O N7 7.5 3.46 
148.9803 335 247 568 325 233 0.162    148.9803 C6 H O N2 S 7.5 -8.1 
61.9884 461 465 670 701 210 0.264    61.9884 O3 N 1.5 0.545 
H0 accepted 13 16 21 
    H0 rejected 21 18 13 
    Total 34 34 34         
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5.8.2.2 ESI-MS Positive ion mode 
Over 177200 features were identified between m/z 50-4000 and over 21500 between m/z 
50-200 in positive ion mode. Many were exogenous background contaminants.  
Multivariate Analysis 
61 ions were discovered from profiling data using MassLynx. From the initial 61 ions (Table 
5.12), 7 ions were selected from the S-plot (Figure 5.13 (A)) modelled from PLS-DA. These 7 
ions were furthest from the centre of the S-plot suggesting possible differences between the 
dorsal (TF) and the plantar (BF) sample regions. The ions selected were found to have 
observed m/z 112.9112, 114.9070, 116.0842, 120.0073, 121.0520, 139.0653, 150.0297. 
PCA was performed using the seven variables and all twenty observations producing a model 
with two significant components with a cumulative variation (R2X) of 81.5% of which 60.8% 
could be cross validated (Q2X) (Figure 5.13 (B)). Two clusters can be observed in the score 
scatter plot (Figure 5.13 (A)). Plantar (BF) samples appear to be tightly clustered whereas the 
dorsal (TF) samples are slightly more spread out. However, two dorsal (TF) observations, UF2 
TF and UF5 TF, are positioned within the plantar (BF) cluster rather than the dorsal (TF) 
cluster. The model shows 83.3% sensitivity for plantar (BF) observations (true positives) 
100% specificity for dorsal (TF) samples (true negatives). Also, observation UF2 BF appears 
outside the 95% hoteling region. This is further proof that participant 2 should be excluded 
from the data set due to incompliance prior to sample collection. 
Using the seven variables and only eighteen observations (participant 2 dorsal (TF) and 
plantar (BF) data excluded), the model produced contained two significant components with 
a cumulative variation (R2X) of 99% of which 95.5% could be cross validated (Q2X). Two 
clusters can be observed in the score scatter plot (Figure 5.13 (C)). Plantar (BF) samples 
appear to be tightly clustered whereas the dorsal (TF) samples are slightly more spread out. 
The model shows 90% sensitivity for plantar (BF) observations (true positives) 100% 
specificity for dorsal (TF) samples (true negatives). Observation dorsal (TF) UF5 is also 
located away from the dorsal (TF) cluster. By examining the contribution plots for the UF5 
dorsal (TF) sample and comparing this observation to all other dorsal (TF) observation, it is 
apparent that for the UF5 dorsal (TF) sample the weight of all ion contributors is 
approximately opposite when compared to all other dorsal (TF) observations (Figure 5.14).  
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Figure 5.13. (A) PLS-DA S-plot obtained from 20 observations analysed by ESI-MS in positive ion, R
2
X = 86.3%, Q
2
X = 47.7%. Unsupervised PCA of LSP skin sensitive ions 
identified from PLS-DA on (B) 20 observations and (C) 18 observations, in positive ion mode. 7 ions were used to model the scatter plot from 61 ions identified from PLS-DA. 
(D) Unsupervised PCA of LSP skin sensitive ions identified from PLS-DA model on 18 observations in positive ion mode. 2 ions (m/z 114.9070 and 116.0842) were used to 
model the scatter plot from 34 ions identified from PLS-DA. 90% sensitivity was obtained for the plantar (BF) sample site observations and 100% specificity was obtained for 
the dorsal (TF) sample site in negative ion mode. R
2
X = 100%, Q
2
X = 100%. Dots = dorsal (TF) observations, circles = plantar (BF) observation. 
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Figure 5.14. PCA ion contribution plot from dorsal (TF) observations from Figure 5.13 (C). Top bars show ion 
contribution for UF5 Dorsal (TF) sample whereas bottom bars show contribution from all other dorsal (TF) 
observations 
For all ions used for the model above the UF5 dorsal (TF) observation has ion weight 
contributions closer to the plantar (BF) samples compared to other dorsal (TF) observations 
hence UF5 dorsal (TF) is observed away from the dorsal (TF) cluster. By removing one ion at 
a time, a model showing the separation between the dorsal (TF) and plantar (BF) sample site 
groups was observed with only two ions used in the data set. Ions (variables) with m/z 
114.9070 and 116.0842 produced a model consisting of two significant components using 
eighteen observations with a cumulative variation (R2X) of 100% of which could be cross 
validated (Q2X) and 100% sensitivity and specificity (Figure 5.13 (D)).  
Descriptive Statistics 
Using the intensities obtained for each ion the differences between the dorsal (TF) and 
plantar (BF) samples were calculated for all sixty one observed ions from the average 
obtained from nine participants (excluding participant UF2). ANOVA was performed on the 
data set to discover whether any statistical differences in variance could be found. At 95%, 
ANOVA provided a calculated F value of 12.4 between the sample sites (Appendix Table 
8.18). This value was much larger than the critical F value of 1.33 thus evidence of significant 
difference between the sample sites was present. Following this a paired t-test was carried 
out, on normalised data (log10 of original value) due to the data set not being from a normal 
distribution, to determine whether the two sample sites were significantly different (Table 
5.12). H0: no difference in intensity obtained from dorsal (TF) and plantar (BF) samples. 
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The largest difference between the dorsal (TF) and plantar (BF) sample sites was found for 
the ion m/z 116.0842 with a difference of 42095 counts. Statistically significant evidence of 
differences between the two sample sites for the ion m/z 116.0842 was found at 99% using 
the paired t-test. Other large differences were found with ions m/z 112.9112, 150.0297, 
120.0073 and 139.0653 with intensities obtained at 30530, 30418, 26592 and 20963, 
respectively. There was also evidence of differences between the two sample sites at 99% 
using a paired t-test for all four of these ions. Ion m/z 150.0297 also showed significant 
difference between the two sites at 99.9%. The smallest difference of intensity between the 
plantar (BF) and dorsal (TF) sample sites was found for ions m/z 82.0282, 56.9784 and 
165.0289. For these three ions, no statistically significant evidence of differences between 
the two sample sites was discovered. Plantar (BF) intensities obtained were higher than 
dorsal (TF) intensities in fifty nine of the sixty one ions whereas for ions m/z 99.0004 and 
165.0289 the dorsal (TF) intensities were found to be slightly higher than the plantar (BF) 
intensities. However, for both of these ions no statistically significant evidence of differences 
was determined between the two sample sites using a paired t-test. From the sixty one ions, 
using a paired t-test, significant differences were found between the plantar (BF) and dorsal 
(TF) sample sites for thirty nine ions at 95%, twenty two ions at 99% and ten ions at 99.9% 
(Table 5.12). 
Significance testing was also carried out to find whether gender differences existed (5 males, 
4 females) between the two sample sites. Between male and female plantar (BF) samples 
differences were found in two of the sixty one ions at 95%, ions with m/z 225.0034 (male = 
7619, female = 1556) and 99.0004 (male = 4091, female = 726), with male higher than 
female intensities for both (Appendix Table 8.19). 
Five of the sixty one ions were found have significant differences between gender for dorsal 
(TF) samples. Ions m/z 112.9112 (male = 24119, female = 2224), 99.0004 (male = 5594, 
female = 1), 148.9789 (male = 1263, female = 105), 98.9343 (male = 901, female = 207) and 
90.1047 (male = 537, female = 87) were determined to have significant gender differences in 
the dorsal (TF) site at 95% and ions m/z 148.9789 was also discovered to have significant 
gender differences at 99% for the dorsal (TF) site (Appendix Table 8.20). 
Accurate Mass Determination 
Four plantar (BF) samples (UF1, UF4, UF5, and UF8) were analysed using nESI-MS in both 
negative and positive ion modes to identify potential molecular formulae for the ions. In 
negative ion mode thirty of the thirty five observed ions yielded possible matches, although 
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structural formulae were not determined (Table 5.11). In positive ion mode forty three of 
the sixty one ions were found to have potential matches (Table 5.12). The suggested 
empirical formulae obtained from accurate mass determination proposed that many of the 
obtained ions could contain nitrogen and sulphur. Ions containing nitrogen and oxygen could 
be nitrate (NO3
-) or nitrite (NO2
-) based compounds. These are known to be in bodily fluids 
and studies carried out proved that the amount of nitrate excreted in urine is higher than 
those in foods indicating that it is a product of biosynthesis.92 
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Table 5.12. Mean (µ), standard deviation (σ) and the difference for 61 ion intensities, of dorsal (TF) and plantar (BF) samples, obtained by ESI-MS n positive ion mode. Results of paired t-
test (Pcalc) and whether H0 was accepted () or rejected () are shown. Participant 2 excluded from data set. Also shown are accurate ion mass, empirical formula, relative double bond 
equivalents (RDB), and mass error (δppm) obtained by nESI-MS in positive ion mode from four participant samples. Ions ordered by intensity difference between plantar (BF) and dorsal 
(TF) samples 
Ion (m/z) 
TF (Total) BF (Total) 
µ (BF) - µ (TF) Pcalc 
H0 accepted (Pcalc>Pcrit) Ion (m/z) 
Empirical formula RDB δppm 
μ σ (n = 9) μ σ (n = 9) Pcrit (0.05) Pcrit (0.01) Pcrit (0.001) Accurate Mass 
116.0842 1949 3881 44044 35600 42095 0.004    116.0706 C5 H10 O2 N 1.5 -0.389 
112.9112 13880 20336 44409 30715 30530 0.003    112.8956 
   
150.0297 6238 5015 36656 18175 30418 0.000    150.0134 C2 H4 O5 N3 2.5 -7.444 
120.0073 14004 9106 40596 18378 26592 0.001    120.0031 C H2 O4 N3 2.5 -7.184 
139.0653 7257 6428 28220 19001 20963 0.003    139.0499 C6 H7 O2 N2 4.5 -2.114 
114.907 6530 10601 21426 15438 14896 0.019    114.0913 C6 H12 O N 1.5 -0.794 
110.0838 3482 4079 16056 14855 12574 0.053    110.0713 C5 H8 N3 3.5 0.419 
130.0939 1003 1871 11922 16657 10920 0.038    130.0861 C6 H12 O2 N 1.5 -1.27 
115.1008 1383 1529 12255 7634 10872 0.010    115.0866 C5 H11 O N2 1.5 -0.257 
70.0783 889 1446 11067 10875 10177 0.013    70.0655 C4 H8 N 1.5 5.626 
155.0909 220 516 9739 17115 9519 0.000    155.0787 C3 H7 N8 4.5 -0.508 
140.0849 803 511 9834 14202 9030 0.006    140.0679 C3 H6 N7 4.5 -0.141 
122.9668 5101 6437 12006 8633 6905 0.057   
    
121.052 15600 10183 21918 17586 6318 0.556    121.0395 C6 H5 O N2 5.5 -0.821 
137.076 302 582 6543 4168 6241 0.000    137.0683 C2 H9 O3 N4 0.5 9.873 
138.0667 1271 1527 6702 4910 5432 0.020    138.0523 C3 H4 N7 5.5 -0.07 
94.9435 4492 5104 9671 6153 5179 0.078   
    
134.0272 4873 4308 10038 5988 5165 0.081    134.0186 C2 H4 O4 N3 2.5 -7.701 
165.9969 616 954 5776 4460 5160 0.001    165.9874 C5 O4 N3 7.5 -5.916 
150.9935 5310 7385 10326 7414 5016 0.101   
    
135.9943 449 679 4895 3148 4446 0.004   
    
144.937 1616 2214 5268 5705 3652 0.255   
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114.0034 1313 1817 4924 4415 3611 0.009    114.0661 C4 H8 O N3 2.5 -1.126 
141.9948 1557 1104 4995 2871 3438 0.048   
    
96.9377 1946 1716 5328 2671 3382 0.055   
    
104.1145 747 1037 4053 1787 3305 0.005    104.1071 C5 H14 O N -0.5 0.666 
164.0496 626 552 3799 2051 3173 0.000    164.029 C3 H6 O5 N3 2.5 -7.174 
156.9937 5698 3948 8785 5843 3087 0.182    156.9845 C8 H N2 S 9.5 -6.531 
160.0446 936 602 3968 1790 3032 0.000    160.0342 C4 H6 O4 N3 3.5 -7.075 
84.0955 281 394 3185 2352 2904 0.004    84.0811 C5 H10 N 1.5 3.498 
133.1022 1365 1828 4185 4189 2820 0.130    133.0969 C5 H13 O2 N2 0.5 -1.76 
60.0578 413 493 3053 4303 2640 0.025    60.0562 C H6 N3 0.5 8.762 
166.9725 2993 6018 5465 3998 2472 0.053   
    162.0714 950 648 3418 1445 2469 0.045    162.0498 C4 H8 O4 N3 2.5 -7.172 
177.0821 163 342 2357 1123 2194 0.000    177.0607 C4 H9 O4 N4 2.5 -6.672 
139.9322 972 1371 3109 2057 2137 0.021   
    
132.9958 2290 1271 4421 3175 2131 0.087    132.9875 C2 H O5 N2 3.5 -7.126 
148.9789 748 1067 2819 2417 2070 0.013    149.0231 C8 H5 O3 6.5 -1.748 
154.0362 109 232 2116 1357 2007 0.000    154.0261 C5 H4 O3 N3 5.5 8.846 
157.0029 2031 3686 3999 5330 1968 0.036    157.0832 C4 H9 O N6 3.5 -0.353 
90.1047 337 457 2196 1119 1859 0.006    90.0916 C4 H12 O N -0.5 2.991 
173.0899 51 77 1394 1131 1344 0.000    173.0781 C4 H9 O2 N6 3.5 -0.405 
164.9579 666 1995 1968 3106 1302 0.035    164.9202 
   176.092 353 199 1599 862 1246 0.001   
    
93.059 1677 1077 2891 2554 1214 0.737    93.0449 C5 H5 N2 4.5 2.098 
98.9343 592 476 1724 788 1132 0.043    98.9755 H3 O4 S -0.5 8.327 
78.9706 1512 1496 2474 2185 962 0.670    79.0182 C5 H3 O 4.5 4.54 
110.9912 276 490 1206 1212 930 0.013   
    71.0822 81 175 980 2354 899 0.087    71.0859 C5 H11 0.5 5.53 
124.975 979 1047 1795 1364 815 0.053   
    
  
1
4
9
 
142.1064 70 178 823 895 754 0.018    142.0471 C2 H4 O N7 4.5 -0.594 
99.0004 3108 5041 2464 3215 644 0.102    98.9843 
   164.1488 823 1975 1436 2588 612 0.046    164.0915 C6 H14 O4 N 0.5 -1.49 
83.0233 338 530 842 838 504 0.056    83.0256 
   
172.0192 62 105 522 337 460 0.004    171.9953 C8 H2 N3 S 9.5 -6.421 
160.9231 822 1355 1193 1328 370 0.554    161.0318 C4 H N8 8.5 -0.55 
172.9783 315 767 682 638 367 0.030    172.9959 H5 O5 N4 S 0.5 -9.286 
168.9755 295 882 501 589 206 0.041    168.9399 C5 H O3 N2 S 6.5 -2.125 
165.0289 174 451 1 0 173 0.175    165.0067 C2 H5 O3 N4 S 2.5 -6.104 
56.9784 285 749 370 1000 85 0.928   
    
82.0282 123 323 130 276 7 0.917    83.0219       
H0 accepted 22 39 51         
H0 rejected 39 22 10 
    Total 61 61 61         
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5.9 Conclusion 
The method development on the LSP presented in this chapter proves that this skin 
sampling device is able to sample human skin. The experiment in section 5.4 showed that 
the LSP concept achieved significant extraction of a selected sample when compared to 
baseline levels. Using a sampling solvent of EDTA the LSP was able to detect a drop of Mn 
that was spiked onto the surface of a nitrile glove. Although the first sample taken using the 
LSP achieved the greatest recovery, multiple washes were needed to extract the remaining 
sample from the sample surface. 4 samples containing Mn were collected with a 41.8% 
recovery for the first sample, 13.5% recovery for the first wash sample, 6.7% recovery for 
the second wash sample and 3.2% for the final wash sample.  
For the next experiment (section 5.5) three sampling solvents were chosen to recover 
known amounts of a selected sample that was placed on a target sample surface, using the 
LSP. The sampling solvents used were EDTA, 2% HNO3 and DI H2O and the highest recovery 
was obtained for samples collected using 2% HNO3 (55.7% recovery for the first sample) as 
the sampling solvent, followed by EDTA (39.9% recovery for the first sample) and then DI 
H2O (18.6% recovery for the first sample). Out of the three sampling solvents, EDTA was 
chosen as the sampling solvent for future experiments despite 2% HNO3 exhibiting higher 
recoveries. This was primarily due to the unsuitability of HNO3 with the human skin which 
could cause potential health risks such as burning and irritation. EDTA was considered a 
more appropriate solvent as it was more compatible with human skin and was a good 
chelating agent to extract metals from the skin surface. 
The first LSP study involving human participants is presented in section 5.6. Samples were 
collected using EDTA, as the sampling solvent, and analysed using ICP-MS. 8 elements were 
recovered from the volar (AE) and plantar (BF) skin sample sites using the LSP. No 
statistically significant evidence differences in elemental recoveries between the two skin 
sample sites were discovered. It was believed that high levels of Si found in the samples was 
due to elemental leeching from the PEEK tubes that transported the sample to and from the 
target skin surface. Consequently, further investigations into the method of cleaning the 
LSP’s prior to human skin sampling, were successfully sought. 
The LSP was used to detect, distinguish and recover elements from four parts of human skin. 
Four skin sampling sites on ten participants (five male and five female) were investigating 
using the LSP in section 5.7. 6 elements were detected over the four sites with the element K 
having the highest amount in each site. K was found to be highest in the dorsal (TF) and 
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plantar (BF) sites when compared to the axilla (AP) and volar (AE). S, Mg, Fe and Al were also 
detected as well as a small amount of Cu. There was also significant differences (95%) 
discovered for K between axilla (AP) and dorsal (TF) sample sites, for Mg between plantar 
(BF) and volar (AE) sites, for S from the volar (AE) sample site between male and females, 
and Mg in the axilla (AP) between the right and left sample site. Gender differences in S 
were also observed as well as Mg differences between the sides sampled in the axilla (AP). 
Semi-VOCs and VOCs were investigated on skin sample sites at the top and bottom of 
human feet, namely the dorsal (TF) and plantar (BF), respectively. A total of ten participants 
(five male and five female) were sampled in the study discussed in section 5.8 where 96 ions 
were detected using ESI-MS. 60 of the 96 ions displayed significant differences between the 
two sample sites. Gender differences were also proven for a number of ions determined. 
High resolution analysis by nESI-MS using the Thermo Exacutive Orbitrap proposed ions 
could contain nitrites, nitrates and sulphur. Although nESI-MS provided accurate mass 
determination, these ions could not be verified due to lack of resources and time. A number 
of possible structures were available for each ion using the instrument libraries. The 
requirement of hundreds of reference samples to prove ion structures was not feasible 
either financially or in programme time. 
Future optimisation of the LSP is required. Different pH levels of EDTA could be studied by 
the addition of a masking agent and then investigating the amount of sample recovered 
from known amounts spiked onto a surface. Anions such as phosphates will interfere with 
the selectivity of EDTA so these must be removed prior to analysis. Metal ions as well as 
EDTA are pH dependant, and for divalent ions, solutions must be kept basic for the reaction 
to go to completion. Many metal ions (e.g. Ca or Mg) only react completed when EDTA is in 
pure anionic form (EDTA4-). Since it is a quadruple acid this can only be realised at pH value 
above 10 for Ca2+ ions, for Mg ions even higher pH > 12. In additional, a vibrating motor 
could be added to the tip of the pen in order to agitate the skin surface with the anticipation 
of better efficiency. Further development of the LSP should continue to enable elemental, 
semi-VOC and VOC mapping of the human body. Different sample heads could be trialled in 
an attempt to optimise sample recovery from parts of the body that are more difficult to 
sample such as the head. Following this, development into real-time analysis of human skin 
should be the aim for the use of the LSP. The LSP can then be used on individuals that have a 
stress condition to determine the biomarkers of stress on human skin from different sites 
around the body.  
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6 Conclusions 
The objective of this research was to identify differences in the chemical profiles of 
biological fluids in the human body obtained from individuals under a variety of stress states 
e.g. physically or mentally. These profiles were collected by analysing biological fluids such 
as blood, saliva, sweat and urine that were attained by both invasive and non-invasive 
sampling techniques. Samples were analysed using a variety of techniques including 
inductively coupled plasma mass spectrometry (ICP-MS), thermal desorption gas 
chromatography mass spectrometry (TD-GC-MS) and high performance liquid 
chromatography-ion mobility mass spectrometry (UPLC-IM-MS). Further to this, a skin 
sampling device was engineered as a potential new collection method to acquire skin 
samples from stressed individuals. 
In the initial experiment forehead skin samples were obtained, using 3MTM TegadermTM 
+pads, from individuals participating in an experiment containing an intervention designed 
to induce psychological stress. Individuals were required for this double cross over 
randomised design with two experimental interventions. One intervention required 
participants to listen to classical music, which was chosen to be neutral, while the other 
required participants to undertake a PASAT that induced cardiovascular responses 
consistent with acute stress. Forehead skin samples were taken from 22 participants (10 
male and 10 female) using patches which were analysed for changes in elemental 
concentrations by ICP-MS. A new formula was devised in order to score stress based upon 
cardiovascular output. During the PASAT intervention an increase in cardiovascular function, 
as a consequence of stress resulting in increased intensity in heart rate and blood pressure, 
triggered the heating of the body inducing sweat onto the skin. This higher than normal skin 
temperature was exhibited in GSR readings where an increase level was observed during the 
PASAT intervention.  
The analysis of the elemental content in these skin patch samples was performed using ICP-
MS following sample collection. Although 11 elements were detected it was discovered that 
the patches used contained high levels of elemental impurities. Consequently, the elemental 
content of patches was to be reduced through solvent washes prior to collecting skin 
samples in future studies. Consequently, MVA did not exhibit any separation. A repeat of 
this study using up to fifty participants and patches reduced in elemental impurities should 
be conducted in order to identify elemental markers of psychological stress. Any future 
repeats of this study should comprise of new participants in order to remove any bias of 
memory effects of the PASAT from participants who have already taken the test. 
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Elemental impurities were removed from patches using a series of solvent washes. Patches 
were washed in 15% HNO3 for 6 hours to remove impurities with basic properties, such as 
alkali’s that react with water forming X-OH e.g. LiOH, NaOH, KOH). A wash with 10% TMAH 
was conducted to remove any acid-soluble impurities i.e. oxides formed with elements with 
low electron affinity e.g. SiO2, SO2, SO3 etc.; DI H2O. Next, 0.1M EDTA was used to remove 
any metal impurities by the chelating effect followed by a DI H2O wash in order to neutralise 
the patches so cleaned patches would not pose any risk to participant skin. In between each 
wash, patches were immersed in DI H2O and dried under IR.  
The second study saw ten male participants take part in an experiment with an intervention 
designed to replicate physical stress. A variety of biological samples were collected prior to 
and following a thirty minute exercise using a cycle ergometer set at a resistance of 2 W.Kg-1 
of participant body mass. The detection of 10 elements in forehead skin (Na, Mg, Al, Si, P, S, 
K, Ca, Cu, Zn), 8 elements in drool saliva (Na, Mg, Si, P, S, K, Zn, I), 8 elements in urine (Na, 
Mg, Si, P, S, K, Ca, Zn, Mo) and 7 elements in blood plasma (Mg, P, K, Cu, Zn, Li, Fe) were 
detected. Elemental changes were discovered in forehead skin, urine and drool saliva 
following stress. No changes were observed in plasma. Data was initially analysed using MVA 
producing statistical models which indicated possible elemental markers of stress. 
Significance testing was then used to confirm whether these biomarkers could be 
statistically scrutinized using commonly used data analysis methods. A physical stress score, 
based using the previous formula invented for psychological stress, was also designed which 
exhibited participant stress levels. Incidentally, this correlated with how participants rated 
their own stress levels. Using 4 globally detected elements (Mg, P, K, Zn) from the four 
biological samples, MVA was used to identify the major contributors of physical stress and 
found significant contributors from forehead skin and urine. 
Further to this, data obtained from saliva analysed using TD-GC-MS, UPLC-IM-MS and ICP-
MS was grouped into one data set and analysed by MVA resulting in a super score plot 
displaying the capability of discovering biomarkers of stress from a variety of techniques and 
presenting them in one statistical model. Although stress states of participants in saliva 
could be established using these techniques there was difficulty in identifying the discovered 
markers due to multiple possibilities of ion identities from instrument libraries for 
discovered masses. Purchasing standards for each ion possibility would not be financially 
feasible and would prove very time consuming. Consequently, further studies should be 
conducted in order to confirm similar biomarkers of stress after which standards should then 
be purchased to identify these biomarkers. 
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Further work includes the analysis of all samples collected from the study. Upon data 
analysis of these samples, the questions posed should include which areas of the human 
body are substantially affected by stress and can pathways of these areas be deduced, 
showing the first effected areas. Once biomarkers are identified there could be a possibility 
to develop counter acting drugs of stress which could be trialled on human volunteers who 
are physically stressed. 
An opportunity was taken to collect saliva in an experiment designed to replicate a trapped 
human in a collapsed building inducing emotion stress. The intervention included the 
participant being placed in an entrapped space for twenty four hours with no food or water. 
Drool saliva was collected prior to and after the intervention and samples were analysed for 
elemental changes by ICP-MS. 9 possible elemental markers were discovered with the 
largest changes detected for Na and I while large changes were also found for Mn, Fe and P. 
Changes for Sr, As, Mg and Si were also observed. It is believed that the presence of Sr was 
due to naturally occurring amounts of the element in human teeth which tend to leech Sr to 
aid the prevention of mouth diseases. Little information can be deduced from this study as 
only one participant was sampled. To confirm whether the elements are markers of 
emotional stress, further studies must be conducted using at least thirty participants.  
Future studies should compare the discovered biomarkers from these different stress states 
using participants who undergo each stress intervention. If any biomarker is detected in all 
three stress studies then it should be closely inspected as it could be a significant biomarker 
of stress. Further development to suppress this biomarker should then be investigated in 
order to try and eliminate stress.  
Finally, the design and construction of a skin sampling device is shown. The Liquid Skin Pen 
(LSP) is capable of acting as a rapid, non-invasive way to collect skin elements and small 
molecules. Analysis of samples collected using the device demonstrated that different body 
parts may be consistently distinguished, and that a wide range of compounds can be 
collected and measured. 
Initial tests showed successful recovery of Mn spiked onto a sample surface, using the LSP. 
Following this the comparison between three sampling solvents were tested. The results 
indicated that the highest recoveries were detected for 2% HNO3 (57.7%) followed by 0.1M 
EDTA (39.9%) and then DI H2O (18.6%). However, due to the requirement to use the LSP on 
human volunteers in further studies, it was much safer to use 0.1M EDTA as the sampling 
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solvent rather than the corrosive HNO3. Therefore 0.1M EDTA was selected as the sampling 
solvent for subsequent studies using the LSP due to achieving higher recoveries then DI H2O. 
The first human experiments using the LSP involved sampling the volar and plantar skin sites. 
8 elements were recovered but no statistically significant evidence of differences in 
elemental recoveries between the two skin sites was determined. High levels of Si were also 
detected and it is believed this presence was due to the leaching from the PEEK transport 
tubes used to carry the samples to and from vials via the target surface. Consequently, a 
new cleaning procedure was produced to eradicate memory effects of previous samples and 
increase efficiency of sample collection using LSP. This process included cleaning the LSP 
using the sampling solvent to be employed by simply flushing it through the transport tubes 
of the LSP’s prior to sample collection. The new cleaning procedure was designed, tested 
and analysed for targeted small molecule ions after which it was utilised for subsequent 
studies. 
The next human experiment using the LSP involved investigating the differences between 
the axilla (AP), dorsal (TF), plantar (BF) and volar (AE). A total of 6 elements were detected 
across these four sites with K observed in each site and differences in elemental 
concentrations discovered between all four sites. The highest elemental concentrations 
were found for K in the dorsal (TF) and plantar (BF). Amounts of the elements S, Mg, Fe, Al 
and Cu were also detected. Gender differences in S were discovered as well as Mg 
differences between the body sides sampled in the axilla. 
MVA was able to identify potential small molecules significant to the dorsal (TF) or plantar 
(BF) of the foot. 96 ions were detected from both positive and negative ion mode using 
electrospray ionisation mass spectrometry (ESI-MS). 60 of these 96 ions displayed significant 
differences between the two sample sites whilst gender differences were also determined 
for a number of ions. Accurate mass determination by nano-electrospray ionisation mass 
spectrometry (nESI-MS) of samples suggested that many compounds discovered in the 
dorsal (TF) and plantar (BF) of human feet could contain nitrites, nitrates and sulphur. 
However, these suggested compounds from the library could not be identified due to the 
lack of standard availability and time constraints.  
This proof-of-concept study demonstrates that the LSP is able to effectively collect elements 
and small molecules from a variety of sites on the human skin where samples obtained can 
be analysed by ESI-MS and ICP-MS. The LSP should be further developed in order to optimise 
the efficiency of sample recovery using a variety of solvents for small molecule analysis or by 
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experimenting with the solvent buffer for elemental analysis. Different bases on the device 
should be tested in order to sample all parts of the body including the head. A vibrating 
motor could be added in the base in order to agitate molecules on the skin possibly 
providing greater efficiency. Further work includes full body mapping using the LSP followed 
by online analysis showing real time data from human skin. Furthermore, the LSP could be 
employed in stress studies to collect skin samples where data from samples obtained using 
the device could be compared against skin data from other skin sampling techniques such as 
using a PDMS membrane, acid wipes or rinsing. 
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8 Appendices 
Appendix I 
 
Table 8.1. Calibration data for the eleven detected elements obtained from forehead 
skin patches by ICP-MS during the psychological stress study 
Element Gradient Intercept R2 Standard Error LOD LOQ 
Na 321912 34857846 0.9993 3374997 31 105 
Zn 8704 52935 0.9995 40717 14.0 46.8 
S 3859 144018 0.9995 19531 15.2 50.6 
Sn 250 3335 0.9995 1259 15.1 50.4 
Ca 2302 60970 0.9997 14337 18.7 62.3 
K 14097 7898 0.9999 61999 13.2 44.0 
Ba 113990 12712 0.9999 35063 0.9 3.1 
Mg 20602 15273 1.0000 1285 0.2 0.6 
Ti 3186 103 1.0000 379 0.4 1.2 
Ni 12133 1434 1.0000 60 0.0 0.0 
Cu 27593 5395 1.0000 1178 0.1 0.4 
Very good linearity was obtained by ICP-MS for the eleven elements detected in sweat 
obtained from skin patches obtained from psychological stress. All coefficients of 
determinant values (R2) are above 0.9990 suggesting the ICP-MS has been calibrated 
correctly and that the semi-quantitation of elements can be used to interpret the result. The 
linearity graphs for these eleven elements can be observed in Figure SI.4.1 in the 
supplementary information. 
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Table 8.2. ANOVA single factor for i) the stress session between male (MS) and female (FS) participants, ii) the neutral session between male 
(MN) and female (FN) participants and iii) between the stress (TS) and neutral (TN) session for all participants 
Groups Count Sum Average Variance Source of Variation SS df MS F P-value F crit 
Between Gender for stress session 
MS 10 462 46 2072 Between Groups 4419 1 4419 1.435 0.245 4.351 
FS 12 896 75 3905 Within Groups 61601 20 3080 
   
     
Total 66020 21 
    Between Gender for neutral session 
MN 10 54 5 41 Between Groups 16 1 16 0.773 0.390 4.351 
FN 12 44 4 5 Within Groups 427 20 21 
   
     
Total 444 21 
    Between stress and neutral session 
TS 22 1359 62 3144 Between Groups 36119 1 36119 22.825 0.000 4.073 
TN 22 98 4 21 Within Groups 66464 42 1582 
             Total 102583 43         
The results for ANOVA show no evidence of significant differences in the variances between gender in the stress session and also in the neutral session as 
Fcalc is smaller than Fcrit. However, there is statistical evidence of a difference in variance between stress and neutral sessions for all participants as Fcrit (22.8) 
is bigger the Fcrit (4.07). 
  
1
6
2
 
Appendix II 
Table 8.3. Sample information summary for biological samples (with their intended instrument of analysis) and heart rate (HR) readings collected from physical stress study 
Sample ID 
Plasma Saliva Skin Urine Breath 
HR readings* Total 
ICP-MS IMS ICP-MS IMS VOC ICP-MS VOC ICP-MS IR-MS IMS GC-MS GC-MS DMS 
CZ1 3 3 3 3 3 4 4 3 3 3 3 3 10 18 66 
CZ2 3 3 3 3 3 4 4 3 3 3 3 3 10 19 67 
CZ3 3 3 2 3 3 4 4 3 3 3 3 3 10 17 64 
CZ4 3 3 3 3 3 4 4 3 3 3 3 3 10 19 67 
CZ5 3 3 3 3 3 4 4 3 3 3 3 3 10 20 68 
CZ6 3 3 3 3 3 4 4 3 3 3 3 3 10 19 67 
CZ7 3 3 2 3 3 4 4 3 3 3 3 3 10 19 66 
CZ8 0 0 3 3 3 4 4 3 3 3 3 3 10 18 60 
CZ9 1 1 3 3 3 4 4 3 3 3 3 3 10 21 65 
CZ10 0 0 2 2 3 4 4 3 3 3 3 3 10 20 60 
Total 22 22 27 29 30 40 40 30 30 30 30 30 100 190 650 
  Plasma = 44 Saliva = 86 Skin = 80 Urine = 120 Breath = 130     
*HR includes experiment start & end, cycling start & end. Readings every 10 minutes phases A, C and D, every 5 minutes phase B. 
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Table 8.4. ANOVA (two way with replicates) for ten elemental skin patch concentrations (ng.mL
-1
) obtained by ICP-MS from ten participants who participated in the physical 
stress study 
  Na Mg Al Si P S K Ca Cu Zn Total 
Phase A                       
Count 10 10 10 10 10 10 10 10 10 10 100 
Sum 4.63E+02 1.59E+01 1.85E+01 7.02E+01 2.59E+01 1.12E+02 8.39E+02 7.04E+02 1.70E+01 1.01E+03 3.28E+03 
Average 4.63E+01 1.59E+00 1.85E+00 7.02E+00 2.59E+00 1.12E+01 8.39E+01 7.04E+01 1.70E+00 1.01E+02 3.28E+01 
Variance 3.61E+03 1.50E+01 2.11E+01 1.52E+02 4.02E+01 2.59E+02 1.51E+04 3.06E+04 1.86E+01 7.43E+04 1.27E+04 
Phase B 
           Count 10 10 10 10 10 10 10 10 10 10 100
Sum 7.62E+04 6.97E+02 1.03E+02 6.09E+01 2.80E+02 3.03E+03 1.15E+05 2.75E+03 3.68E+01 3.72E+02 1.98E+05 
Average 7.62E+03 6.97E+01 1.03E+01 6.09E+00 2.80E+01 3.03E+02 1.15E+04 2.75E+02 3.68E+00 3.72E+01 1.98E+03 
Variance 1.71E+08 7.89E+02 8.28E+01 8.02E+01 3.98E+02 1.84E+04 4.03E+07 9.31E+03 2.81E+00 8.92E+03 3.45E+07 
Phase C 
           Count 10 10 10 10 10 10 10 10 10 10 100
Sum 3.37E+04 8.67E+01 2.81E+01 7.74E+01 7.58E+01 1.08E+03 1.11E+04 1.01E+03 1.04E+01 6.46E+01 4.73E+04 
Average 3.37E+03 8.67E+00 2.81E+00 7.74E+00 7.58E+00 1.08E+02 1.11E+03 1.01E+02 1.04E+00 6.46E+00 4.73E+02 
Variance 1.91E+07 3.15E+02 3.21E+01 1.58E+02 2.42E+02 7.89E+04 2.49E+06 4.96E+04 3.29E+00 1.25E+02 3.02E+06 
Phase D 
           Count 10 10 10 10 10 10 10 10 10 10 100
Sum 2.36E+03 8.40E+00 4.37E+01 8.67E+01 4.91E+00 9.11E+01 9.53E+02 2.60E+02 1.00E+00 6.05E+01 3.87E+03 
Average 2.36E+02 8.40E-01 4.37E+00 8.67E+00 4.91E-01 9.11E+00 9.53E+01 2.60E+01 1.00E-01 6.05E+00 3.87E+01 
Variance 2.47E+05 9.35E-01 3.27E+01 4.17E+02 1.53E+00 8.97E+01 2.48E+04 1.66E+03 2.14E-34 1.10E+02 3.00E+04 
Total 
           Count 40 40 40 40 40 40 40 40 40 40 
 Sum 1.13E+05 8.08E+02 1.93E+02 2.95E+02 3.86E+02 4.32E+03 1.28E+05 4.72E+03 6.52E+01 1.51E+03 
 Average 2.82E+03 2.02E+01 4.84E+00 7.38E+00 9.66E+00 1.08E+02 3.19E+03 1.18E+02 1.63E+00 3.77E+01 
 Variance 5.37E+07 1.11E+03 5.00E+01 1.87E+02 2.79E+02 3.72E+04 3.35E+07 3.01E+04 7.48E+00 2.08E+04 
 ANOVA 
           Source of Variation SS df MS F P-value F crit 
     Sample 2.56E+08 3 8.54E+07 14.60 5.39E-09 2.63 
     Columns 5.67E+08 9 6.30E+07 10.77 7.65E-15 1.91 
     Interaction 1.04E+09 27 3.87E+07 6.61 5.43E-19 1.52 
     Within 2.10E+09 360 5.85E+06 
        Total 3.97E+09 399           
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Table 8.5. ANOVA (two way with replicates) for eight elemental drool saliva concentrations (ng.mL
-1
) obtained by ICP-MS from ten participants who 
participated in the physical stress study 
  Na Mg Si P S K Zn I Total 
Phase A                   
Count 7 7 7 7 7 7 7 7 56 
Sum 2.99E+01 1.95E+01 1.30E+01 3.07E+01 2.65E+01 3.08E+01 8.31E+00 2.54E+01 1.84E+02 
Average 4.26E+00 2.79E+00 1.86E+00 4.38E+00 3.78E+00 4.40E+00 1.19E+00 3.63E+00 3.29E+00 
Variance 7.27E-02 8.29E-02 1.03E-01 2.82E-02 4.89E-02 7.40E-01 2.28E-01 1.99E-01 1.49E+00 
Phase C 
         Count 7 7 7 7 7 7 7 7 56
Sum 2.99E+01 1.96E+01 1.29E+01 3.03E+01 2.61E+01 3.03E+01 7.53E+00 2.40E+01 1.81E+02 
Average 4.27E+00 2.80E+00 1.85E+00 4.33E+00 3.73E+00 4.33E+00 1.08E+00 3.42E+00 3.23E+00 
Variance 8.35E-02 3.44E-02 1.23E-02 1.57E-02 2.42E-02 5.25E-01 3.79E-01 1.20E-01 1.47E+00 
Phase D 
         Count 7 7 7 7 7 7 7 7 56
Sum 3.03E+01 1.93E+01 1.24E+01 3.01E+01 2.56E+01 2.71E+01 8.75E+00 2.33E+01 1.77E+02 
Average 4.32E+00 2.76E+00 1.77E+00 4.30E+00 3.66E+00 3.87E+00 1.25E+00 3.33E+00 3.16E+00 
Variance 2.15E-02 2.97E-02 6.51E-02 8.85E-03 1.69E-02 8.12E-01 7.65E-02 8.95E-02 1.29E+00 
Total 
         Count 21 21 21 21 21 21 21 21 
 Sum 9.00E+01 5.85E+01 3.83E+01 9.11E+01 7.82E+01 8.82E+01 2.46E+01 7.27E+01 
 Average 4.29E+00 2.78E+00 1.83E+00 4.34E+00 3.72E+00 4.20E+00 1.17E+00 3.46E+00 
 Variance 5.39E-02 4.45E-02 5.60E-02 1.70E-02 2.99E-02 6.81E-01 2.10E-01 1.39E-01 
 ANOVA 
         Source of Variation SS df MS F P-value F crit 
   Sample 4.75E-01 2 2.37E-01 1.492 0.228 3.059 
   Columns 2.10E+02 7 3.00E+01 188.592 0.000 2.074 
   Interaction 1.26E+00 14 8.98E-02 0.565 0.889 1.761 
   Within 2.29E+01 144 1.59E-01 
      Total 2.35E+02 167         
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Table 8.6. ANOVA (two way with replicates) for eight elemental urine concentrations (ng.mL
-1
) obtained by ICP-MS from ten participants who 
participated in the physical stress study 
  Mg Si P S K Ca Zn Mo Total 
Phase A                   
Count 10 10 10 10 10 10 10 10 80 
Sum 1.90E+06 9.57E+04 1.61E+07 1.41E+07 4.03E+07 5.46E+05 3.18E+03 5.59E+02 7.31E+07 
Average 1.90E+05 9.57E+03 1.61E+06 1.41E+06 4.03E+06 5.46E+04 3.18E+02 5.59E+01 9.14E+05 
Variance 3.83E+10 4.95E+07 2.68E+12 1.08E+12 6.70E+12 1.94E+09 8.61E+04 2.01E+03 3.00E+12 
Phase C 
         Count 10 10 10 10 10 10 10 10 80
Sum 9.47E+05 6.65E+04 4.84E+06 8.45E+06 3.28E+07 3.14E+05 2.16E+03 3.29E+02 4.75E+07 
Average 9.47E+04 6.65E+03 4.84E+05 8.45E+05 3.28E+06 3.14E+04 2.16E+02 3.29E+01 5.93E+05 
Variance 9.57E+09 4.07E+07 4.06E+11 4.18E+11 3.97E+12 7.11E+08 4.28E+04 2.03E+03 1.68E+12 
Phase D 
         Count 10 10 10 10 10 10 10 10 80
Sum 3.22E+06 1.77E+05 1.15E+07 2.10E+07 5.66E+07 5.91E+05 6.06E+03 6.44E+02 9.31E+07 
Average 3.22E+05 1.77E+04 1.15E+06 2.10E+06 5.66E+06 5.91E+04 6.06E+02 6.44E+01 1.16E+06 
Variance 1.02E+11 1.58E+08 1.10E+12 1.70E+12 7.96E+12 1.81E+09 1.90E+05 2.42E+03 4.66E+12 
Total 
         Count 30 30 30 30 30 30 30 30 
 Sum 6.07E+06 3.39E+05 3.25E+07 4.36E+07 1.30E+08 1.45E+06 1.14E+04 1.53E+03 
 Average 2.02E+05 1.13E+04 1.08E+06 1.45E+06 4.32E+06 4.84E+04 3.80E+02 5.11E+01 
 Variance 5.56E+10 9.93E+07 1.52E+12 1.27E+12 6.79E+12 1.54E+09 1.27E+05 2.19E+03 
 ANOVA 
         Source of Variation SS df MS F P-value F crit 
   Sample 1.31E+13 2 6.54E+12 6.00 2.91E-03 3.04 
   Columns 4.71E+14 7 6.72E+13 61.67 4.34E-48 2.05 
   Interaction 3.09E+13 14 2.21E+12 2.03 1.71E-02 1.74 
   Within 2.35E+14 216 1.09E+12 
      Total 7.50E+14 239         
  
1
6
6
 
Table 8.7. ANOVA (two way with replicates) for seven elemental plasma (venous blood) concentrations (ng.mL
-1
) obtained by ICP-MS from 
ten participants who participated in the physical stress study 
  Li Mg P K Fe Cu Zn Total 
Phase A                 
Count 7 7 7 7 7 7 7 49 
Sum 2.80E+04 9.04E+04 6.64E+05 9.42E+05 5.55E+03 4.78E+03 6.23E+03 1.74E+06 
Average 4.00E+03 1.29E+04 9.49E+04 1.35E+05 7.93E+02 6.83E+02 8.91E+02 3.55E+04 
Variance 1.86E+06 1.90E+06 2.47E+08 7.68E+08 8.04E+04 2.12E+04 7.57E+04 2.82E+09 
Phase C 
        Count 7 7 7 7 7 7 7 49 
Sum 2.60E+04 8.75E+04 6.05E+05 8.36E+05 5.63E+03 4.30E+03 5.55E+03 1.57E+06 
Average 3.71E+03 1.25E+04 8.65E+04 1.19E+05 8.05E+02 6.14E+02 7.93E+02 3.20E+04 
Variance 2.40E+06 1.95E+06 3.12E+08 1.14E+09 1.33E+04 2.25E+04 7.09E+04 2.33E+09 
Phase D 
        Count 7 7 7 7 7 7 7 49 
Sum 2.61E+04 8.63E+04 6.05E+05 1.00E+06 5.84E+03 4.54E+03 5.70E+03 1.74E+06 
Average 3.72E+03 1.23E+04 8.64E+04 1.43E+05 8.35E+02 6.49E+02 8.14E+02 3.54E+04 
Variance 2.98E+06 1.48E+06 3.32E+08 6.84E+08 6.89E+04 2.06E+04 5.60E+04 2.95E+09 
Total 
        Count 21 21 21 21 21 21 21 
 Sum 8.01E+04 2.64E+05 1.87E+06 2.78E+06 1.70E+04 1.36E+04 1.75E+04 
 Average 3.81E+03 1.26E+04 8.92E+04 1.32E+05 8.11E+02 6.49E+02 8.33E+02 
 Variance 2.19E+06 1.66E+06 2.84E+08 8.79E+08 4.91E+04 2.01E+04 6.26E+04 
 ANOVA 
        Source of Variation SS df MS F P-value F crit 
  Sample 3.83E+08 2 1.91E+08 1.15 3.20E-01 3.07 
  Columns 3.66E+11 6 6.09E+10 366 3.65E-77 2.17 
  Interaction 1.97E+09 12 1.65E+08 0.99 4.65E-01 1.83 
  Within 2.10E+10 126 1.67E+08 
     Total 3.89E+11 146             
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Table 8.8. Heart rate t-test scores (P). Values in bold are those where H0 was rejected (P < 0.05) indicating statistically significant differences between the 
indicating phases 
Between phases CZ1 CZ2 CZ3 CZ4 CZ5 CZ6 CZ7 CZ8 CZ9 CZ10 H0 () H0 (X) 
A & B 0.0000 0.0001 0.0000 0.0000 0.0002 0.0000 0.0001 0.0003 0.0035 0.0000 0 10 
B & C 0.0001 0.0004 0.0000 0.0000 0.0010 0.0001 0.0003 0.0075 0.0585 0.0002 1 9 
C & D 0.0670 0.0570 0.0314 0.0556 0.0611 0.0790 0.1207 0.0326 0.0079 0.0585 7 3 
A & D 0.0000 0.0008 0.0004 0.0001 0.0019 0.0000 0.0000 0.0000 0.4093 0.0001 1 9 
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Table 8.9. Calibration data for the nine statistically significant elements 
Element Gradient Intercept R2 Standard Error LOD (ng.mL-1) LOQ (ng.mL-1) 
Na 804864 14150099 0.9998 696332 2.60 8.65 
Mg 27762 27690 0.9999 11071 1.20 3.99 
Si 15180 171394 0.9988 20863 4.12 13.74 
P 1690 8456 0.9993 1755 3.11 10.38 
Mn 46667 1195 1.0000 1587 0.10 0.34 
Fe 41869 6796 1.0000 3022 0.22 0.72 
As 113864 19782 0.9997 28200 0.74 2.48 
Sr 1297070 0 0.9999 21990 0.05 0.17 
I 374 34043 0.9997 427 3.42 11.41 
The calibration standards data in Table 8.9 shows that the nine elements of interest 
produced good linearity. As a result, concentration could be calculated using the equation of 
a straight line (y = mx + C). y = sample intensity obtained from the ICP-MS, m = gradient, x = 
unknown and C = intercept. Element concentrations were checked against the calculated 
limited of detection (LOD) and limit of quantification (LOQ) to ensure they were higher in 
concentration. If concentrations were lower than the differences between pre and post 
intervention samples could not be calculated for the selected element. All sample 
concentrations for the selected nine elements were higher than the LOD. 
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Table 8.10. Analysis of variance (ANOVA) data for pre and post intervention saliva 
Source of Variation SS df MS F P-value F crit 
Two-Factor Without Replication 
Pre (n=3) 
Rows 1.28E+10 2 6.38E+09 1.624 0.207 3.183 
Columns 3.47E+12 25 1.39E+11 35.332 0.000 1.727 
Error 1.96E+11 50 3.93E+09 
   Total 3.68E+12 77 
    Post (n=3) 
Rows 7.80E+08 2 3.90E+08 1.340 0.271 3.183 
Columns 2.01E+12 25 8.04E+10 276.033 0.000 1.727 
Error 1.46E+10 50 2.91E+08 
   Total 2.03E+12 77 
    Two-Factor With Replication 
Sample 1.61E+10 1 1.61E+10 7.481 0.007 3.932 
Columns 5.35E+12 25 2.14E+11 99.211 0.000 1.612 
Interaction 1.26E+11 25 5.02E+09 2.328 0.002 1.612 
Within 2.25E+11 104 2.16E+09 
   Total 5.72E+12 155         
The two-factor without replication ANOVA carried out shows that no statistically significant 
difference (95%) was evident between the replicate samples (rows) in the pre and post 
intervention samples as the critical F value (3.183) is bigger than the calculated F value (Pre 
Fcalc = 1.624, Post Fcalc = 1.340). Within each replicate, there is statistical evidence to suggest 
there is a difference between elements (columns) as for both the pre and post intervention 
samples the critical F value (1.727) is smaller than the calculated F values (Pre Fcalc = 35.332, 
Post Fcalc = 276.033). 
Two way-factor with replication ANOVA shows the results of the relationship between the 
pre and post intervention samples. There is statistical evidence (95%) that elemental 
concentrations between the two groups (interaction) are different as the critical value of F 
(1.612) is smaller than the calculated F value (2.328).  
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Table 8.11. Descriptive statistics for all analysed elements showing Fcalc and Tcalc (P) 
scores 
Sample 
Pre Post 
Fcalc Tcalc (P) 
µ σ (n=3) µ σ (n=3) 
Li 1 1.77 2 1.41 0.78 0.68 
B 55 14.67 36 7.28 0.40 0.13 
Na 120276 31755.22 52 14.34 0.00 0.00 
Mg 3807 771.97 7318 895.17 0.85 0.01 
Al 41 26.24 115 163.98 0.05 0.48 
Si 340 32.09 541 70.20 0.35 0.01 
P 214235 29940.89 151849 16516.24 0.47 0.03 
S 70385 6202.47 74974 7192.34 0.85 0.45 
K 1087388 319364.24 829161 85644.33 0.13 0.25 
Ca 39811 4514.35 41501 3453.74 0.74 0.63 
V 0 0.05 0 0.00 0.00 0.37 
Cr 1 0.19 1 0.14 0.66 0.13 
Mn 44 16.15 12 1.77 0.02 0.03 
Fe 105 35.84 37 5.24 0.04 0.03 
Co 1 0.83 0 0.14 0.06 0.14 
Ni 5 1.61 4 1.57 0.97 0.47 
Cu 37 9.82 26 3.88 0.27 0.14 
Zn 181 65.49 136 76.30 0.85 0.48 
As 3 1.34 7 1.34 1.00 0.01 
Se 1 1.08 2 0.32 0.16 0.64 
Sr 10 2.83 46 4.73 0.53 0.00 
Mo 1 1.07 1 0.73 0.63 0.89 
In 0 0.00 0 0.00 0.74 0.86 
Sn 2125 868.53 1159 150.55 0.06 0.13 
I 107567 25058.21 10363 560.42 0.00 0.00 
Pb 1 0.56 1 0.40 0.68 0.51 
 
For the twenty six elements analysed an F test to test for variance, between the pre and post 
intervention samples, was conducted. For all elements the calculated F values were lower 
than the critical F values (Fcrit = 23 degrees of freedom 2,2). As a result an equal variance T 
test (two tailed), to test differences in two experimental means, was carried out. Tcalc values 
below 0.05 implied statistical difference at 95% between pre and post intervention samples.  
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Figure 8.1. Schematic of the LSP, all dimensions in mm  
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Figure 8.2. Dilution mass (g) of samples collected using the LSP with 2% HNO3 prior to ICP-MS 
anlysis. n = 3 
Sample 
2% HNO3 Sample Total 
µ σ RSD (%) µ σ RSD (%) 
EDTA               
LSP Blank 3.9908 0.0001 0.0014 1.0400 0.0001 0.0056 5.03 
B 4.0760 0.0001 0.0025 1.0418 0.0001 0.0096 5.12 
B1 4.1263 0.0001 0.0014 1.0437 0.0001 0.0111 5.17 
B2 4.0497 0.0001 0.0029 1.0471 0.0002 0.0146 5.10 
B3 4.0820 0.0001 0.0014 1.0449 0.0002 0.0146 5.13 
2% HNO3 
       LSP Blank 4.0940 0.0002 0.0037 1.0213 0.0002 0.0150 5.12 
B 4.0382 0.0001 0.0029 0.9993 0.0001 0.0116 5.04 
B1 3.9996 0.0001 0.0025 1.0305 0.0001 0.0056 5.03 
B2 4.0283 0.0000 0.0000 1.0364 0.0001 0.0056 5.06 
B3 3.9848 0.0000 0.0000 1.0377 0.0001 0.0096 5.02 
DI H2O 
       LSP Blank 4.0352 0.0001 0.0029 1.0189 0.0001 0.0113 5.05 
B 4.0714 0.0002 0.0038 1.0124 0.0001 0.0057 5.08 
B1 4.0206 0.0001 0.0014 1.0184 0.0001 0.0057 5.04 
B2 3.9692 0.0001 0.0029 1.0077 0.0001 0.0099 4.98 
B3 3.9922 0.0001 0.0029 1.0071 0.0001 0.0115 5.00 
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Table 8.12. ANOVA: Two-factor with replication (n = 10) of the elements detected from the elemental profiling of the volar 
(AE) and plantar (BF) using the LSP 
  Al Si P S K Fe Ni Zn Total 
Volar                   
Count 10 10 10 10 10 10 10 10 80 
Sum 939 17009 242 6255 2786 743 62 214 28249 
Average 94 1701 24 625 279 74 6 21 353 
Variance 1946 988214 1094 480602 14302 3423 35 433 470980 
Plantar 
         Count 10 10 10 10 10 10 10 10 80 
Sum 1027 21613 217 3579 7361 410 75 149 34431 
Average 103 2161 22 358 736 41 7 15 430 
Variance 2510 1021331 374 42877 878092 214 69 178 711820 
Total 
         Count 20 20 20 20 20 20 20 20 
 Sum 1967 38622 458 9834 10147 1152 137 363 
 Average 98 1931 23 492 507 58 7 18 
 Variance 2131 1007675 697 266808 477803 2014 50 301 
 ANOVA 
         Source of Variation SS df MS F P-value F crit 
   Sample 238798 1 238798 1.11 0 3.91 
   Columns 60287921 7 8612560 40.11 0 2.07 
   Interaction 2232053 7 318865 1.48 0 2.07 
   Within 30921240 144 214731 
      Total 93680012 159               
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Table 8.13. Single factor ANOVA between different solvent used for the comparison of solvents experiment using the LSP 
Groups Count Sum Average Variance Source of Variation SS df MS F P-value F crit 
EDTA Sample 3 1454804 484935 253490587 Between Groups 2.2E+11 2 1.1E+11 346.02 6.4E-07 5.14 
HNO3 Sample 3 2056624 685541 544748674 Within Groups 1.9E+09 6 3.2E+08 
   DI H2O Sample 3 913276 304425 147117936 Total 2.2E+11 8      
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Table 8.14. ANOVA: Two-factor with replication (n = 10) of the elements detected from the four 
skin sites sampled using the LSP 
  Mg Al S K Fe Cu Total 
Axilla 
       Count 10 10 10 10 10 10 60 
Sum 5.47 2.23 11.78 23.72 7.88 4.87 55.95 
Average 0.55 0.22 1.18 2.37 0.79 0.49 0.93 
Variance 0.45 0.50 1.04 0.76 0.56 0.31 1.06 
Dorsal 
       Count 10 10 10 10 10 10 60 
Sum 9.96 6.70 14.88 30.64 9.06 2.04 73.28 
Average 1.00 0.67 1.49 3.06 0.91 0.20 1.22 
Variance 0.36 0.55 0.66 0.25 0.41 0.11 1.20 
Plantar 
       Count 10 10 10 10 10 10 60 
Sum 13.22 4.18 16.44 30.89 10.98 2.65 78.36 
Average 1.32 0.42 1.64 3.09 1.10 0.27 1.31 
Variance 0.55 0.50 1.57 0.24 0.21 0.12 1.37 
Volar 
       Count 10 10 10 10 10 10 60 
Sum 3.79 8.69 10.26 26.85 7.35 2.27 59.20 
Average 0.38 0.87 1.03 2.69 0.73 0.23 0.99 
Variance 0.48 0.85 1.00 0.30 0.52 0.16 1.17 
Total 
       Count 40 40 40 40 40 40 
 Sum 32.44 21.79 53.36 112.11 35.27 11.83 
 Average 0.81 0.54 1.33 2.80 0.88 0.30 
 Variance 0.57 0.62 1.05 0.44 0.41 0.18 
 ANOVA 
       Source of Variation SS df MS F P-value F crit 
 Sample 5.85 3 1.95 3.75 0.01 2.65 
 Columns 161.57 5 32.31 62.19 0.00 2.26 
 Interaction 9.24 15 0.62 1.19 0.28 1.71 
 Within 112.24 216 0.52 
    Total 288.90 239           
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Table 8.15. ANOVA (two way with replicates) results for ions obtained from ESI-MS in negative ion mode for the profiling of the doral and plantar (BF) 
Ion m/z 
Dorsal Plantar Total 
Count Sum Average Variance Count Sum Average Variance Count Sum Average Variance 
61.9884 9 14.52 1.61 2.35 9 17.61 1.96 2.20 18 32.13 1.79 2.17 
72.0091 9 8.72 0.97 2.16 9 31.39 3.49 0.16 18 40.10 2.23 2.77 
74.0248 9 24.57 2.73 0.44 9 33.40 3.71 0.04 18 57.97 3.22 0.48 
82.0299 9 12.85 1.43 1.30 9 28.96 3.22 0.05 18 41.81 2.32 1.48 
84.0456 9 1.43 0.16 0.23 9 21.06 2.34 0.31 18 22.50 1.25 1.51 
87.0088 9 13.05 1.45 3.22 9 18.21 2.02 3.77 18 31.25 1.74 3.38 
89.0245 9 37.40 4.16 2.49 9 43.80 4.87 0.03 18 81.20 4.51 1.32 
90.0278 9 26.34 2.93 1.30 9 31.58 3.51 0.05 18 57.92 3.22 0.73 
91.0221 9 20.59 2.29 0.87 9 25.80 2.87 0.03 18 46.39 2.58 0.51 
92.9281 9 23.31 2.59 1.55 9 32.25 3.58 0.22 18 55.56 3.09 1.10 
93.0346 9 35.78 3.98 0.05 9 40.69 4.52 0.04 18 76.47 4.25 0.12 
94.0492 9 22.53 2.50 0.15 9 29.39 3.27 0.08 18 51.93 2.88 0.26 
101.0233 9 1.18 0.13 0.15 9 0.00 0.00 0.00 18 1.18 0.07 0.08 
104.0354 9 33.75 3.75 0.10 9 40.51 4.50 0.03 18 74.26 4.13 0.21 
114.0215 9 15.68 1.74 1.97 9 28.32 3.15 0.02 18 44.00 2.44 1.46 
114.0561 9 8.47 0.94 2.01 9 16.07 1.79 2.88 18 24.54 1.36 2.49 
115.0185 9 27.18 3.02 1.42 9 34.61 3.85 0.02 18 61.79 3.43 0.86 
116.0278 9 2.19 0.24 0.53 9 18.85 2.09 1.52 18 21.04 1.17 1.87 
116.0506 9 24.77 2.75 0.18 9 33.32 3.70 0.03 18 58.09 3.23 0.34 
118.0511 9 26.78 2.98 0.17 9 34.31 3.81 0.03 18 61.10 3.39 0.28 
124.0075 9 2.20 0.24 0.54 9 11.72 1.30 1.77 18 13.92 0.77 1.38 
128.0354 9 36.70 4.08 0.07 9 43.07 4.79 0.03 18 79.76 4.43 0.18 
129.0389 9 21.12 2.35 2.07 9 32.87 3.65 0.02 18 53.98 3.00 1.43 
130.0875 9 28.33 3.15 0.06 9 36.25 4.03 0.03 18 64.58 3.59 0.25 
131.0828 9 18.83 2.09 1.70 9 23.49 2.61 2.27 18 42.32 2.35 1.94 
132.0304 9 12.57 1.40 1.79 9 33.50 3.72 0.03 18 46.08 2.56 2.29 
133.0316 9 10.72 1.19 2.13 9 18.62 2.07 2.43 18 29.34 1.63 2.35 
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137.0358 9 32.75 3.64 0.06 9 37.16 4.13 0.06 18 69.91 3.88 0.12 
138.0392 9 20.85 2.32 0.13 9 26.24 2.92 0.09 18 47.09 2.62 0.20 
146.0461 9 7.09 0.79 0.85 9 23.58 2.62 0.09 18 30.67 1.70 1.33 
146.9833 9 22.94 2.55 1.09 9 28.38 3.15 0.13 18 51.33 2.85 0.67 
148.9803 9 20.04 2.23 0.76 9 24.08 2.68 0.09 18 44.12 2.45 0.45 
150.0175 9 7.27 0.81 0.94 9 21.51 2.39 0.05 18 28.78 1.60 1.13 
151.0403 9 -50.00 -5.56 277.78 9 23.72 2.64 0.04 18 -26.28 -1.46 148.49 
154.0625 9 15.31 1.70 0.56 9 26.25 2.92 0.10 18 41.56 2.31 0.70 
Total 315 587.79 1.87 10.89 315 970.58 3.08 1.51 
    ANOVA 
            Source of Variation Sample Columns Interaction Within Total 
       SS 232.59 960.40 279.86 2655.38 4128.22 
       df 1 34 34 560 629 
       MS 232.59 28.25 8.23 4.74 
        F 49.05 5.96 1.74 
         P-value 7.2E-12 2.3E-21 0.0068 
         F crit 3.86 1.45 1.45          
  
  
1
7
8
 
Table 8.16. ESI-MS negative ion mode results for t test between gender plantar (BF) samples for the profiling of the doral and plantar (BF). M BF = male plantar, F BF = female plantar. 
Samples ordered by largest to smallest difference between genders 
Ion (m/z) 
Male BF Female BF 
µ (M BF) - µ (F BF) Fcalc F4,3 crit (P = 0.05, 2 tail) H0 accepted (Fcalc<Fcrit) Pcalc 
H0 accepted (Pcalc>Pcrit) 
µ (n=9) σ (n=9) µ (n=9) σ (n=9) Pcrit  (0.05) Pcrit (0.01) Pcrit (0.001) 
128.0354 76928 34847 50582 5614 26346 0.052 9.12 No 0.16   
93.0346 47001 28568 25549 4447 21452 0.114 9.12 No 0.12   
89.0245 88066 34826 67197 24192 20870 0.748 9.12 No 0.37   
104.0354 39354 18325 27114 4158 12241 0.121 9.12 No 0.23   
137.0358 20652 14621 9909 1973 10743 0.110 9.12 No 0.11   
87.0088 5133 5042 880 1761 4253 0.891 9.12 No 0.13   
118.0511 8387 4097 5401 815 2986 0.083 9.12 No 0.21   
92.9281 7108 5682 4139 3431 2969 0.587 9.12 No 0.42   
115.0185 8461 2112 5854 1339 2607 0.897 9.12 No 0.07   
132.0304 6679 2477 4366 1021 2313 0.320 9.12 No 0.14   
130.0875 12353 6598 10213 1500 2140 0.068 9.12 No 0.72   
129.0389 5686 1842 3564 767 2123 0.565 9.12 No 0.04   
94.0492 3134 2345 1280 393 1854 0.315 9.12 No 0.08   
131.0828 2913 3036 1413 1195 1500 0.911 9.12 No 0.77   
74.0248 6177 3750 4950 1242 1227 0.196 9.12 No 0.71   
90.0278 4191 2277 3014 1435 1177 0.619 9.12 No 0.48   
116.0506 5963 3748 4930 582 1034 0.024 9.12 No 0.86   
82.0299 2312 1475 1321 292 992 0.182 9.12 No 0.18   
72.0091 4428 3742 3589 785 839 0.020 9.12 No 0.70   
138.0392 1409 1167 603 181 806 0.149 9.12 No 0.17   
146.9833 2113 1256 1420 846 693 0.547 9.12 No 0.62   
116.0278 816 596 161 186 655 0.044 9.12 No 0.13   
133.0316 1201 929 577 667 624 0.661 9.12 No 0.41   
61.9884 922 787 356 496 566 0.720 9.12 No 0.36   
84.0456 628 677 171 124 458 0.776 9.12 No 0.23   
114.0215 1655 576 1241 324 415 0.703 9.12 No 0.23   
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154.0625 1229 1041 832 518 397 0.820 9.12 No 0.58   
124.0075 454 803 99 184 355 0.794 9.12 No 0.54   
146.0461 668 408 319 146 349 0.490 9.12 No 0.17   
91.0221 897 316 648 217 250 0.960 9.12 No 0.25   
148.9803 661 398 452 193 209 0.270 9.12 No 0.65   
150.0175 317 203 230 72 87 0.445 9.12 No 0.57   
151.0403 501 281 435 146 66 0.403 9.12 No 0.85   
114.0561 986 1354 956 694 30 0.798 9.12 No 0.42   
H0 accepted 33 34 34 
H0 rejected 1 0 0 
Total 34 34 34 
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Table 8.17. ESI-MS negative ion mode results for t test between gender dorsal (TF) samples for the profiling of the doral (TF) and plantar (BF). M TF = male dorsal, F TF = female dorsal 
Samples ordered by largest to smallest difference between gender 
Ion (m/z) 
M TF F TF 
[µ (M TF) - µ (F TF)] Fcalc F4,3 crit (P = 0.05, 2 tail) H0 accepted (Fcalc<Fcrit) Pcalc 
H0 accepted (Pcalc>Pcrit) 
µ (n=9) σ (n=9) µ (n=9) σ (n=9) Pcrit  (0.05) Pcrit (0.01) Pcrit (0.001) 
89.0245 66065 43716 28978 24224 37087 0.001 9.12 No 0.32   
128.0354 15884 8458 11177 5088 4707 0.951 9.12 No 0.45   
104.0354 8344 5387 5147 2509 3197 0.901 9.12 No 0.40   
115.0185 4294 4038 1661 1698 2633 0.010 9.12 No 0.27   
90.0278 3127 2701 1163 1023 1965 0.010 9.12 No 0.28   
92.9281 2438 1574 570 640 1868 0.573 9.12 No 0.33   
146.9833 1499 836 276 260 1223 0.023 9.12 No 0.15   
131.0828 1164 1832 371 410 794 0.970 9.12 No 0.60   
87.0088 2142 3620 1362 2724 780 0.930 9.12 No 0.48   
74.0248 798 960 1574 1425 776 0.786 9.12 No 0.37   
129.0389 1145 1467 1577 1408 432 0.769 9.12 No 0.85   
118.0511 1444 938 1023 612 421 0.482 9.12 No 0.53   
133.0316 532 791 132 217 400 0.729 9.12 No 0.92   
114.0215 681 968 301 352 381 0.711 9.12 No 0.55   
137.0358 5067 2233 4693 2308 374 0.290 9.12 No 0.71   
61.9884 611 384 272 544 339 0.736 9.12 No 0.16   
148.9803 477 231 158 123 320 0.013 9.12 No 0.22   
91.0221 566 359 289 384 278 0.006 9.12 No 0.24   
130.0875 1702 1064 1497 810 205 0.697 9.12 No 0.74   
132.0304 292 292 103 133 190 0.902 9.12 No 0.64   
116.0506 776 786 891 737 115 0.539 9.12 No 0.95   
72.0091 309 691 403 653 94 0.781 9.12 No 0.50   
114.0561 206 460 298 404 92 0.738 9.12 No 0.47   
82.0299 180 229 96 132 84 0.724 9.12 No 0.97   
138.0392 300 239 235 142 65 0.689 9.12 No 0.70   
146.0461 62 74 2 3 60 0.118 9.12 No 0.16   
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93.0346 10444 3873 10483 5065 39 0.267 9.12 No 0.84   
124.0075 32 71 0 0 32 n / a 9.12 No n / a   
116.0278 31 69 0 0 31 n / a 9.12 No n / a   
150.0175 27 59 43 38 16 0.931 9.12 No 0.20   
94.0492 399 227 413 249 15 0.131 9.12 No 0.76   
154.0625 102 96 117 117 14 0.918 9.12 No 0.87   
84.0456 5 12 0 0 5 n / a 9.12 No n / a   
151.0403 0 0 0 0 0 n / a 9.12 No n / a   
H0 accepted 34 34 34 
H0 rejected 0 0 0 
Total 34 34 34 
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Table 8.18. ANOVA (two way with replicates) results for ions obtained from ESI-MS in positive ion mode for the profiling of the doral and plantar (BF) 
Ion m/z 
Dorsal Plantar Total 
Count Sum Average Variance Count Sum Average Variance Count Sum Average Variance 
56.9784 9 5.82 0.65 1.70 9 5.95 0.66 1.79 18 11.78 0.65 1.64 
60.0578 9 13.74 1.53 2.20 9 26.07 2.90 1.39 18 39.81 2.21 2.19 
70.0783 9 19.80 2.20 1.70 9 34.47 3.83 0.25 18 54.27 3.02 1.62 
71.0822 9 5.04 0.56 1.24 9 11.91 1.32 2.61 18 16.94 0.94 1.97 
78.9706 9 21.73 2.41 2.09 9 23.88 2.65 2.34 18 45.61 2.53 2.10 
82.0282 9 5.06 0.56 1.30 9 5.47 0.61 1.46 18 10.53 0.59 1.30 
83.0233 9 8.97 1.00 2.24 9 18.10 2.01 2.34 18 27.07 1.50 2.43 
84.0955 9 14.07 1.56 1.67 9 30.27 3.36 0.17 18 44.34 2.46 1.72 
90.1047 9 14.51 1.61 1.72 9 29.54 3.28 0.06 18 44.05 2.45 1.58 
93.0590 9 28.28 3.14 0.08 9 27.03 3.00 1.40 18 55.31 3.07 0.70 
94.9435 9 27.94 3.10 1.56 9 35.09 3.90 0.09 18 63.04 3.50 0.94 
96.9377 9 25.77 2.86 1.26 9 33.07 3.67 0.05 18 58.84 3.27 0.79 
98.9343 9 19.82 2.20 1.60 9 28.80 3.20 0.04 18 48.61 2.70 1.03 
99.0004 9 14.66 1.63 3.84 9 22.79 2.53 2.28 18 37.45 2.08 3.10 
104.1145 9 20.18 2.24 1.17 9 32.12 3.57 0.04 18 52.29 2.91 1.04 
110.0838 9 23.96 2.66 2.50 9 35.55 3.95 0.32 18 59.51 3.31 1.77 
110.9912 9 8.58 0.95 2.06 9 23.86 2.65 1.13 18 32.44 1.80 2.26 
112.9112 9 33.86 3.76 0.38 9 40.52 4.50 0.18 18 74.38 4.13 0.41 
114.0034 9 15.96 1.77 2.96 9 31.14 3.46 0.29 18 47.10 2.62 2.28 
114.9070 9 27.48 3.05 1.69 9 37.86 4.21 0.14 18 65.34 3.63 1.21 
115.1008 9 24.30 2.70 1.15 9 36.03 4.00 0.09 18 60.33 3.35 1.03 
116.0842 9 18.64 2.07 2.65 9 40.07 4.45 0.26 18 58.71 3.26 2.87 
120.0073 9 36.54 4.06 0.09 9 41.11 4.57 0.04 18 77.64 4.31 0.13 
121.0520 9 36.94 4.10 0.09 9 37.61 4.18 0.19 18 74.55 4.14 0.14 
122.9668 9 25.45 2.83 2.71 9 35.40 3.93 0.18 18 60.85 3.38 1.68 
124.9750 9 18.55 2.06 2.44 9 27.73 3.08 0.24 18 46.29 2.57 1.53 
130.0939 9 12.73 1.41 2.89 9 27.00 3.00 3.23 18 39.73 2.21 3.54 
132.9958 9 29.17 3.24 0.19 9 31.95 3.55 0.09 18 61.12 3.40 0.16 
133.1022 9 13.80 1.53 3.32 9 22.22 2.47 3.51 18 36.03 2.00 3.45 
134.0272 9 28.82 3.20 1.58 9 35.30 3.92 0.09 18 64.12 3.56 0.92 
135.9943 9 9.37 1.04 2.44 9 29.50 3.28 1.56 18 38.87 2.16 3.21 
137.0760 9 8.60 0.96 2.08 9 33.48 3.72 0.11 18 42.08 2.34 3.05 
138.0667 9 21.53 2.39 1.94 9 33.59 3.73 0.09 18 55.12 3.06 1.43 
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139.0653 9 33.21 3.69 0.19 9 39.15 4.35 0.12 18 72.36 4.02 0.26 
139.9322 9 19.06 2.12 1.84 9 30.66 3.41 0.09 18 49.72 2.76 1.35 
140.0849 9 23.24 2.58 0.99 9 33.85 3.76 0.18 18 57.08 3.17 0.91 
141.9948 9 25.39 2.82 1.19 9 32.47 3.61 0.11 18 57.86 3.21 0.78 
142.1064 9 4.65 0.52 1.09 9 17.89 1.99 2.31 18 22.54 1.25 2.17 
144.9370 9 14.07 1.56 3.45 9 22.91 2.55 3.70 18 36.98 2.05 3.62 
148.9789 9 17.20 1.91 2.17 9 30.02 3.34 0.10 18 47.23 2.62 1.61 
150.0297 9 33.17 3.69 0.11 9 40.65 4.52 0.05 18 73.81 4.10 0.26 
150.9935 9 24.85 2.76 2.76 9 31.90 3.54 1.85 18 56.76 3.15 2.33 
154.0362 9 5.31 0.59 1.38 9 29.17 3.24 0.09 18 34.48 1.92 2.55 
155.0909 9 5.82 0.65 1.67 9 32.46 3.61 0.32 18 38.28 2.13 3.25 
156.9937 9 29.54 3.28 1.66 9 31.31 3.48 1.79 18 60.85 3.38 1.64 
157.0029 9 13.54 1.50 3.33 9 26.55 2.95 1.55 18 40.09 2.23 2.85 
160.0446 9 26.02 2.89 0.08 9 32.03 3.56 0.04 18 58.04 3.22 0.18 
160.9231 9 12.59 1.40 2.81 9 16.40 1.82 3.02 18 28.99 1.61 2.79 
162.0714 9 23.77 2.64 1.04 9 31.48 3.50 0.04 18 55.25 3.07 0.70 
164.0496 9 24.08 2.68 0.11 9 31.71 3.52 0.06 18 55.79 3.10 0.27 
164.1488 9 15.09 1.68 1.95 9 22.64 2.52 1.19 18 37.73 2.10 1.66 
164.9579 9 3.78 0.42 1.59 9 16.45 1.83 3.20 18 20.22 1.12 2.78 
165.0289 9 5.42 0.60 1.47 9 0.00 0.00 0.00 18 5.42 0.30 0.79 
165.9969 9 9.77 1.09 2.65 9 32.43 3.60 0.18 18 42.20 2.34 3.01 
166.9725 9 24.49 2.72 1.40 9 32.52 3.61 0.13 18 57.01 3.17 0.94 
168.9755 9 3.42 0.38 1.30 9 14.48 1.61 2.36 18 17.90 0.99 2.12 
172.0192 9 6.66 0.74 1.25 9 21.85 2.43 0.86 18 28.51 1.58 1.74 
172.9783 9 6.08 0.68 1.82 9 17.79 1.98 2.23 18 23.87 1.33 2.35 
173.0899 9 6.50 0.72 1.18 9 27.22 3.02 0.12 18 33.72 1.87 2.01 
176.0920 9 20.59 2.29 0.76 9 25.80 2.87 1.18 18 46.39 2.58 1.00 
177.0821 9 6 1 2 9 30 3 0 18 35.59 1.98 2.68 
Total 549 1083 2 3 549 1716 3 2 
    ANOVA 
            Source of Variation Sample Columns Interaction Within Total 
       SS 366 951 149 1250 2716 
       df 1 60 60 976 1097 
       MS 366 15.9 2.49 1.28 
        F 285 12.4 1.94 
         P-value 2.41E-56 9.65E-84 3.94E-05 
         F crit 3.85 1.33 1.33            
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Table 8.19. ESI-MS positive ion mode results for t test between gender plantar (BF) samples for the profiling of the doral and plantar (BF). M BF = male plantar, 
F BF = female plantar. Samples ordered by largest to smallest difference between genders 
Ion (m/z) 
M BF (Total) F BF (Total) 
[µ (M BF) - µ (F TF)] Fcalc F3,3crit H0 accepted Pcalc 
H0 accepted (Pcalc>Pcrit) 
μ (n=9) σ (n=9) μ (n=9) σ (n=9) Pcrit (0.05) Pcrit (0.01) Pcrit (0.001) 
116.0842 61942 35301 21672 22736 40270 13.96 15.44 Yes 0.061   
112.9112 58136 30811 27252 23314 30884 10.56 15.44 Yes 0.143   
150.0297 44476 21291 26880 6863 17596 14.30 15.44 Yes 0.258   
114.9070 29077 15739 11862 9259 17215 10.96 15.44 Yes 0.093   
155.091 15776 21948 2193 1457 13584 2.52 15.44 Yes 0.125   
115.101 16398 7668 7076 3552 9322 15.51 15.44 Yes 0.068   
121.0520 25994 20817 16823 13587 9171 6.80 15.44 Yes 0.451   
110.0838 19252 16187 12062 14170 7189 2.76 15.44 Yes 0.553   
140.0849 12849 19100 6064 4162 6786 3.71 15.44 Yes 0.722   
139.0653 31209 19948 24485 19968 6723 17.55 15.44 Yes 0.435   
70.0783 14006 12848 7392 7927 6614 4.43 15.44 Yes 0.362   
114.0034 7619 4119 1556 1462 6063 7.47 15.44 Yes 0.024   
130.0939 14331 18517 8912 16153 5419 10.64 15.44 Yes 0.136   
138.0667 8852 5730 4015 1787 4837 8.88 15.44 Yes 0.175   
165.9969 7803 4389 3243 3457 4560 9.47 15.44 Yes 0.101   
134.0272 12036 6561 7541 4824 4495 17.66 15.44 Yes 0.256   
137.0760 8388 4660 4237 2149 4151 7.81 15.44 Yes 0.263   
150.9935 12063 8602 8155 6051 3908 27.02 15.44 Yes 0.329   
99.0004 4091 3583 432 726 3659 14.56 15.44 Yes 0.027   
156.994 10166 4843 7058 7254 3108 51.90 15.44 Yes 0.263   
144.937 3899 4999 6980 6815 3081 1.09 15.44 Yes 0.629   
135.9943 6190 3226 3276 2501 2914 41.47 15.44 Yes 0.251   
94.9435 10851 5371 8196 7568 2655 13.45 15.44 Yes 0.410   
164.9579 3130 3860 514 890 2616 1.45 15.44 Yes 0.557   
96.9377 6485 2673 3882 2115 2603 22.05 15.44 Yes 0.152   
148.9789 3930 2849 1429 356 2502 7.50 15.44 Yes 0.115   
166.9725 6482 4806 4195 2819 2287 5.62 15.44 Yes 0.601   
133.1022 5199 4786 2917 3521 2282 1.64 15.44 Yes 0.434   
122.9668 13000 7020 10764 11372 2237 5.03 15.44 Yes 0.653   
132.996 5390 3927 3209 1670 2182 7.86 15.44 Yes 0.452   
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84.0955 4027 2557 2132 1837 1896 6.47 15.44 Yes 0.299   
164.0496 4635 2478 2754 645 1881 11.19 15.44 Yes 0.326   
154.036 2878 1365 1162 493 1716 13.84 15.44 Yes 0.053   
71.0822 1714 3091 62 122 1652 2.24 15.44 Yes 0.252   
164.1488 2087 3451 622 621 1464 2.22 15.44 Yes 0.787   
139.9322 3730 2281 2332 1703 1398 14.59 15.44 Yes 0.275   
104.1145 4634 2097 3327 1176 1308 19.98 15.44 Yes 0.387   
177.0821 2861 1175 1727 755 1134 19.38 15.44 Yes 0.180   
141.995 4573 2417 5522 3677 948 19.88 15.44 Yes 0.963   
93.0590 3261 3120 2429 1975 832 2.56 15.44 Yes 0.602   
60.0578 3398 4777 2622 4302 777 13.25 15.44 Yes 0.304   
142.106 1155 1088 409 382 746 1.75 15.44 Yes 0.967   
56.9784 665 1325 1 1 664 2.79 15.44 Yes 0.202   
120.0073 40310 18989 40954 20483 644 19.94 15.44 Yes 0.935   
98.9343 2005 919 1374 484 632 25.51 15.44 Yes 0.262   
160.9231 1469 1456 847 1262 622 1.02 15.44 Yes 0.724   
172.9783 927 701 375 450 553 1.47 15.44 Yes 0.361   
160.045 4203 2161 3676 1452 527 18.13 15.44 Yes 0.813   
168.9755 720 708 227 278 493 1.21 15.44 Yes 0.647   
176.0920 1816 860 1328 905 488 49.05 15.44 Yes 0.317   
83.0233 1016 951 625 742 392 1.51 15.44 Yes 0.880   
124.9750 1951 931 1599 1927 352 13.02 15.44 Yes 0.328   
78.9706 2336 2016 2648 2690 312 1.30 15.44 Yes 0.919   
90.1047 2310 1100 2054 1294 256 17.22 15.44 Yes 0.691   
82.0282 233 350 1 1 232 2.26 15.44 Yes 0.194   
157.0029 4084 6015 3892 5244 192 8.99 15.44 Yes 0.436   
172.019 460 132 600 515 140 125.36 15.44 Yes 0.463   
162.0714 3370 1591 3479 1477 110 20.38 15.44 Yes 0.835   
173.09 1430 1393 1350 905 80 7.20 15.44 Yes 0.932   
110.9912 1219 586 1190 1860 29 25.21 15.44 Yes 0.271   
165.0289 1 0 1 1 0 n / a 15.44 n / a n / a   
H0 accepted 59 61 61 
H0 rejected 2 0 0 
Total 61 61 61 
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Table 8.20. ESI-MS positive ion mode results for t test between gender dorsal (TF) samples for the profiling of the doral and plantar (BF). M TF = male dorsal, F 
TF = female dorsal. Samples ordered by largest to smallest difference between genders 
Ion (m/z) 
M TF (Total) F TF (Total) 
[µ (M TF) - µ (F TF)] Fcalc F3,3crit H0 accepted Pcalc 
H0 accepted (Pcalc>Pcrit) 
μ σ (n = 9) μ σ (n = 9) Pcrit (0.05) Pcrit (0.01) Pcrit (0.001) 
112.9112 23204 24119 2224 1047 20980 3.451 15.44 Yes 0.03   
114.9070 11172 12801 728 638 10444 5.361 15.44 Yes 0.07   
122.9668 7659 7801 1904 2197 5756 15.739 15.44 Yes 0.09   
99.0004 5594 5783 1 1 5593 2.895 15.44 Yes 0.01   
94.9435 6559 6100 1908 1959 4651 11.877 15.44 Yes 0.18   
156.994 7748 2217 3137 4389 4611 214.204 15.44 Yes 0.13   
150.9935 7304 9438 2817 3428 4488 7.999 15.44 Yes 0.16   
166.9725 4970 7824 522 539 4448 4.520 15.44 Yes 0.12   
150.0297 7863 6157 4207 2570 3656 10.340 15.44 Yes 0.27   
139.0653 8341 8496 5903 3091 2438 3.510 15.44 Yes 0.98   
114.0034 2301 1960 79 155 2222 1.525 15.44 Yes 0.07   
96.9377 2924 1715 725 585 2199 21.504 15.44 Yes 0.13   
134.0272 4049 2842 5904 6015 1855 22.002 15.44 Yes 0.50   
116.0842 2654 5303 1067 893 1587 1.348 15.44 Yes 0.69   
139.9322 1647 1569 129 147 1519 2.665 15.44 Yes 0.06   
132.996 2936 1093 1484 1074 1452 37.223 15.44 Yes 0.13   
130.0939 1566 2417 298 594 1269 1.376 15.44 Yes 0.34   
160.9231 1383 1657 122 241 1261 1.838 15.44 Yes 0.27   
120.0073 13451 8712 14696 10898 1245 10.970 15.44 Yes 0.93   
164.9579 1198 2677 1 1 1197 2.853 15.44 Yes 0.41   
110.0838 2952 5160 4145 2796 1193 1.499 15.44 Yes 0.83   
148.9789 1263 1225 105 208 1158 7.907 15.44 Yes 0.01   
164.1488 1333 2656 187 123 1146 3.354 15.44 Yes 0.42   
165.9969 1109 1068 1 1 1108 3.187 15.44 Yes 0.07   
104.1145 1181 1259 205 215 976 2.236 15.44 Yes 0.19   
124.9750 1370 1234 491 569 879 1.443 15.44 Yes 0.36   
135.9943 807 750 1 1 806 2.931 15.44 Yes 0.07   
98.9343 901 375 207 243 695 56.112 15.44 Yes 0.05   
70.0783 1194 1942 509 449 686 1.046 15.44 Yes 0.84   
157.0029 2305 4292 1688 3374 617 1.085 15.44 Yes 0.46   
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83.0233 607 598 1 1 606 2.693 15.44 Yes 0.07   
133.1022 1622 1800 1043 2085 579 1.062 15.44 Yes 0.39   
172.9783 566 999 1 1 565 2.823 15.44 Yes 0.20   
168.9755 530 1184 1 1 529 2.343 15.44 Yes 0.41   
144.937 1383 1966 1907 2778 524 1.108 15.44 Yes 0.80   
56.9784 512 988 1 1 511 2.641 15.44 Yes 0.20   
110.9912 497 587 1 1 496 2.490 15.44 Yes 0.07   
60.0578 618 543 156 311 462 1.149 15.44 Yes 0.14   
90.1047 537 533 87 173 450 3.175 15.44 Yes 0.03   
138.0667 1451 1930 1045 1062 407 1.186 15.44 Yes 0.87   
115.101 1555 1990 1169 917 386 2.085 15.44 Yes 0.57   
137.0760 444 759 124 247 320 1.467 15.44 Yes 0.63   
78.9706 1654 1614 1335 1556 319 10.740 15.44 Yes 0.21   
165.0289 312 594 1 1 311 2.295 15.44 Yes 0.20   
140.0849 940 542 632 485 308 25.556 15.44 Yes 0.31   
84.0955 395 470 138 267 257 1.176 15.44 Yes 0.23   
164.0496 726 700 502 349 224 7.521 15.44 Yes 0.64   
82.0282 220 427 1 1 219 2.028 15.44 Yes 0.20   
155.091 309 689 109 216 200 1.170 15.44 Yes 0.98   
154.036 195 295 1 1 194 2.130 15.44 Yes 0.19   
162.0714 1027 833 853 414 174 1.915 15.44 Yes 0.57   
160.045 1010 679 845 575 165 14.608 15.44 Yes 0.63   
176.0920 418 183 273 213 145 60.220 15.44 Yes 0.26   
71.0822 145 223 1 1 144 1.919 15.44 Yes 0.19   
142.106 108 240 22 41 87 1.491 15.44 Yes 0.93   
121.0520 15563 12608 15645 8037 82 9.242 15.44 Yes 0.87   
93.0590 1644 1319 1717 878 73 10.760 15.44 Yes 0.84   
177.0821 194 431 124 247 70 1.018 15.44 Yes 0.93   
172.019 90 133 27 51 64 1.611 15.44 Yes 0.60   
173.09 40 87 65 74 25 1.408 15.44 Yes 0.45   
141.995 1560 1365 1554 877 6 2.138 15.44 Yes 0.52   
H0 accepted 56 60 61 
H0 rejected 5 1 0 
Total 61 61 61 
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Appendix V Documentation for studies involving human volunteers 
Study Participant Information Sheets 
Chapter 2: A study into the effect of psychological stress on the elemental content of 
human forehead sweat as measured by ICP-MS 
What will happen to me if I take part? 
If you agree to take part we will arrange for you to visit our laboratory for two separate visits 
each lasting about 2 hours. During this visit we will first ask you a series of questions relating 
to factors that can influence the chemical substances we are interested in.  These will 
include questions about food, drink, medications recently consumed and smoking habits. 
We will also ask you some questions about personal care including toiletries, perfumes and 
dental and personal care products. We will also ask you for information about diet and 
digestion. For the same reasons, you may be asked to refrain from eating, drinking (other 
than unflavoured water), smoking and using personal care products for an agreed time 
period prior to the study visit.   
At the beginning of the first session you will be asked to read and fill out a health screen 
questionnaire and be given the opportunity to ask any questions that you may have about 
the research. Then if you are still willing to participate you will be asked to sign a consent 
form. 
Next you will be asked to fill in some short questionnaires on demographics, health habits, 
anxiety, mood and leadership. Once these are complete the investigator will measure your 
blood pressure and heart rate using an inflatable cuff attached to the upper part of your 
arm. 
 After we have collected this information, we will then begin taking samples.  This involves 
placing a small section of an inert strip on the surface of your skin and covering it with a 
dressing. We will also take a breath sample; this involves wearing a face mask that is 
connected to an air supply.  You will be asked to breathe normally throughout the test, 
whilst sitting comfortably in a chair.  A sampling tube is connected to the mask on which we 
will collect the sample. 
When you are ready you will be asked to perform four, computer based cognitive function 
tests which assess memory, executive functioning and attention. These tests require you to 
press buttons on the keyboard to answer the questions.  
After we have collected this information, we will then begin taking saliva samples.   This 
involves placing a small strip of an inert material under your , it will be held by thin locking 
forceps that you will have control of to prevent you from swallowing or choking on it. The 
forceps have been selected for your comfort and are completely rounded and should feel 
similar to brushing your teeth or using an oral thermometer. This sample will take up to a 
maximum of 5 minutes. Once sampling is complete you will simply hand the forceps to the 
investigator. We will then issue you with a collection tube for whole saliva sample collection. 
This involves sitting comfortably in a chair with your head tilted slightly forward. In this 
position saliva will begin pool at the front of your mouth. After 30 seconds to 1 minute a 
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sufficient amount of saliva will have collected, at this time you may dispense the pooled 
saliva into the collection tube. To help this procedure you may wish to imagine your 
favourite food. We will continue to collect saliva in this manner until you feel you wish to 
stop or a sufficient quantity of saliva has been collected. 
At the end of the sampling period the investigator will take the collection tube from you. At 
this point tissues and drink of water will be available to you should you wish.  
During the next ten minutes you will be asked to complete either a mental arithmetic task or 
relax and listen to some music, you will complete different tasks on each visit. The mental 
arithmetic test is known as the Paced Auditory Serial Addition Test (PASAT), this is designed 
to require inert mental effort, with incorrect responses eliciting a ‘buzzer’ sound that you 
may find stressful. You will be given a full explanation of the test prior to starting and will be 
given the opportunity to ask any questions that you may have. During the task your blood 
pressure and heart rate will be monitored. 
The cognitive tests and chemical tests described above will then be repeated. We may ask 
for any or all of the described samples.  
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Chapter 3: The effect of physical stress on elemental content in human plasma, skin 
and urine 
Ethical Advisory Committee 
PART 1                  Monday, 31st January – Friday 4th 
February 2011 
 
Invitation to participant  
We would like to invite you to take part in a research study. Before you decide you need to 
understand why the research is being done and what it would involve for you. Please take 
time to read the following information carefully. Talk to others about the study if you wish. 
This part (Part 1) tells you the purpose of this study and what will happen to you if you take 
part. Part 2 gives you more detailed information about the conduct of the study. 
Please ask us if there is anything that is not clear, or if you would like more information. 
Please take time to decide whether or not you wish to take part.  
 
What is the purpose of this study? 
This study is investigating the effect of exercise on physiological functions combined with 
the chemical profile of the body. We are testing new methods of detecting changes in the 
human body by monitoring tiny amounts of chemical substances in saliva, breath, urine, 
blood and on the skin. These substances arise from all the processes and reactions that 
occur in the body and we think that analysis of these compounds may be able to give us 
information about health and well-being of individuals. In this study we aim to determine 
chemical markers for physical stress by taking measurements before and after a series of 
tests. 
 
Why have I been invited to participate? 
You have been invited because you are a healthy, non-smoking adult between the ages of 18 
and 35. 
 
Do I have to take part? 
It is up to you to decide. 
We will describe the study and go through this information sheet, which we will then give to 
you. You will have the opportunity to ask questions of the researchers and will be given time 
to consider whether you wish to participate. We will then ask you to sign a consent form to 
show you have agreed to take part. You are free to withdraw at any time, and you do not 
have to give us a reason. 
 
What will happen to me if I take part? 
If you agree to take part we will arrange for you to visit our laboratory for a single visit 
lasting approximately 3 hours. During this visit we will first ask you a series of questions 
relating to factors that can influence the chemical substances we are interested in.  
Please see the brief information sheet for further detail. 
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At the beginning of the visit you will be asked to provide a urine sample and both your 
weight and height measurements will be taken. You will be asked to wear a heart monitor 
on your chest, and a skin conductivity meter on your upper left arm, throughout the session. 
Also, please be aware that you will be required to drink a small amount of water at pre-
determined points during your visit. 
 
There will be four 30 minute periods of sampling. The first, third and fourth period will be 
very similar in sampling whilst sitting on a chair within the chamber whereas in the second 
period, you will be asked to exercise on a cyclometer. 
 
In the non-exercise periods the following samples will be taken; 
Urine 
2 x sweat samples by placing patches onto your forehead 
Skin tremor 
15ml of blood taken via a butterfly cannula from your left arm 
Saliva (drool) 
Saliva – PDMS rod 
Breath 
Breath (BioVoc) DMS – Only the third and fourth period 
During the exercise period the following samples will be taken; 
2 x sweat samples by placing patches onto your forehead 
Breath (BioVoc) DMS – Only the third and fourth period  
 
You will then have the option to take shower and if you want a shower – towel will be 
provided. After your shower you will be asked to complete a final questionnaire (very quick) 
and you will be provided with snacks and a sports drink (Powerade). Any questions you may 
have will be answered and you will then be free to leave the laboratory area /building. 
*Please note that a new puncture will be made to your left arm for every blood sample 
taken. However, in some cases it may be appropriate to take blood out of the right arm. 
 
What will I have to do? 
You will have to refrain from smoking, eating, brushing your teeth, using mouthwash, taking 
throat lozenges or chewing gum etc. or drinking anything other than unflavoured water for 
60 minutes prior to the study visit. 
We also ask you not to swim, shower, use perfumed products (which include not only 
perfume, but also deodorants, after-shaves), any facial products (such as make-up or creams 
(scented or unscented) or wash your hair on the morning of your visit. You may shower the 
evening before. 
It is important that you do not drink alcohol the night before your visit. 
Please wear comfortable clothing (e.g. shorts and t-shirt) and appropriate footwear as you 
will be conducting part of the experiment on a cyclometer. 
 
What are the possible disadvantages and risks of taking part? 
We do not anticipant any risk from taking part in this study. New and sterile needles and 
cannulas will be used for every sample of blood that is taken. 
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There is some mild discomfort in providing a blood sample and a risk of bruising is always 
associated with giving a blood sample. 
Following the experiment, you may feel a little fatigued. This is nothing to worry about as 
you should re-energise upon consuming some of the energy snacks /drinks. 
 
What are the possible benefits of taking part? 
There will be no direct benefits to you from taking part in this research. You will however 
receive information regarding your height and weight as well as your blood pressure and 
heart rate upon request. 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any possible 
harm you might suffer will be addressed. You may withdraw from the study at any time; 
either before or during the study. The detailed information on this is given in Part 2. 
 
If the information in Part 1 has interested you and you are considering participation, 
please read the additional information in Part 2 before making any decision. 
 
PART 2 
 
What will happen if I don’t want to carry on with the study? 
You are under no obligation to participate in this study and you may withdraw from the 
study at any stage with no adverse consequences. 
We will ensure that you are able to stop the sampling procedure at any time quickly and 
easily should you want to. 
 
What is there is a problem? 
If you have any concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions (contact number 01509 222 549 
– Prof. Paul Thomas). You may ask a researcher to clarify anything about the study at any 
time, both before and during sampling. If you remain unhappy and wish to complain 
formally, you can do this through the Loughborough University Complaints Procedure. 
Details can be obtained from the University. 
In the event that something does go wrong and you are harmed during the research due to 
someone’s negligence, then you may have ground for a legal action for compensation 
against Loughborough University but you may have to pay your legal costs. 
 
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of research will be kept 
strictly confidential, and any information about you which leaves the Laboratory will have 
your name and address removed so that you cannot be recognised. All information will be 
treated in accordance to with the Data Protection Act 1998. 
 
What will happen to the samples I give? 
Two sets of skin samples are collected. The first set of skin samples are collected on inert 
strips which are placed directly into small tubes when removed from the skin; these are then 
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sealed and will be processed at the Department of Chemistry at Loughborough University. 
The second set of skin samples will be collected on cotton pads which are placed directly 
into polypropylene tubes when collected; these are then sealed and will be processed at the 
Department of Chemistry at Loughborough University. 
 
The components are collected from exhaled breath onto adsorbent tubes which are sealed 
and will be processed at the Department of Chemistry at Loughborough University. 
Blood, urine and saliva samples will be divided into aliquots in smaller vials, to be stored at -
80ºC, and identified only with a code. Your name and personal details will be in no way 
associated with the physical samples. 
 
Data from the heart rate monitor and blood pressure cuff will be processed at the 
Department of Chemistry at Loughborough University, using only your experiment identifier. 
Skin conductivity and skin tremor data will be processed at Unilever Research, Port Sunlight, 
Merseyside. Please note that nothing more than a created participant identification number 
will be used and Unilever will not receive any personal information of yours. 
All samples processed at the Department of Chemistry at Loughborough University will be 
destroyed in an appropriate manner, which is approved by ethics. 
 
Your name will be removed, and the samples identified only with a code. No genetic testing 
with be performed on any of your samples. 
 
What will happen to the results of the research study? 
It is intended to publish the results of this study in a scientific journal. Data generated will be 
kept at the Department of Chemistry at Loughborough University. Your name and address 
will not be kept with the data although a record of your participation will be maintained by 
the principle investigator. This information will be kept in a separate locked drawer. 
The measurement data will only be made available to people who are directly involved with 
the study. 
 
Who is organising and funding the research? 
The study is collaboration between the Department of Chemistry and the School of Sport, 
Exercise and Health Science at Loughborough University. 
 
Who has reviewed the study? 
This study has been reviewed and has been given a favourable opinion by Loughborough 
University Ethics Committee to protect your safety, rights, wellbeing and dignity. 
 
Who should I contact for further information? 
Prof. C. L. Paul Thomas 
Professor of Analytical Science 
Centre for Analytical Sciences, Department of Chemistry, Loughborough University 
LE11 3TU, Tel: 01509 222 549 
Thank you for taking time to read this information sheet and considering helping us with our 
research. Please retain a copy for your reference.  
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Chapter 5 Non-invasive fast skin profiling for elements from the volar and plantar 
and 5.7.Non-invasive fast skin profiling for elements from the axilla, dorsal, plantar 
and volar 
What is the purpose of the study? 
The researchers intend to test the effectiveness of a new, non-invasive skin odour sampling 
device called the Liquid Skin Pen (see Figure 1, overleaf). This is a hand-held device that uses 
a gentle flow of ethanol and water to sample the range of chemical compounds that are 
present on, and evaporate from, human skin. The researchers intend to use the Liquid Skin 
Pen to study the range of chemicals released from healthy human skin. 
 
Normal metabolic processes result in the release, via the skin surface, of a wide range of 
chemical compounds, a large proportion of which are classed as volatile organic compounds 
(VOCs). These compounds may be derived directly from the diet, or they may be formed 
during the day-to-day functioning of individual bodily organs. A number of these chemicals 
contribute to the characteristic odour of the human body. 
 
It is known that this chemical profile is dynamic – an individual’s profile (and hence odour) 
fluctuates according to diet, alteration in skin microbial populations, and time of year. Of 
greatest interest, though, is the fact that some internal metabolic conditions also induce 
changes in the nature of this chemical profile. Once we understand the nature of a healthy, 
normal human skin chemical profile, we can begin to look for chemical indicators of 
metabolic change.  
 
For this study, the researchers are looking at how effectively the Liquid Skin Pen samples the 
odour of healthy human skin. 
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Figure 8.3. Schematic of the Liquid Skin Pen 
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Who is doing this research and why? 
This study is sponsored by Unilever. The project leader is Professor Paul Thomas, of 
Loughborough University’s Centre for Analytical Science. The researchers intend to test the 
effectiveness of a new, non-invasive skin odour sampling device called the Liquid Skin Pen. 
Are there any exclusion criteria? 
We require healthy male participants between the ages of 18 and 65. Participants with 
sensitive skin will be excluded. 
Once I take part, can I change my mind? 
Yes, of course.  After you have read this information, and asked any questions you may have, 
we will ask you to complete an Informed Consent Form. However, if at any time before, 
during or after the sessions you wish to withdraw from the study, please contact the main 
investigator, Professor Thomas. You can withdraw at any time, for any reason, and you will 
not be asked to explain your reasons for withdrawing. 
Will I be required to attend any sessions and where will these be? 
You will be asked to come to Room F2.08 in the Department of Chemistry at Loughborough 
University.  
How long will it take? 
The entire procedure should be completed within 2 hours. 
Is there anything I need to do before the sessions? 
We would require you to fast from midnight on the night before the session. Water, 
however, will be allowed. 
What will I be asked to do? 
At the familiarisation session 
You will come to Room F2.08, and we will show you around the laboratory. You will have the 
opportunity to see the Skin Pen and meet the researchers involved in the study. Please feel 
free to contact Professor Thomas or Dr Burns if you have any questions after the 
familiarisation session. 
You will be asked to fast overnight. Water, however, will be allowed.  
At the testing session 
The following morning in Room F2.08, at the beginning of the proceedings, you will be asked 
to complete a Health Screen Questionnaire and to sign a Consent Form.   
 
We will then wash your skin with distilled water, and dry the skin using cotton wool. The 
exact region of your skin to be sampled will be discussed and agreed with you beforehand; 
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typical regions for sampling would include the underarm, forearm and back. You will then be 
asked to return to the laboratory in two hours, at which point sampling will begin. 
 
Each skin surface will be sampled for 5 minutes. We will map the odour of the body by 
taking samples from several surfaces. The total sampling time will amount to no more than 
75 minutes.  
What personal information will be required from me? 
We will take your name, age and contact details. Participants will be required to complete a 
Health Screen Questionnaire.  
Are there any risks in participating? 
We do not anticipate any risks associated with participating in this study.  
Will my taking part in this study be kept confidential? 
Absolutely. Although we will record your name, age and contact details, these will be stored 
in a secure place to which only the researchers involved in the study will have access. You 
will be assigned a Participant Identifier code, and this code will be used instead of your name 
to identify the samples during analysis and processing.  
What will happen to the results of the study? 
The researchers will input the results into a database, which will describe the compounds 
detected from samples of healthy human skin. At some stage, the researchers may publish 
the results of the study, but be assured that your name will not be included in any 
publication.  
What do I get for participating? 
Your contribution to this research may ultimately help clinicians diagnose, in a non-invasive 
way, the earliest stages of metabolic change - potentially saving lives in the future.  
I have some more questions. Who should I contact? 
Please contact Professor Paul Thomas on 01509 222549, (C.L.P.Thomas@lboro.ac.uk), or Dr 
Corrinne Burns, on 01509 222590 (C.Burns@lboro.ac.uk)  
What if I am not happy with how the research was conducted? 
The University has a policy relating to Research Misconduct and Whistle Blowing which is 
available online at 
http://www.lboro.ac.uk/admin/committees/ethical/Whistleblowing(2).htm.  Please ensure 
that this link is included on the Participant Information Sheet. 
Main Investigator: 
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Professor Paul Thomas, Centre for Analytical Science, Department of Chemistry, 
Loughborough University, Leicestershire LE11 3TU. Telephone: 01509 222549 
Additional Investigators: 
Professor Colin Creaser, Centre for Analytical Science, Department of Chemistry, 
Loughborough University, Leicestershire LE11 3TU 
Helen Martin, Doctoral Student, Centre for Analytical Science, Department of Chemistry, 
Loughborough University, Leicestershire LE11 3TU 
Pareen Patel, Doctoral Student, Centre for Analytical Science, Department of Chemistry, 
Loughborough University, Leicestershire LE11 3TU 
Dr Corrinne Burns, Centre for Analytical Science, Department of Chemistry, Loughborough 
University, Leicestershire LE11 3TU. Telephone: 01509 222590  
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Chapter 5 Section 5.8 Non-invasive fast profiling of the dorsal and plantar for semi-
volatile organic compounds and non-volatile organic compounds 
What is the purpose of the study? 
The researchers intend to test the effectiveness of a new, non-invasive skin odour sampling 
device called the Liquid Skin Pen (see Figure 1, overleaf). This is a hand-held device that uses 
a gentle flow of ethanol and water to sample the range of chemical compounds that are 
present on, and evaporate from, human skin. The researchers intend to use the Liquid Skin 
Pen to study the range of chemicals released from healthy human skin. 
Normal metabolic processes result in the release, via the skin surface, of a wide range of 
chemical compounds, a large proportion of which are classed as volatile organic compounds 
(VOCs). These compounds may be derived directly from the diet, or they may be formed 
during the day-to-day functioning of individual bodily organs. A number of these chemicals 
contribute to the characteristic odour of the human body. 
It is known that this chemical profile is dynamic – an individual’s profile (and hence odour) 
fluctuates according to diet, alteration in skin microbial populations, and time of year. Of 
greatest interest, though, is the fact that some internal metabolic conditions also induce 
changes in the nature of this chemical profile. Once we understand the nature of a healthy, 
normal human skin chemical profile, we can begin to look for chemical indicators of 
metabolic change.  
For this study, the researchers are looking at how effectively the Liquid Skin Pen samples the 
odour of healthy human skin. 
 
 
Figure 1. Skin sampling using the liquid skin pen 
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Figure 2. The liquid skin pen 
(above) and the sampling base 
(below) 
 
Who is doing this research and why? 
This study is sponsored by Unilever. The project leader is Professor Paul Thomas, of 
Loughborough University’s Centre for Analytical Science. The researchers intend to test the 
effectiveness of a new, non-invasive skin odour sampling device called the Liquid Skin Pen. 
Are there any exclusion criteria? 
We require healthy male and female participants between the ages of 18 and 65. 
Participants with sensitive skin will be excluded. 
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Once I take part, can I change my mind? 
Yes, of course.  After you have read this information, and asked any questions you may have, 
we will ask you to complete an Informed Consent Form. However, if at any time before, 
during or after the sessions you wish to withdraw from the study, please contact the main 
investigator, Professor Thomas. You can withdraw at any time, for any reason, and you will 
not be asked to explain your reasons for withdrawing. 
Will I be required to attend any sessions and where will these be? 
You will be asked to come to Room F2.08 in the Department of Chemistry at Loughborough 
University for 1 sampling session.  
How long will it take? 
The entire procedure should be completed within 1 hour. 
Is there anything I need to do before the sessions? 
You are asked to cover your feet (including during sleeping hours) for two days before the 
trial. Socks and soap (please do not use any other soap or shampoo during this time) will be 
provided. 
What will I be asked to do? 
You will be asked to fast overnight. Water, however, will be allowed.  
At the testing session 
The following morning in Room F2.08, at the beginning of the proceedings, you will be asked 
to complete a Health Screen Questionnaire and to sign a Consent Form.   
 
We will then wash your skin with distilled water, and dry the skin using cotton wool. The 
exact region of your skin to be sampled will be discussed and agreed with you beforehand; 
typical regions for sampling would include the top and bottom of one foot. Sampling will 
then commence. 
 
Each skin surface will be sampled for approximately 5 minutes. We will map the odour of the 
feet by taking samples from the top and the base. The total sampling time will amount to no 
more than 10 minutes.  
What personal information will be required from me? 
We will take your name, age and contact details. Participants will be required to complete a 
Health Screen Questionnaire.  
Are there any risks in participating? 
We do not anticipate any risks associated with participating in this study.  
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Will my taking part in this study be kept confidential? 
Absolutely. Although we will record your name, age and contact details, these will be stored 
in a secure place to which only the researchers involved in the study will have access. You 
will be assigned a Participant Identifier code, and this code will be used instead of your name 
to identify the samples during analysis and processing.  
What will happen to the results of the study? 
The researchers will input the results into a database, which will describe the compounds 
detected from samples of healthy human skin. At some stage, the researchers may publish 
the results of the study, but be assured that your name will not be included in any 
publication.  
What do I get for participating? 
Your contribution to this research may ultimately help clinicians diagnose, in a non-invasive 
way, the earliest stages of metabolic change - potentially saving lives in the future.  
I have some more questions. Who should I contact? 
Please contact Professor Paul Thomas on 01509 222549, (C.L.P.Thomas@lboro.ac.uk), or 
Pareen Patel, on 01509 222556 (P.Patel@lboro.ac.uk)  
What if I am not happy with how the research was conducted? 
The University has a policy relating to Research Misconduct and Whistle Blowing which is 
available online at 
http://www.lboro.ac.uk/admin/committees/ethical/Whistleblowing(2).htm.   
Main Investigator: 
Professor Paul Thomas, Centre for Analytical Science, Department of Chemistry, 
Loughborough University, Leicestershire LE11 3TU. Telephone: 01509 222549 
Additional Investigators: 
Professor Colin Creaser, Centre for Analytical Science, Department of Chemistry, 
Loughborough University, Leicestershire LE11 3TU 
Dr James Reynolds, Centre for Analytical Science, Department of Chemistry, Loughborough 
University, Leicestershire LE11 3TU 
Pareen Patel, Doctoral Student, Centre for Analytical Science, Department of Chemistry, 
Loughborough University, Leicestershire LE11 3TU 
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PASAT Instruction 
The participants are given these standardised instructions: 
On the tape you will hear a series of numbers, you must add the most recent numbers 
together and say the answers out loud, for example if you hear 4.......6....... you say 10. You 
then must remember the second number, in this case 6, and add it to the next number you 
hear. 
It is important that you speak clearly and answer a quickly as possible, this is a performance 
test and you will be marked against other participants. 
There will be a live video feed of your face played on the screen in front of you, you will be 
asked to look at this at all times during the PASAT.  
We will take your blood pressure 4 times during the test but will be unable to warn you as it 
will interfere with the test so do not be alarmed if you feel the blood pressure cuff tightening. 
If you feel more uncomfortable than during the previous blood pressure measurements 
please let us know. 
The test will begin with a 30 second practice clip and then we will move onto the live test. 
Do you have any questions before we begin? 
The participant is given the practice test then given another chance to ask questions before 
the live test begins. 
During the live test wrong answers are indicated by a loud blast on a horn, this often 
overlaps with the next number causing more errors – this is designed to frustrate and 
disorientate the participant. On the answer sheet you will observe series of boxes 
highlighted in grey, during these times the horn will be sounded for a correct answer as well.  
The boxes shaded in black on the answer sheet indicate the point at which blood pressure 
readings are started. 
During the study visit the participant completes a set of cognitive function tests, then the 
PASAT (or placebo) then the same cognitive function tests again. The sensewearTM was 
applied to the underside of the upper arm when the participants arrived. The time stamp 
was pressed at the start of each cognitive battery and at the start of the PASAT (or placebo). 
Attached is a log of the sensewearTM usage. It is important to note that many participants 
found the final cognitive function test (~9min after the start of the cognitive battery) difficult 
and many said they found it stressful. 
The placebo condition was designed to last the same time as the PASAT practise and live test 
combined. It is a continuous track of music designed to be relaxing, participants were only 
monitored by their blood pressure at the same time intervals as for the PASAT, other than 
that they were encouraged to sit comfortably and relax, windows media player visual effects 
were on the screen in front of them but they were not encouraged or discouraged from 
watching them. 
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Figure 8.4. PASAT answer sheet 
Date:
4 Answer 6 8 9 18 2 3
6 10 6 12 3 12 9 11
3 9 2 8 8 11 2 11
1 4 4 6 1 9 9 11
7 8 6 10 3 4 1 10
3 10 3 9 2 5 2 3
3 6 3 6 5 7 4 6
2 5 5 8 3 8 5 9
2 4 1 6 5 8 4 9
4 6 5 6 7 12 7 11
4 8 8 13 4 11 9 16
9 13 5 13 6 10 8 17
5 14 9 14 6 12 3 11
7 12 4 13 4 10 6 9
1 8 8 12 8 12 2 8
8 9 9 17 5 13 1 3
8 16 7 16 7 12 6 7
6 14 7 14 8 15 1 7
9 15 3 10 3 11 3 4
5 14 4 7 9 12 6 9
5 10 8 12 6 15 7 13
4 9 3 11 6 12 4 11
5 9 1 4 1 7 2 6
6 11 8 9 4 5 9 11
7 13 6 14 3 7 8 17
3 10 7 13 7 10 4 12
3 6 8 15 9 16 7 11
6 9 8 16 9 18 2 9
8 14 3 11 3 12 3 5
9 17 7 10 5 8 7 10
1 10 7 14 2 7 3 10
5 6 9 16 2 4 7 10
3 8 5 14 3 5 8 15
7 10 4 9 7 10 8 16
2 9 1 5 4 11 2 10
9 11 1 2 8 12 2 4
2 11 6 7 1 9 3 5
8 10 2 8 8 9 6 9
1 9 4 6 8 16 5 11
9 10 2 6 5 13 4 9
8 17 5 7 6 11 1 5
7 15 4 9 7 13 2 3
1 8 3 7 2 9 5 7
6 7 6 9 4 6 5 10
4 10 7 13 3 7 2 7
2 6 8 15 7 10 9 11
4 6 2 10 3 10 7 16
1 5 3 5 7 10 7 14
7 8 6 9 8 15 2 9
1 8 1 7 3 11 7
9 10 5 6 4 7
2 11 8 13 5 9 Total
2 4 9 17 1 6 10min
Participant Code:
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Health Screen Questionnaire for study volunteers 
Participant identifier: ..................................................... 
Trial Supervisor 
Prof. Paul Thomas, Professor Analytical Science, Department of Chemistry, Loughborough 
University, LE11 3TU 
Tel. 0150 922 2549 
Before participating in our study we would like you to complete this health screen 
questionnaire, you are not obligated to answer any of the questions if you feel 
uncomfortable about doing so. 
Please circle the appropriate response.  
Do you have any current mouth sores, dental problems, gingivitis or 
gum disease? 
Yes No 
Do you have any specific dietary preferences? (e.g., vegan, 
vegetarian) 
Yes No 
Do you have any chest or breathing problems? Yes No 
Are you taking or using any medicines, pills, tablets, ointments, 
injections or any other drug, either from your doctor or on your own 
accord (except contraception) 
Yes No 
Have you ever suffered from any of the following:   
Heart or blood pressure problems? Yes No 
Convulsions or epilepsy? Yes No  
Asthma? Yes No 
Eczema? Yes No 
Disturbance of vision? Yes No 
Ear or hearing problems? Yes No 
Diabetes? Yes No 
Blood disorders? Yes No 
Head injury? Yes No 
Kidney or liver problems? Yes No 
If you answered ‘Yes’ to any of the above could you please provide further information : 
..................................................................................................................................................... 
Do you have any allergies that you are aware of?                                 Yes           No 
If YES please provide details here: (include allergies to food, medicines and plasters)           
..................................................................................................................................................... 
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Is there anything else relating to your health that you feel we should be aware of? 
..................................................................................................................................................... 
Has any otherwise healthy member of your family under the age of 25 died suddenly during 
or soon after exercise?     Yes     No 
If YES please describe the circumstances briefly if you feel able 
..................................................................................................................................................... 
Please provide contact details of a suitable person for us to contact in the event of any 
incident or emergency. 
Name:..........................................................................................................................................
....... 
Telephone 
Number:............................................................................................................................ 
Relationship to 
Participant…………….................................................................................................... 
Are you currently involved in any other studies at the University?  Yes          No 
If yes please provide details of the study 
.....................................................................................................................................................
....... 
Please inform us of any changes in the above before the study starts. 
To the best of my knowledge this information is correct.  I confirm that I have read and 
understood the information sheet for the above study and have had the opportunity to ask 
questions.  
 
PLEASE SIGN HERE........................................................................................................ 
Date........................................... 
Many thanks for your help.  
 Private and Confidential 
Subject to contract 
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Appendix VI Patent 
Schedule 1 
 
Details of Invention 
 
 
Intellectual property as identified within the patent application generated from the 
research undertaken under the Sponsored Research Agreement - University Ref: 
J12552; Unilever UK Central Resources Ltd Ref: PS-2010-0126 for the project 
entitled “Skin Pen Development” during the period 2010 – 2011.  
(Please note, the results of this collaboration belong to Unilever.) 
 
Title and Abstract of Patent: Skin Surface Sampling System 
 
“The present invention provides a skin surface sampling device in which a supply tube and a 
recovery tube are housed in an elongated hand-holdable tubular sleeve, the sleeve having 
upper and lower ends positioned along a longitudinal axis and the lower end being provided 
with a sampling head; 
in which: 
the supply tube is adapted to convey liquid from a liquid source to the sampling head; 
the recovery tube is adapted to convey liquid from the sampling head to a liquid collection 
vessel; 
the sampling head has a planar surface adapted for application to the surface of the skin to 
form a contact 
therewith during sampling; 
the planar surface has a liquid entry port adapted for liquid communication with the supply 
tube and a liquid 
exit port adapted for liquid communication with the recovery tube; 
and characterised in that: 
the liquid entry port and the liquid exit port are connected via a guide channel which is 
adapted to 
guide liquid from the liquid entry port, along the surface of the skin for the elution of materials 
on the skin 
surface, and then to the liquid exit port for recovery. 
 
The device can be used in a rapid and non-invasive system of skin surface sampling, 
enabling the sampling of a wide range of compounds (including but not limited to VOCs and 
SVOCs) from the surface of the skin, and which can be used over all areas of the body.” 
 
 
Inventors:     Corrinne Burns      (University) 
        Peter David Carroll     (Company) 
        Pareenkumar Patel     (University) 
        Svetlana Riazanskaia    (Company) 
        Charles Laurence Paul Thomas (University) 
 
Applicant:      Unilever Plc 
        Unilever House, 100 Victoria Embankment, London,  
        EC4Y 0DY, UK 
 
Filing Date:  10 May 2012 
 
Application Number: EP12167428 
 
Unilever Plc Case No.: T3269(C) 
 
LU Technology ID No:  714 
 Ag 7d Lo (Univ/UKCR partial rights) 
208 
 
SCHEDULE 
 
Intellectual property as identified within the patent application generated from the research 
undertaken under the Sponsored Research Agreement - University Ref: J12552 (Tech ID No. 
714); Company Ref: PS-2010-0126 for the project entitled “Skin Pen Development” during the 
period 2010 – 2011. 
 
(Please note, the results of this collaboration belong to Unilever.) 
 
 
PATENT APPLICATION: 
 
Title of Invention:   Skin Surface Sampling System 
 
Application Number:  EP12167428 
 
Filing Date:     10 May 2012 
 
Inventors:     Corrinne Burns       (University) 
        Peter David Carroll      (Company) 
        Pareenkumar Patel     (University) 
        Svetlana Riazanskaia     (Company) 
        Charles Laurence Paul Thomas  (University) 
 
Applicant:      Unilever Plc 
        Unilever House, 100 Victoria Embankment, London, EC4Y 0DY, UK 
 
Case No.:      T3269(C) 
 
 
EP Abstract  
 
 
“The present invention provides a skin surface sampling device in which a supply tube and a 
recovery tube are housed in an elongated hand-holdable tubular sleeve, the sleeve having 
upper and lower ends positioned along a longitudinal axis and the lower end being provided 
with a sampling head; 
in which: 
the supply tube is adapted to convey liquid from a liquid source to the sampling head; 
the recovery tube is adapted to convey liquid from the sampling head to a liquid collection 
vessel; 
the sampling head has a planar surface adapted for application to the surface of the skin to 
form a contact 
therewith during sampling; 
the planar surface has a liquid entry port adapted for liquid communication with the supply 
tube and a liquid 
exit port adapted for liquid communication with the recovery tube; 
and characterised in that: 
the liquid entry port and the liquid exit port are connected via a guide channel which is 
adapted to 
guide liquid from the liquid entry port, along the surface of the skin for the elution of materials 
on the skin 
surface, and then to the liquid exit port for recovery. 
 
The device can be used in a rapid and non-invasive system of skin surface sampling, 
enabling the sampling of a wide range of compounds (including but not limited to VOCs and 
SVOCs) from the surface of the skin, and which can be used over all areas of the body.” 
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1 Statistical Analysis 
Analytical methods should be free from systematic error meaning the value given for the 
amount of analyte should be the true value. However, even if no systematic errors are 
present, random errors make it unlikely that the achieved value would exactly equal to a 
reference amount (a standard or experimental value). In order to determine whether these 
differences can be attributed to random variations, a significant test can be employed. 
Significance tests are testing the truth of a hypothesis which is known as the null hypothesis 
(H0). The term null implied there is no difference between the observed and known (or 
second experimental) values other than that which can be attributed to random variation. 
Assuming H0 is true, statistical theory can be utilized to calculate the probability that the 
differences between the observed and known values are due to random errors. The lower 
the probability that the differences occur by chance the less likely H0 is true. 
1.1.1.1 Comparison of experimental means (t-test) 
One method to employ significance tests is to compare an obtained value with a second 
value obtained from a different method (i.e. second sample site) with the test containing 
two experimental means     and    . To test whether the two methods give the same result, 
i.e.  :    =     a test whether (    -    ) differs significantly from zero, the statistical t is 
calculated. If the two samples have standard deviations which are not significantly different, 
a pooled estimate (s) of the standard deviation can be calculated from the two individual 
standard deviations    and   . 
  
(         
 √
 
  
  
 
  
  (Equation SI.2.1) 
where s is calculated from 
   
(       
  (       
 
(        
 
 
Where n = number of samples and t has         degrees of freedom. This method 
assumes that the samples are drawn from populations with equal standard deviations. If 
standard deviations are likely to be equal than it is no longer suitable to use a pooled 
standard deviation and a different method giving an overall estimate of the standard 
deviation should be employed (Equation SI.2.2). 
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With degrees of freedom (df) 
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With the value obtained being truncated to an integer. 
 
1.1.1.2 Comparison of standard deviation (F-test) 
As well as comparing the systematic errors of two means it is also important to compare the 
random errors by comparing the standard deviations of two sets of data i.e. to test whether 
Method A and Method B differ in their precision. To test whether the difference between 
two sample variances is significant, i.e. to test     
     
 , the statistic F is calculated: 
  
  
 
   
 
(Equation SI.2.3) 
where 1 and 2 are allocated in the equation so that F is always ≥ 1. Degrees of free of the 
numerator and denominator are      and     , respectively. 
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1.1.1.3 Analysis of Variance 
Often more than two means need to be compared e.g. comparing the mean results obtained 
of analyte concentration from several different target sites, where there are two possible 
sources of variation. The first is random error and the second possible source of variation is 
due to controlled (fixed-effect) factor such as the target site used. Analysis of variation 
(ANOVA) can be used to separate and estimate the different causes of variation. It can be 
used to separate any variation which is caused by changing the controlled factor from the 
variation due to random error thus used to test whether significant differences between 
mean values obtained result from altering the controlled factor. 
When two factors can affect the experimental result, their effect must be studied by 
employing two way ANOVA (Table SI.1.1). Each of the N measurements, XiJ, is classified 
under treatment levels (c) and blocks (r), so N = cr. The row totals (T1., T2., etc.) and column 
totals (T.1, T.2, etc.), and the grand total, T, are given and used in the calculation. 
Table SI.1.1. Formulae for two-way ANOVA 
Source of variation Sum of squares Degrees of freedom 
Between-treatment 
Between-block 
Residual 
Σ   
         
Σ   
        By subtraction 
c – 1 
r – 1 
by subtraction 
Total ΣΣ   
       N -1  
where N  = nh = total number of measurements 
 Ti = sum of all measurements in the ith sample 
 T  = sum of all the measurements, grand total. 
The test statistic is 
   
                         
                        
 (Eq. 2.4) 
And the critical value is Fh-1,N-h. 
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2 A study into the effect of psychological stress on the elemental content of human forehead sweat as 
measured by ICP-MS 
Table SI.2.1. Participant information summary for the elemental profiling of sweat, by ICP-MS, obtained from psychological stress 
Participant 
Visit 1 Visit 2 
Gender 
No. of 
samples 
Sample 
Storage Sample 
Date 
Sample 
ID 
Sample 
Day 
Sample 
Time 
Intervention 
Sample 
Date 
ID 
Sample 
Day 
Sample 
Time 
Intervention 
1 10/02/2010 TE03 P 1 0900-1100 PASAT 23/03/2010 TE03 O 29 0900-1100 Placebo Male 4 2% HNO3 at RT 
2 11/02/2010 TE04 O 2 0900-1100 Placebo 25/03/2010 TE04 P 31 0900-1100 PASAT Female 4 2% HNO3 at RT 
3 12/02/2010 TE05 P 3 0900-1100 PASAT 22/03/2010 TE05 O 28 0900-1100 Placebo Male 4 2% HNO3 at RT 
4 15/02/2010 TE06 O 4 0900-1100 Placebo 23/03/2010 TE06 P 29 1100-1300 PASAT Male 4 2% HNO3 at RT 
5 15/02/2010 TE07 P 4 1100-1300 PASAT 08/03/2010 TE07 O 17 1100-1300 Placebo Male 4 2% HNO3 at RT 
6 16/02/2010 TE08 O 5 0900-1100 Placebo 02/03/2010 TE08 P 14 0900-1100 PASAT Female 4 2% HNO3 at RT 
7 17/02/2010 TE09 P 6 0900-1100 PASAT 24/02/2010 TE09 O 11 0900-1100 Placebo Female 4 2% HNO3 at RT 
8 16/02/2010 TE10 O 5 1100-1300 Placebo 23/02/2010 TE10 P 10 1100-1300 PASAT Male 4 2% HNO3 at RT 
9 18/02/2010 TE11 P 7 0900-1100 PASAT 25/02/2010 TE11 O 12 1100-1300 Placebo Female 4 2% HNO3 at RT 
23 19/02/2010 TE12 O 8 0900-1100 Placebo No sample obtained as participant did not take part Male 2 2% HNO3 at RT 
10 22/02/2010 TE13 P 9 1100-1300 PASAT 01/03/2010 TE13 O 13 0900-1100 Placebo Male 4 2% HNO3 at RT 
11 22/02/2010 TE14 O 9 0900-1100 Placebo 09/03/2010 TE14 P 19 1100-1300 PASAT Male 4 2% HNO3 at RT 
12 23/02/2010 TE15 P 10 0900-1100 PASAT 02/03/2010 TE15 O 14 1100-1300 Placebo Female 4 2% HNO3 at RT 
13 25/02/2010 TE16 O 12 0900-1100 Placebo 12/03/2010 TE16 P 22 0900-1100 PASAT Female 4 2% HNO3 at RT 
14 03/03/2010 TE17 P 15 0900-1100 PASAT 10/03/2010 TE17 O 20 0900-1100 Placebo Male 4 2% HNO3 at RT 
15 03/03/2010 TE18 O 15 1100-1300 Placebo 10/03/2010 TE18 P 20 1100-1300 PASAT Female 4 2% HNO3 at RT 
16 05/03/2010 TE19 P 16 0900-1100 PASAT 16/03/2010 TE19 O 24 1100-1300 Placebo Male 4 2% HNO3 at RT 
17 09/03/2010 TE20 O 18 0900-1100 Placebo 16/03/2010 TE20 P 24 0900-1100 PASAT Female 4 2% HNO3 at RT 
18 24/03/2010 TE21 P 30 0900-1100 PASAT 26/03/2010 TE21 O 32 0900-1100 Placebo Female 4 2% HNO3 at RT 
19 11/03/2010 TE22 O 21 0900-1100 Placebo 18/03/2010 TE22 P 26 0900-1100 PASAT Female 4 2% HNO3 at RT 
20 12/03/2010 TE23 P 22 1100-1300 PASAT 24/03/2010 TE23 O 30 1100-1300 Placebo Female 4 2% HNO3 at RT 
21 15/03/2010 TE24 O 23 0900-1100 Placebo 17/03/2010 TE24 P 25 1100-1300 PASAT Female 4 2% HNO3 at RT 
24 15/03/2010 TE25 P 23 1100-1300 PASAT No sample obtained as participant did not take part Male 2 2% HNO3 at RT 
22 19/03/2010 TE26 O 27 1100-1300 Placebo 22/03/2010 TE26 P 28 1100-1300 PASAT Male 4 2% HNO3 at RT 
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Table SI.2.2. Skin sample information summary for the elemental profiling of sweat, by ICP-MS, obtained from 
psychological stress 
Sample ID 
Sample 
Date 
Time to collect sample 
(min) 
Analysis 
Date 
Analysis 
order 
No. of days in 
storage 
Patch Blank 1 15/06/2010 30 15/06/2010 1 0 
Patch Blank 2 15/06/2010 30 15/06/2010 2 0 
Patch Blank 3 15/06/2010 30 15/06/2010 3 0 
E3 O1 23/03/2010 30 15/06/2010 4 84 
E3 O2 23/03/2010 30 15/06/2010 5 84 
E3 P1 10/02/2010 30 15/06/2010 6 125 
E3 P2 10/02/2010 30 15/06/2010 7 125 
E4 O1 11/02/2010 30 15/06/2010 8 124 
E4 O2 11/02/2010 30 15/06/2010 9 124 
E4 P1 25/03/2010 30 15/06/2010 10 82 
E4 P2 25/03/2010 30 15/06/2010 11 82 
E5 O1 22/03/2010 30 15/06/2010 12 85 
E5 O2 22/03/2010 30 15/06/2010 13 85 
E5 P1 12/02/2010 30 15/06/2010 14 123 
E5 P2 12/02/2010 30 15/06/2010 15 123 
E6 O1 15/02/2010 30 15/06/2010 16 120 
E6 O2 15/02/2010 30 15/06/2010 17 120 
E6 P1 23/03/2010 30 15/06/2010 18 84 
E6 P2 23/03/2010 30 15/06/2010 19 84 
E7 O1 08/03/2010 30 15/06/2010 20 99 
E7 O2 08/03/2010 30 15/06/2010 21 99 
E7 P1 15/02/2010 30 15/06/2010 22 120 
E7 P2 15/02/2010 30 15/06/2010 23 120 
E8 O1 16/02/2010 30 15/06/2010 24 119 
E8 O2 16/02/2010 30 15/06/2010 25 119 
E8 P1 02/03/2010 30 15/06/2010 26 105 
E8 P2 02/03/2010 30 15/06/2010 27 105 
E9 O1 24/02/2010 30 15/06/2010 28 111 
E9 O2 24/02/2010 30 15/06/2010 29 111 
E9 P1 17/02/2010 30 15/06/2010 30 118 
E9 P2 17/02/2010 30 15/06/2010 31 118 
E10 O1 16/02/2010 30 15/06/2010 32 119 
E10 O2 16/02/2010 30 15/06/2010 33 119 
E10 P1 23/02/2010 30 15/06/2010 34 112 
E10 P2 23/02/2010 30 15/06/2010 35 112 
Patch Blank 1 15/06/2010 30 15/06/2010 36 0 
Patch Blank 2 15/06/2010 30 15/06/2010 37 0 
Patch Blank 3 15/06/2010 30 15/06/2010 38 0 
E11 O1 25/02/2010 30 15/06/2010 39 110 
E11 O2 25/02/2010 30 15/06/2010 40 110 
E11 P1 18/02/2010 30 15/06/2010 41 117 
E11 P2 18/02/2010 30 15/06/2010 42 117 
E12 O1 19/02/2010 30 15/06/2010 43 116 
E12 O2 19/02/2010 30 15/06/2010 44 116 
E13 O1 01/03/2010 30 15/06/2010 45 106 
E13 O2 01/03/2010 30 15/06/2010 46 106 
E13 P1 22/02/2010 30 15/06/2010 47 113 
 6 
E13 P2 22/02/2010 30 15/06/2010 48 113 
E14 O1 22/02/2010 30 15/06/2010 49 113 
E14 O2 22/02/2010 30 15/06/2010 50 113 
E14 P1 09/03/2010 30 15/06/2010 51 98 
E14 P2 09/03/2010 30 15/06/2010 52 98 
E15 O1 02/03/2010 30 15/06/2010 53 105 
E15 O2 02/03/2010 30 15/06/2010 54 105 
E15 P1 23/02/2010 30 15/06/2010 55 112 
E15 P2 23/02/2010 30 15/06/2010 56 112 
E16 O1 25/02/2010 30 15/06/2010 57 110 
E16 O2 25/02/2010 30 15/06/2010 58 110 
E16 P1 12/03/2010 30 15/06/2010 59 95 
E16 P2 12/03/2010 30 15/06/2010 60 95 
E17 O1 10/03/2010 30 15/06/2010 61 97 
E17 O2 10/03/2010 30 15/06/2010 62 97 
E17 P1 03/03/2010 30 15/06/2010 63 104 
E17 P2 03/03/2010 30 15/06/2010 64 104 
E18 O1 03/03/2010 30 15/06/2010 65 104 
E18 O2 03/03/2010 30 15/06/2010 66 104 
E18 P1 10/03/2010 30 15/06/2010 67 97 
E18 P2 10/03/2010 30 15/06/2010 68 97 
E19 O1 16/03/2010 30 15/06/2010 69 91 
E19 O2 16/03/2010 30 15/06/2010 70 91 
E19 P1 05/03/2010 30 15/06/2010 71 102 
E19 P2 05/03/2010 30 15/06/2010 72 102 
E20 O1 09/03/2010 30 15/06/2010 73 98 
E20 O2 09/03/2010 30 15/06/2010 74 98 
E20 P1 16/03/2010 30 15/06/2010 75 91 
E20 P2 16/03/2010 30 15/06/2010 76 91 
E21 O1 26/03/2010 30 15/06/2010 77 81 
E21 O2 26/03/2010 30 15/06/2010 78 81 
E21 P1 24/03/2010 30 15/06/2010 79 83 
E21 P2 24/03/2010 30 15/06/2010 80 83 
E22 O1 11/03/2010 30 15/06/2010 81 96 
E22 O2 11/03/2010 30 15/06/2010 82 96 
E22 P1 18/03/2010 30 15/06/2010 83 89 
E22 P2 18/03/2010 30 15/06/2010 84 89 
E23 O1 24/03/2010 30 15/06/2010 85 83 
E23 O2 24/03/2010 30 15/06/2010 86 83 
E23 P1 12/03/2010 30 15/06/2010 87 95 
E23 P2 12/03/2010 30 15/06/2010 88 95 
E24 O1 15/03/2010 30 15/06/2010 89 92 
E24 O2 15/03/2010 30 15/06/2010 90 92 
E24 P1 17/03/2010 30 15/06/2010 91 90 
E24 P2 17/03/2010 30 15/06/2010 92 90 
E25 P1 15/03/2010 30 15/06/2010 93 92 
E25 P2 15/03/2010 30 15/06/2010 94 92 
E26 O1 19/03/2010 30 15/06/2010 95 88 
E26 O2 19/03/2010 30 15/06/2010 96 88 
E26 P1 22/03/2010 30 15/06/2010 97 85 
E26 P2 22/03/2010 30 15/06/2010 98 85 
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Figure SI.2.1. ICP-MS calibration graphs of (A) sodium (B) zinc (C) potassium (D) sulphur (E) calcium and (F) tin 
in standards used for calculating elemental concentrations in the skin patches used for psychological stress 
study 
Serially diluted chemical standards (multi-element) were analysed by ICP-MS to establish 
whether a linear calibration existed for the instrument used. Figure SI.2.1 and Figure SI.2.2 
show that for the concentrations of analyte analysed a linear calibration existed for Na, Zn, 
K, S, Ca, Sn, Ba, Ni, Cu, Ti and Mg. A line of best fit was then be applied to the measured 
points and the equation of a straight line (y = mx + c) was used to calculate the 
concentrations of elements from skin patches. 
(A) (B)
(C) (D)
(E) (F)
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Figure SI.2.2. ICP-MS calibration graphs of (A) barium (B) nickel (C) copper (D) titanium and (E) magnesium in 
standards used for calculating elemental concentrations in the skin patches used for psychological stress study 
(A) (B)
(C) (D)
(E)
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3 The effect of physical stress on elemental content in human plasma, skin and urine and the effect on 
elements, volatile organic compounds and small molecules in human saliva 
Table SI.3.1. Sample information summary for the blanking of skin patches 
Patch Sample 
Sample 
ID 
Sample 
Date 
Sample 
Day 
Sample 
storage 
HNO3 Mass 
(g) 
Analysis 
Date 
Analysis 
Order 
No. of days in 
storage 
Blank Patch 0 21/01/2011 1 2% HNO3 14.0298 09/05/2011 1 108 
15% HNO3 Patch 1 21/01/2011 1 2% HNO3 14.0303 09/05/2011 2 108 
DI H2O (wash 1) Patch 2 22/01/2011 2 2% HNO3 14.0277 09/05/2011 3 107 
10% TMAH Patch 3 23/01/2011 3 2% HNO3 14.0211 09/05/2011 4 106 
DI H2O (wash 2) Patch 4 24/01/2011 4 2% HNO3 14.0066 09/05/2011 5 105 
0.1M EDTA (di-Na) Patch 5 25/01/2011 5 2% HNO3 14.0375 09/05/2011 6 104 
DI H2O (wash 3) Patch 6 26/01/2011 6 2% HNO3 14.0187 09/05/2011 7 103 
DI H2O (wash 4) Patch 7 27/01/2011 7 2% HNO3 14.0112 09/05/2011 8 102 
Table SI.3.2. Participant information summary for sample collection from physical stress study. M = mass, H = height and R = resistance (R = 2 x M) 
Participant Sample Date Sample ID Visit Day Time M (kg) H (m) R (W) Age Total samples & readings Sample storage 
1 31/01/2011 CZ1 1 0715-1015 hrs 69.64 1.77 139 28 66  -80°C 
2 31/01/2011 CZ2 1 1030-1330 hrs 73.46 1.74 147 32 67  -80°C 
3 01/02/2011 CZ3 2 0715-1015 hrs 82.92 1.89 166 24 64  -80°C 
4 01/02/2011 CZ4 2 1030-1330 hrs 83.52 1.96 167 22 67  -80°C 
5 02/02/2011 CZ5 3 0715-1015 hrs 72.20 1.74 144 27 68  -80°C 
6 02/02/2011 CZ6 3 1030-1330 hrs 74.02 1.82 148 25 67  -80°C 
7 03/02/2011 CZ7 4 0715-1015 hrs 92.08 1.92 184 24 66  -80°C 
8 03/02/2011 CZ8 4 1030-1330 hrs 88.12 1.78 176 29 60  -80°C 
9 04/02/2011 CZ9 5 0715-1015 hrs 100.04 1.77 200 18 65  -80°C 
10 04/02/2011 CZ10 5 1030-1330 hrs 88.66 1.68 177 28 60  -80°C 
        
 
        Total =  650   
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Table SI.3.3. Skin sample information summary 
Sample ID 
Sample 
date 
Mass (g) Amount In 
added (µg.L-1) 
Analysis 
date 
Analysis 
order 
No days in 
storage Sample + 2% HNO3 Internal Standard (In) Total 
CZ1 Blank 31/01/2011 15 0.7017 15.7017 50.2 27/04/2011 84 86 
CZ1 Field Blank 31/01/2011 15 0.6998 15.6998 50.1 18/04/2011 29 77 
CZ1 A 31/01/2011 15 0.9970 15.9970 70.0 27/04/2011 95 86 
CZ1 B 31/01/2011 15 0.7011 15.7011 50.1 20/04/2011 63 79 
CZ1 C 31/01/2011 15 0.7027 15.7027 50.3 20/04/2011 64 79 
CZ1 D 31/01/2011 15 0.7040 15.7040 50.3 27/04/2011 99 86 
CZ2 Blank 31/01/2011 15 0.7019 15.7019 50.2 27/04/2011 77 86 
CZ2 Field Blank 31/01/2011 15 0.7029 15.7029 50.3 18/04/2011 17 77 
CZ2 A 31/01/2011 15 0.7016 15.7016 50.2 18/04/2011 10 77 
CZ2 B 31/01/2011 15 0.7036 15.7036 50.3 20/04/2011 66 79 
CZ2 C 31/01/2011 15 0.7028 15.7028 50.3 18/04/2011 31 77 
CZ2 D 31/01/2011 15 0.7007 15.7007 50.1 18/04/2011 11 77 
CZ3 Blank 01/02/2011 15 0.7015 15.7015 50.2 20/04/2011 68 78 
CZ3 Field Blank 01/02/2011 15 0.7032 15.7032 50.3 18/04/2011 32 76 
CZ3 A 01/02/2011 15 0.7037 15.7037 50.3 20/04/2011 42 78 
CZ3 B 01/02/2011 15 0.7034 15.7034 50.3 20/04/2011 65 78 
CZ3 C 01/02/2011 15 0.7028 15.7028 50.3 27/04/2011 85 85 
CZ3 D 01/02/2011 15 0.7037 15.7037 50.3 20/04/2011 46 78 
CZ4 Blank 01/02/2011 15 0.7046 15.7046 50.4 20/04/2011 59 78 
CZ4 Field Blank 01/02/2011 15 0.7045 15.7045 50.4 27/04/2011 102 85 
CZ4 A 01/02/2011 15 0.7036 15.7036 50.3 18/04/2011 13 76 
CZ4 B 01/02/2011 15 0.7046 15.7046 50.4 18/04/2011 15 76 
CZ4 C 01/02/2011 15 0.7025 15.7025 50.2 27/04/2011 100 85 
CZ4 D 01/02/2011 15 0.7037 15.7037 50.3 27/04/2011 78 85 
CZ5 Blank 02/02/2011 15 0.7031 15.7031 50.3 27/04/2011 101 84 
CZ5 Field Blank 02/02/2011 15 0.7035 15.7035 50.3 20/04/2011 43 77 
CZ5 A 02/02/2011 15 0.7028 15.7028 50.3 20/04/2011 47 77 
CZ5 B 02/02/2011 15 0.7033 15.7033 50.3 27/04/2011 96 84 
CZ5 C 02/02/2011 15 0.7039 15.7039 50.3 18/04/2011 14 75 
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CZ5 D 02/02/2011 15 0.7019 15.7019 50.2 20/04/2011 61 77 
CZ6 Blank 02/02/2011 15 0.7041 15.7041 50.4 20/04/2011 60 77 
CZ6 Field Blank 02/02/2011 15 0.7037 15.7037 50.3 27/04/2011 80 84 
CZ6 A 02/02/2011 15 0.7044 15.7044 50.4 20/04/2011 62 77 
CZ6 B 02/02/2011 15 0.7044 15.7044 50.4 20/04/2011 44 77 
CZ6 C 02/02/2011 15 0.7027 15.7027 50.3 27/04/2011 83 84 
CZ6 D 02/02/2011 15 0.7065 15.7065 50.5 18/04/2011 26 75 
CZ7 Blank 03/02/2011 15 0.7051 15.7051 50.4 20/04/2011 50 76 
CZ7 Field Blank 03/02/2011 15 0.7038 15.7038 50.3 20/04/2011 45 76 
CZ7 A 03/02/2011 15 0.7023 15.7023 50.2 18/04/2011 27 74 
CZ7 B 03/02/2011 15 0.7016 15.7016 50.2 20/04/2011 67 76 
CZ7 C 03/02/2011 15 0.7042 15.7042 50.4 18/04/2011 8 74 
CZ7 D 03/02/2011 15 0.7032 15.7032 50.3 27/04/2011 98 83 
CZ8 Blank 03/02/2011 15 0.7030 15.7030 50.3 18/04/2011 25 74 
CZ8 Field Blank 03/02/2011 15 0.7037 15.7037 50.3 27/04/2011 93 83 
CZ8 A 03/02/2011 15 0.7071 15.7071 50.6 20/04/2011 48 76 
CZ8 B 03/02/2011 15 0.7058 15.7058 50.5 27/04/2011 94 83 
CZ8 C 03/02/2011 15 0.7034 15.7034 50.3 20/04/2011 49 76 
CZ8 D 03/02/2011 15 0.7060 15.7060 50.5 18/04/2011 30 74 
CZ9 Blank 04/02/2011 15 0.7055 15.7055 50.5 18/04/2011 34 73 
CZ9 Field Blank 04/02/2011 15 0.7024 15.7024 50.2 20/04/2011 51 75 
CZ9 A 04/02/2011 15 0.7034 15.7034 50.3 27/04/2011 79 82 
CZ9 B 04/02/2011 15 0.7060 15.7060 50.5 27/04/2011 76 82 
CZ9 C 04/02/2011 15 0.7034 15.7034 50.3 18/04/2011 28 73 
CZ9 D 04/02/2011 15 0.7025 15.7025 50.2 18/04/2011 9 73 
CZ10 Blank 04/02/2011 15 0.7063 15.7063 50.5 18/04/2011 12 73 
CZ10 Field Blank 04/02/2011 15 0.7058 15.7058 50.5 27/04/2011 97 82 
CZ10 A 04/02/2011 15 0.7059 15.7059 50.5 18/04/2011 33 73 
CZ10 B 04/02/2011 15 0.7045 15.7045 50.4 27/04/2011 82 82 
CZ10 C 04/02/2011 15 0.7055 15.7055 50.5 27/04/2011 81 82 
CZ10 D 04/02/2011 15 0.7051 15.7051 50.4 18/04/2011 16 73 
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Table SI.3.4. Ten blank subtracted elemental skin patch concentrations (µg.L
-1
) obtained 
by ICP-MS from ten participants who participated in the physical stress study 
Sample ID Na Mg Al Si P S K Ca Cu Zn 
CZ1 A 132 12 0 33 20 52 165 561 0 90 
CZ1 B 32921 37 0 17 17 103 3262 327 7 22 
CZ1 C 200 0 0 27 0 0 40 0 0 0 
CZ1 D 51 0 0 0 0 0 0 0 0 0 
CZ2 A 0 0 15 11 0 0 31 91 0 46 
CZ2 B 0 79 27 25 30 444 17386 218 4 17 
CZ2 C 12636 16 18 0 0 39 1914 124 3 22 
CZ2 D 0 0 15 23 0 0 51 76 0 31 
CZ3 A 0 0 0 0 0 0 24 0 0 0 
CZ3 B 0 128 12 0 29 477 13638 184 3 0 
CZ3 C 2271 0 0 0 0 11 241 0 0 0 
CZ3 D 0 0 15 63 0 0 0 0 0 0 
CZ4 A 0 0 0 0 0 20 19 0 14 872 
CZ4 B 0 72 17 12 28 235 11955 343 2 10 
CZ4 C 1420 0 0 0 0 9 172 0 0 0 
CZ4 D 85 0 0 0 0 12 14 0 0 0 
CZ5 A 0 0 0 26 0 15 56 0 0 0 
CZ5 B 28855 64 0 0 19 252 8505 412 5 8 
CZ5 C 3493 0 0 0 0 32 1115 152 0 30 
CZ5 D 0 0 0 0 0 11 40 100 0 11 
CZ6 A 0 0 0 0 0 0 0 0 0 0 
CZ6 B 14392 42 22 0 11 117 2008 158 4 305 
CZ6 C 67 0 0 0 0 0 37 0 0 12 
CZ6 D 61 0 0 0 0 0 25 0 0 0 
CZ7 A 95 0 0 0 0 0 402 0 0 0 
CZ7 B 0 78 0 0 77 313 10332 231 2 0 
CZ7 C 4212 0 0 0 15 47 1266 0 0 0 
CZ7 D 209 0 0 0 0 0 401 77 0 17 
CZ8 A 151 0 0 0 0 11 104 0 0 0 
CZ8 B 0 33 0 0 0 480 10215 185 0 0 
CZ8 C 14 57 0 17 50 907 5180 714 5 0 
CZ8 D 334 0 0 0 0 31 38 0 0 0 
CZ9 A 69 0 0 0 0 0 37 0 2 0 
CZ9 B 0 87 0 0 42 337 13835 263 4 9 
CZ9 C 9397 0 0 0 0 25 1153 21 0 0 
CZ9 D 1616 0 0 0 0 0 382 0 0 0 
CZ10 A 0 0 0 0 0 0 0 46 0 0 
CZ10 B 0 77 0 7 19 272 23655 425 4 0 
CZ10 C 0 0 0 32 0 11 4 0 0 0 
CZ10 D 0 0 0 0 0 17 0 0 0 0 
μ (A) 45 1 1 7 2 10 84 70 2 101 
σ (A) 61 4 5 12 6 17 123 175 4 273 
μ (B) 7617 70 8 6 27 303 11479 275 4 37 
σ (B) 13095 28 11 9 21 136 6347 96 2 94 
μ (C) 3371 7 2 8 6 108 1112 101 1 6 
σ (C) 4365 18 6 13 16 281 1577 223 2 11 
μ (D) 236 0 3 9 0 7 95 25 0 6 
σ (D) 497 0 6 20 0 11 157 41 0 11 
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Table SI.3.5. Saliva sample information summary 
Sample ID 
Sample 
date 
Mass (g) 
Saliva 
DF 
Amount In added 
(µg.L
-1
) 
Analysis 
date 
Analysis 
Order 
No days in 
storage 
2% 
HNO3 
Saliva 
Internal 
standard (In) 
Total 
CZ1 A R1 31/01/2011 3.6050 0.4093 4.0392 8.0535 19.7 62.0 29/06/2011 10 149 
CZ1 A R2 31/01/2011 3.5999 0.3640 4.0038 7.9677 21.9 62.1 07/07/2011 43 157 
CZ1 C R1 31/01/2011 3.6048 0.3793 4.0000 7.9841 21.0 61.9 06/07/2011 39 156 
CZ1 C R2 31/01/2011 3.6063 0.3008 4.0003 7.9074 26.3 62.5 05/07/2011 30 155 
CZ1 D R1 31/01/2011 3.6089 0.4082 4.0041 8.0212 19.7 61.7 28/06/2011 6 148 
CZ1 D R2 31/01/2011 3.6001 0.4095 4.0001 8.0097 19.6 61.7 05/07/2011 28 155 
CZ2 A R1 31/01/2011 3.6047 0.4015 4.0132 8.0194 20.0 61.8 14/07/2011 50 164 
CZ2 A R2 31/01/2011 3.6043 0.3553 4.0073 7.9669 22.4 62.1 07/07/2011 45 157 
CZ2 C R1 31/01/2011 3.6033 0.4023 4.0051 8.0107 19.9 61.8 05/07/2011 29 155 
CZ2 C R2 31/01/2011 3.6067 0.2861 4.0094 7.9022 27.6 62.7 07/07/2011 46 157 
CZ2 D R1 31/01/2011 3.6037 0.4007 4.0104 8.0148 20.0 61.9 29/06/2011 11 149 
CZ2 D R2 31/01/2011 3.6067 0.3998 4.0038 8.0103 20.0 61.8 05/07/2011 27 155 
CZ3 A R1 01/02/2011 3.6083 0.2150 4.0184 7.8417 36.5 63.3 07/07/2011 48 156 
CZ3 D R1 01/02/2011 3.6019 0.3801 4.0028 7.9848 21.0 62.0 30/06/2011 21 149 
CZ4 A R1 01/02/2011 3.6016 0.4058 4.0058 8.0132 19.7 61.8 28/06/2011 5 147 
CZ4 C R1 01/02/2011 3.6081 0.4082 4.0066 8.0229 19.7 61.7 30/06/2011 24 149 
CZ4 C R2 01/02/2011 3.6076 0.4003 4.0058 8.0137 20.0 61.8 05/07/2011 25 154 
CZ4 D R1 01/02/2011 3.6042 0.4029 4.0038 8.0109 19.9 61.8 29/06/2011 13 148 
CZ4 D R2 01/02/2011 3.6045 0.4020 4.0023 8.0088 19.9 61.7 14/07/2011 51 163 
CZ4 D R3 01/02/2011 3.6099 0.4231 4.0002 8.0332 19.0 61.5 07/07/2011 44 156 
CZ5 A R1 02/02/2011 3.6014 0.4073 4.0032 8.0119 19.7 61.8 06/07/2011 34 154 
CZ5 C R1 02/02/2011 3.6058 0.3717 4.0064 7.9839 21.5 62.0 30/06/2011 22 148 
CZ5 D R1 02/02/2011 3.6090 0.2484 4.0413 7.8987 31.8 63.2 30/06/2011 18 148 
CZ6 A R1 02/02/2011 3.6092 0.3688 4.0023 7.9803 21.6 62.0 30/06/2011 17 148 
CZ6 A R2 02/02/2011 3.6087 0.4066 4.0049 8.0202 19.7 61.7 28/06/2011 2 146 
CZ6 C R1 02/02/2011 3.6038 0.3585 4.0073 7.9696 22.2 62.2 28/06/2011 4 146 
CZ6 C R2 02/02/2011 3.6031 0.3681 4.0078 7.9790 21.7 62.0 07/07/2011 42 155 
CZ6 D R1 02/02/2011 3.6043 0.3694 4.0386 8.0123 21.7 62.3 05/07/2011 26 153 
CZ6 D R2 02/02/2011 3.6002 0.3998 4.0104 8.0104 20.0 61.9 28/06/2011 7 146 
CZ6 D R3 02/02/2011 3.6030 0.3269 4.5048 8.4347 25.8 66.0 29/06/2011 9 147 
CZ7 A R1 03/02/2011 3.6106 0.3362 4.0106 7.9574 23.7 62.3 06/07/2011 36 153 
CZ7 D R1 03/02/2011 3.6031 0.3327 4.0061 7.9419 23.9 62.4 05/07/2011 32 152 
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CZ8 A R1 03/02/2011 3.6013 0.4038 4.0071 8.0122 19.8 61.8 30/06/2011 23 147 
CZ8 A R2 03/02/2011 3.6056 0.4595 4.0050 8.0701 17.6 61.3 14/07/2011 49 161 
CZ8 A R3 03/02/2011 3.6065 0.4057 4.0124 8.0246 19.8 61.8 06/07/2011 37 153 
CZ8 C R1 03/02/2011 3.6049 0.4226 4.0019 8.0294 19.0 61.6 06/07/2011 38 153 
CZ8 D R1 03/02/2011 3.6022 0.4013 4.0038 8.0073 20.0 61.8 29/06/2011 16 146 
CZ8 D R2 03/02/2011 3.6037 0.4101 4.0082 8.0220 19.6 61.8 30/06/2011 19 147 
CZ8 D R3 03/02/2011 3.6035 0.4161 4.0125 8.0321 19.3 61.7 07/07/2011 41 154 
CZ9 A R1 04/02/2011 3.5996 0.4051 4.0034 8.0081 19.8 61.8 28/06/2011 1 144 
CZ9 A R2 04/02/2011 3.5989 0.3704 4.0059 7.9752 21.5 62.1 28/06/2011 3 144 
CZ9 A R3 04/02/2011 3.6079 0.3643 4.0083 7.9805 21.9 62.1 29/06/2011 14 145 
CZ9 C R1 04/02/2011 3.6061 0.4268 4.0070 8.0399 18.8 61.6 29/06/2011 15 145 
CZ9 C R2 04/02/2011 3.6038 0.4083 4.0120 8.0241 19.7 61.8 28/06/2011 8 144 
CZ9 C R3 04/02/2011 3.6096 0.4152 4.0066 8.0314 19.3 61.6 07/07/2011 47 153 
CZ9 D R1 04/02/2011 3.6051 0.4016 3.9998 8.0065 19.9 61.8 06/07/2011 35 152 
CZ9 D R2 04/02/2011 3.6074 0.4024 4.0335 8.0433 20.0 62.0 06/07/2011 33 152 
CZ9 D R3 04/02/2011 3.6050 0.4017 4.0233 8.0300 20.0 61.9 30/06/2011 20 146 
CZ10 A R1 04/02/2011 3.6054 0.4014 4.0023 8.0091 20.0 61.8 05/07/2011 31 151 
CZ10 A R2 04/02/2011 3.6084 0.4015 4.0070 8.0169 20.0 61.8 29/06/2011 12 145 
CZ10 D R1 04/02/2011 3.6065 0.2718 4.0074 7.8857 29.0 62.8 14/07/2011 55 160 
Drinking water 04/02/2011 3.6042 0.4064 4.0059 8.0165 19.7 61.7 14/07/2011 52 160 
Saliva tube 04/02/2011 3.6105 0.4132 4.0066 8.0303 19.4 61.6 14/07/2011 53 160 
MVA sample 14/07/2011   21.5533 21.6039 43.1572   62.1 14/07/2011 54 0 
54 samples analysed in total, 51 participant samples. 6 Complete sample sets (A, C & D) participants 1, 2, 5, 6, 8 and 9. Only phases A & D from PP 3, 
4, 7 & 10.
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Table SI.3.6. Eight blank subtracted elemental drool saliva concentrations (µg.L
-1
) 
obtained by ICP-MS from ten participants who participated in the physical stress study 
Sample ID Na Mg Si P S K Zn I 
CZ1 A 16558 733 162 28117 6681 95109 24 7067 
CZ1 C 11981 553 80 21043 4759 59161 13 4748 
CZ1 D 14957 573 110 24519 4949 1349 21 4150 
CZ2 A 15043 442 43 16859 4645 97395 19 1391 
CZ2 C 19148 699 76 15767 4953 41386 27 1459 
CZ2 D 16964 620 57 18140 4943 1158 18 1739 
CZ4 A 17341 490 96 23959 5357 1414 15 4081 
CZ4 C 23517 512 55 18954 4221 1615 10 2193 
CZ4 D 19787 594 37 22505 4407 112701 15 2158 
CZ5 A 48577 2084 205 49322 15347 163077 85 28139 
CZ5 C 26946 1004 84 33602 9907 2329 33 11468 
CZ5 D 27198 1053 128 24828 7682 2514 44 6645 
CZ6 A 6639 290 49 14924 3623 1622 2 3642 
CZ6 C 5353 336 60 15295 3631 41444 1 1849 
CZ6 D 13963 285 35 14880 3052 1140 6 1460 
CZ8 A 16543 382 26 23335 3857 54239 8 1409 
CZ8 C 26551 543 51 22794 4553 87787 17 1082 
CZ8 D 30617 460 29 22741 3373 41643 12 829 
CZ9 A 30745 919 61 24905 8674 32494 20 4784 
CZ9 C 40120 1178 103 27871 7764 63829 31 2600 
CZ9 D 30680 683 79 15472 4658 60533 30 1761 
µ (A) 21635 763 92 25917 6883 63621 25 7216 
σ (A) 13828 622 67 11307 4123 58870 28 9434 
µ (C) 21945 689 72 22189 5684 42507 19 3628 
σ (C) 11265 298 18 6627 2280 31810 12 3656 
µ (D) 22024 610 68 20441 4723 31577 21 2678 
σ (D) 7315 235 39 4210 1504 43072 13 2033 
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Table SI.3.7. Urine sample information summary 
Sample ID 
Sample 
date 
Mass (g) Urine 
DF 
Amount Ru 
added (µg.L
-1
) 
Analysis 
Date 
Analysis 
Order 
No of days in 
storage Sample 2% HNO3 Internal standard (Ru) Total 
CZ1 A R1 31/01/2011 0.4927 3.0355 1.0130 4.5412 9.2 56.0 21/09/2011 5 233 
CZ1 A R2 31/01/2011 0.3484 3.0067 1.0053 4.3604 12.5 57.8 10/10/2011 62 252 
CZ1 A R3 31/01/2011 0.4045 3.0082 1.0068 4.4195 10.9 57.2 10/10/2011 64 252 
CZ1 C R1 31/01/2011 0.4643 3.0155 1.0038 4.4836 9.7 56.2 22/09/2011 20 234 
CZ1 C R2 31/01/2011 0.4746 3.0018 1.0069 4.4833 9.4 56.4 06/10/2011 59 248 
CZ1 C R3 31/01/2011 0.4823 3.0162 1.0172 4.5157 9.4 57.1 01/11/2011 77 274 
CZ1 D R1 31/01/2011 0.4549 3.0166 1.0120 4.4835 9.9 56.6 22/09/2011 10 234 
CZ1 D R2 31/01/2011 0.1286 3.0046 1.0036 4.1368 32.2 73.6 01/11/2011 80 274 
CZ1 D R3 31/01/2011 0.4699 3.0109 1.0052 4.4860 9.5 56.2 06/10/2011 54 248 
CZ2 A R1 31/01/2011 0.9426 3.0054 1.0045 4.9525 5.3 50.9 22/09/2011 17 234 
CZ2 A R2 31/01/2011 0.9597 3.0040 1.0056 4.9693 5.2 61.4 01/11/2011 84 274 
CZ2 A R3 31/01/2011 0.9433 3.0069 1.0053 4.9555 5.3 61.5 01/11/2011 83 274 
CZ2 C R1 31/01/2011 0.9129 3.0131 1.0158 4.9418 5.4 51.6 22/09/2011 11 234 
CZ2 C R2 31/01/2011 0.9048 3.0166 1.0014 4.9228 5.4 51.0 01/10/2011 38 243 
CZ2 C R3 31/01/2011 0.9143 3.0165 1.0023 4.9331 5.4 51.0 01/10/2011 32 243 
CZ2 D R1 31/01/2011 0.9675 3.0245 1.0129 5.0049 5.2 50.8 21/09/2011 6 233 
CZ2 D R2 31/01/2011 0.9333 3.0040 1.0068 4.9441 5.3 51.1 10/10/2011 63 252 
CZ2 D R3 31/01/2011 0.9491 3.0219 1.0037 4.9747 5.2 61.2 01/11/2011 87 274 
CZ3 A R1 01/02/2011 1.0162 3.0054 1.0140 5.0356 5.0 50.5 21/09/2011 7 232 
CZ3 A R2 01/02/2011 1.0061 3.0118 1.0098 5.0277 5.0 50.9 01/11/2011 78 273 
CZ3 A R3 01/02/2011 0.9746 3.0184 1.0034 4.9964 5.1 50.4 06/10/2011 49 247 
CZ3 C R1 01/02/2011 0.9757 3.0234 1.0150 5.0141 5.1 50.8 22/09/2011 12 233 
CZ3 C R3 01/02/2011 0.9821 3.0116 1.0028 4.9965 5.1 50.4 01/10/2011 46 242 
CZ3 C R3 01/02/2011 0.9406 3.0087 1.0081 4.9574 5.3 51.6 01/11/2011 76 273 
CZ3 D R1 01/02/2011 0.9457 3.0091 1.0158 4.9706 5.3 51.3 21/09/2011 9 232 
CZ3 D R2 01/02/2011 0.9903 3.0078 1.0050 5.0031 5.1 50.4 01/10/2011 48 242 
CZ3 D R3 01/02/2011 0.9920 3.0080 1.0060 5.0060 5.0 60.9 01/11/2011 86 273 
CZ4 A R1 01/02/2011 0.9292 3.0113 1.0121 4.9526 5.3 51.3 20/09/2011 3 231 
CZ4 A R2 01/02/2011 0.9886 3.0217 1.0065 5.0168 5.1 50.3 01/10/2011 40 242 
CZ4 A R3 01/02/2011 0.9784 3.0093 1.0053 4.9930 5.1 50.5 06/10/2011 53 247 
CZ4 C R1 01/02/2011 0.9630 3.0214 1.0015 4.9859 5.2 50.4 22/09/2011 15 233 
CZ4 C R2 01/02/2011 0.9662 3.0087 1.0069 4.9818 5.2 50.7 10/10/2011 71 251 
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CZ4 C R3 01/02/2011 0.9755 3.0178 1.0016 4.9949 5.1 50.3 01/10/2011 37 242 
CZ4 D R1 01/02/2011 0.9364 3.0058 1.0015 4.9437 5.3 50.8 01/10/2011 25 242 
CZ4 D R2 01/02/2011 0.9489 3.0070 1.0072 4.9631 5.2 50.9 10/10/2011 72 251 
CZ4 D R3 01/02/2011 0.9108 3.0007 1.0072 4.9187 5.4 51.4 10/10/2011 69 251 
CZ5 A R1 02/02/2011 0.9419 3.0140 1.0062 4.9621 5.3 50.9 01/10/2011 29 241 
CZ5 A R2 02/02/2011 0.9798 3.0089 1.0103 4.9990 5.1 50.7 10/10/2011 65 250 
CZ5 A R3 02/02/2011 0.9683 3.0167 1.0198 5.0048 5.2 51.1 10/10/2011 67 250 
CZ5 C R1 02/02/2011 0.9231 3.0155 1.0014 4.9400 5.4 50.9 01/10/2011 26 241 
CZ5 C R2 02/02/2011 0.9585 3.0155 1.0065 4.9805 5.2 50.7 01/10/2011 35 241 
CZ5 C R3 02/02/2011 0.9874 3.0184 1.0113 5.0171 5.1 50.6 10/10/2011 68 250 
CZ5 D R1 02/02/2011 0.4372 3.0054 1.0001 4.4427 10.2 56.5 22/09/2011 14 232 
CZ5 D R2 02/02/2011 0.9723 3.0003 1.0087 4.9813 5.1 61.4 01/11/2011 79 272 
CZ5 D R3 02/02/2011 0.9903 3.0196 1.0024 5.0123 5.1 50.2 01/10/2011 42 241 
CZ6 A R1 02/02/2011 0.9331 3.0017 1.0134 4.9482 5.3 51.4 21/09/2011 8 231 
CZ6 A R2 02/02/2011 0.9986 3.0155 1.0055 5.0196 5.0 50.8 01/11/2011 73 272 
CZ6 A R3 02/02/2011 1.0001 3.0063 1.0006 5.0070 5.0 50.1 01/10/2011 45 241 
CZ6 C R1 02/02/2011 1.0197 3.0097 1.0005 5.0299 4.9 49.9 22/09/2011 13 232 
CZ6 C R2 02/02/2011 1.0120 3.0050 1.0075 5.0245 5.0 50.9 01/11/2011 74 272 
CZ6 C R3 02/02/2011 0.9907 3.0058 1.0062 5.0027 5.0 50.5 06/10/2011 60 246 
CZ6 D R1 02/02/2011 0.8872 0.0153 1.0038 1.9063 2.1 132.1 22/09/2011 18 232 
CZ6 D R2 02/02/2011 0.9751 3.0025 1.0069 4.9845 5.1 50.7 06/10/2011 58 246 
CZ6 D R3 02/02/2011 0.9593 3.0079 1.0059 4.9731 5.2 50.8 01/10/2011 33 241 
CZ7 A R1 03/02/2011 0.9742 3.0180 1.0154 5.0076 5.1 50.9 20/09/2011 1 229 
CZ7 A R2 03/02/2011 0.9877 3.0166 1.0060 5.0103 5.1 50.4 06/10/2011 56 245 
CZ7 A R3 03/02/2011 1.0078 3.0045 1.0037 5.0160 5.0 60.7 01/11/2011 88 271 
CZ7 C R1 03/02/2011 0.9370 3.0015 1.0149 4.9534 5.3 51.4 20/09/2011 2 229 
CZ7 C R2 03/02/2011 0.9337 3.0044 1.0074 4.9455 5.3 61.8 01/11/2011 81 271 
CZ7 C R3 03/02/2011 0.9974 3.0032 1.0054 5.0060 5.0 60.9 01/11/2011 85 271 
CZ7 D R1 03/02/2011 0.9321 3.0113 1.0050 4.9484 5.3 51.0 22/09/2011 21 231 
CZ7 D R2 03/02/2011 0.9618 3.0078 1.0030 4.9726 5.2 50.6 01/10/2011 47 240 
CZ7 D R3 03/02/2011 0.9535 3.0146 1.0047 4.9728 5.2 50.7 06/10/2011 52 245 
CZ8 A R1 03/02/2011 0.9247 3.0060 1.0133 4.9440 5.3 51.4 20/09/2011 4 229 
CZ8 A R2 03/02/2011 0.9703 3.0113 1.0042 4.9858 5.1 50.5 01/10/2011 44 240 
CZ8 A R3 03/02/2011 0.9731 3.0041 1.0066 4.9838 5.1 50.7 06/10/2011 51 245 
CZ8 C R1 03/02/2011 0.9817 3.0210 1.0005 5.0032 5.1 50.2 22/09/2011 16 231 
CZ8 C R2 03/02/2011 1.0023 3.0209 1.0053 5.0285 5.0 50.2 01/10/2011 36 240 
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CZ8 C R3 03/02/2011 1.0019 3.0054 1.0081 5.0154 5.0 50.4 06/10/2011 50 245 
CZ8 D R1 03/02/2011 0.9527 3.0105 1.0043 4.9675 5.2 50.7 01/10/2011 30 240 
CZ9 A R1 04/02/2011 0.9757 3.0088 1.0001 4.9846 5.1 50.3 01/10/2011 27 239 
CZ9 A R2 04/02/2011 1.0114 3.0123 1.0049 5.0286 5.0 60.6 01/11/2011 82 270 
CZ9 A R3 04/02/2011 0.9867 3.0177 1.0061 5.0105 5.1 50.4 01/10/2011 34 239 
CZ9 C R1 04/02/2011 0.9995 3.0285 1.0010 5.0290 5.0 49.9 01/10/2011 28 239 
CZ9 C R2 04/02/2011 0.9774 3.0125 1.0006 4.9905 5.1 50.3 01/10/2011 41 239 
CZ9 C R3 04/02/2011 0.9762 3.0027 1.0072 4.9861 5.1 50.7 10/10/2011 66 248 
CZ9 D R1 04/02/2011 0.9401 3.0225 1.0051 4.9677 5.3 50.8 22/09/2011 24 230 
CZ9 D R2 04/02/2011 0.9933 3.0227 1.0007 5.0167 5.1 50.0 01/10/2011 43 239 
CZ9 D R3 04/02/2011 0.9489 3.0058 1.0081 4.9628 5.2 51.0 10/10/2011 70 248 
CZ10 A R1 04/02/2011 0.9255 3.0038 1.0039 4.9332 5.3 51.1 22/09/2011 19 230 
CZ10 A R2 04/02/2011 0.9746 3.0108 1.0060 4.9914 5.1 50.6 06/10/2011 57 244 
CZ10 A R3 04/02/2011 0.8591 3.0253 1.0061 4.8905 5.7 51.6 01/10/2011 39 239 
CZ10 C R1 04/02/2011 0.9081 3.0069 1.0068 4.9218 5.4 51.3 22/09/2011 22 230 
CZ10 C R2 04/02/2011 0.9850 3.0048 1.0076 4.9974 5.1 50.6 10/10/2011 61 248 
CZ10 C R3 04/02/2011 1.0060 3.0065 1.0098 5.0223 5.0 51.0 01/11/2011 75 270 
CZ10 D R1 04/02/2011 0.9527 3.0117 1.0052 4.9696 5.2 50.8 22/09/2011 23 230 
CZ10 D R2 04/02/2011 0.9135 3.0066 1.0047 4.9248 5.4 51.2 01/10/2011 31 239 
CZ10 D R3 04/02/2011 0.9834 3.0151 1.0067 5.0052 5.1 50.5 06/10/2011 55 244 
MVA Sample 12/10/2011             12/10/2011 89 0 
Pot 1 12/10/2011 1.0135 3.0056 1.0058 5.0249 5.0 60.7 12/10/2011 90 0 
Pot 2 12/10/2011 1.0040 3.0155 1.0040 5.0235 5.0 60.6 12/10/2011 91 0 
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Table SI.3.8. Eight blank subtracted elemental urine concentrations (µg.L
-1
) obtained by ICP-MS from ten 
participants who participated in the physical stress study 
Sample ID Mg Si P S K Ca Zn Mo 
CZ1 A 179295 12623 1117704 1581731 4395455 148703 813 86 
CZ1 C 85180 5638 204822 957477 2960584 63733 258 0 
CZ1 D 153876 14329 296812 1479541 5114787 84535 881 0 
CZ2 A 7252 1087 61027 258579 1440865 7182 0 0 
CZ2 C 11139 2278 84250 287281 1889069 10383 122 0 
CZ2 D 40592 6970 371088 683235 2729142 22087 298 46 
CZ3 A 104652 3802 1166407 848603 1809429 47414 222 19 
CZ3 C 16131 3013 133741 648143 2750812 30078 0 0 
CZ3 D 201593 18601 1410752 3990159 9417103 88497 518 0 
CZ4 A 95916 8118 1262844 949861 3251645 36403 479 0 
CZ4 C 12457 3129 241458 189696 344388 5408 0 9 
CZ4 D 83889 13629 843747 697082 1714648 15270 325 58 
CZ5 A 550888 9441 4480589 2840938 8660429 93027 694 51 
CZ5 C 252574 8889 1451993 1538030 7142834 46785 481 33 
CZ5 D 394678 11840 1507232 1727938 6002618 48491 691 0 
CZ6 A 6693 3841 261781 443338 2865846 22090 0 41 
CZ6 C 2793 2324 44251 240950 1357473 13179 0 0 
CZ6 D 4966 4836 130981 516586 2085060 18136 24 27 
CZ7 A 185174 28313 2099510 1869746 2878737 91801 933 284 
CZ7 C 130103 25516 1022245 1593391 3529179 89183 627 225 
CZ7 D 652941 51594 2412782 3380679 6136854 90445 1236 78 
CZ8 A 70110 2733 54322 430711 2587045 13039 0 28 
CZ8 C 60399 2879 34788 445870 2837930 9225 0 28 
CZ8 D 837247 18879 1678989 3721293 7870350 49241 864 105 
CZ9 A 522804 11671 3340923 2892711 7342667 50939 354 86 
CZ9 C 218982 7742 140664 1177725 2878264 37604 175 35 
CZ9 D 751947 16805 224746 3163296 7774028 143091 637 0 
CZ10 A 129582 5455 592205 1348902 4500254 18262 207 56 
CZ10 C 122515 3824 635539 1162582 4274951 18151 164 74 
CZ10 D 242608 13968 1573415 2219290 6415545 34339 746 66 
µ (Phase A) 185237 8709 1443731 1346512 3973237 52886 370 65 
σ (Phase A) 194955 7898 1469400 954312 2350893 45259 348 83 
µ (Phase C) 91227 6523 399375 824114 2996548 32373 183 40 
σ (Phase C) 89387 7061 484237 533712 1830530 27423 218 69 
µ (Phase D) 336434 17145 1045054 2157910 5526014 59413 622 38 
σ (Phase D) 307050 12934 779039 1331612 2612786 41284 347 38 
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Table SI.3.9. Plasma sample information summary 
Sample ID Sample date 
Mass (g) 
Plasma DF Analysis date Analysis Order No of days in storage 
Sample 0.5% HNO3 Total  
CZ1 A 31/01/2011 0.1973 9.8144 10.0117 50.7 12/07/2012 1 528 
CZ1 C 31/01/2011 0.2014 9.7991 10.0005 49.7 13/07/2012 19 529 
CZ1 D 31/01/2011 0.2051 9.7971 10.0022 48.8 12/07/2012 3 528 
CZ2 A 31/01/2011 0.2161 9.8116 10.0277 46.4 12/07/2012 12 528 
CZ2 C 31/01/2011 0.2008 9.8142 10.0150 49.9 12/07/2012 9 528 
CZ2 D 31/01/2011 0.2023 9.8043 10.0066 49.5 13/07/2012 15 529 
CZ3 A 01/02/2011 0.2006 9.8009 10.0015 49.9 13/07/2012 17 528 
CZ3 C 01/02/2011 0.2009 9.8053 10.0062 49.8 12/07/2012 4 527 
CZ3 D 01/02/2011 0.2022 9.7990 10.0012 49.5 13/07/2012 16 528 
CZ4 A 01/02/2011 0.1998 9.8103 10.0101 50.1 12/07/2012 2 527 
CZ4 C 01/02/2011 0.2015 9.8026 10.0041 49.6 13/07/2012 23 528 
CZ4 D 01/02/2011 0.2019 9.8034 10.0053 49.6 13/07/2012 22 528 
CZ5 A 02/02/2011 0.2005 9.8062 10.0067 49.9 12/07/2012 11 526 
CZ5 C 02/02/2011 0.2014 9.8088 10.0102 49.7 13/07/2012 14 527 
CZ5 D 02/02/2011 0.2021 9.7988 10.0009 49.5 12/07/2012 5 526 
CZ6 A 02/02/2011 0.2021 9.8049 10.0070 49.5 13/07/2012 20 527 
CZ6 C 02/02/2011 0.2021 9.8096 10.0117 49.5 13/07/2012 18 527 
CZ6 D 02/02/2011 0.2022 9.8002 10.0024 49.5 12/07/2012 6 526 
CZ7 A 03/02/2011 0.2013 9.8072 10.0085 49.7 12/07/2012 7 525 
CZ7 C 03/02/2011 0.2037 9.8083 10.0120 49.2 13/07/2012 13 526 
CZ7 D 03/02/2011 0.2019 9.8028 10.0047 49.6 12/07/2012 8 525 
2% HNO3 12/07/2012         12/07/2012 10 0 
DI H2O 12/07/2012         13/07/2012 21 1 
QC sample 13/07/2012 1.0000 49.0093 50.0093 50.0       
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Table SI.3.10. Seven blank subtracted elemental plasma (venous blood) concentrations 
(µg.L
-1
) obtained by ICP-MS from ten participants who participated in the physical 
stress study 
Sample ID Li Mg P K Fe Cu Zn 
CZ1 A 4720 14226 118367 169618 930 775 1264 
CZ1 C 3062 12062 80484 57857 724 498 830 
CZ1 D 6784 14650 112908 184314 944 777 1228 
CZ2 A 4631 12403 90094 125720 583 628 1060 
CZ2 C 4522 12823 99118 141756 753 699 1220 
CZ2 D 1752 11510 63522 116765 462 433 689 
CZ3 A 2421 11044 70939 102129 537 471 522 
CZ3 C 6759 14563 118182 166764 957 891 1023 
CZ3 D 2873 10727 70756 116795 651 491 552 
CZ4 A 5872 14598 105918 170695 1265 895 992 
CZ4 C 3593 12110 78707 108212 755 594 605 
CZ4 D 2109 12138 79308 123012 892 609 637 
CZ5 A 2313 11314 104330 128570 883 742 1013 
CZ5 C 2941 11748 87324 131092 979 601 776 
CZ5 D 4666 12297 105158 165827 1140 813 1028 
CZ6 A 3200 13542 84998 104907 896 541 541 
CZ6 C 1937 10362 63123 111630 777 424 419 
CZ6 D 3535 12774 94119 153198 1131 708 756 
CZ7 A 4870 13244 89771 139885 458 727 842 
CZ7 C 3159 13873 78298 118806 688 593 679 
CZ7 D 4357 12194 78735 142270 624 711 807 
µ (Phase A) 4004 12910 94917 134503 793 683 891 
σ (Phase A) 1364 1377 15719 27714 284 146 275 
µ (Phase C) 3711 12506 86462 119445 805 614 793 
σ (Phase C) 1551 1398 17675 33797 115 150 266 
µ (Phase D) 3725 12327 86358 143169 835 649 814 
σ (Phase D) 1728 1216 18218 26162 262 144 237 
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4 A study into the effect of emotion stress on the elemental content of saliva as measured by ICP-MS 
Table SI.4.1. Sample information summary for the elemental profiling of whole saliva, by ICP-MS, from emotional stress and sleep determination 
Sample 
ID 
Sample 
Date 
Sample 
Day 
Pre ICP-MS dilution 
Analysis 
Date 
Analysis 
Order 
No. of days in 
storage 
whole saliva (g) 2% HNO3 (g) Dilution 
Factor µ (n=3) σ (n=3) µ (n=3) σ (n=3) 
Pre A 09/11/2011 1 0.9230 0.0002 4.0148 0.0001 5.35 07/12/2011 6 28 
Pre B 09/11/2011 1 0.9373 0.0002 4.0020 0.0002 5.27 07/12/2011 1 28 
Pre C 09/11/2011 1 0.9333 0.0002 4.0038 0.0001 5.29 07/12/2011 7 28 
Post A 10/11/2011 2 1.0396 0.0002 4.0148 0.0001 4.86 07/12/2011 4 27 
Post B 10/11/2011 2 1.3866 0.3580 4.0055 0.0001 3.89 07/12/2011 2 27 
Post C 10/11/2011 2 1.0819 0.0001 4.0078 0.0001 4.70 07/12/2011 3 27 
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Table SI.4.2. ICP-MS operating parameters for the analysis of saliva 
Entry Isotope 
Accurate 
Mass 
Settling 
Time 
Sample 
Time 
Samples 
per 
Peak 
Segment 
Duration 
Scan Type 
Detection 
Mode 
Low                 
1 
7
Li 7.0155 0.300 0.01 20 0.10 E Scan Triple 
2 
11
B 11.0088 0.015 0.01 20 0.10 E Scan Triple 
3 
23
Na 22.9892 0.030 0.01 50 0.10 E Scan Triple 
4 
75
As 74.9211 0.064 0.01 50 0.10 E Scan Triple 
5 
88
Sr 87.9051 0.001 0.01 50 0.10 E Scan Triple 
6 
95
Mo 94.9053 0.001 0.01 50 0.10 E Scan Triple 
7 
115
In 114.9033 0.030 0.01 50 0.10 E Scan Triple 
8 
118
Sn 117.9011 0.001 0.01 50 0.10 E Scan Triple 
9 
127
I 126.9039 0.001 0.01 50 0.10 E Scan Triple 
10 
208
Pb 207.9761 0.051 0.01 50 0.10 E Scan Triple 
Medium                 
1 
24
Mg 23.9845 0.300 0.05 20 1.25 E Scan Triple 
2 
27
Al 26.9810 0.001 0.05 20 1.25 E Scan Triple 
3 
28
Si 27.9764 0.001 0.05 20 1.25 E Scan Triple 
4 
31
P 30.9732 0.001 0.05 20 1.25 E Scan Triple 
5 
32
S 31.9715 0.039 0.05 20 1.25 E Scan Triple 
6 
44
Ca 43.9549 0.042 0.05 20 1.25 E Scan Triple 
7 
51
V 50.9434 0.001 0.05 20 1.25 E Scan Triple 
8 
52
Cr 51.9400 0.001 0.05 20 1.25 E Scan Triple 
9 
55
Mn 54.9375 0.001 0.05 20 1.25 E Scan Triple 
10 
56
Fe 55.9344 0.001 0.05 20 1.25 E Scan Triple 
11 
59
Co 58.9327 0.042 0.05 20 1.25 E Scan Triple 
12 
60
Ni 59.9302 0.001 0.05 20 1.25 E Scan Triple 
13 
63
Cu 62.9291 0.001 0.05 20 1.25 E Scan Triple 
14 
66
Zn 65.9255 0.001 0.05 20 1.25 E Scan Triple 
High                 
1 
39
K 38.9632 0.300 0.20 60 5.00 E Scan Triple 
2 
78
Se 77.9168 0.066 0.20 60 5.00 E Scan Triple 
3 
83
Kr 82.9136 0.001 0.20 60 5.00 E Scan Triple 
  [min:sec:ms]   [h:min:sec] Runs/Passes (Measured): 1*1 + 1*3  + 1*3 
Low  00:02:194    00:00:07 Runs/Passes (Evaluated): 1*1 + 1*3  + 1*3 
Med.  00:18:633    00:00:56 Res. Switch Delay [s]: 2 
High  00:16:067    00:00:48           
  Total time    00:01:55           
In the saliva samples a total of twenty seven elements were scanned with the ICP-MS, ten 
elements in low resolution, fourteen in medium resolution and three in high resolution. 
However, as well as being profiled the signal obtained for 118Sn was also used as a correction 
for 115In signal whilst the signal for 83Kr was used only as a correction for the 78Se signal. 
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Figure SI.4.1. ICP-MS calibration graphs of (A) sodium (B) magnesium (C) silicon (D) phosphorus (E) manganese (F) iron (G) arsenic (H) strontium and 
(I) iodine in the standards used for calculating elemental concentrations in whole saliva 
(A) (B) (C)
(D) (E) (F)
(G) (H) (I)
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5 The Liquid Skin Pen 
Table SI.5.1. Sample information summary for Mn recovery testing using the LSP 
Sample ID Sample Day Number of samples 
Storage 
Temp (°C) Duration (days) 
EDTA Blank A 1 1 -20 1 
Sample 1 B 1 1 -20 1 
Wash 1 B1 1 1 -20 1 
Wash 2 B2 1 1 -20 1 
Wash 3 B3 1 1 -20 1 
DI H2O Blank C 1 1 -20 1 
HNO3 Blank D 1 1 -20 1 
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Table SI.5.2. Mass (g) of capped delivery vial and solvent (DVS), capped collection vial and solvent (CVS) pre and post sampling of target area using the LSP using three different 
sample solvents; EDTA; 2% HNO3; and DI H2O. SDEL = solvent delivered, SCOL = Solvent collected and SLOST = solvent lost, following sample collection, and E = efficiency. n =3 
Sample (ID) 
DVS 
SDEL* 
CVS 
SCOL* SLOST** 
SLOST 
(%) 
E (%) Pre Post Pre Post 
µ σ RSD (%) µ σ RSD (%) µ σ RSD (%) µ σ RSD (%) 
EDTA                                   
LSP Blank 3.6243 0.0003 0.0073 2.0450 0.0001 0.0028 1.5793 1.9949 0.0001 0.0029 3.5524 0.0001 0.0016 1.5575 0.0218 1.38 98.6 
Sample (B) 3.6242 0.0001 0.0016 2.0606 0.0001 0.0049 1.5636 2.0025 0.0001 0.0029 3.5891 0.0001 0.0028 1.5866 -0.0230 -1.47 101.5 
Sample wash 1 (B1) 3.5992 0.0005 0.0137 2.0598 0.0001 0.0028 1.5394 1.9902 0.0001 0.0029 3.5178 0.0002 0.0043 1.5276 0.0118 0.77 99.2 
Sample wash 2 (B2) 3.6045 0.0001 0.0016 2.0468 0.0001 0.0049 1.5577 1.9537 0.0001 0.0030 3.4981 0.0001 0.0017 1.5445 0.0133 0.85 99.1 
Sample wash 3 (B3) 3.6146 0.0001 0.0016 2.0124 0.0002 0.0076 1.6023 2.0039 0.0001 0.0029 3.6203 0.0001 0.0032 1.6165 -0.0142 -0.89 100.9 
2% HNO3 
                 LSP Blank 3.5029 0.0002 0.0044 2.0524 0.0001 0.0049 1.4505 1.9892 0.0003 0.0127 3.4737 0.0001 0.0017 1.4845 -0.0340 -2.34 102.3 
Sample (B) 3.5923 0.0001 0.0028 2.0693 0.0001 0.0048 1.5230 1.9941 0.0001 0.0058 3.5214 0.0001 0.0028 1.5273 -0.0043 -0.28 100.3 
Sample wash 1 (B1) 3.5539 0.0001 0.0016 2.0723 0.0002 0.0074 1.4817 1.9961 0.0001 0.0050 3.4682 0.0001 0.0029 1.4721 0.0096 0.65 99.4 
Sample wash 2 (B2) 3.5070 0.0001 0.0016 2.0431 0.0001 0.0028 1.4638 1.9835 0.0001 0.0029 3.4431 0.0002 0.0050 1.4596 0.0043 0.29 99.7 
Sample wash 3 (B3) 3.5499 0.0001 0.0028 2.0326 0.0001 0.0028 1.5173 1.9910 0.0001 0.0029 3.5065 0.0001 0.0016 1.5156 0.0017 0.11 99.9 
DI H2O 
                 LSP Blank 3.5824 0.0001 0.0028 2.0389 0.0001 0.0028 1.5435 2.0317 0.0001 0.0049 3.5911 0.0001 0.0016 1.5594 -0.0159 -1.03 101.0 
Sample (B) 3.4717 0.0001 0.0017 2.0017 0.0001 0.0029 1.4700 2.0105 0.0001 0.0050 3.1600 0.5773 18.2695 1.1495 0.3205 21.80 78.2 
Sample wash 1 (B1) 3.6019 0.0001 0.0016 2.0249 0.0001 0.0029 1.5770 1.9939 0.0001 0.0029 3.4673 0.0001 0.0029 1.4734 0.1036 6.57 93.4 
Sample wash 2 (B2) 3.6524 0.0001 0.0016 2.0397 0.0001 0.0028 1.6126 1.9584 0.0001 0.0029 3.6828 0.0001 0.0027 1.7244 -0.1118 -6.93 106.9 
Sample wash 3 (B3) 3.5312 0.0001 0.0028 2.0270 0.0001 0.0057 1.5042 2.0313 0.0001 0.0049 3.5343 0.0001 0.0016 1.5030 0.0011 0.08 99.9 
 27 
Table SI.5.3. Participant information summary for the elemental profiling of the volar and plantar 
Sample Date Sample Day Participant ID Gender No of samples Sample storage 
25/07/2011 1 LSP 1 Female 3  -80°C 
26/07/2011 2 LSP 2 Male 3  -80°C 
27/07/2011 3 LSP 3 Female 3  -80°C 
28/07/2011 4 LSP 4 Male 3  -80°C 
29/07/2011 5 LSP 5 Female 3  -80°C 
01/08/2011 8 LSP 6 Male 3  -80°C 
02/08/2011 9 LSP 7 Female 3  -80°C 
03/08/2011 10 LSP 8 Male 3  -80°C 
04/08/2011 11 LSP 9 Female 3  -80°C 
05/07/2011 12 LSP 10 Male 3  -80°C 
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Table SI.5.4. Sample information summary for the elemental profiling of the volar and plantar 
Sample ID 
Sample 
Date 
Collection vial mass (g) Amount 
of EDTA 
sampled 
(g) 
Time 
to 
collect 
sample 
(s) 
Pre ICP-MS dilution 
Analysis 
Date 
Analysis 
Order 
No. of 
day in 
storage 
Pre Post Sample (g) 2% HNO3 (g) 
Total 
Dilution 
factor µ (n = 3) σ (n = 3) µ (n = 3) σ (n = 3) µ (n = 3) σ (n = 3) µ (n = 3) σ (n = 3) 
LSP1 SP Blank 25/07/2011                         10/08/2011 4 17 
LSP1 E1 25/07/2011 2.2510 0.0000 3.6207 0.0001 1.3697 < 60 1.0010 0.0002 4.0088 0.0001 5.0098 5.0048 10/08/2011 8 17 
LSP1 F1 25/07/2011 2.2511 0.0001 3.6238 0.0001 1.3728 < 60 1.0196 0.0001 4.0037 0.0001 5.0233 4.9267 11/08/2011 18 18 
LSP2 SP Blank 26/07/2011                         10/08/2011 2 16 
LSP2 E1 26/07/2011 2.2484 0.0001 3.6588 0.0001 1.4104 < 60 1.0050 0.0001 4.0035 0.0001 5.0086 4.9835 12/08/2011 30 18 
LSP2 F1 26/07/2011 2.2534 0.0000 3.6758 0.0001 1.4224 < 60 1.0154 0.0001 4.0084 0.0001 5.0238 4.9477 12/08/2011 27 18 
LSP3 SP Blank 27/07/2011                         11/08/2011 15 16 
LSP3 E1 27/07/2011 1.9703 0.0001 3.4629 0.0001 1.4925 < 60 1.0103 0.0002 4.0008 0.0002 5.0110 4.9601 11/08/2011 16 16 
LSP3 F1 27/07/2011 1.9961 0.0001 3.4522 0.0001 1.4561 < 60 1.0082 0.0001 4.0078 0.0001 5.0160 4.9750 11/08/2011 9 16 
LSP4 SP Blank 28/07/2011                         11/08/2011 13 15 
LSP4 E1 28/07/2011 1.9709 0.0001 3.4361 0.0001 1.4652 < 60 1.0034 0.0002 4.0043 0.0003 5.0077 4.9906 10/08/2011 7 14 
LSP4 F1 28/07/2011 1.9774 0.0001 3.4848 0.0001 1.5074 < 60 1.0107 0.0001 4.0012 0.0002 5.0120 4.9587 11/08/2011 10 15 
LSP5 SP Blank 29/07/2011                         11/08/2011 11 13 
LSP5 E1 29/07/2011 1.9806 0.0001 3.4795 0.0001 1.4988 < 60 1.0051 0.0001 4.0116 0.0001 5.0167 4.9911 12/08/2011 20 14 
LSP5 F1 29/07/2011 2.0116 0.0001 3.5133 0.0001 1.5016 < 60 1.0118 0.0001 4.0014 0.0002 5.0132 4.9547 12/08/2011 21 14 
LSP6 SP Blank 01/08/2011                         10/08/2011 6 9 
LSP6 E1 01/08/2011 2.0088 0.0001 3.3526 0.0001 1.3438 < 60 1.0266 0.0001 4.0132 0.0001 5.0399 4.9091 10/08/2011 3 9 
LSP6 F1 01/08/2011 1.9923 0.0001 3.4787 0.0003 1.4864 < 60 1.0120 0.0002 4.0168 0.0001 5.0288 4.9690 10/08/2011 5 9 
LSP7 SP Blank 02/08/2011                         12/08/2011 26 10 
LSP7 E1 02/08/2011 1.9624 0.0001 3.4888 0.0001 1.5264 < 60 1.0170 0.0004 4.0075 0.0001 5.0245 4.9403 12/08/2011 29 10 
LSP7 F1 02/08/2011 2.0169 0.0002 3.5085 0.0001 1.4915 < 60 1.0296 0.0002 4.0111 0.0002 5.0406 4.8959 11/08/2011 17 9 
LSP8 SP Blank 03/08/2011                         12/08/2011 22 9 
LSP8 E1 03/08/2011 2.0086 0.0001 3.5126 0.0001 1.5040 < 60 1.0225 0.0001 4.0087 0.0003 5.0312 4.9205 11/08/2011 12 8 
LSP8 F1 03/08/2011 2.0197 0.0001 3.4825 0.0001 1.4628 < 60 1.0078 0.0002 4.0071 0.0001 5.0149 4.9761 12/08/2011 24 9 
LSP9 SP Blank 04/08/2011                         10/08/2011 1 6 
LSP9 E1 04/08/2011 1.9738 0.0001 3.4767 0.0001 1.5028 < 60 1.0043 0.0001 4.0084 0.0001 5.0127 4.9914 12/08/2011 19 8 
LSP9 F1 04/08/2011 1.9705 0.0001 3.4098 0.0001 1.4393 < 60 1.0045 0.0002 4.0182 0.0001 5.0227 5.0004 12/08/2011 23 8 
LSP10 SP Blank 05/07/2011                         12/08/2011 28 7 
LSP10 E1 05/07/2011 1.9685 0.0002 3.4752 0.0001 1.5066 < 60 1.0130 0.0001 4.0031 0.0001 5.0161 4.9519 11/08/2011 14 6 
LSP10 F1 05/07/2011 1.9680 0.0001 3.4656 0.0001 1.4976 < 60 1.0164 0.0002 4.0102 0.0002 5.0267 4.9454 12/08/2011 25 7 
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Table SI.5.5. Sample information summary for the elemental profiling of the axilla, dorsal, plantar and volar 
Sample ID 
Sample 
Date 
Collection vial mass (g) Amount 
of EDTA 
sampled 
(g) 
Time 
to 
collect 
sample 
(s) 
Pre ICP-MS dilution 
Analysis 
Date 
Analysis 
Order 
No. of 
day in 
storage 
Pre Post Sample (g) 2% HNO3 (g) 
Total 
Dilution 
factor µ (n = 3) σ (n = 3) µ (n = 3) σ (n = 3) µ (n = 3) σ (n = 3) µ (n = 3) σ (n = 3) 
U1 AP 29/09/2011 1.9967 0.0001 3.3914 0.0001 1.3948 < 60 1.0062 0.0001 4.0017 0.0001 5.0080 4.98 08/12/2011 1 70 
U1 AP Blank 29/09/2011             0.5007 0.0002 4.0666 0.0001 4.5673 9.12 16/12/2011 63 78 
U1 TF 29/09/2011 2.0053 0.0001 3.4466 0.0001 1.4413 < 60 1.0125 0.0001 4.0326 0.0155 5.0451 4.98 08/12/2011 15 70 
U1 TF Blank 29/09/2011             0.8462 0.0002 4.0178 0.0001 4.8640 5.75 04/01/2012 78 97 
U1 BF 29/09/2011 2.0084 0.0001 3.4105 0.0001 1.4021 < 60 1.0216 0.0001 4.0099 0.0001 5.0315 4.92 15/12/2011 31 77 
U1 BF Blank 29/09/2011             0.3315 0.0001 4.0017 0.0001 4.3332 13.07 08/12/2011 7 70 
U1 AE 29/09/2011 2.0007 0.0001 3.5166 0.0001 1.5159 < 60 1.0261 0.0001 4.0195 0.0001 5.0455 4.92 16/12/2011 51 78 
U1 AE Blank 29/09/2011             0.4765 0.0001 4.0121 0.0002 4.4886 9.42 04/01/2012 72 97 
U2 AP 29/09/2011 1.9976 0.0001 3.4420 0.0001 1.4444 < 60 1.0085 0.0001 4.0080 0.0001 5.0165 4.97 15/12/2011 42 77 
U2 AP Blank 29/09/2011             0.6777 0.0001 4.0276 0.0001 4.7053 6.94 08/12/2011 6 70 
U2 TF 29/09/2011 2.0196 0.0001 3.4704 0.0001 1.4508 < 60 1.0245 0.0001 4.0050 0.0001 5.0294 4.91 08/12/2011 16 70 
U2 TF Blank 29/09/2011             0.4737 0.0002 4.0009 0.0001 4.4746 9.45 15/12/2011 35 77 
U2 BF 29/09/2011 1.9654 0.0001 3.4289 0.0001 1.4634 < 60 1.0141 0.0002 4.0245 0.0002 5.0386 4.97 08/12/2011 8 70 
U2 BF Blank 29/09/2011             0.4594 0.0001 4.0053 0.0001 4.4648 9.72 15/12/2011 33 77 
U2 AE 29/09/2011 2.0324 0.0001 3.5505 0.0001 1.5181 < 60 1.0149 0.0001 4.0074 0.0001 5.0224 4.95 16/12/2011 69 78 
U2 AE Blank 29/09/2011             0.6701 0.0001 4.0000 0.0001 4.6701 6.97 04/01/2012 84 97 
U3 AP 29/09/2011 2.0075 0.0000 3.5195 0.0001 1.5120 < 60 1.0120 0.0001 4.0145 0.0001 5.0265 4.97 08/12/2011 5 70 
U3 AP Blank 29/09/2011             0.6753 0.0001 4.0153 0.0001 4.6906 6.95 04/01/2012 71 97 
U3 TF 29/09/2011 2.0009 0.0001 3.6252 0.0001 1.6243 < 60 1.0087 0.0001 4.0201 0.0002 5.0288 4.99 14/12/2011 30 76 
U3 TF Blank 29/09/2011             0.7631 0.0001 4.0088 0.0002 4.7719 6.25 16/12/2011 65 78 
U3 BF 29/09/2011 1.9659 0.0001 3.4915 0.0001 1.5257 < 60 1.0209 0.0001 4.0114 0.0001 5.0324 4.93 16/12/2011 70 78 
U3 BF Blank 29/09/2011             1.0802 0.0001 4.0258 0.0001 5.1060 4.73 16/12/2011 64 78 
U3 AE 29/09/2011 1.9712 0.0000 3.5137 0.0001 1.5425 < 60 1.0152 0.0001 4.0124 0.0002 5.0275 4.95 16/12/2011 55 78 
U3 AE Blank 29/09/2011             0.9999 0.0001 4.0106 0.0001 5.0105 5.01 14/12/2011 27 76 
U4 AP 29/09/2011 2.0248 0.0001 3.4830 0.0001 1.4582 < 60 1.0169 0.0001 4.0167 0.0001 5.0335 4.95 08/12/2011 11 70 
U4 AP Blank 29/09/2011             1.0062 0.0001 4.0120 0.0001 5.0181 4.99 14/12/2011 22 76 
U4 TF 29/09/2011 1.9715 0.0001 3.4557 0.0001 1.4842 < 60 1.0186 0.0001 4.0186 0.0001 5.0372 4.95 08/12/2011 19 70 
U4 TF Blank 29/09/2011             1.0198 0.0001 4.0192 0.0001 5.0389 4.94 08/12/2011 9 70 
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U4 BF 29/09/2011 1.9760 0.0001 3.4943 0.0000 1.5183 < 60 1.0112 0.0002 4.0363 0.0001 5.0475 4.99 14/12/2011 28 76 
U4 BF Blank 29/09/2011             1.0060 0.0001 4.0221 0.0001 5.0281 5.00 16/12/2011 61 78 
U4 AE 29/09/2011 1.9686 0.0001 2.5656 0.0001 0.5970 < 60 0.5868 0.0001 4.0016 0.0001 4.5884 7.82 08/12/2011 13 70 
U4 AE Blank 29/09/2011             0.9989 0.0001 4.0270 0.0001 5.0259 5.03 16/12/2011 62 78 
U5 AP 29/09/2011 1.9596 0.0001 3.3776 0.0000 1.4180 < 60 0.9993 0.0002 4.0213 0.0000 5.0206 5.02 16/12/2011 58 78 
U5 AP Blank 29/09/2011             1.0000 0.0001 4.0034 0.0001 5.0034 5.00 16/12/2011 67 78 
U5 TF 29/09/2011 2.0096 0.0000 3.4801 0.0001 1.4705 < 60 1.0146 0.0001 4.0027 0.0001 5.0173 4.95 14/12/2011 23 76 
U5 TF Blank 29/09/2011             1.0057 0.0001 4.0041 0.0002 5.0097 4.98 15/12/2011 48 77 
U5 BF 29/09/2011 2.0311 0.0001 3.6291 0.0001 1.5980 < 60 1.0141 0.0001 4.0098 0.0001 5.0238 4.95 08/12/2011 10 70 
U5 BF Blank 29/09/2011             1.0118 0.0000 4.0090 0.0001 5.0208 4.96 15/12/2011 49 77 
U5 AE 29/09/2011 1.9803 0.0001 3.4402 0.0001 1.4599 < 60 1.0148 0.0001 4.0189 0.0001 5.0338 4.96 14/12/2011 26 76 
U5 AE Blank 29/09/2011             0.9960 0.0001 4.0123 0.0002 5.0084 5.03 14/12/2011 25 76 
U6 AP 30/09/2011 2.0129 0.0001 3.3809 0.0001 1.3680 < 60 1.0051 0.0002 4.0162 0.0001 5.0212 5.00 15/12/2011 41 76 
U6 AP Blank 30/09/2011             1.0047 0.0001 4.0152 0.0001 5.0199 5.00 16/12/2011 66 77 
U6 TF 30/09/2011 1.9940 0.0001 3.4641 0.0001 1.4701 < 60 1.0006 0.0001 4.0118 0.0001 5.0124 5.01 14/12/2011 24 75 
U6 TF Blank 30/09/2011             0.9784 0.0001 4.0108 0.0001 4.9891 5.10 15/12/2011 34 76 
U6 BF 30/09/2011 2.0025 0.0001 3.3758 0.0001 1.3733 < 60 1.0143 0.0001 4.0075 0.0001 5.0218 4.95 08/12/2011 17 69 
U6 BF Blank 30/09/2011             1.0049 0.0000 4.0102 0.0002 5.0151 4.99 08/12/2011 4 69 
U6 AE 30/09/2011 2.0021 0.0001 3.4008 0.0001 1.3987 < 60 1.0180 0.0001 4.0047 0.0001 5.0227 4.93 08/12/2011 3 69 
U6 AE Blank 30/09/2011             1.0038 0.0001 4.0216 0.0001 5.0255 5.01 16/12/2011 57 77 
U7 AP 30/09/2011 1.9998 0.0001 3.3993 0.0001 1.3995 < 60 1.0116 0.0001 4.0108 0.0002 5.0224 4.96 16/12/2011 59 77 
U7 AP Blank 30/09/2011             0.9938 0.0001 4.0173 0.0001 5.0112 5.04 15/12/2011 37 76 
U7 TF 30/09/2011 1.9645 0.0001 3.4811 0.0001 1.5166 < 60 1.0115 0.0000 4.0182 0.0002 5.0297 4.97 14/12/2011 21 75 
U7 TF Blank 30/09/2011             1.0025 0.0001 4.0238 0.0002 5.0263 5.01 15/12/2011 40 76 
U7 BF 30/09/2011 2.0072 0.0001 3.5154 0.0001 1.5083 < 60 1.0126 0.0001 4.0119 0.0001 5.0246 4.96 15/12/2011 36 76 
U7 BF Blank 30/09/2011             0.9998 0.0001 4.0042 0.0001 5.0040 5.01 04/01/2012 73 96 
U7 AE 30/09/2011 1.9601 0.0001 3.4381 0.0000 1.4780 < 60 1.0158 0.0001 4.0172 0.0002 5.0329 4.95 15/12/2011 47 76 
U7 AE Blank 30/09/2011             0.9981 0.0002 4.0830 0.1039 5.0812 5.09 15/12/2011 50 76 
U8 AP 30/09/2011 2.0221 0.0001 3.5114 0.0001 1.4894 < 60 1.0082 0.0001 4.0256 0.0001 5.0338 4.99 15/12/2011 43 76 
U8 AP Blank 30/09/2011             1.0085 0.0002 4.0262 0.0001 5.0347 4.99 16/12/2011 60 77 
U8 TF 30/09/2011 1.9866 0.0001 3.5731 0.0001 1.5866 < 60 1.0169 0.0001 4.0182 0.0002 5.0351 4.95 14/12/2011 29 75 
U8 TF Blank 30/09/2011             1.0046 0.0001 4.0160 0.0001 5.0206 5.00 04/01/2012 80 96 
U8 BF 30/09/2011 2.0086 0.0001 3.4964 0.0001 1.4878 < 60 1.0223 0.0001 4.0095 0.0001 5.0318 4.92 04/01/2012 81 96 
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U8 BF Blank 30/09/2011             1.0253 0.0001 4.0183 0.0001 5.0436 4.92 08/12/2011 12 69 
U8 AE 30/09/2011 1.9676 0.0001 3.4125 0.0001 1.4449 < 60 1.0174 0.0001 4.0144 0.0002 5.0318 4.95 16/12/2011 53 77 
U8 AE Blank 30/09/2011             1.0062 0.0001 4.0166 0.0002 5.0227 4.99 04/01/2012 82 96 
U9 AP 30/09/2011 1.9973 0.0001 3.4554 0.0001 1.4581 < 60 1.0119 0.0001 4.0060 0.0001 5.0179 4.96 04/01/2012 75 96 
U9 AP Blank 30/09/2011             1.0074 0.0001 4.0157 0.0002 5.0230 4.99 04/01/2012 74 96 
U9 TF 30/09/2011 2.0050 0.0000 3.4106 0.0001 1.4056 < 60 1.0081 0.0001 4.0073 0.0001 5.0153 4.98 15/12/2011 44 76 
U9 TF Blank 30/09/2011             0.9983 0.0001 4.0149 0.0001 5.0132 5.02 08/12/2011 14 69 
U9 BF 30/09/2011 1.9829 0.0001 3.3857 0.0001 1.4028 < 60 1.0202 0.0001 4.0151 0.0001 5.0353 4.94 08/12/2011 20 69 
U9 BF Blank 30/09/2011             1.0094 0.0003 4.0101 0.0001 5.0196 4.97 15/12/2011 32 76 
U9 AE 30/09/2011 1.9748 0.0000 3.3454 0.0001 1.3706 < 60 1.0120 0.0001 4.0148 0.0001 5.0268 4.97 08/12/2011 18 69 
U9 AE Blank 30/09/2011             1.0085 0.0001 4.0282 0.0001 5.0366 4.99 04/01/2012 83 96 
U10 AP 30/09/2011 1.9835 0.0001 3.3126 0.0001 1.3291 < 60 1.0155 0.0002 4.0057 0.0003 5.0212 4.94 04/01/2012 77 96 
U10 AP Blank 30/09/2011             1.0026 0.0001 4.0137 0.0002 5.0162 5.00 04/01/2012 76 96 
U10 TF 30/09/2011 1.9979 0.0001 3.5313 0.0001 1.5335 < 60 1.0095 0.0002 4.0106 0.0001 5.0201 4.97 15/12/2011 38 76 
U10 TF Blank 30/09/2011             1.0075 0.0001 4.0095 0.0001 5.0171 4.98 16/12/2011 54 77 
U10 BF 30/09/2011 2.0039 0.0001 3.3958 0.0001 1.3920 < 60 1.0200 0.0002 4.0078 0.0001 5.0278 4.93 15/12/2011 45 76 
U10 BF Blank 30/09/2011             1.0032 0.0001 4.0029 0.0002 5.0061 4.99 16/12/2011 56 77 
U10 AE 30/09/2011 1.9989 0.0001 3.4578 0.0000 1.4589 < 60 1.0216 0.0001 4.0093 0.0001 5.0308 4.92 04/01/2012 79 96 
U10 AE Blank 30/09/2011             1.0048 0.0001 4.0092 0.0001 5.0139 4.99 08/12/2011 2 69 
EDTA Field Blank 30/09/2011 
     
 
      
15/12/2011 39 76 
EDTA Blank 30/09/2011                   15/12/2011 46 76 
2% HNO3 Blank 30/09/2011 
     
 
      
16/12/2011 52 77 
DI H2O Blank 30/09/2011                         17/12/2011 68 78 
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Table SI.5.6. Participant information summary for the profiling of the dorsal and plantar 
Sample 
Date 
Sample 
Day 
Participant 
ID 
Gender 
Sample side No of 
samples 
Sample 
Storage Dorsal Plantar 
01/06/2012 1 UF1 Male LEFT FOOT 5 -80°C 
01/06/2012 1 UF2 Female RIGHT FOOT 5 -80°C 
06/06/2012 2 UF3 Male RIGHT FOOT 5 -80°C 
06/06/2012 2 UF4 Female LEFT FOOT 5 -80°C 
08/06/2012 3 UF5 Male LEFT FOOT 5 -80°C 
12/06/2012 4 UF6 Female RIGHT FOOT 5 -80°C 
12/06/2012 4 UF7 Male RIGHT FOOT 5 -80°C 
13/06/2012 5 UF8 Female LEFT FOOT 5 -80°C 
13/06/2012 5 UF9 Male LEFT FOOT 5 -80°C 
13/06/2012 5 UF10 Female RIGHT FOOT 5 -80°C 
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Table SI.5.7. Sample information summary for the profiling of the dorsal and plantar 
Sample ID 
Sample 
date 
Collection vial mass (g) 
Amount of 
EtOH 
sampled (g) 
Time to 
collect 
sample (s) 
ES- ES+ 
Pre Post Analysis 
date 
Analysis 
date 
Analysis 
date 
Analysis 
date 
Analysis 
order* 
No. of 
days in 
storage µ (n=3) σ (n=3) µ (n=3) σ (n=3) 
UF1 FB 01/06/2012 1.9976 0.0001 2.9074 0.0001 0.9098 < 60 05/07/2012 29 34 29/10/2012 5 150 
UF1 TF B 01/06/2012 1.9989 0.0001 3.0192 0.0001 1.0203 < 60 05/07/2012 20 34 29/10/2012 28 150 
UF1 TF 01/06/2012 2.0050 0.0001 2.9860 0.0001 0.9811 < 60 05/07/2012 40 34 29/10/2012 33 150 
UF1 BF B 01/06/2012 2.0018 0.0003 3.1074 0.0001 1.1056 < 60 05/07/2012 17 34 29/10/2012 36 150 
UF1 BF 01/06/2012 1.9947 0.0002 2.9724 0.0001 0.9777 < 60 05/07/2012 38 34 29/10/2012 38 150 
UF2 FB 01/06/2012 2.0087 0.0001 3.0327 0.0001 1.0240 < 60 05/07/2012 33 34 29/10/2012 37 150 
UF2 TF B 01/06/2012 1.9990 0.0001 2.9890 0.0001 0.9900 < 60 05/07/2012 45 34 29/10/2012 34 150 
UF2 TF 01/06/2012 2.0617 0.0001 3.1177 0.0001 1.0560 < 60 05/07/2012 30 34 29/10/2012 27 150 
UF2 BF B 01/06/2012 2.0011 0.0001 2.8057 0.0001 0.8046 < 60 05/07/2012 42 34 29/10/2012 9 150 
UF2 BF 01/06/2012 1.9908 0.0001 3.0395 0.0001 1.0487 < 60 05/07/2012 35 34 29/10/2012 7 150 
UF3 FB 06/06/2012 2.0563 0.0001 3.0669 0.0002 1.0106 < 60 05/07/2012 49 29 29/10/2012 1 145 
UF3 TF B 06/06/2012 2.0332 0.0001 2.9395 0.0001 0.9064 < 60 05/07/2012 22 29 29/10/2012 50 145 
UF3 TF 06/06/2012 2.0576 0.0001 3.0121 0.0001 0.9545 < 60 05/07/2012 8 29 29/10/2012 3 145 
UF3 BF B 06/06/2012 2.0149 0.0001 2.7536 0.0001 0.7387 < 60 05/07/2012 2 29 29/10/2012 10 145 
UF3 BF 06/06/2012 1.9971 0.0001 2.9650 0.0001 0.9680 < 60 05/07/2012 34 29 29/10/2012 40 145 
UF4 FB 06/06/2012 2.0011 0.0001 3.0302 0.0001 1.0291 < 60 05/07/2012 51 29 29/10/2012 41 145 
UF4 TF B 06/06/2012 2.0342 0.0001 2.7886 0.0001 0.7544 < 60 05/07/2012 37 29 29/10/2012 6 145 
UF4 TF 06/06/2012 1.9913 0.0001 2.9682 0.0001 0.9768 < 60 05/07/2012 1 29 29/10/2012 45 145 
UF4 BF B 06/06/2012 1.9995 0.0001 2.7207 0.0001 0.7212 < 60 05/07/2012 47 29 29/10/2012 31 145 
UF4 BF 06/06/2012 2.0019 0.0001 2.9634 0.0001 0.9616 < 60 05/07/2012 6 29 29/10/2012 24 145 
UF5 FB 08/06/2012 2.0043 0.0001 2.7046 0.0002 0.7003 < 60 05/07/2012 4 27 29/10/2012 26 143 
UF5 TF B 08/06/2012 1.9899 0.0001 3.0137 0.0002 1.0238 < 60 05/07/2012 36 27 29/10/2012 48 143 
UF5 TF 08/06/2012 1.9940 0.0001 2.9996 0.0002 1.0056 < 60 05/07/2012 46 27 29/10/2012 20 143 
  
3
4
 
UF5 BF B 08/06/2012 2.0037 0.0001 2.7535 0.0001 0.7498 < 60 05/07/2012 5 27 29/10/2012 47 143 
UF5 BF 08/06/2012 2.0674 0.0001 3.0168 0.0001 0.9494 < 60 05/07/2012 44 27 29/10/2012 35 143 
UF6 FB 12/06/2012 2.0589 0.0001 2.9025 0.0001 0.8437 < 60 05/07/2012 43 23 29/10/2012 11 139 
UF6 TF B 12/06/2012 2.0314 0.0001 3.0971 0.0001 1.0657 < 60 05/07/2012 12 23 29/10/2012 13 139 
UF6 TF 12/06/2012 2.0023 0.0001 3.0332 0.0001 1.0308 < 60 05/07/2012 23 23 29/10/2012 39 139 
UF6 BF B 12/06/2012 2.0565 0.0001 2.9565 0.0001 0.8999 < 60 05/07/2012 3 23 29/10/2012 12 139 
UF6 BF 12/06/2012 2.0354 0.0001 3.0274 0.0001 0.9919 < 60 05/07/2012 39 23 29/10/2012 23 139 
UF7 FB 12/06/2012 1.9927 0.0004 3.0076 0.0001 1.0149 < 60 05/07/2012 41 23 29/10/2012 14 139 
UF7 TF B 12/06/2012 2.0588 0.0001 3.1112 0.0001 1.0524 < 60 05/07/2012 25 23 29/10/2012 42 139 
UF7 TF 12/06/2012 2.0357 0.0001 2.8327 0.0001 0.7971 < 60 05/07/2012 21 23 29/10/2012 29 139 
UF7 BF B 12/06/2012 1.9805 0.0001 2.9374 0.0001 0.9569 < 60 05/07/2012 32 23 29/10/2012 18 139 
UF7 BF 12/06/2012 1.9956 0.0001 2.7970 0.0001 0.8015 < 60 05/07/2012 9 23 29/10/2012 4 139 
UF8 FB 13/06/2012 2.0672 0.0001 2.9540 0.0001 0.8868 < 60 05/07/2012 31 22 29/10/2012 16 138 
UF8 TF B 13/06/2012 1.9975 0.0000 3.5124 0.0001 1.5149 < 60 05/07/2012 27 22 29/10/2012 44 138 
UF8 TF 13/06/2012 2.0063 0.0001 3.0048 0.0001 0.9985 < 60 05/07/2012 7 22 29/10/2012 49 138 
UF8 BF B 13/06/2012 2.0356 0.0001 3.2051 0.0001 1.1695 < 60 05/07/2012 19 22 29/10/2012 25 138 
UF8 BF 13/06/2012 1.9905 0.0001 2.9297 0.0001 0.9392 < 60 05/07/2012 13 22 29/10/2012 22 138 
UF9 FB 13/06/2012 2.0630 0.0001 3.1272 0.0001 1.0642 < 60 05/07/2012 24 22 29/10/2012 46 138 
UF9 TF B 13/06/2012 1.9997 0.0001 3.1234 0.0001 1.1238 < 60 05/07/2012 48 22 29/10/2012 21 138 
UF9 TF 13/06/2012 2.0023 0.0001 2.9152 0.0001 0.9129 < 60 05/07/2012 10 22 29/10/2012 17 138 
UF9 BF B 13/06/2012 2.0407 0.0001 3.4768 0.0001 1.4360 < 60 05/07/2012 26 22 29/10/2012 30 138 
UF9 BF 13/06/2012 2.0309 0.0001 3.1003 0.0001 1.0695 < 60 05/07/2012 15 22 29/10/2012 8 138 
UF10 FB 13/06/2012 2.0527 0.0001 2.9688 0.0001 0.9161 < 60 05/07/2012 16 22 29/10/2012 19 138 
UF10 TF B 13/06/2012 1.9833 0.0001 3.4181 0.0001 1.4348 < 60 05/07/2012 28 22 29/10/2012 32 138 
UF10 TF 13/06/2012 2.0057 0.0001 2.9775 0.0001 0.9718 < 60 05/07/2012 50 22 29/10/2012 2 138 
UF10 BF B 13/06/2012 1.9816 0.0001 2.9163 0.5774 0.9347 < 60 05/07/2012 14 22 29/10/2012 15 138 
UF10 BF 13/06/2012 2.0070 0.0001 3.0236 0.0001 1.0166 < 60 05/07/2012 18 22 29/10/2012 51 138 
EtOH Blank 31/06/2012             05/07/2012 11 35 29/10/2012 43 151 
 
 
